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Abstract
Bacterial resistance to antibiotics has become a major health problem worldwide. The rapid
development of drug-resistant strains to clinically used antibiotics and the slow rate of development of
new treatment options threaten a healthcare catastrophe. Currently, 700,000 deaths per year are
attributable to antimicrobial resistance. By 2050, antibiotic resistance is estimated to contribute to the
deaths of 10 million people per year. In recent years, bacteria have emerged resistance to all classes of
antibiotics. More than ever, there is a necessity for new antibiotics, exploring new mechanisms of action.
In the search for new drug targets, it is fundamentally important to understand how bacteria
battle and develop resistance to antibiotics used in the clinic. It is possible that by understanding the
mechanisms of the DNA damage response that promote resistance to antibiotics, new drug targets may be
identified. The scope of this thesis is to characterise DNA repair and damage tolerance pathways in
Escherichia coli, focusing on the interconnectivity between error-prone DNA polymerases and
homologous recombination. Using single-molecule fluorescence live-cell imaging, it has been possible to
monitor proteins involved in these pathways directly and in real time.
Monitoring proteins at the single-molecule level in live cells has allowed me to make significant
new discoveries. My PhD work challenges long-standing models in the fields of translesion synthesis
(TLS) and homologous recombination in Escherichia coli. The error-prone DNA polymerase IV (pol IV)
has long been assumed to mainly carry out TLS at stalled replication forks. My live-cell work has
revealed that pol IV primarily acts at recombination intermediates and rarely, if ever, binds at replisomes.
The resection of DNA double-strand breaks is crucial to pol IV activity in cells, suggesting that pol IV
could be a recombination protein. Strikingly, this requirement is shared for cells treated with antibiotics
that have different primary targets in cells. The common element appears to be surges in cellular ROS
levels, which induce DNA breakage and thus create substrates for pol IV.
My real-time live-cell imaging approach also allowed me to functionally dissect the RecFOR
pathway for homologous recombination. Conventionally, the recombination mediators RecF, RecO and
RecR have been described to collectively load the RecA recombinase on single-stranded DNA. Contrary
to this model, single-molecule imaging revealed that RecF and RecO rarely form a complex in vivo and
indicated that RecF and RecO have distinct functions. RecF binds mainly at replisomes while RecO binds
to DNA in the region between the nucleoid and membrane, the same region of the cell in which large
RecA bundles form in cells carrying DNA damage. Following RecF, I further showed that RecF impacts
on pol IV binding at the replisome; a new link connecting the fields of TLS and homologous
recombination. This Thesis provides unprecedented single-molecule level insight into the mechanisms of
TLS and homologous recombination in Escherichia coli cells suffering DNA damage and, importantly,
reveals new and unexpected links between the two processes.
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Context statement
This Thesis summarizes studies at the interface of translesion synthesis (TLS) and homologous
recombination, revealing that in many ways the pathways are interlinked. Throughout there is a focus on
understanding mutation-promoting processes and their potential roles in antimicrobial resistance
development. By understanding how repair enzymes within different pathways contribute to resistance,
new drug targets may be identified. To observe repair enzymes within living cells, I employed singlemolecule fluorescence live-cell imaging, in combination with microfluidic devices, monitoring proteins as
they bind to their targets in real time during the dynamic DNA repair response. To follow each protein of
interest, fluorescent protein fusion constructs were used, where the protein of interest is covalently
coupled to a fluorescent protein due to genetic alterations. The motion of repair enzymes was then
determined by following the signal of their fluorescent protein tag. This approach is very powerful when
combined with genetics approaches as mutants that cause alterations to protein binding behavior give
clues about how that protein may function within living cells.

Live-Cell Imaging Revolution. Single-molecule microscopy went through a revolution during
the last decades. The discovery of the green fluorescent protein, GFP, started the revolution, pushing the
experimental tools in life sciences.
The ‘green revolution’ created the platform for novel functional imaging of live probes and for
single-molecule fluorescence microscopy. In 1997, the Moerner lab demonstrated single GFP molecules
blinking upon laser exposure, where bleached GFP molecules could be switched back on following laser
exposure. With the blinking phenomenon and the advantage that GFP can mature in vivo, protein-based
fluorescent probes became attractive as fluorescent biological labels. In the following years, the
development in molecular cloning techniques generated numerous GFP mutants with improved
photophysical characteristics, improving for instance photostability for longer measurement time in life
cells. Molecular cloning techniques also made it possible to generate genetically encoded fluorescent
probes, where the protein of interest is covalently linked with a fluorescent protein. This approach
enabled researchers to follow proteins by watching the fluorescent protein tag in cells. This approach is
called detection-by-localisation. To allow the detection of all locations of target molecules, which can be
limited due to photobleaching, photoactivatable probes were developed which can be repeatedly activated
and imaged. These probes lead to the development of new imaging approaches such as photoactivated
localization microscopy (PALM) and stochastic optical reconstruction microscopy (STROM).
Localisation microscopy with either non-photoactivatable or photoactivatable fluorescent fusion
protein constructs allowed researchers to measure several previously inaccessible parameters which are
however required to understand cellular processes. For example, analysis of focus lifetimes can allow
binding kinetics to be measured as individual proteins bind to their substrates in live cells. To untangle
the function of proteins within biological processes, mutants can be employed to alter protein functions,
and the resulting changes in focus lifetimes can be monitored. Localisation microscopy can also be used
to determine the stoichiometry of a protein complex, where the known intensity of a single fluorescent
protein can be used to determine the number of proteins in a focus. A prominent example for this
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measurement was published by Reyes-Lamothe et al., where the authors determined the composition of
the Escherichia coli replisome. Furthermore, the known intensity of a single fluorescent protein together
with the fluorescent intensity measured for single cells can be used to determine the number of molecules
per cell; a useful approach to monitoring changes in protein expression levels, or transcription bursts.
At the beginning of my PhD in 2016, a small collection of single-molecule live-cell imaging
studies has been performed using these approaches. Besides determining the replisome composition in
Escherichia coli and localizing proteins to the fork, other systems were studied such as the role of the CI
repressor in regulating the expression of λ genes in Escherichia coli (Hensel et al.). Another example is
the visualization of the hexameric state of the FtsK N-terminal domain at the division site in Escherichia
coli (Bisicchia et al.). In the van Oijen group, single-molecule live-cell imaging began with a study of the
error-prone DNA polymerase V in Escherichia coli, revealing a novel type of spatiotemporal regulation
that is induced upon response to DNA damage (Robinson et al.). This study laid the basis for further in
vivo studies to be conducted in live cells, investigating other low-abundance systems in Escherichia coli,
in particular those responsible for DNA replication and repair.

Thesis context. Two major DNA repair and damage tolerance pathways were of interest for this
Thesis: those involving error-prone translesion synthesis polymerases (TLS polymerases) and the
homologous recombination system responsible for the repair of single-stranded DNA gaps, comprised by
the RecF, RecO and RecR proteins. The goal of my Thesis was to understand how DNA damage filters
through these two seemingly independent pathways. My thesis is based on four specific aims: 1. Identify
major substrates of the error-prone DNA polymerase IV (pol IV) in Escherichia coli. At the beginning of
my studies, pol IV was most often described to work in TLS at stalled replisomes, assisting in the
recovery of DNA replication in cells experiencing extensive DNA damage. Thus, I initially focused on
replisomes as a pol IV binding target and later investigated the role of pol IV in homologous
recombination. 2. Determine the composition of the RecFOR complex following DNA damage induction,
where RecFOR facilitated homologous recombination reactions. The main open questions were whether a
RecFOR complex exists and whether RecF and RecO have the same binding targets. 3. Compare pol IV
to other error-prone DNA polymerases such as DNA polymerase V (pol V). Therefore, I investigated if
these polymerases, both being error-prone, work on the same DNA substrate; or rather bind to different
substrates. 4. Determine mechanistic differences between pol V and its homolog pol VICE, which is much
more error-prone than pol V. To investigate these four aims, I primarily employed single-molecule livecell imaging, allowing me to determine expression levels, localisations, co-localisation against other
markers, stoichiometries and binding lifetimes.
This Thesis presents single-molecule live-cell imaging studies on pol IV, pol V, pol VICE, RecF
and RecO. The findings presented begin to draw a broad picture of how bacterial cells deal with DNA
damage, starting to understand how DNA damage is distributed to different pathways for repair or
damage tolerance. In particular, my findings reveal that the major role of pol IV is in double-strand break
repair, intertwining the fields of TLS and homologous recombination. We are just beginning to scratch
the surface of these systems, and all the other systems into which single-molecule imaging can provide
new insight. My work represents important first steps in this endeavor.
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Chapter 1 broadly reviews current literature on the development of antibiotic resistance, written
in my 1st year and expanded over the course of my PhD. My supervisors Andrew Robinson and Antoine
M. van Oijen monitored my progress and provided assistance in writing this review. Briefly, cells have
evolved different DNA repair and damage tolerance pathways to overcome endogenous and exogenous
damage. This literature review primarily elaborates on error-prone DNA polymerases which generate
mutations, as well as, the major DNA repair pathway, homologous recombination. Historically, errorprone polymerases have been described to carry out TLS at stalled replisomes. Pol IV has however also
been described to work on single-stranded DNA gaps originating from replisomal lesion skipping, stalled
transcription complexes and recombination intermediates.
The study described in Chapter 2 measures the DNA binding activities of the error-prone DNA
polymerase IV close to, and away from replisomes in vivo. Using different DNA damaging agents
(methylmethane sulfonate [MMS] and ciprofloxacin) and UV light, this study shows that the majority of
DNA polymerase IV (pol IV) activity occurs outside of replisomes, presumably at substrates other than
stalled replisomes. This study demonstrates that only 5–10% of foci induced by DNA damage form
nearby replisomes, indicating that pol IV predominantly works in a non-replisomal context. In addition,
replisomal formed pol IV foci exhibit a broad distribution of colocalisation distances, suggesting that pol
IV carries out postreplicative TLS in gaps behind the replisome, or carries out activities at other structures
that form close behind replication forks. For this study, Elizabeth A. Wood (from Michael M. Cox’s lab,
Department of Biochemistry, University of Wisconsin-Madison, Madison, United States) constructed the
majority of strains by using λRED recombination. I was also involved in the construction of strains,
transducing alleles produced by Wood into selected cell lines and carrying out transformations to
introduce plasmids. Using these strains, I carried out plate-based spot assays to measure cell survival
upon antibiotic treatment, determining whether cells expressing fluorescent protein fusions exhibited
similar tolerance to stressors as wild-type cells, or if the presence of the fluorescent protein impaired the
activity of the tagged repair enzymes. I further carried out ciprofloxacin resistance assays to compare
rates of ciprofloxacin-resistance evolution in the various strains. After characterization, I recorded all the
microscopy data that forms the main basis of the study. Live-cell single-molecule experiments were
carried out in either quartz- or PDMS-based flow-cells, which were home-built. Single-colour time-lapse
movies of pol IV were recorded to characterize its up-regulation in cells exposed to DNA-damaging
agents, while video rate movies were collected to investigate the nucleoid-binding behavior of pol IV. I
further recorded two-colour time-lapse movies to quantify rates of pol IV focus formation at, and away
from replisomes. Analysis of data utilised scripts from past and present lab members, as well as scripts
that I wrote myself in MATLAB and java, then run in ImageJ. Western blotting of DinB expression levels
was carried out by John P. McDonald in Roger Woodgate’s lab, Laboratory of Genomic Integrity,
National Institute of Child Health and Human Development, National Institutes of Health, Bethesda,
United States. The manuscript was drafted by myself, Andrew Robinson, Michael M. Cox, Roger
Woodgate, Myron F. Goodman. Antoine van Oijen edited drafts and contributed intellectually to the
study design and data interpretation.
Chapter 3 reviews different models of error-prone DNA polymerase activities that have been
described in Escherichia coli, in particular activities other than TLS at stalled replication forks. The
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review was inspired by the findings of the study described in Chapter 2; if pol IV rarely works at
replication forks, where might it (and other TLS polymerases) work? Genetic and biochemical studies
have generated evidence for TLS polymerases being involved in nucleotide excision repair, homologous
recombination and transcription pathways. In addition, treatments with cell stressors (compounds that
damage DNA, deplete the nucleotide pool, inhibit cell wall synthesis etc.) are known to result in
accumulation of reactive oxygen species within cells, oxidizing the nucleotide pool. Oxidation of the
nucleotide pool increases mutation rates by promoting TLS. The review was written by me with input
from Andrew Robinson. Antoine van Oijen reviewed the manuscript.
In Chapter 4, I show that processing of DNA double-strand breaks via the RecBCD pathway is
crucial for both the damage-induced upregulation of pol IV expression, and for the binding of pol IV to its
substrates on the nucleoid. The study utilized two antibiotics, ciprofloxacin and trimethoprim, which both
promote the formation of double-strand breaks, but have different mechanisms of action. Both antibiotics
induce SOS-mediated upregulation of pol IV in cells. The SOS signal originates from double-strand
breaks, some of which are dependent of reactive-oxygen species (ROS). Formation of ROS-dependent
double-strand breaks is a known property of many antibiotics. These observations support that pol IV
primarily works in DSB repair in cells. Ultimately, ROS-induced DSBs may contribute to pol IV activity
in mutagenic DSB repair. This project evolved from observations that I made and I drove the study. It is
important to point out, however, that Camille Henry (from Michael M. Cox’s lab, Department of
Biochemistry, University of Wisconsin-Madison, Madison, United States) also played a key role in the
development of this study, bringing in her knowledge about the accumulation of ROS during antibiotic
treatment. Strain construction was a collaborative effort between Camille Henry, Steven T. Bruckbauer
and Elizabeth A. Wood (all three from Michael M. Cox’s lab, Department of Biochemistry, University of
Wisconsin-Madison, Madison, United States), Roger Woodgate (Laboratory of Genomic Integrity,
National Institute of Child Health and Human Development, National Institutes of Health, Bethesda,
United States) and Megan E. Cherry (PhD student in the Robinson/van Oijen lab, School of Chemistry
and Molecular Bioscience, University of Wollongong, Wollongong, Australia), and myself. ROS reporter
plasmids and MuGam-PAmCherry vector were constructed by Camille Henry, Steven T. Bruckbauer and
Elizabeth A. Wood. The MuGam vector is based on a plasmid construct from Harshad Ghodke (PostDoc
in the van Oijen lab, School of Chemistry and Molecular Bioscience, University of Wollongong,
Wollongong, Australia). Fluorescent protein fusion constructs were characterized by Camille Henry,
employing DNA damaging agent sensitivity assays. I carried out the survival assay for the MuGamPAmCherry vector, to determine the induction level for single-molecule imaging, choosing a non-toxic
expression range. All plate-reader assays were carried out by me, measuring increases in intracellular
ROS and SOS induction levels. In addition, I carried out all single-molecule experiments of this live-cell
study, performing experiments in home-build quartz flow cells. From previous work by Yvonne
Hellmich, a former intern (now PhD student at Institute of Biochemistry, Goethe Universität, Frankfurt,
Germany), I adapted trimethoprim concentrations used for single-molecule live-cell imaging. Time-lapse
experiments were recorded to follow pol IV, pol V, replisome markers and SOS induction levels. Twocolour video rate movies of pol IV were recorded to determine if pol IV binds longer at or away from
replisomes, comparing cells before and after DNA damage induction. I performed the data analysis by
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using MATLAB and java scripts from past and present members of the van Oijen lab, as well as scripts
that I wrote myself. Western blotting was carried out by John P. McDonald in Roger Woodgate’s lab. I
drafted the manuscript, which was initially edited by Camille Henry, Harshad Ghodke and Andrew
Robinson. Roger Woodgate, Michael M. Cox and Antoine van Oijen reviewed later versions of the
manuscript.
Subchapter 4.8 contains additional data obtained during this study, which link the nucleoidbinding activities of pol IV with the recombination mediator protein RecF. Cells lacking RecF show
increased colocalization between pol IV and replisome markers, suggesting that RecF normally inhibits
pol IV binding near replisomes. Strain construction and experiments for this subchapter involved
Elizabeth A. Wood and myself. I wrote the subchapter.
The study described in Chapter 5 shows that RecA and UmuD cleavage modulate the binding
activity of pol IV, providing a possible model for regulation of the error-prone activity of pol IV. The
recombinase RecA, in particular RecA* nucleoprotein filament structures, recruit pol IV to the nucleoid.
Up to 40% of pol IV foci colocalised with the RecA* probe mCI. It has been reported that RecA
modulates the mutagenic activity of pol IV (i.e. during DSB repair). Based on these reports, pol IV might
be expected to incorporate nucleotides with low fidelity when acting at these RecA* structures. The
results described in this chapter further support the notion that pol IV primarily works in homologous
recombination. Furthermore, Chapter 5 also investigates the UmuD protein as another regulator of pol IV
mutagenicity in vivo. In the absence of DNA damage, full-length UmuD promotes error-free, long-lived
pol IV binding events which last for some seconds. Following DNA damage, RecA* filaments promote
the autocleavage of UmuD to its cleaved form UmuDʹ. In the presence of UmuDʹ, pol IV is known to
generate -1 frameshift mutations at an elevated rate. However, I found that UmuDʹ also reduces pol IV
binding, suggesting that UmuDʹ helps to control the mutagenic activity of pol IV by reducing its binding
to the nucleoid. For this study, the strain construction involved Elizabeth A. Wood (from Michael M.
Cox’s lab, Department of Biochemistry, University of Wisconsin-Madison, Madison, United States),
Roger Woodgate (Laboratory of Genomic Integrity, National Institute of Child Health and Human
Development, National Institutes of Health, Bethesda, United States) and me. Plasmids for singlemolecule imaging experiments were designed and constructed by John P. McDonald from Roger
Woodgate’s lab and Roger Woodgate himself. All single-molecule experiments were carried out and
analyzed by me using the previously established analysis pipeline. Time-lapse experiments revealed that
pol IV foci colocalise with the RecA* probe after DNA damage indcution. Rapid video-rate movies
showed that pol IV foci are promoted in different backgrounds such as recAE38K cells and cells
expressing the uncleavable UmuDK96A enzyme. My single-molecule observations brought forward the
idea that we should test if pol IV directly interacts with RecA*, which required purification of pol IV and
RecA. Proteins were expressed and purified Matthew L. Ritger (former intern in Michael M. Cox’s lab)
and Phuong T. Pham (Assistant Professor in Myron F. Goodman’s lab, Departments of Biological
Sciences and Chemistry, University of Southern California, Los Angeles, United States). The interaction
between pol IV and RecA* was tested through surface plasmon resonance experiments. These
experiments confirmed that pol IV can associate with RecA* filaments on DNA, intriguingly, pol IV can
even bind to filaments formed on double-stranded DNA when using RecAE38K mutant. The same mutant
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promotes the formation of pol IV foci in cells, even in the absence of exogenous DNA damage. Together
the observations support a physical interaction between pol IV and RecA* in vivo. These experiments
were performed by Amy E. McGrath (PostDoc in Nicholas E. Dixon’s and Aaron J. Oakley’s lab, School
of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, Australia) and
Slobodan Jergic (Senior PostDoc in the van Oijen lab, School of Chemistry and Molecular Bioscience,
University of Wollongong, Wollongong, Australia). These experiments were designed by Harshad
Ghodke and Slobodan Jergic (both at School of Chemistry and Molecular Bioscience, University of
Wollongong, Wollongong, Australia). To support that RecAE38K filaments form on double-stranded
DNA, Matthew L. Ritger from Michael M. Cox’s lab performed the LexA cleavage assay and ATPase
assay. Ritger showed that RecAE38K filaments formed on double-stranded DNA can cleave LexA, which
is the signal for SOS induction in cells. This finding is consistent with recAE38K cells constitutively
having the SOS response turned on. I drafted the manuscript, which was initially edited by Amy E.
McGrath, Harshad Ghodke and Andrew Robinson. Myron F. Goodman, Michael M. Cox and Antoine van
Oijen reviewed the manuscript.
Chapters 4 and 5 revealed new links between pol IV and RecA-dependent processes. Chapter 6
investigates recombination mediator proteins that are thought to assist in loading RecA onto singlestranded DNA gaps. During the repair of ssDNA gaps, the proteins RecF, RecO and RecR have been
described to load RecA recombinase on ssDNA gaps as a complex. The study described in Chapter 6
sought to resolve a long-standing controversy in the field; whether or not RecF, RecO and RecR act
independently, or as a complex. The study revealed that RecF and RecO rarely colocalize in cells,
implying that they do not form a complex in vivo. Single-molecule imaging revealed several differences
in the spatiotemporal behaviours of RecF and RecO, suggesting that RecF and RecO have distinct
functions in cells. RecF frequently binds at sites of replisomes, whereas RecO binds to DNA in a region
of the cell between the main nucleoid mass and the cell membrane. This is the same region in which large
bundles of RecA protein have been observed by others. In addition, the study revealed that RecF
dimerizes in cells exposed to UV irradiation, and that RecF focus formation depends on RecR. This
observation, together with previous published reports, implies that RecF and RecR act as a complex in
vivo. Beyond this, stalling of active replicative by using a temperature-sensitive helicase mutant, results in
the loss of replisome, RecF and RecO foci. This observation might be consistent with RecF and/or RecO
working around post-replicative gaps and/or being physically coupled to the replisome. Interestingly,
initial findings suggest that the RecF may exclude pol IV from its binding sites close to replisomes. This
project originates from the lab of Michael M Cox (Department of Biochemistry, University of WisconsinMadison, Madison, United States), who developed the project together with Elizabeth A. Wood. Strains
used in this study were constructed by Elizabeth A. Wood, Camille Henry (both from Michael M. Cox’s
lab, Department of Biochemistry, University of Wisconsin-Madison, Madison, United States), Harshad
Ghodke (from the van Oijen lab, School of Chemistry and Molecular Bioscience, University of
Wollongong, Wollongong, Australia) and me. Camille Henry together with undergraduate interns Neema
Mbele, Roopashi Saxena,and Upasana Basu, measured growth curves and fitness values of fusion strain
constructs, determining if fusion constructs behave similar to wild-type cells. For fitness measurements,
they used a modified growth competition assay described by Lenski et al., a two-colour colony assay

vii

using tetrazolium arabinose indicator plates. They further conducted UV survival, SOS induction assays
using mytomycin C and plate-based sensitivity assays. I carried out all microscopy experiments,
recording time-lapse movies of RecF, RecO and replisome markers, capturing their spatiotemporal
behaviour. In addition, I recorded video-rate movies of RecF and RecO, to determine if they exist in a
monomeric or dimeric form. With the exception of the autocorrelation analysis, which was carried out by
Andrew Robinson, I analyzed all other data using MATLAB and java scripts written by past and present
van Oijen lab members and by myself. I drafted the manuscript together with Camille Henry and Michael
M. Cox. Initial edits were made by Andrew Robinson and Harshad Ghodke. Antoine van Oijen reviewed
the manuscript.
Subchapter 6.7 explains additional data, imaging RecF and RecO in context of the RecA* probe
mCI, which binds to RecA* filaments, the intermediates of recombination reactions. Strain construction
and experiments involved Elizabeth A. Wood, Harshad Ghodke and me. I wrote this subchapter.
The study described in Chapter 7 investigates another class of RecA-dependent process, DNA
synthesis by the highly error-prone polymerase V (pol V) and its homolog encoded on an integrative
conjugative element, pol VICE391. Besides RecA* being a key regulator for pol IV activity, it has long been
understood that RecA* filaments are required for the activation of pol V and pol VICE391. Both of the
pol V enzymes investigated in this chapter are highly mutagenic. Pol VICE391 is however more efficient at
promoting spontaneous mutagenesis than pol V; it is the most potent pol V mutator reported to date. To
understand how the high mutagenicity of pol VICE391 materializes from events occurring at the molecular
level, we compared polVICE391 with pol V behavior via single-molecule imaging. We observed that both
polymerases bind repetitively to the nucleoid, with pol VICE391 binding to its substrates for longer periods
than pol V. Additionally, pol VICE391 also incorporates nucleotides much faster than pol V. For these slow
polymerases, it is unlikely that every binding event leads to the incorporation of nucleotides, however the
probability is increased for pol VICE391, which binds for longer and act faster. This study further utilizes a
steric gate pol VICE391 variant (pol VICE391_Y13A), which exhibits increased mutation rates due to its
ability to incorporate ribonucleotides into the E. coli genome. In cells that conduct ribonucleotide
excision repair (RER), mutation rates are minimized because active RER removes misincorporated
ribonucleotides. When removing RNase HII, nucleotide excision repair (NER) contributes to the removal
of misincorporated ribonucleotides. Most RNaseHII and NER-independent RER are found on the lagging
strand, which is an important activity in genome maintenance. This project was developed by Roger
Woodgate and his laboratory (Laboratory of Genomic Integrity, National Institute of Child Health and
Human Development, National Institutes of Health, Bethesda, United States). Bacterial strains and
plasmids were made by John P. McDonald, Roger Woodgate (both Woodgate lab), Thomas J. Armstrong
and me (both PhDs student in the Robinson/van Oijen lab, School of Chemistry and Molecular
Bioscience, University of Wollongong, Wollongong, Australia). Quantitative spontaneous mutagenesis
was measured by Erin Walsh. Western blotting to detect plasmid encoded UmuC and RumB proteins was
performed by John P. McDonald (in Laboratory of Genomic Integrity, National Institute of Child Health
and Human Development, National Institutes of Health, Bethesda, United States). He also expressed and
purified pol VICE391_Y13A and conducted the in vitro replication assays. Measurements of leading vs
lagging strand lacZ mutagenesis were performed by Alexandra Vaisman, Karolina Makiela-Dzbenska,
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Krystian Łazowski, Piotr Jonczyk and Iwona J. Fijalkowska (Institute of Biochemistry and Biophysics,
Polish Academy of Science, Warsaw, Poland). Live-cell single-molecule experiments were performed by
Thomas J. Armstrong and me (PhD student in the van Oijen lab, School of Chemistry and Molecular
Bioscience, University of Wollongong, Wollongong, Australia). Both of us analyzed data. The
autocorrelation analysis was carried out by Andrew Robinson. The manuscript was drafted by Erin Walsh
and Roger Woodgate and initially edited and finally reviewed by every other collaborating author
including me.

Emerging Themes. This Thesis, as with many studies before it, puts RecA at the center of the
DNA damage response. The TLS polymerases clearly have an intimate relationship with RecA. It is a key
player in the SOS-induced upregulation of pol IV. RecA* structures recruit pol IV to the nucleoid.
Double-strand break resection and a physical interaction with RecA are crucial for focus formation by pol
IV. Thus RecA* structures, particularly those formed during double-strand break repair, regulate pol IV
activity at multiple levels. My finding is that pol IV predominantly works in recombination intermediates
in live cells opposed to assisting in the restart of stalled replisomes. RecA* filaments also play important
roles in regulating the activity of pol IV. RecA is required for the damage-induced upregulation of pol V
subunits, the auto-cleavage of one of those subunits, UmuD, which allows the polymerase-containing
subunit UmuC to escape the membrane, and for the production of the catalytically competent complex pol
V Mut (UmuD′2- UmuC-RecA-ATP). Observations described in Chapter 4 suggest that pol V does not act
in double-strand break repair, as pol IV does. The involvement of RecA* nucleoprotein filaments in
regulating pol V, together with a previously described observation that pol V does not act at replisomes,
make other recombination intermediates prime candidates as substrates for pol V activity in cells. Thus
far, however, the substrates for pol V-dependent synthesis remain to be identified.
The work described in this Thesis agrees with a recent model of TLS polymerases being
specialized for specific DNA substrates. Pol IV and pol V appear to work differently in a cellular context.
For instance, ROS-induced DSBs promote pol IV focus formation but not pol V focus formation,
consistent with pol IV, and not pol V, working on ROS-induced DSBs or pol IV activity being promoted
following oxidation of the nucleotide pool. Furthermore, pol IV and pol V differ in their SOS-mediated
upregulation. Pol IV is upregulated following trimethoprim treatment, where the nucleotide pool is
depleted from thymine and ROS covert single-stranded gaps into DSBs. Pol V is neither unregulated nor
activated upon trimethoprim treatment. Intriguingly, RecA* filaments, which are essential for pol V Mut
activation, are however potentially formed in trimethoprim-treated cells; SOS induction is observed
which requires RecA* filament formation to cleave the SOS-repressor LexA. This Thesis opens up
questions about the regulation of error-prone DNA polymerases in Escherichia coli, informing about
possible mutagenesis promotors. Furthermore, observations about pol IV and pol V open questions about
the third TLS polymerase in Escherichia coli, DNA polymerase II (pol II). Single-molecule microscopy
will likely reveal the main targets of pol II and its regulation in living cells.
This Thesis begins to suggest that bacterial error-prone DNA polymerases could be involved in
many DNA repair and damage tolerance pathways. Besides RecA*, other recombination mediators
appear to regulate pol IV focus formation such as RecF, suggesting another degree of interconnectivity
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between translesion synthesis homologous recombination. Other studies have indicated that pol IV
activity might also feed into base excision repair (BER), incorporating oxidized nucleotides. Two closely
spaced oxidized guanines can be removed by enzymes of the BER pathway, thereby, possibly creating
DSBs and fueling pol IV activity. Overall, repair and damage tolerance pathways appear to operate not as
neatly as described in text books, making it fundamentally necessary to study each enzyme involved in
depth. In the future, multidisciplinary projects are likely to uncover molecular mechanisms, where singlemolecule microscopy will likely play a valuable role in assessing the merits of mechanistic models with
in living cells.
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1.1

Glossary

adaptation

An organism evolves to become better suited to a new environment.

clonal interference

Competition for survival between populations of different cell types,
for example between wild-type cells and newly arising mutant cells.

collateral sensitivity

Susceptibility for resistance development when exposed to drugs
because a resistance to another drug is already gained.

combination therapy

Therapy in which the patient is treated with more than one type of
antibiotic at the same time.

conjugation

Transfer of genetic material between cells through physical contact,
also known as “bacterial sex”. DNA is passed from the donor cell to
the recipient through a proteinaceous tube called a pilus.

epistatic interaction

An effect on the function of a gene that is exerted by one or more
other genes present in the cell.

fitness

The capacity for an organism to survive in a particular environment.
For a pure culture, the fitness is directly related to growth rate. In a
complex environment, fitness also encompasses the ability of an
organism to compete for resources with other organisms.

fitness landscape

The distribution of fitness values of different genotypes (e.g. mutants
of a parent organism) in a particular environment.

gene amplification

Increase in the copy number of a gene on the chromosome due to
recombination between repeat sequences. Gene amplification allows
the cell to produce more of the protein encoded by that gene. Further
amplification of the gene allows the cell to even produce more protein.

genomic rearrangement

Movement, deletion or amplification of parts of the chromosome via
recombination.

horizontal gene transfer

Transfer of genetic material between cells, including cells of different
species, via conjugation, transformation or transduction. Also known
as lateral gene transfer.

mutation

Technically speaking, any change in DNA sequence. In the context of
this report mutation refers to relatively small changes, such as
insertion or deletion of one or two nucleotides, or change in sequence
of a single base-pair.

1

mutation supply rate

The number of new mutations evolving in a particular amount of time;
typically the generation time. For example, E. coli has a mutation
supply rate of 1 x 10-3 mutations per genome per generation.

selection pressure

Environmental conditions that cause cells (more accurately genes)
with particular attributes to survive and others to perish.

sequential therapy

Therapy in which the patient is treated with one type of antibiotic,
administered one after the other, or in regular cycles.

stress-induced mutagenesis

Increase in the mutation rate induced in response to environmental
factors, in particular those that cause DNA damage.

transduction

Transfer of genetic material between cells through viral infection.
Host DNA is inadvertently packaged into the virus particle and upon
reinfection is transferred to a new host cell.

transformation

Direct uptake of genetic material from the environment

2

1.2

Antibiotic resistance is a major challenge to world health
Antibiotics drugs are used to treat diseases caused by pathogenic bacteria (1). Antibiotics work

either by killing bacteria (bactericidal antibiotics) and/or by stopping their growth (bacteriostatic
antibiotics) (2–7). Since their introduction in the 1930s, antibiotics have saved countless lives.
Unfortunately however, extensive use (and overuse) of antibiotics has led bacterial pathogens to evolve
resistance to these drugs, in turn causing treatments to fail. Antibiotic resistance is genetic: once a
bacterium develops drug resistance, it can pass its genes on to its progeny and even to other unrelated
bacteria (8)
A particularly serious situation arises when life-threatening organisms become drug-resistant, for
example extensively drug-resistant Mycobacterium tuberculosis (XDR-TB) and Methicillin-resistant
Staphylococcus aureus (MRSA). Some strains of each organism have become resistant to virtually all
available antibiotics and thus no treatment options exist for infected patients (1). Antibiotic resistant
bacteria are already estimated to kill 700,000 people every year. Unfortunately, as the rate of antibiotic
resistance continues to rise, projections indicate that this number could rise to 10 million by 2050.
Beyond the challenge this poses for world health, antibiotic resistance costs world economies billions
each year (9). In the USA alone, resistant bacteria are estimated to cost the health system $20 billion per
year (1).
Why has antibiotic resistance become such a big problem? As soon as pharma developed
antibiotics as a way to fight antimicrobial pathogens, the issue of resistance development was already
reported (1). Despite this, neither companies nor the government have invested in finding a solution for
antimicrobial resistance and the pipeline for developing new antibiotics has been allowed to stagnate. It is
also important to note that antibiotic resistance is driven by antibiotic use. Importantly, there are no rapid
diagnostic tests available for detecting and characterising bacterial infections, meaning most prescriptions
are issued “just in case” the patient has a bacterial infection. Existing antibiotics have been badly
misused, partly through inappropriate prescribing practices, but also through extensive use of subtherapeutic doses of antibiotics as growth-enhancers in agriculture (10). Furthermore, the need to treat
antibiotic resistance as a global risk has only been recognised recently. Globalization of trade and
increased travel has increased the rate at which resistant microorganisms spread around the world (11).
Despite the fact that antibiotic resistance is predicted to soon become the biggest challenge to
human health, we know little about the evolutionary dynamics and mechanisms that lead to resistance
generation. There is an urgent need to better understand how antibiotic treatment leads to the evolution of
resistant pathogens.

1.3

How do bacteria become resistant to antibiotics?
The emergence of resistant pathogens is a process of adaptation (see Glossary) (12). Bacteria

become resistant to antibiotics in one of three ways. Bacteria can acquire resistance genes from other
organisms in a process known as horizontal gene transfer (HGT, see Glossary). Here, resistance genes are
passed from one organism to another on mobile genetic elements such as plasmids, transposons and
integrons. Because transfer can occur across species boundaries, resistance genes can be taken from a
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very large gene pool (known as the mobile metagenome) (13). Horizontal gene transfer is the most
common mechanism by which antibiotic resistance spreads in hospital pathogens. A famous example is
the gene encoding extended spectrum beta-lactamase (ESBL), which travels between organisms on
plasmids and provides resistance to nearly all antibiotics in the beta-lactam family (14,15). HGT is
facilitated by bacteriophage transduction, conjugation or transformation (16). In transduction, DNA is
passed from one bacterium to another by a virus or a viral vector. Conjugation involves the transfer of
genetic material via physical contact between two cells and is mediated by a tube-like structure called a
pilus. Transformation describes genetic alteration due to the direct incorporation of exogenous genetic
material, absorbed from the surroundings through the cell membrane. The mobile genetic elements
acquired by bacteria during HGT often contain multiple resistance genes, leading to multi-drug resistance
(17,18).
A second route for antibiotic resistance to arise is through genomic rearrangement, in particular
gene amplification (12,19,20). Here, the copy number of a gene on the chromosome is increased due to
recombination between repeat sequences. One recombination event duplicates the gene, doubling its copy
number and allowing the cell to produce more of the protein encoded by that gene. Subsequent
recombinations further amplify the gene, producing even more protein. If the protein is the target of an
antibiotic, this amplification process allows to cell to tolerate higher concentrations of drug. Resistance to
the drug trimethoprim commonly occurs in this way (21). Trimethoprim inhibits the enzyme
dihydrofolate reductase, blocking a key step in the production of folate (22,23). As folate is required for
the synthesis of the nucleotide bases that comprise DNA, this leads to inhibition of DNA replication.
Cells develop resistance to trimethoprim by amplifying the gene that encodes dihydrofolate reductase,
dhfr, allowing higher amounts of the enzyme to be produced and thus higher concentrations of
trimethoprim to be tolerated.
A third route towards antibiotic resistance is mutation (12). Here, errors in DNA replication lead
to changes in the DNA sequence of the bacterium. Most mutations are non-beneficial for drug survival,
however in rare cases mutations occur that increase survival in the presence of antibiotic. For example,
resistance to the drug rifampicin occurs commonly by mutation (24). Rifampicin inhibits cell growth by
binding to RNA polymerase and thus inhibiting transcription. Resistance occurs when mutations arise in
the rpoB gene, altering the structure of RNA polymerase such that it no longer binds rifampicin, yet
remains competent for transcription. A common example is the mutation rpoB(S531L), in which a change
in the rpoB gene sequence causes a change from serine to leucine at position 531 of the RpoB protein (the
β-subunit of RNA polymerase), which reduces the efficiency of rifampicin. In many organisms, including
Mycobacterium tuberculosis, mutation represents the major route through which drug resistance is
developed. In addition, mutations in repressor genes or mutations that activate regulons can alter
expression of efflux pumps, leading to increased efflux transport of antibiotics (25).

1.4

How does antibiotic use influence the way bacteria evolve?
Antibiotics apply strong selection: they kill, or completely inhibit the growth of, any non-

resistant bacteria, while resistant bacteria continue to grow normally (12). The serious consequence for
health is that antibiotic use rapidly selects for resistant cells, allowing them to quickly become the
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dominant species in the environment. The strength of the selection pressure applied varies with the drug
and its concentration. Strength of selection pressure, however, is not the only factor that shapes how
organisms evolve. To understand how antibiotics use encourages antibiotic resistance, we need to
understand the complex interplay between cells, population genetics and environmental factors that occur
in patients, agricultural animals and the wider environment.

Figure 1: Evolution is self-referential. The environment shapes the cell population and the survivors
shape the environment.
An antibiotic dose represents a change in a bacterium’s environment. In order to survive the new
environment, the species must adapt to the new conditions. How do cells adapt to environmental changes?
Like all evolution events, resistance development involves the complex interplay of many factors (12).
Evolution is uniquely self-referential (26): changing the environment affects the survival of organisms
within that environment, while at the same time the organisms that survive in an environment play an
important role in shaping that environment (Figure 1).
An important factor that influences the rate of evolution is the mutation supply rate: the rate at
which cells evolve mutations (12). In general higher mutation rates promote faster evolution. High
mutation rates cause populations to rapidly diversify. Since antibiotics supply strong selective pressure,
members of the population that develop mutations that increase fitness in the presence of antibiotic are
strongly selected. Different mutants in a population hold different fitness levels: some are better suited to
the environmental conditions than others. This distribution of fitness amongst different variants (or
potential variants) is known as the fitness landscape (27). For some antibiotics the fitness landscape will
contain broad peaks: many different mutations may lead to an increase in fitness. For other antibiotics, the
fitness landscape may contain sharp peaks. Here a few rare mutations may dramatically increase fitness,
whereas most are of little or no benefit. It may therefore be ‘easier’ to find resistance mutations for some
antibiotics than for others.
It was recently demonstrated that resistance development can be driven along a concentration
gradient of antibiotics, i.e. along changes in the ‘selection landscape’ (12). High-level resistance to
antibiotics often requires that cells accumulate a series of mutations within several genes. In situations
where the change from low to high concentrations is very sharp, either in time or in space, cells need to
somehow accumulate all the necessary mutations for high-level resistance before they can survive
antibiotic exposure. Even with high mutation supply rates, the likelihood of producing all necessary
mutations prior to selection by the antibiotic is extremely low. If there is a more gradual gradient in
antibiotic concentration, however, cells can accumulate the mutations one at a time, becoming resistant to
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a slightly higher antibiotic concentration in each step. Gradients in antibiotic concentration may thus
accelerate the development of drug resistance.
Selective pressure also interacts with population effects (12). As shown in Figure 2, a
particularly important parameter is the population size. Under very strong selection pressure (top two
panels), resistance mutations have a large fitness benefit and thus come to dominate the population even
when extremely rare. Under weaker selection pressures (bottom two panels), the fitness benefit of
resistance mutants is low relative to the original cells. Here, the size of the population becomes important.
In small populations, a single resistant cell represents a sizeable proportion of the population and thus has
a high probability of survival. In very large populations, however, any resistant mutants that arise will
most likely be out-competed for nutrients by the other members of the population. Thus small population
sizes allow rare mutations to fix in the population with much higher probability than it would in a large
population.

Figure 2: A small (left panel) and large population (right panel) are shown under a weak (lower panel)
and strong selective pressure (upper panel). A fitter mutant is indicated by a red circles and the remaining
population of wild-type cells are indicated by grey circles. Applying strong selective pressure results in
the domination of the population by the red fitter mutant in both large and small populations (upper
panels). Under weak selection pressure, the red, resistant variant grows best, however its advantage over
wild-type cells is small. Thus in large populations it has a high probability of being out-competed by
wild-type cells, despite its higher fitness (lower-right panel). Rare mutations have a higher probability of
fixing in small populations (lower-left panel).
Importantly, in order to circumvent drug resistance, patients are often treated with more than one
type of antibiotic at the same time (12). This treatment is known as combination therapy. Other therapies
involve cycling between drugs or drug combinations (28). This is known as sequential therapy. While
these strategies have seen great successes in the short-term, their long-term outcomes in terms of drug
resistance are unclear. The potential for multi-drug resistance to arise from combination or succession
therapies is of particular concern and requires further study (29).
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1.5

Some antibiotics cause bacteria to mutate faster
Mutation supply rates are generally considered to be constant. However, use of some types of

antibiotics has been shown to result in stress-induced mutagenesis, i.e. the bacteria increase their mutation
rate upon coming in contact with the antibiotic (30). As shown in Figure 3, this may allow bacteria to
adapt to the presence of the antibiotic faster than if the mutation rate was constant. Under stress-induced
mutagenesis, exposure of a population of cells to an antibiotic causes cells to increase their mutation
rates, leading diversification the population. In figure 3, newly arising cells containing different mutations
are indicated in red, black and light yellow, while the remaining wild-type cells appear grey. The
antibiotic also applies selection; non-beneficial mutations (in this case those in the black and yellow
cells), as well as the wild-type cells, are quickly outcompeted by the resistant (red) mutant. Stress-induced
mutagenesis is expected to be important in situations where genetic diversity limits the rate of evolution.

Figure 3: Increased mutagenesis can be induced by exposure to antibiotics as a result of the SOS
response (first arrow). This produces a range of different mutants (red, light yellow, black and grey
circles) with in the population. Selection pressure applied by the antibiotic selects for the most beneficial
mutations, i.e. those that provide antibiotic resistance.
The commonly used antibiotics ciprofloxacin, nitrofurantoin and trimethoprim are all thought to
cause stress-induced mutagenesis (31). The common thread between these drugs is that they inhibit DNA
replication and induce the SOS response. The obvious question is whether the increased mutagenesis
induced by these drugs promotes the evolution of drug resistance. This seemingly simple question is
extremely difficult to answer experimentally, primarily because the systems that regulate the mutation rate
in cells also regulate proteins that repair DNA. It is therefore difficult to design experiments that separate
the effects of mutagenesis from those of DNA damage tolerance. To address the question properly, the
complex interplay of evolutionary factors has to be understood. In this light, a better understanding of
how and when mutations are produced, and how they influence evolution dynamics, would be particularly
beneficial.

1.6

DNA repair and damage tolerance
How does DNA damage channel through the different DNA repair and damage tolerance

mechanisms? How does stress-induced mutagenesis occur? Many elements of DNA repair are directed by
the SOS response; a transcriptional response to DNA damage in which a set of genes (~40 in E. coli) are
up-regulated (32). Most of these genes encode DNA repair proteins and are involved in error-free DNA
repair pathways such as homologous recombination. Recombinational DNA repair is the exchange of
nucleotide sequences between similar or identical strands. Classically, two main types of homologous
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recombination were described: the RecBCD pathway and the RecF pathway. Both are involved in
maintaining the genome. In addition to error-free repair pathways, many bacteria also express specialised,
error-prone DNA polymerases during the SOS response. These polymerases carry out a special type of
DNA replication on damaged DNA, known as translesion synthesis (TLS). TLS polymerases tend to be
error-prone and are largely responsible for the increase in mutagenesis brought on by SOS induction.
While it is clear that many antibiotics induce the SOS response, not much is known about how DNA
damage feeds into DNA repair and damage tolerance. Recombination is shown to play a critical role;
however, it is unknown where, when and how recombination takes places. Moreover, TLS polymerases
and increased mutation rates go hand in hand but the level of TLS activity that results and where in the
cell TLS occurs remain open questions.

1.6.1 DNA replication in the absence of antibiotics
The SOS response is induced when chromosomal DNA replication becomes interrupted by the
presence of damage in the template DNA. In the absence of damage, DNA replication is performed by a
complex multi-protein machine known as the replisome (33). The process of DNA replication is initiated
at the origin (oriC). The initiator protein DnaA binds to the origin and separates the two strands of the
parental DNA (see Figure 4). The primosome (DnaB6-DnaG3), composed of the primase (DnaG) and the
5’ → 3’ DNA helicase (DnaB), is assembled at the melted origin and loaded on both ssDNA substrates
(see Figure 4). DnaB unwinds the dsDNA bidirectional and DnaG synthesises RNA primers. Once the
template is primed, DNA polymerase III (Pol III) holoenzyme (HE) is assembled, completing the
replisome complex (34). One strand, the leading strand, is replicated by Pol III HE continuously. As
replication only occurs in the 3’ → 5’ direction, the other strand, known as the lagging strand, is
replicated discontinuously as Okazaki fragments.

Figure 4: Initiation of DNA replication in Escherichia coli. Unwinding of the origin by DnaA leads to
melting of the two strands (left panel). This is followed by assembly of the primosome (middle panel),
consisting of the primase DnaG (shown in red) and the DNA helicase DnaB (shown in yellow). The next
step is Pol III HE assembly (right panel) to begin the elongation phase. Pol III HE consists of the clamp
loader complex shown in violet, the sliding clamp shown in green and the core (αεθ). The core is
composed of the α- (blue subunit), the ε- (red subunit) and the θ-subunit (purple subunit) (33) .
Pol III HE is assembled from a series of subcomplexes – two or three Pol III cores (αεθ), which
are each connected to the clamp loader complex (𝜏𝑛 𝛾3−𝑛 𝛿𝛿′𝜒𝜓)(32,34,35). Each Pol III core is composed
of an α-subunit (family C polymerase from the DnaE family), an ε-subunit (3’→5’ proofreading
exonuclease from the DnaQ family) and a θ-subunit (stabilising role for ε). While synthesising DNA,
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each Pol III core interacts with a homodimeric β-sliding clamp processivity factor (β2), through contacts
on the α- and ε-subunits. Importantly, the β-sliding clamp also interacts with a series of other DNAprocessing proteins, including TLS polymerases.

1.6.2 DNA damage inhibits replication and induces the SOS response
Pol III HE is a fast, processive and accurate DNA copier. However, if the template DNA
becomes damaged (for example by exposure to UV light or certain antibiotics), Pol III HE stalls (32). In
some cases, replication restarts downstream of the damage, in a process known as lesion-skipping (37).
Both stalling and lesion-skipping lead to accumulation of ssDNA gaps, which ultimately represents the
signal that triggers the SOS response (38). In the first step, the recombinase protein RecA is loaded onto
ssDNA regions, displacing the single-stranded binding protein SSB, producing nucleoprotein filaments
known as RecA* (see Figure 5a). Similarly to gaps, resected double-strand breaks serve as a substrate for
RecA* nucleoprotein filaments (see Figure 5b) (39). These activated RecA* filaments co-catalyse selfcleavage of the transcriptional repressor protein LexA. In the resting state, LexA represses the expression
of SOS genes as it binds to their SOS repressor boxes. RecA*-mediated cleavage of LexA inactivates the
repressor and thus leads to increased expression of SOS genes. LexA however has different affinities for
different SOS repressor boxes, regulating when which SOS gene is induced. The earliest SOS genes to be
induced constitute non-mutagenic DNA repair pathways such as homologous recombination. If damage
persists beyond these early stages, a mutagenic stage is initiated in which TLS polymerases become
(more highly) activated. LexA is also highly expressed during the SOS response, allowing the system to
reset once the DNA damage has been repaired.

Figure 5: RecA loading onto SSB-coated ssDNA regions with filament growth from 5’-to-3’. (A) Singlestranded DNA gap is coated with the single-stranded binding protein SSB. SSB is replaced by the
recombinase RecA, forming a RecA* nucleoprotein filament. (B) RecA is loaded onto a resected doublestrand break.

1.6.3

Recombinational DNA repair: a strongly regulated pathway
To maintain genomic integrity, ssDNA regions have to be repaired error-free. In bacteria, the

major error-free repair pathway is homologous recombination (HR, see Figure 6). In this pathway, RecAcoated ssDNA undergoes homology search to pair this ssDNA region with its complementary duplex,
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leading to strand invasion and the formation of a displacement loop (D-loop) (39). Following DNA
synthesis, the HR intermediate is resolved.

Figure 6: Homologous recombination. Recombinant ssDNA invades complementary duplex forming a
displacement loop. The invading 3’ end primes DNA synthesis. (A) Repair of single-stranded gap. (B)
Repair of double-strand break.
RecA loading and filament growth are temporally and spatially regulated otherwise leading to
deleterious consequences for genomic integrity (39). Although being one key regulator of the SOS
response, RecA is controlled within the SOS regulon. RecA is a high abundant protein with
approximately 7,000-15,000 molecules per cell in undamaged cells and up to 105–106 molecules per cell
after SOS induction (40–44). Another level of regulation is RecA’s autoregulation by supressing its
activities under certain conditions. Beyond this, RecA activity is regulated on various levels by several
proteins that ensure that RecA activities are directed.

1.6.3.1 RecF, RecO and RecR proteins facilitate RecA loading and stabilisation
Historically, RecF, RecO and RecR are commonly described as working together in a RecFOR
complex to facilitate RecA loading and stabilise RecA filaments (39,45–56). This pathway is called the
RecFOR pathway or RecF pathway (39,44–56). RecF, RecO and RecR play a key role in post-replicative
gap repair which is important for DNA damage repair and restart of stalled replication forks. The study
described in chapter 6 of this thesis, however, indicates that RecF and RecO function independently.
Mutants of recF exhibit UV sensitivity showing impaired DNA repair (58,59). The RecF protein
has a weak ATPase activity; the ADP bound form of RecF has a lower affinity for dsDNA (60). Without
ATP present, RecF forms aggregates. Interestingly, RecF interacts with RecR, forming a complex with
stoichiometry RecF2RecR4 (61–63). RecF and RecR together have been described to confine RecA
filament extension to the single strand gap (64). Furthermore, RecF is necessary for processing DNA
damage-induced replication fork regression (65). The recF gene is also associated with operons encoding
replisome components such as dnaN and dnaA, suggesting that recF is linked to replication at the level of
genomic organisation (65,66). Besides, the 3′ end of the recF gene includes the promotor sequence for the
gyrB gene downstream, which encodes for the DNA gyrase B subunit (67). DNA gyrase removes positive
supercoils in DNA, relieving topological stress that arises from the translocation of transcription and
replication complexes along DNA (68,69). Genomic organisation of recF and gyrB suggests a role for
RecF in supercoiling.
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Similar to RecF, RecO has been identified as a recombinational protein using UV sensitivity
assays in combination with recBC mutants (58). RecO also forms a complex with RecR, however, has no
ATPase activity and is monomeric in solution (46,47,70–73). RecO and RecR together catalyse the
nucleation step of RecA proteins onto SSB-coated ssDNA which is slowed by RecO competing off SSB
(73). Besides, RecO mediates the renaturation of complementary single-stranded DNA independently of
ATP which is also enhanced with SSB in the reaction (70,74). RecR however reduces this efficiency
suggesting that RecR competes with RecO for SSB binding sites (74).
Mutants of recR exhibit the same sensitivity to UV light as recF and recO mutants (59,75,76).
The RecR protein itself has no ATPase activity but slows down the ATP dependent dissociation of RecF
from dsDNA (60). In solution, E. coli RecR is dimeric, whereas, the structure of D. radiodurans RecR
revealed a tetrameric ring structure which might allow sliding on dsDNA suggesting a DNA clamp like
function (47,61). Additionally, RecR forms complexes with RecO and RecF. Alike RecF, RecR is
required to protect and maintain the replication fork upon DNA damage induction (65). The recR gene is
also closely associated with operons otherwise encoding components of the replication system and is cotranscribed with the dnaX gene (66).

1.6.3.2 Mechanism of RecA loading at gaps
The RecFOR proteins are grouped in the same pathway due to in vivo and in vitro experiments.
In vivo, deletion mutants alone or in combination show similar phenotypes using UV sensitivity assays
(58). In vitro, polymerisation and the ATPase activity of RecA are enabled by RecFOR and are also
enhanced under some conditions when all three are combined (48). RecR however can only interact with
either RecF or RecO suggesting that RecF and RecO compete for binding to RecR (77). Beyond this,
RecO and RecR together are sufficient for RecA loading onto SSB-coated ssDNA (47,78). A recent study
has shown that RecA loading is only dependent on RecOR in B. subtilis (79). RecO binds for few
hundred milliseconds after DNA damage induction (80). These binding sites are spread over the whole
chromosome and do not form repair hubs. Furthermore, the compaction of the nucleoid in response to UV
damage is only dependent of RecOR as it is of RecA (81). Within this context, RecF has a catalytic
function; it speeds up RecA loading and the process of nucleoid compaction upon UV damage induction.
These facts open questions such as: What is the function of RecF/RecFR? Is RecOR involved in
RecA filament nucleation or also RecA filament growth? Which recombination mediator proteins load
RecA in ssDNA gaps? Understanding the function of RecF, RecO and RecR in vivo would possibly
reveal the mechanism of RecA loading.

1.6.3.3 Mechanism of RecA loading at double-strand breaks
In Escherichia coli, double-strand breaks are processed by RecBCD helicase/nuclease (82,83).
The activity of the RecBCD enzyme is regulated by a unique DNA sequence, known as Chi (83). Once
reaching the Chi site, RecBCD creates a new 3ʹ end and loads RecA on to the resected DSB, making a
recombinant ssDNA strand. Thereby, the RecBC enzyme (also called exonuclease V) has an ATPdependent nuclease function (83). RecD is required for Chi hot spot activity (83). In a recB deficient
mutant, RecJ nuclease is essential for SOS induction after introduction of a DSB (84). In a recBC mutant,
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the helicase RecQ and the gap repair proteins RecJ, RecF, RecO and RecR can catalyse DSB resection
and repair (82). It however still remains unclear which recombination mediator proteins load RecA on
resected double-strand breaks in vivo.
In comparison to RecFOR, RecBCD is found less frequently over genomes (82). Some bacteria
use different proteins than RecBCD, for instance Bacillus subtilis utilises AddAB (82).

1.6.4 Translesion DNA synthesis: an important source of mutations
DNA damage that is not repaired during the early stages of the SOS response channels into the
mutagenic stage, the damage tolerance pathway. Furthermore, cells increase the accumulation of the
sigma factor RpoS, activating the RpoS general stress response (85). During this stage, TLS polymerases
are expressed. In E. coli this includes: Pol II, encoded by polB; Pol IV encoded by dinB; and Pol V,
encoded by the umuDC operon (86,87).

1.6.4.1 TLS polymerases work on damaged DNA
Unlike Pol III HE, TLS polymerases have the ability to insert nucleotide bases opposite DNA
lesions (see Figure 3). Chapter 3 reviews the activities of TLS polymerases in Escherichia coli.

Figure 5: Translesion DNA synthesis: insertion of nucleotide bases opposite a DNA lesion by Pol V Mut
(87).
This activity allows ssDNA gaps to be filled in, thus the cell avoids potentially catastrophic
problems brought on by long-term stalling of replication and transcription. Importantly, damaged
nucleotide bases are not removed during TLS; it represents a damage tolerance mechanism, as opposed to
a repair mechanism. Another consequence of TLS is that often the base inserted opposite the lesion by a
TLS polymerase is incorrect, producing a mutation (89). For example, when Pol V carries out TLS at a TT cyclopyrimidine dimer (a lesion consisting of a covalently cross-linked pair of thymidine bases, which
is commonly produced by UV irradiation), it frequently inserts the sequence GA, rather than the
canonical AA (90,91). This type of mutation, occurring at a lesion, is called targeted mutation (92). Even
on undamaged portions of DNA, however, TLS polymerases tend to be much less accurate than Pol III
HE and thus contribute to an increased mutation rate. This untargeted mutagenesis may lead to a
significant number of mutations under SOS conditions. Thus, both targeted and untargeted mutagenesis
by TLS polymerases are likely to factor into the evolution of antibiotic resistance. As described below,
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TLS polymerases each have different mutational signatures, producing characteristic mutations at
different types of lesions.
In undamaged E. coli cells, DNA polymerase II is estimated to be expressed at a level of 50
molecules per cell. Upon SOS induction, its production is assessed to increase around seven-fold,
reaching approximately 350 molecules per cell (34,88). Pol II is a relatively high-fidelity enzyme,
possessing the capacity for proof-reading through its 3’→5’ exonuclease activity. While Pol II generally
carries out error-free TLS, it can produce mutations in cells exposed to N2-acetylaminofluorene (AAF). In
this case, Pol II bypass of AAF-adducts of guanine lead to a -2 frameshift, i.e. deletion of two nucleotides
(89,93).
Pol IV has been estimated to be the most abundant polymerase with approximately 250
molecules per cell in undamaged cells and up to 2,500 molecules per cell after SOS induction by western
blotting (94). Pol IV is devoid of 3’→5’ proofreading activity and, once overexpressed in vivo after
alkylation damage, responsible for -1 frameshifts, i.e. deletion of a single nucleotide (93,95). These
however are supressed when co-overexpressing UmuD (pol V subunit) (96). Furthermore, Mallik et al.
found that adducts to the N2 position of guanines are primarly bypassed by Pol IV even in a mostly errorfree fashion (94). These lesions can be induced by addition of benzo(α)pyrene or 4-nitroquinoline-1-oxide
(NQO), a DNA damaging agent. Pol IV also bypasses a variety of alkylation lesions, most often without
inducing mutations (97). Additionally, pol IV is involved in transcription-coupled repair (98) and double
strand break-repair repair (99–102), and contributes significantly to cell fitness in late stationary phase
cultures in the absence of any exogenous DNA damage (103). The study described in chapter 4 and 5 of
this thesis, however, indicates that pol IV primarily works at recombination intermediates.
The third TLS polymerase, pol V, can replicate past a wide variety of chemical and radiationinduced DNA lesions. Pol V is devoid of proofreading activity and is highly mutagenic (32,104). Its
fidelity on undamaged templates is far lower than Pols III and IV. It also promotes targeted mutagenesis.
For example, Pol V has a strong tendency to insert G opposite the 3’-T of a TT(6-4) photoproduct dimer
(92). In undamaged cells, pol V is rarely abundant with less than 15 copies per cell (105). After inducing
SOS, fewer than 200 molecules are present per cell (105). Recent findings by Robinson et al. provide key
insight into mechanisms that limit DNA polymerase V activity during the SOS response (32).
Accumulation of pol V is shown relatively late during SOS response. Moreover, time-lapse analyses
show three tightly regulated, distinct phases within UV-irradiated cells. First, a small amount of UmuC is
produced that is primarily bound to the cell membrane, away from the DNA. In phase II, the umuDC
operon is depressed by cleavage of LexA. As a consequence, the UmuC molecules in cells increase to a
large extent, but remain associated with the cell membrane. During the last phase, the UmuC is release
into the cytosol in its active form, Pol V Mut (a complex of UmuC with the doubly-cleaved form of
UmuD2, called UmuDʹ2, and a molecule of RecA bound to ATP; UmuDʹ2C-RecA-ATP). In total Pol V
activity is thus limited by its induction late in the SOS response, requirement for RecA*-dependent
cleavage of UmuD, membrane binding and requirement for extracting a RecA-ATP from a RecA*
filament. Once activated, pol V Mut inserts only a few bases before the complex dynamically deactivates
and dissociates from the DNA. Besides pol V, RumAʹ2B (also known as pol VICE391) also belong to the
umu family of error-prone polymerases (106,107). This polymerase however has a much higher mutation
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rate than pol V, despite being a pol V orthologue. To date, it remains unknown why RumAʹ2B
incorporates many more mutations than pol V. Possibilities might be 1. RumAʹ2B might be more errorprone than pol V. 2. RumAʹ2B might be more processive than pol V, incorporating many more
nucleotides. 3. RumAʹ2B might have a higher affinity for the DNA template than pol V, and thus, this
polymerase might be bound to DNA for a longer time, incorporating many more nucleotides.
Unpublished in vitro studies have however shown that RumAʹ2B is as error-prone as pol V. The study
described in chapter 7 reveals that Rum polymerase is bound to DNA for a longer time than pol V,
suggesting that Rum could be more processive than pol V in vivo.

1.6.3.4 Mutagenic double-strand break repair
The activation of the RpoS general stress response is also a mutagenic switch for homologous
recombination (30,99,102,108). Then, error-prone DNA polymerases participate in repairing DSBs,
inducing mutations. Consistent with RpoS regulating DSB repair dependent stress-induced mutations, the
deletion of rssB, a negative regulator for RpoS, strongly increases mutations during starvation (109). In
addition, for I-SecI endonuclease induced DSB during starvation, error-prone DSB repair is a major
source of spontaneous mutations which strongly depends on DNA polymerase IV (109). The study
described in chapter 4 and 5 support a role for pol IV in DSB repair. DSB processing is crucial for pol IV
DNA binding activity in vivo.
Double-strand breaks are mutagenic hotspots in stressed cells (99,102,109,110). At DSBs, TLS
polymerases are involved in strong local mutation hotspotting covering a range of ~60 kb. TLS
polymerases however also provide long-distance hotspotting over ~1 Mb (100). In addition, strong local
hotspotting at DSB requires RecBCD-mediated degradation from DSB ends. In vivo, mutations arising
from DSB repair have been shown to depend on pol II and pol IV activity (111). Single-molecule in vivo
assays also revealed that DNA polymerase IV localises to an induced DSB site and also localises to RecA
structures (93). In vitro, DNA polymerases IV is highly proficient in copying DNA in recombination
intermediates (D-loops) (112). This activity is called error-prone recombination-directed replication.
Besides, long-distance hotspotting might be induced by break-induced replication.

1.6.4.2 Regulation and activity of DNA polymerases
How are TLS polymerases regulated? Pol V is regulated on several levels before being released
into the cytosol as active pol V Mut (32). This opens up the question of a regulatory system for pol II and
pol IV activities. Recent studies suggest that UmuD affects pol IV’s mutagenic activity by enclosing its
open site and thus preventing -1 frameshifts (96). In chapter 5, the study shows that UmuD promotes
long-lived pol IV binding events while UmuDʹ inhibits pol IV binding to DNA.
Furthermore, where do TLS polymerases actually act inside cells? It has long been assumed that
TLS polymerases are recruited to stalled replicated forks to facilitate the restart of DNA replication. In
recent years, however, evidence was found showing that these specialised polymerases also act on other
substrates than replisomes. For example, Pol V Mut mostly binds away from replication forks inside live
cells (32). Are there proteins that facilitate lesion-skipping and thus create lesion containing gaps left
behind the replication fork? These structures could be a TLS polymerase target. It remains an open
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question which TLS polymerases act behind the replisomes, which TLS polymerases act at replisomes,
and which act at other structures. Nonetheless, there is compelling evidence that Pol IV does act at
replisomes, competing for binding sites with Pol III HE (94). Chapter 2 elaborates on the activity of pol
IV at replisomes. It remains also unknown if TLS polymerases have cofactors that allow these
polymerases into replisomes. With UmuD binding pol IV and UmuD being proposed to inhibit the bond
between  and , UmuD might make it easier for pol IV to get into the replisome (113). The role of
UmuD in the replisomal activity of pol IV is further discussed in chapter 5.
To determine the relevance of mutagenic TLS polymerase activity in the evolution of antibiotic
resistance, we need to better understand where these polymerases work and how these proteins compete
with other proteins, in the presence of antibiotics.

1.7

Single-molecule imaging: observing cellular processes in live bacterial cells

Sarah S. Henrikus
Published in ASM NSW-ACT Branch Syntrophy Newsletter, 2018; 19(2):3.

Single-molecule microscopy is a powerful new technique for studying molecular processes in
bacterial cells. Recent advances in camera technology and the availability of high power laser excitation
sources allow us to construct wide-field microscopes with such high sensitivity that the dynamics of
individual molecules can be observed within live cells in real time. Most commonly the molecules being
observed are proteins, which are fused to a bright fluorescent protein such as YPet, which is 2.5 x brighter
than eGFP. This is typically accomplished by modifying the gene encoding a protein of interest so that
the protein is fused to a fluorescent protein when expressed. The fluorescent protein signal in cells then
informs on the spatio-temporal behaviour of the protein in question. Provided that the modification leaves
regulatory sequences intact, fluorescence levels can be used to accurately monitor gene expression (114).
Single-molecule microscopy yields information that is not accessible through traditional
microscopy techniques. The most important difference is that diffusion modes of individual molecules
can be observed directly when imaging at the single-molecule level (115). Depending on the imaging rate
employed and the behaviour of the target protein, some molecules within cells will be detected as
punctate foci whereas others will be blurred. In other words, the diffusion behaviour of the protein
imparts contrast in the images. This contrast can yield information on protein activity. For instance,
video-rate movies recorded at 30 frames per second (30 Hz) cannot resolve a freely diffusing protein in
the cytoplasm as it moves too quickly (D ≈ 10 μm2/s). Consequently, a freely diffusing protein appears as
a blur not a distinct feature (see Fig. 6A). On the other hand, a molecule will diffuse more slowly when
bound to another molecule or to a larger structure. For example, a molecule bound to DNA moves slowly
in time and space (D ≈ 10-5 μm2/s). Thus when imaging at video rate, this molecule appears as a distinct,
bright feature, a static focus that can be resolved against a background of up to ~100 freely diffusing
molecules (see Figure 6B). Similarly, a protein in a multiprotein complex associated with DNA forms a
focus.

15

Figure 6: Blur vs distinct focus: features of the error-prone DNA polymerase IV tagged with the
fluorescent protein YPet. (A) In the absence of DNA damage, error-prone DNA polymerase IV has no
substrate to bind to. The fluorescent signal appears as a blur and not a distinct focus (B) After damage
induction using the antibiotic ciprofloxacin, binding sites for DNA polymerase IV open. Consequently,
this error-prone polymerase binds to DNA which is observed as distinct focus.
The concept described above is known as detection by localisation and allows us to observe
proteins as they carry out their cellular activities. Thus far the approach has most often been applied to
study DNA repair proteins and DNA polymerases, which are typically expressed at relatively low levels
(<1000 copies) and produce large diffusional contrast as they bind to, and dissociate from, sites on the
DNA (116).
Single-molecule microscopy allows for measurement of several parameters that cannot be
extracted with other techniques but are highly important to understand cellular processes. For example,
binding kinetics for individual proteins can be observed by analysing focus lifetimes (117). In
combination with mutants, binding modes can be correlated with its specific task in a cellular process.
Moreover, by increasing the image capture rate the position of a single protein can be tracked to reveal
microscopic changes in diffusive behaviour.
Detection by localisation can also be used to determine the stoichiometry of a protein complex by
correlating the intensity of a focus to the known intensity of a single fluorescent protein. This additional
information leads to a better understanding of how molecular machines might actually work. For instance,
single-molecule imaging allowed the composition and architecture of the Escherichia coli replisome
complex to be measured in live cells (33,36,116). Historically, the active replisome was believed to
contain two polymerase subunits. The live-cell imaging revealed that the replisome actually can contain
two or three.
Recently, my co-workers and I published on the error-prone Escherichia coli DNA polymerase
IV (pol IV) (118). Here we used two-colour co-localisation measurement to test competing models for
translesion DNA synthesis. In the most-cited model, translesion polymerases, such as pol IV, should
mainly act within the replisome and assist in lesion bypass. Our data demonstrated, however, that when
pol IV binds to DNA, it mainly does so outside of replisomes. Based on these observations and a previous
study on a second polymerase, pol V, we hypothesise that translesion polymerases primarily contribute to
DNA damage tolerance through post-replicative gap filling and other pathways, rather than by rescuing
stalled replisomes.
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In Escherichia coli, damage to the chromosomal DNA induces the SOS response, setting in motion a
series of different DNA repair and damage tolerance pathways. DNA polymerase IV (pol IV) is one
of three specialised DNA polymerases called into action during the SOS response to help cells
tolerate certain types of DNA damage. The canonical view in the field is that pol IV primarily acts
at replisomes that have stalled on the damaged DNA template. However, the results of several
studies indicate that pol IV also acts on other substrates, including single-stranded DNA gaps left
behind replisomes that re-initiate replication downstream of a lesion, stalled transcription
complexes and recombination intermediates. In this study, we use single-molecule time-lapse
microscopy to directly visualize fluorescently labelled pol IV in live cells. We treat cells with the
DNA-damaging antibiotic ciprofloxacin, Methylmethane sulfonate (MMS) or ultraviolet light and
measure changes in pol IV concentrations and cellular locations through time. We observe that
only 5–10% of foci induced by DNA damage form close to replisomes, suggesting that pol IV
predominantly carries out non-replisomal functions. The minority of foci that do form close to
replisomes exhibit a broad distribution of colocalisation distances, consistent with a significant
proportion of pol IV molecules carrying out postreplicative TLS in gaps behind the replisome.
Interestingly, the proportion of pol IV foci that form close to replisomes drops dramatically in the
period 90–180 min after treatment, despite pol IV concentrations remaining relatively constant. In
an SOS-constitutive mutant that expresses high levels of pol IV, few foci are observed in the
absence of damage, indicating that within cells access of pol IV to DNA is dependent on the
presence of damage, as opposed to concentration-driven competition for binding sites.

I carried out and analysed all in vivo single-molecule experiments, 4-nitroquinolone-1oxide survival assays and ciprofloxacin resistance assays. I was involved in strain
construction, analysis of Western blotting and the preparation of the manuscript.
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2.1

Author Summary
Translesion DNA polymerases play a critical role in DNA damage tolerance in all cells. In

Escherichia coli, the translesion polymerases include DNA polymerases II, IV, and V. At stalled
replication forks, DNA polymerase IV is thought to compete with, and perhaps displace the polymerizing
subunits of DNA polymerase III to facilitate translesion replication. The results of the current
fluorescence microscopy study challenge that view. The results indicate that DNA polymerase IV acts
predominantly at sites away from the replisome. These sites may include recombination intermediates,
stalled transcription complexes, and single-stranded gaps left in the wake of DNA polymerase III
replisomes that re-initiate replication downstream of a lesion.

2.2

Introduction
Translesion synthesis (TLS) DNA polymerases are produced at elevated levels in bacteria as part

of the SOS response to DNA damage (1). They have historically been thought to serve as a last resort
DNA damage-tolerance mechanism, re-starting replication forks that have stalled at damage sites on the
DNA (1–7). TLS polymerases are highly error prone: inducing their activities leads to increased rates of
mutation (error rates of up to 1 in every 100 nucleotides incorporated into DNA). TLS is an important
source of mutations that fuel bacterial evolution (8–13). For several species of bacteria, deleting genes for
TLS polymerases dramatically reduces rates of antibiotic resistance development in laboratory
measurements, and in some cases even reduces infectivity (9,14–22). Many of the drugs used to treat
bacterial infections cause an increase in mutation rates as a result of TLS (16). It remains unclear,
however, whether TLS polymerases contribute to resistance by providing damage tolerance, increasing
cell survival and thus the chances that a resistant mutant will be found, or by facilitating adaptive
mutation – selectively increasing mutation rates to speed the evolution of drug resistance (14–19).
DNA polymerase (pol) IV is thought to be the most abundant TLS polymerase in E. coli. From
Western blots, it has been estimated that levels of pol IV increase from approximately 250 molecules per
cell in the absence of DNA damage, to 2500 molecules per cell upon activation of the SOS damage
response (23,24). Pol IV promotes TLS on a variety of different lesion-containing DNA substrates,
although its tendency for misincorporation varies with lesion type (25–32). Pol IV bypasses adducts to the
N2 position of guanines and a variety of alkylation lesions in a mostly error-free fashion (28–30,33–35).
When overexpressed, pol IV induces -1 frameshift mutations in cells treated with alkylating agents (36).
In addition to these lesion bypass activities, pol IV participates in transcription (37–40) and double strand
break-repair repair (41–45), and contributes significantly to cell fitness in late stationary phase cultures in
the absence of any exogenous DNA damage (8). Pol IV is also reported to be required for formation of
adaptive point mutations in the lac operon and was found to be a major determinant in the development of
ciprofloxacin resistance in a laboratory culture model (9,46).
Visualisation of pol IV within live bacterial cells would make it possible to better understand
how pol IV activity is regulated in response to DNA damage and test proposed models for its TLS activity
at replisomes. Here, we report a single-molecule time-lapse approach to investigate pol IV dynamics and
kinetics in live E. coli cells under normal growth conditions and following treatment with the antibiotic
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ciprofloxacin, the DNA-damaging agent MMS, or ultraviolet (UV) light. Our analysis indicates that most
pol IV molecules carry out DNA synthesis predominantly outside replisomes and that access of pol IV to
DNA is governed by more than simple concentration-action driven polymerase exchange.

2.3

Results

2.3.1 Construction and validation of a chromosomal dinB-YPet fusion
To visualise time-dependent changes in pol IV activity in response to DNA damage, we
constructed an E. coli strain in which pol IV is fluorescently labelled, then imaged the resulting cells on a
purpose-built single-molecule fluorescence microscope (47). We created the pol IV-labelled strain in two
steps. We started with a plasmid-based dinB-eYFP construct, shown previously to be active for pol IVdependent DNA damage tolerance and mutagenesis by Mallik et al. (30). We first replaced the gene for
eYFP with the gene for the similar, but brighter, fluorescent protein, YPet. We then replaced the native
dinB gene on the E. coli K12 MG1655 chromosome with the dinB-YPet fusion gene using λRED
recombineering to create the strain EAW633. These cells express pol IV from its natural promoter, at its
native chromosomal locus, but with YPet fused to its C-terminus through a twenty-amino acid linker (Fig
1A). To facilitate two-colour imaging of pol IV and replisomes, we also produced two strains with DNA
polymerase III holoenzyme (pol III HE) markers. These strains expressed red fluorescent protein fusions
of the pol III HE τ-subunit (EAW643; dnaX-mKate2 dinB-YPet) and ε-subunit (EAW641; dnaQ-mKate2
dinB-YPet) respectively. We have previously used dnaX-YPet and dnaQ-YPet fusions to indicate the
position of replisomes (47). Both the dnaX-mKate2 and dnaQ-mKate2 alleles used here are fully
functional, having no impact on the growth of cells and showing no tendency for fluorescent proteininduced aggregation (48).
The expression and activity of the DinB-YPet fusion protein was verified using a series of three
assays. First, we carried out Western blots using anti-DinB antibodies in order to compare the expression
levels of DinB-YPet to those of untagged DinB (pol IV) in wild-type cells (Fig 1B, Supplementary
figure 1). In cells treated with ciprofloxacin, DinB-YPet is expressed at levels equivalent to wild-type
DinB, although a small amount (~20%) is proteolysed to two shorter fragments within the cells. The
larger fragment is probably produced via cleavage between the linker sequence and YPet, yielding YPet
and DinB-linker. The smaller fragment migrates similarly to DinB and is probably produced via cleavage
between the linker and DinB, yielding DinB and linker-YPet.
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p<0.05

Figure 1. Construction of E. coli cells expressing labelled pol IV and analysis of bypass and mutagenic
functions. (A) Construction of EAW633 (lexA+ dinB-YPet). The dinB gene of E. coli K12 MG1655 was
modified using λRED recombineering so that pol IV is expressed as a fusion with the bright yellow
fluorescent protein YPet (DinB-YPet). (B) Confirmation of DinB-YPet expression in ciprofloxacintreated cells. (Upper part) Western blot of extracts from cells (treated with 30 ng/ml ciprofloxacin for 120
min), developed using anti-DinB antibodies. Lanes: i) molecular weight marker; ii) MG1655; iii)
EAW633 (dinB-YPet); iv) EAW643 (dinB-YPet dnaX-mKate2); v) BL21 pLysS pET-DinB (uninduced
cell extract). Bands corresponding to full length DinB-YPet are clearly visible in lanes ii and iii. A small
amount of two DinB-containing fragments are also visible. Fragment 1 corresponds to DinB+linker.
Fragment 2 corresponds to DinB +/- one or two residues. (Lower part) Results of densitometry
measurements for lanes ii–iv. DinB-YPet is expressed at levels equivalent to wild-type DinB, however
~20% is proteolysed within the cells. (C) DinB-YPet retains lesion bypass activity. Strains were grown to
exponential growth phase (OD600 = 0.2), serial diluted, and spotted onto LB agar plates containing 8 μM
of 4-nitroquinolone-1-oxide (NQO). Because of an inability to bypass lesions induced by NQO, cells
lacking dinB are sensitized by 3 orders of magnitude relative to wild type cells. Cells expressing DinBYPet survival to levels equivalent to wild-type cells, indicating that DinB-YPet retains full lesion bypass
activity. (D) DinB-YPet facilitates mutation to ciprofloxacin resistance. Approximately 108 log-phase
cells were spread onto LB agar plates containing 40 ng/ml ciprofloxacin and incubated at 37°C for 13
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days. Colonies appearing on the plates were counted on days 4, 8 and 13. The number of new colonies
appearing between each interval was determined and normalised against viable cell counts, as described
in reference (9). Cells lacking dinB produced only 10% as many ciprofloxacin-resistant colonies as wildtype cells. DinB-YPet expressing cells produced similar number of resistant colonies as wild-type cells,
indicating that DinB-YPet supports mutagenic pol IV activities. p < 0.05 in two-sample t test for
differences of means of MG1655 and EAW633, 9-13 days.
We next exposed cells to the DNA damaging agent 4-nitroquinoline-1-oxide (NQO) and measured
survival using plate-based dilution assays (Fig 1C). As has been observed previously (29,44), cells
lacking pol IV (ΔdinB) were much more sensitive to NQO than wild-type cells. Cells expressing the
DinB-YPet fusion (EAW633) showed similar survival as wild-type cells, indicating that DinB-YPet
retains pol IV-dependent lesion bypass activity.
When plated on LB agar containing an inhibitory concentration of the antibiotic ciprofloxacin, E.
coli cells produce colonies of resistant mutants over the course of 13 days (9). It was found previously
that cells lacking pol IV activity give rise to fewer resistant mutants than wild-type cells (9). We repeated
these measurements and found that cells lacking pol IV (ΔdinB) produced only 10% as many
ciprofloxacin-resistant mutants as wild-type cells (Fig 1D). Cells expressing DinB-YPet (EAW633 and
EAW 643) produced similar numbers of resistant mutants as wild-type cells, indicating that DinB-YPet
also remains active for pol IV-dependent mutagenesis.

2.3.2

Direct observation of pol IV activity during the SOS response
We imaged EAW643 cells in the context of home-built flow-cells, which enable continuous flow

of media throughout our measurements. For this study, we recorded two types of fluorescence movies:
rapid-acquisitions, which capture the motions of molecules on the milliseconds–seconds timescale; and
time-lapse measurements, which capture changes in pol IV behaviour over the course of hours. Singlemolecule level measurements allow us to observe binding of pol IV molecules to DNA or pol IV as part
of a DNA-bound multiprotein complex. On our imaging timescale (34 ms exposures), proteins moving
freely through the cytosol diffuse quickly (D ≈ 10 μm2/s) and thus appear as a blur (Fig 2A). Any pol IV
molecules bound to specific binding sites on the DNA, however, should move much more slowly; their
motion will be dictated by the motion of the binding site. In E. coli, individual sites on the chromosome
have an apparent diffusion constant D ≈ 10-5 μm2/s (49). As pol IV requires ~100 ms to incorporate a
single nucleotide, we expect that any molecules synthesising DNA will appear relatively static in our
images and thus produce bright foci.
In the absence of damage, we observed small, but measureable DinB-YPet signals within cells,
consistent with continuous low-level production of pol IV (Fig 2B). It is possible to calibrate the
fluorescence intensities of cells against the intensity of individual molecules in order to determine the
number of molecules in each cell (see Experimental Procedures). We calculated that EAW643 cells
express 20 ± 3 molecules of DinB-YPet per cell (STD = 36; n = 105 cells) in the absence of damage.
Using cell size parameters measured from bright-field images it is further possible to determine the
volume of each cell, and subsequently to determine the DinB-YPet concentration. We calculate that in the
absence of damage the DinB-YPet concentration is 6 ± 1 nM.
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Figure 2. Single-molecule imaging of cells expressing DinB-YPet. (A) Detection of DNA-bound
molecules in single-molecule images. Molecules of DinB-YPet that are not bound to DNA will diffuse
quickly (D ≈ 10 μm2/s for a typical cytosolic protein) and thus signals from individual molecules will blur
over the entire cell in our images (exposure time = 30–100 ms). Molecules of DinB-YPet that are bound
to DNA, however, experience greatly reduced motion and thus appear as punctate foci. Because of this
diffusional contrast, it is possible to detect individual molecules of DinB-YPet when bound to DNA. (B)
Single-molecule sensitive fluorescence image of undamaged EAW643 cells showing low-level DinBYPet signals at 50 ms exposure time. (C) Average projection of rapid acquisition (effective exposure time
306 ms) for DinB-YPet (left) and DinBD103N-YPet (right). (D)Time-lapse imaging of pol IV upregulation in response to ciprofloxacin treatment. Images shown are a montage of a three-hour time-lapse
series. Cells were initially grown in rich medium in the absence of exogenous DNA damage. At t = 0 min,
the flow cell inlet was switched to medium containing 30 ng/ml ciprofloxacin. At each field-of-view, a
bright-field image and a DinB-YPet fluorescence image were collected every 5 min for 180 min. Time
stamps indicate hours after ciprofloxacin addition.
The pol IV levels measured here by microscopy are somewhat lower than previous estimates of 250
molecules of pol IV per cell, based on Western blots (24). It has been demonstrated previously that under
conditions similar to those used here that >90% of YPet molecules are in the mature, fluorescently active
form (50). The small amount of proteolysis of DinB-YPet observed in the Western blot (Fig 1B) would be
expected to yield an intact YPet fragment. Thus, the microscopy-based measurements should still produce
an accurate measure of DinB levels. At worst, DinB levels would be underestimated by ~20%. To probe
this discrepancy further, we repeated the Western blot analysis (Supplementary figure 1). The values we
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calculated varied considerably between replicates, reflecting the difficulties associated with quantifying
Western blots of low abundance proteins. All values were, however, significantly lower than those
determined in the Kim et al. study and were consistent with the fluorescence microscopy results. Taking
the mean of two independent blots, the current Westerns indicate that MG1655 contain 33 molecules of
DinB per cell on average. The strain used in the Kim et al. study, YG2247 (a derivative of P90C) returns
similar value: 30 molecules per cell on average. DinB-YPet was measured at 19 molecules per cell. The
fluorescence microscopy measurements presented here are much more sensitive, and far less variable,
than Western blotting and likely to provide more accurate results. We therefore conclude that the value
measured by fluorescence microscopy, 20 molecules of DinB per cell, is correct and that the original
value of 250 was an overestimation (24).
In rapid acquisition movies, we observe that the DinB-YPet signal is primarily diffuse (Fig 2B):
cells contain 0.5 ± 0.5 foci per cell on average (i.e. one focus for every two cells; STD 1.11; n = 105
cells).
We then induced DNA damage by switching to medium containing 30 ng/mL ciprofloxacin, an
antibiotic that inhibits DNA gyrase and forms covalent adducts on the DNA (51). These inhibit DNA
replication and lead to induction of the SOS response. Under these conditions, we observed that cells
were longer and exhibited stronger DinB-YPet signals (Fig 2C). This observation is consistent with
increasing production of pol IV as part of the SOS response, leading to higher concentrations of pol IV in
the cell. Punctate foci were visible after ciprofloxacin addition, consistent with pol IV binding to DNA.
Cells expressing a catalytically dead variant of pol IV (52,53), DinB(D103N)-YPet, did not produce foci
when imaged under the same conditions (Fig 2C). We therefore conclude that ciprofloxacin treatment
leads to a significant increase in the number of pol IV binding events on the DNA.
Time-lapse analysis indicated that cells filament and exhibit a strong increase in DinB-YPet
fluorescence, beginning approximately 20 min after the addition of ciprofloxacin (Fig 2D; Fig3A–B,
Supplementary Movie 1). From 90–180 min, the DinB-YPet concentrations plateaus. We calculate that
at this point, cells contain an average of 279 ± 33 DinB-YPet molecules per cell (STD 28; n = 105 cells).
Thus, ciprofloxacin-treated cells contain 14 times more molecules of DinB-YPet than undamaged cells.
Due to damage-induced filamentation, however, the ciprofloxacin-treated cells are 2.5 times larger in
volume. Thus, the concentration of DinB-YPet after treatment with ciprofloxacin is 34± 3 nM, is only 5.5
times higher than in the absence of damage. The number of pol IV molecules per cell that we measure by
microscopy after ciprofloxacin treatment is lower than previous estimates of pol IV expression (~2500
molecules per cell) based on Western blotting of MMS-treated cells (24). Values measured by Western
blot during the current study were highly variable, but all were significantly lower than the previous
estimate of 2500 molecules per cell. The values measured here, ~100 molecules per cell following
treatment with 30 ng/ml ciprofloxacin for 2 h, are more consistent with those measured by fluorescence
microscopy (Supplementary figure 1). We conclude that the value originally published by Kim et al. is
likely to be overestimated. Based on the microscopy results, which are likely to be more accurate than
those of Western blots, we concluded that there are 250 molecules of DinB per cell following
ciprofloxacin treatment.
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Figure 3. Scatter plots of cell-size and fluorescence signal parameters from time-lapse imaging of DinBYPet cells treated with ciprofloxacin. White points indicate individual data-points, while blue-to-red
contours indicate frequencies of observations. Blue areas indicate regions of the plot containing few data
points; red areas indicate regions containing a large number of data points. Frequencies were normalised
at each time-point to the maximum value at that time-point. (A) Distribution of cell lengths based on
bright-field images, showing ciprofloxacin-induced filamentation. (B) DinB-YPet fluorescence per cell,
measured as the mean pixel intensity within each cell, showing up-regulation of DinB-YPet. (C) Density
of DinB-YPet foci, measured as the number of foci per cell area (μm2), showing the density remains
relatively constant over the three-hour measurement. (D) Integrated fluorescence intensity of foci. Each
focus was fit with a 2D Gaussian function; the volume under this function represents the integrated
fluorescence intensity. Foci become brighter over the course of the measurement, indicating that a higher
number of DinB-YPet molecules bind at each binding site. We conservatively estimate that >100 cells
were used in each measurement.
We next measured as a function of time the number of DinB-YPet foci per cell area (i.e. the density of
foci throughout the cell) and their intensities. The density of DinB-YPet foci in cells remained relatively
constant (Fig 3C), the intensities of foci increased slightly over time (Fig 3D), following a similar trend
as the increase in pol IV concentration (Fig 3B). These observations indicate that the number of binding
sites for pol IV in each cell remains relatively constant from 30–180 min after ciprofloxacin addition,
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whereas the number of molecules bound at each binding site increases in time. Comparing the intensities
of DinB-YPet foci to the intensity of a single YPet molecule, we calculate that in the early stages of the
response (30–90 min, foci contain 1–2 DinB-YPet molecules while in the later stages (90–180 min), foci
contain 2–4 molecules (Supplementary Figure 2).

2.3.3

Colocalisation between pol IV and replisomes
Two models have been proposed for pol IV activity in the vicinity of replisomes. In the first and

most widely cited model, pol IV acts within the replisome (1–7). Here the pol IV exchanges with a pol III
that has stalled at a lesion in the template, bypasses the lesion, then exchanges back out of the replisome,
allowing pol III to continue with processive DNA synthesis. In the second model pol IV carries out
postreplicative TLS at gaps left in the wake of replisomes that skip over lesions (54–56). In principal both
mechanisms could be at play within cells. In addition to these (near) replisomal activities, a number of
studies have implicated pol IV in a variety of other cellular processes, including transcription and
recombination (30,37–45).
To further examine the activities of pol IV inside and outside the replisomal context, we imaged
both DinB-YPet and a replisome marker, either DnaX-mKate2 or DnaQ-mKate2, which allowed us to
visualise the position of pol III HE complexes. The DnaX (τ-subunit) and DnaQ (ε-subunit) proteins are
stably associated within the pol III HE in E. coli; they do not exchange in and out of the complex (48).
We assume that foci formed by DnaX-mKate2 and DnaQ-mKate2 exclusively indicate the positions of
pol III HE complexes acting within replisomes. From this point, we make reference to replisome markers
and replisome foci. These refer to DnaX-mKate2 foci unless otherwise stated. As the pol III HE contains
(at least) two polymerases, we expect that if pol IV exchanges with one of the pol III cores, pol III HE
will remain bound and the pol IV and replisome markers will colocalise. On the other hand, if pol III HE
does fully dissociate from the DNA as pol IV binds at the replication fork, the DinB-YPet and replisome
foci would not colocalise. In this case we would expect that as the number of DinB-YPet foci in cells
increased, there would be a significant decline in the number of replisome foci.
We recorded two-colour time-lapse movies and measured the number of replisome and pol IV
foci as a function of time, as well as their colocalisation (Fig 4). Two forms of analysis were carried out.
To further investigate whether pol IV acts within or behind replisomes, we measured pair-wise distances
between pol IV foci and replisome markers. To investigate the balance between (near) replisomal and
non-replisomal activities of pol IV, we measured time-dependent changes in the proportion of pol IV foci
that tightly colocalised with replisome markers.
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Figure 4. Colocalisation of pol IV with replisomes. (A) Montage of two-colour time-lapse movie
recorded after treatment 30 ng/mL ciprofloxacin. Pol IV (DinB-YPet) foci appear green and replisome
(DnaX-mKate2) foci appear in magenta. Colocalised foci appear white. For display purposes, images
were subjected to spatial filtering to enhance foci (47). (B-C) Analysis of colocalisation distances for foci
detected in two-colour images. (B) Diagram of area shells used for colocalisation analysis. As
colocalisation is a radial measurement, histograms of colocalisation distances are constructed using bins
of linearly increasing area rather than distance. (C) Histograms of colocalisation distances for foci within
a doubly labelled replisome strain (EAW203; dnaX-YPet dnaQ-mKate2) and a two-colour pol
IV/replisome strain (EAW643; dinB-YPet dnaX-mKate2). As expected, distances between DnaX-YPet
and DnaQ-mKate2 foci fall within a narrow distribution, indicative of ‘tight’ colocalisation. Distances
between DinB-YPet and DnaX-mKate2 foci present a much broader distribution, indicative of ‘loose’
colocalisation. (D) Plot of the number of pol IV and replisome foci per EAW643 cell as a function of
time. Data were compiled from ten technical replicates. Shaded areas indicate the standard error of the
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mean between these replicates. Some cells were lost from the coverslip surface during the measurement.
A total of 188 cells remained bound and were analysed over the full course of the measurement. (E) Plots
of mean cell intensity and colocalisation between pol IV and replisome foci. The mean cell intensity (grey
shaded area) is a direct measure of the pol IV concentration in cells. Foci located within 200 nm of each
other were defined as being colocalised. Colocalisation was measured in two ways: the proportion of pol
IV foci that contain a colocalised replisome focus (black line), and the proportion of replisome foci that
contain a colocalised pol IV focus (orange line). Data were compiled from ten technical replicates.
Shaded areas indicate the standard error of the mean between these replicates. The total number of cells
analysed were not determined in these measurements. We conservatively estimate that >1000 cells were
used in each measurement. The analysis includes a total of 17005 DnaX-mKate2 foci and 12408 DinBYPet foci.
If pol IV carries out replicative TLS (within the replisome), one would expect to observe ‘tight’
colocalisation of pol IV foci with replisome foci; a histogram of pair-wise distances between DinB-YPet
and DnaX-mKate2 foci would be expected to produce a relatively sharp peak. One might also expect
enrichment of pol IV foci close to replisomes if pol IV instead carries out postreplicative TLS in gaps left
behind the replisome. In this case however, replisomes would be expected to rapidly move away from
gaps after they are created. This would lead to a type of ‘loose’ colocalisation that would manifest as a
broad distribution of distances between pol IV foci and replisome markers.
We first measured pair-wise distances between foci in the strain EAW203 (dnaX-YPet dnaQmKate2) as a control. In this strain, the replisomes are labelled in two colours, producing a very high
degree of colocalisation in two-colour images (48). Pair-wise distances between DnaX-YPet and DnaQmKate2 foci were plotted as a histogram. As colocalisation is a radial measurement there is a higher
probability of detecting pairs separated by longer distances because longer search radii will cover a larger
area of the image. To account for this, we assigned histogram bins based on shells of regularly increasing
area rather than binning by linear distances (Fig 4B). For the two-colour replisome strain, the histogram
contained a sharp peak (Fig 4C). All mKate2 foci fell within 218 nm of a YPet focus (i.e. they fell within
a 15 × 104 nm2 area shell). The width of the peak reports on the colocalisation error, which is a product of
the localisation errors associated with fitting the YPet and mKate2 foci and any sample motion that occurs
in the interval between collecting images in each colour channel (~2 s). We then repeated the analysis for
the two-colour pol IV/replisome strain. A histogram of pair-wise distances for pol IV and replisome foci
showed a considerably broader peak (Fig 4C), indicative of ‘loose’ colocalisation. Together these
observations suggest that many DinB-YPet foci form close to, but not at replisomes. Thus, the results of
this analysis are consistent with pol IV carrying out postreplicative TLS. With the current data, it is not
possible to determine if pol IV carries out postreplicative TLS exclusively, or if both replicative and
postreplicative TLS occur.
We next analysed time-dependent changes in colocalisation behaviour. Based on the histogram
of pair-wise distances for the two-colour replisome strain (Fig 4C), we defined foci detected in time-lapse
analyses as being colocalised if their fitted centroid positions fell within 200 nm of each other. We found
that following ciprofloxacin treatment the number of replisome spots in cells remained relatively constant
over time, indicating that pol III HE was not being removed from replisomes to a large extent (Fig 4D).
We determined colocalisation in both directions, i.e. we measured the proportion of DinB-YPet foci that
overlapped with a replisome focus, as well as the proportion of replisome foci that overlapped with a pol
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IV focus. From 0–100 min after ciprofloxacin addition, 10% of pol IV foci colocalise with replisomes
(Fig 4E), significantly above levels expected by chance (~5%, see Experimental Procedures), but well
below levels expected if pol IV predominantly operates in the vicinity of replisomes. This observation
suggests that the majority of pol IV’s activities could be non-replisomal (see Discussion). Additionally,
we found that in the late stages of the SOS response there was an even higher proportion of nonreplisomal pol IV foci: from 100 min the proportion of pol IV foci that colocalise with replisomes falls to
just 2.5%. Similar behaviour is observed when measuring colocalisation in the other direction. From 0–60
min, the proportion of replisomes that contain pol IV increases to 7%, tracking the increase in pol IV
concentration within that period. From 60–100 min, the colocalisation plateaus at this level (modestly
above the level expected by chance), in line with a plateau in the pol IV concentration. From 100–180
min, however, the proportion of replisomes that contain pol IV falls sharply; the average colocalisation is
~3% between 110–180 min, close to levels expected by chance. In contrast, the pol IV concentration
remains elevated during this period. For both replisomes and pol IV, a plot of the number of foci per cell
shows no evidence of a sharp transition at 100 min (Fig 4D), ruling out the possibility that the drop in
colocalisation (Fig 4E) results from sudden loss of replisome or pol IV foci. Throughout the first 100
min, the concentration of pol IV increases, whereas the proportion of pol IV foci that colocalise with a
replisome marker remains relatively constant. This indicates that the proportion of pol IV molecules that
bind near replisomes is independent of the pol IV concentration. Similar results were obtained using
EAW641, in which replisomes are marked by expression of DnaQ-mKate2 rather than DnaX-mKate2
(Supplementary figure 3).
To determine which DinB-YPet foci are likely to represent catalytically active molecules, we
measured colocalisation using a longer (300 ms) exposure time. Pol IV molecules engaged in DNA
synthesis may remain associated with the DNA for longer than molecules that bind non-productively to
DNA or to other factors. In 300 ms images, foci are visible in DinB-YPet cells, but not in cells expressing
catalytically dead DinB(D103N)-YPet (Fig 2C). In time-lapse images we detected fewer foci than when
using 50 ms exposures (Supplementary figure 4), however the proportion of foci that colocalised with
replisomes in 300 ms images (5%; Supplementary Figure 4) was similar to that observed in 50 ms
exposures (10%; Fig 4E). Furthermore, a similar drop in colocalisation at 100 min was observed. From 090 min, 5% of pol IV foci overlap with a replisome (Supplementary figure 4). From 100-180 min, the
colocalisation drops to 1.5%. Colocalisation of replisomes with pol IV shows a similar trend. From 0-90
min, 0.5% of replisomes have a pol IV focus, however, after 90 min only 0.2% of replisomes contain a
pol IV focus. The fact that colocalisation was similar for both the 50 ms and 300 ms exposures indicates
that there is no major difference in the lifetimes of foci formed near to, or away from replisomes and
suggests that pol IV engages in DNA synthesis at sites both near to, and away from replisomes.

2.3.4

Pol IV activity is not governed by mass action-driven competition
In light of the observation that the colocalisation of pol IV and replisomes does not track with

pol IV concentration, it is unlikely that access of pol IV to different DNA substrates is governed by mass
action-driven competition alone. To explore this issue further, we altered the expression levels of pol IV
in two different ways and examined the effects on pol IV focus formation and colocalisation with
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replisomes. We first increased the amount of pol IV in cells by transforming SSH001 cells (ΔdinB dnaQmKate2) with the DinB-eYFP plasmid used by Mallik et al (30). Within this plasmid, pol IV is expressed
from its natural promoter. However, because the plasmid is maintained at ~5–10 copies per cell, pol IV
levels are expected to be much higher than when it is expressed from the chromosome.
We repeated the time-lapse analysis for this plasmid-containing strain and observed much higher
levels of fluorescence (Fig 5A). We calculated that cells contain approximately 7000 molecules of DinBeYFP after 90 min; already 14-fold higher than in cells expressing only DinB-YPet from the chromosome
(280 molecules per cell) after >120 min. Despite this large change in the amount of pol IV, we observed
the same time-dependent loss of colocalisation as before, although colocalisation in the initial stages of
SOS was somewhat higher (Fig 5B). In the plasmid-containing strain, we found that the proportion of
replisomes that contained a pol IV focus increased from 3 to 20 % within the first 90 min after
ciprofloxacin addition. Similarly, the proportion of pol IV that colocalise with a replisome focus is 25–30
% from 0 – 90 min. We found that pol IV foci were noticeably brighter in the presence of the pol IVexpressing plasmid than in its absence, especially after 100 min (Supplementary Figure 5A). We
calculated that each focus contains ~3-10 molecules of pol IV, while at the later stages foci contain > 30
molecules of pol IV (Supplementary Figure 5B). Cells that carried the dinB-eYFP plasmid only (i.e.
they lacked a chromosomal copy of dinB) produced foci that showed similar levels of colocalisation with
replisomes as cells that contained both dinB-YPet and dinB-eYFP (Supplementary Figure 6).

Figure 5. Colocalisation of pol IV with replisomes in the presence of additional fluorescently labelled pol
IV expressed from a plasmid. (A) Mean cell intensity measurements for EAW643 cells (Pol IV+; light
grey line) and EAW643 cells containing pPFB1188 (expressing additional DinB-eYFP from the dinB
promoter; Pol IV++; dark grey line). Cells containing pFB1188 clearly express much higher levels of
labelled pol IV, however because cells contain an unknown ratio two different YFPs (DinB-YPet and
DinB-eYFP), it is not possible to measure the pol IV concentration. (B) Plots of mean cell intensity and
colocalisation between pol IV (DinB-YPet/DinB-eYFP) foci and replisome (DnaX-mKate2) foci. The
mean cell intensity (grey shaded area) is a convoluted measure of the combined DinB-YPet and DinBeYFP concentrations in cells. Colocalisation was measured in two ways: the proportion of pol IV foci that
contain a colocalised replisome focus (black line), and the proportion of replisome foci that contain a
colocalised pol IV focus (orange line). Data were compiled from ten technical replicates. The total
number of cells analysed were not determined in these measurements. We conservatively estimate that
>500 cells were used in each measurement. The analysis includes a total of 27651 DnaX-mKate2 foci and
31978 DinB-YPet/DinB-eYFP foci.
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Importantly, we found that the dinB-eYFP plasmid is toxic to cells during the late SOS response. We
observed that 17% of cells carrying the dinB-eYFP plasmid lysed upon ciprofloxacin treatment
(Supplementary Figure 7). In comparison, <3% of wild-type MG1655 or EAW643 cells lysed during the
measurements. We also noted that cells containing the DinB-eYFP plasmid elongated at a much slower
rate than the either EAW643 lacking the plasmid or wild-type cells. These observations suggest that in the
presence of the dinB-eYFP plasmid, pol IV reaches concentrations high enough above wild-type levels
that it begins to interfere with cell growth.
We next examined pol IV behaviour in lexA(Def) cells. This background contains a mutation that
inactivates the LexA repressor protein, causing cells to constitutively express high levels of all proteins
within the SOS regulon, including pol IV (23,57,58). To prevent cell death from constitutive SOS-driven
filamentation, we also introduced a sulA- mutation. The lexA(Def) background allowed us to investigate if
high concentrations of pol IV allow it to bind to DNA in the absence of DNA damage. In the lexA(Def)
background, we calculate the concentration of pol IV to be 96.5 ± 7.29 nM (STD 53.54 nM, n = 54 cells),
15.6 times higher than undamaged wild-type cells, and 2.8 times higher than wild-type cells treated with
ciprofloxacin for 2h. The elevated concentrations of DinB-YPet in the lexA(Def) background created a
high background of diffuse fluorescence signal, making it difficult to observe pol IV foci directly (Fig
6A). Instead, we recorded fluorescence movies at high time resolution as DinB-YPet photobleached.
Once ~50% of the DinB-YPet had bleached, it was possible to observe foci. These foci, however, were
extremely transient, rarely persisting beyond a single 34 ms frame, indicative of only short-lived events
on the DNA. It appeared that very few of these transient foci colocalised with replisomes. To examine this
more closely, we analysed time-dependent fluctuations in DinB-YPet signals at replisomes, and away
from replisomes, and compared signals from undamaged lexA(Def) cells against signals from wild-type
cells treated with ciprofloxacin (Fig 6B; Supplementary figures 8-9). The trajectories indicate some
transient binding of DinB-YPet at replisomes in the lexA(Def) strain, however these trajectories appear
comparable to those for regions-of-interest placed outside of replisomes. In comparison, replisome
trajectories in the ciprofloxacin-treated wild-type cells often indicated pol IV binding events lasting >1s
before dissociation or photobleaching occurs. These observations clearly indicate that even the highest
concentrations of pol IV that could naturally occur in cells at the height of the SOS response are not
enough to allow pol IV to enter replisomes and productively synthesise DNA. Pol IV either requires DNA
damage, or additional factors that accumulate in response to damage, to be recruited to DNA.
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Figure 6. Comparison of DinB-YPet behaviour in untreated, lexA(Def) cells and ciprofloxacin-treated
lexA+ cells. (A) Representative images of ciprofloxacin-treated lexA+ cells (left) and untreated lexA(Def)
cells (right). (B) Representative intensity vs time trajectories for DinB-YPet signals in the vicinity of
replisomes. Additional, randomly selected trajectories appear in Supplementary figure 7 (ciprofloxacintreated lexA+ cells) and Supplementary figure 8 (untreated lexA(Def) cells). 5×5 pixel regions of interest
were placed at replisome foci, then used to monitor fluctuations in DinB-YPet signals (see panel A). In
ciprofloxacin-treated lexA+ cells, DinB-YPet signals are elevated in the vicinity of replisomes for multiple
frames, indicating long-lived binding events. In untreated lexA(Def) cells no events are visible in which
the DinB-YPet is elevated in the vicinity of replisomes for more than a single 34 ms frame, indicating no
long-lived binding events.

2.4

Discussion

2.4.1 Non-replisomal activities of pol IV
We observed that only 5–10% of pol IV foci tightly colocalise with replisome markers.
Assuming that these foci indicate sites of pol IV binding (short- and long-lived binding events) to the
DNA, this observation implies that the vast majority of pol IV molecules could work on other, as yet
unidentified substrates. What other DNA structures might pol IV work at? Do the mutagenic and nonmutagenic lesion-bypass activities of pol IV relate to its action at replisomes, as is often assumed, or do
they relate to activities at other DNA structures? Pol IV has been previously found to be involved in a
range of different pathways, including rescue of stalled transcription complexes (38), double-strand break
repair (30,59), adaptive mutation (46,60) and stationary phase fitness (8). It is possible that the non-
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replisomal DinB-YPet foci that we observe represent pol IVs participation in these pathways.
Determining how pol IV activity is distributed amongst these various pathways is far beyond the scope of
this study. It is clear, however, that two-colour fluorescence imaging has a large part to play in
characterising the range of substrates used by pol IV in cells.

2.4.2

Replisome-proximal

activities

of

pol

IV:

TLS

is

predominantly

postreplicative
The minority of pol IV foci that do form near replisomes show only loose colocalisation: there is
a very broad distribution of distances between pol IV foci and replisomes. This result is inconsistent with
the notion that pol IV-dependent TLS exclusively takes place at replications forks that have stalled at a
damage site on the template DNA (1–7). The results strongly suggest that pol IV is capable of carrying
out post-replicative TLS within gaps behind the fork. The results do not indicate, however, whether pol
IV acts purely in a post-replicative sense, or whether both replicative and post-replicative TLS are
possible. Although the DinB-YPet fusion behaves like wild-type pol IV in the NQO-survival and
ciprofloxacin resistance assays, we cannot formally rule out the possibility that the addition of YPet to pol
IV somehow alters the balance between TLS at replication forks vs TLS within gaps.
There is a well-established, and growing, body of literature that points to replisomal lesion
skipping as a major mechanism of DNA damage tolerance in bacteria (54–56; 61–68). The idea that pol
IV participates in post-replicative TLS is consistent with the lesion-skipping scenario, as proposed
previously (69–72). Rather than replisomes stalling when they encounter lesions, they simply re-prime the
template and continue synthesis downstream of the lesion. In its wake, the replisome leaves a lesioncontaining single stranded DNA gap. Such gaps could not be repaired by pathways that work on double
stranded DNA, such as nucleotide excision repair, and would instead be initially bypassed, either by TLS,
or by recFOR-mediated daughter strand gap repair. Based on a lack of colocalisation with replisome
markers, we have previously hypothesised that another TLS polymerase, pol V, also carries out postreplicative TLS in single stranded DNA gaps (47). It would of considerable interest to determine if the
third TLS polymerase in E. coli, pol II, also shows loose colocalisation with replisomes in cells carrying
DNA damage.

2.4.3

Pol IV does not access replisomes through mass action-driven exchange

with pol III HE
A conventional view has been that pol IV gains access to replisomes upon SOS induction
because it is produced at higher concentrations, allowing it to better compete with pol III HE for binding
to replication forks (1–7,54). Observations made during the current study are inconsistent with this simple
mass action-driven mechanism.
The most direct evidence comes from the analysis of SOS-constitutive lexA(Def) cells (Fig 6).
Introduction of the lexA(Def) mutation increased the concentration of DinB-YPet to nearly 100 nM; more
than 15-times higher than the concentration present in undamaged lexA+ cells. Despite this increase in
concentration, there were almost no pol IV foci visible in the lexA(Def) cells. This indicates that pol IV
concentrations up to 100 nM are insufficient for pol IV to enter the replisome, or for that matter, any other
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binding site on the DNA. In contrast, pol IV is able to access the DNA in cells treated with DNA
damaging agents, even when the pol IV concentration was significantly below 100 nM. Thus, it appears
that DNA damage is required for pol IV to access the DNA, at least within the concentration regimes
expected to occur in wild-type cells. Interestingly, the pol IV concentration did affect the number of pol
IV molecules that bound to each binding site on the DNA. Expression of DinB-eYFP from a low-copy
plasmid increased the concentration of labelled pol IV up to 14-fold relative to when DinB-YPet was
expressed from the chromosome. This induced only a mild increase in the proportion of pol IV foci that
colocalised with replisomes, however the number of molecules present within each focus increased: in the
absence of damage there were 1–2 DinB-YPet molecules per focus, increasing to 3–10 molecules per
focus when DinB-eYFP was expressed from the plasmid; in the presence of damage there were 3–4
DinB-YPet molecules per focus, increasing to >30 molecules per focus when DinB-eYFP was expressed
from the plasmid. Thus, within the bounds of cellular pol IV concentrations, higher pol IV concentrations
do not open up new binding sites at replisomes, or any other site on the DNA. High concentrations do,
however, allow more pol IV to bind at each binding site.

2.4.4

Pol IV is granted only temporary access to replisome regions
We conclude that pol IV has very limited access to the region close to replisomes, even after the

induction of the SOS response. Access to the replisome region, be it direct access to the replisome or
access to ssDNA gaps, is restricted to the first 100 minutes after induction of the SOS response
(colocalisation drops after this point), and involves only a small subset of the replisomes and pol IV
molecules. What factors could temporarily licence pol IV to enter the area of cells close to replication
forks?
In eukaryotes, TLS polymerases are licenced to enter replisomes at least in part through
ubiquitination of the PCNA sliding clamp (73). To our knowledge, pol IV and replisome components are
not altered biochemically during the SOS response. Pol IV is currently thought to access replisomes
through a series of physical interactions that it forms with the β-sliding clamp and pol III (74–78). Such
interactions could conceivably provide pol IV with access to gaps behind the replisome. These gaps are
unlikely to contain pol III HE. There is, however, evidence supporting that three pol III core subunits
present at the fork in E. coli allow for shorter Okazaki fragment (79). Perhaps pol III cores compete with
pol IV for binding to gaps and the previously described interactions between the two facilitate switching
in that context.
It is assumed that when the replisome skips a lesion it leaves a β-sliding clamp behind at the gap.
The known interactions of pol IV with the β-sliding clamp are likely to be involved during postreplicative TLS by pol IV. It is difficult to imagine, however, how these interactions could be modulated
to provide access to gaps during early stages of the SOS response, while excluding pol IV in late stages of
the SOS response. One possibility is that the gaps are no longer created during late stages of the SOS
response. Another possibility is that a protein (or complex) binds to either pol IV, or the β-sliding clamp
during the late SOS response and prevents pol IV from acting at gaps. Alternatively, a protein (or
complex) that is active only during the early stages of SOS could help to recruit pol IV to gaps.
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2.4.5

SOS progresses through periods of distinct enzyme activities
A new model of the bacterial SOS-response is emerging in which different proteins are put into

play during discrete time periods, as depicted in Figure 7. In the current study, we revealed that pol IV is
permitted access to the region close to replisomes 30–100 min after ciprofloxacin addition, after which it
is excluded from these regions. This behaviour is not limited to ciprofloxacin treatment: we observe a
similar series of events following treatment with both MMS and ultraviolet light (Supplementary figure
10). Interestingly, the time-point where pol IV is ejected from the replisome region matches well with the
timing of a key event in the regulation of another TLS polymerase, pol V (47). We previously discovered
that pol V becomes activated for TLS 90–120 min after cells are damaged with ultraviolet light. We
found that the pol V subunit, UmuC, is produced ~45 min after irradiation. However, the protein is
sequestered at the inner membrane, keeping it away from the DNA. From ~90 min after damage, the
other critical component of pol V, UmuD′2, is produced by RecA*-mediated autoproteolysis of UmuD2
(78). As this point, the pol V complex (UmuD′2-UmuC) forms, becomes activated to pol V Mut (UmuD′2UmuC-RecA-ATP) through interaction with a RecA* nucleoprotein filament, and is released from the
membrane to catalyse TLS. This same series of events occurs when treating pol V-labelled cells with
ciprofloxacin (Supplementary figure 11).
That the ejection of pol IV from the replisome region occurs at ~90–100 min, the same timepoint at which pol V is released from the membrane (Fig 7), suggests a possible functional link between
the two enzymes. In the previous study, we demonstrated that pol V Mut does not act at replisomes,
ruling out the possibility that pol IV is excluded from replisome regions because it is out-competed by pol
V. Based on far-Western blots and pull-down experiments, it has been previously suggested that pol IV
interacts with both UmuD2 and UmuD′2 (78). UmuD2 (and presumably UmuD′2) are produced in excess
over UmuC, at concentrations similar to pol IV. It is therefore tempting to speculate that UmuD2,
UmuD′2, or both, modulate the access of pol IV to replisome regions. This hypothesis will be tested
further in future work. Put together, the results of our previous and current studies suggest that the SOS
response progresses through (at least) three stages: an early period (0–30 min) of predominantly error-free
repair; a middle period (30–90 min) that includes pol IV-catalysed TLS at gaps behind the replication
fork; and finally, a mutagenic period (>90 min) in which pol V Mut is active.
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Figure 7. Timeline of translesion DNA synthesis based on single-molecule imaging studies. Pol IV is
expressed relatively early after DNA damage is incurred and is allowed access to replisomes until cells
abruptly transition into the late stage. At this transition, pol IV is ejected from replisomes and a second
TLS polymerase, pol V Mut becomes activated. Pol IV continues to act on non-replisome substrates. The
timescale indicated for these transitions is likely to be specific to our growth conditions (EZ glucose
medium; APTES-treated flow cell; 37°C). We anticipate that under different conditions the same
transitions would be observed, but at different time-points.

2.5

Experimental procedures

2.5.1 Cell constructs and plasmids
EAW633 is E. coli K-12 MG1655 dinB-YPet (80). It was made by λRED recombination (81),
replacing the wild-type dinB gene with dinB-YPet and a mutant FRT-Kanamycin resistance-wt FRT
cassette. Positive colonies were selected for kanamycin resistance. The fusion gene dinB-YPet encodes
pol IV, a C-terminal twenty amino acid spacer (as used in (29)), followed by YPet.
EAW641 and EAW643 are two-colour strains derived from EAW633. The kanamycin resistance
marker in EAW633 was removed via FLP-FRT recombination using the plasmid pLH29 (81). To
construct EAW643, λRED recombination was used to replace the dnaX gene of EAW633 with dnaXmKate2 and a mutant FRT-Kanamycin resistance-wt FRT cassette. Colonies were selected for kanamycin
resistance. The dnaX-mKate2 fusion encodes the τ-subunit of pol III HE, a C-terminal 11 amino acid
linker followed by mKate2. EAW641 was constructed in a similar manner, replacing the dnaQ gene in
EAW633 with a dnaQ-mKate2 fusion.
To increase the intracellular concentration of labelled pol IV, we used the plasmid pPFB1188,
which expresses DinB-eYFP (pol IV labelled at its C-terminus with eYFP, through a twenty amino-acid
linker; (30)). To generate EAW643 pPFB1188 cells, we transformed EAW643 cells with pPFB1188,
selecting for ampicillin resistance. Cells carrying a replisome marker, but lacking dinB were used in
control measurements. SSH001 is E. coli MG1655 dnaQ-mKate2 lexA+ dinB::kanR. It was made by
transferring dinB::kanR by P1 transduction from SF2006 (8) into EAW192 (48). SSH001 pPFB1188 was
generated by transforming SSH001 cells with pPFB1188 (30).
RW1594 is E. coli MG1655 dinB-YPet dnaX-mKate2 lexA(Def) sulA::kanR. It was made in two
steps: first the wild-type sulA+ gene of EAW643 was replaced with sulA::kan by P1 transduction from
EAW26 (47), to create RW1588; then lexA51(Def) malB::Tn9 was transferred from DE406 (82) into
RW1588 by P1 transduction, selecting for chloramphenicol resistance. To confirm the presence of the
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lexA(Def) genotype, colonies were then screened for high levels of RecA expression by Western blotting
with anti-RecA antibodies (83).
Strain

Relevant Genotype

dinB+ lexA+
ΔdinB
sulA- lexA(Def)
dinB-YPet lexA+
dinB(D103N)-YPet
lexA+
EAW641
dinB-YPet dnaQmKate2 lexA+
EAW643
dinB-YPet dnaXmKate2 lexA+
EAW643/pPFB1188
dinB-YPet dnaXmKate2 lexA+
+ pPFB1188
(dinB-eYFP)
dinB+ dnaQ-mKate2
EAW192
lexA+
dnaX-YPet dnaQEAW203
mKate2 dinB+ lexA+
ΔdinB dnaQ-mKate2
SSH001
lexA+
ΔdinB dnaQ-mKate2
SSH001/pPFB1188
lexA+
+ pPFB1188
(dinB-eYFP)
RW1588
dinB-YPet dnaXmKate2 sulA::kanR
RW1594
dinB-YPet dnaXmKate2 sulA::kanR
lexA(Def) CmR
EAW282
dnaX-YPet umuCmKate2 lexA+
CC108
dinB+;
F' plasmid dinB+
FC1243
ΔdinB;
F' plasmid ΔdinB
YG2247
dinB+;
F' plasmid ΔdinB
Table 1. Strains used in this study.
MG1655
EAW18
EAW26
EAW633
EAW830

Parent strain

Source/technique

MG1655
MG1655
MG1655
MG1655

(79)
Lambda RED recombination
(47)
Lambda RED recombination
Lambda RED recombination

EAW633

Lambda RED recombination

EAW633

Lambda RED recombination

EAW643

Transformation of EAW643 with
pPFB1188 (29)

MG1655

(48)

JJC5945

(48)

EAW192

Transduction of EAW192 with P1
grown on SF2006 (8)
Transformation of SSH001 with
pPFB1188 (29)

SSH001

EAW643
RW1588

Transduction of EAW643 with P1
grown on EAW26
Transduction of RW1588 with P1
grown on DE406

JJC5945

(47)

-

(24)

CC108

(24)

CC108

(24)

2.5.2 Western blotting for DinB expression levels
Cell cultures were grown in Luria-Bertani media at 37°C. The following morning, they were
diluted 1:100 in fresh media until they reached exponential phase (OD600 ~0.5). Where noted, cultures
were treated with 30ng/mL ciprofloxacin for 2 hours prior to harvesting. After cells were harvested by
centrifugation, the cell pellet was resuspended in NuPage LDS sample buffer (Novex) and freeze-thawed
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to produce whole cell extracts. Dilutions of purified pol IV protein were made in FC1243 (dinB) whole
cell extracts. Aliquots of whole cell extracts, representing approximately 1.5 × 108 cells, or DinB
dilutions (containing 0.5 – 8 ng of purified DinB (42)), were electrophoresed in NuPage 4-12% Bis-Tris
gels (Novex). Proteins were transferred to an Invitrolon PVDF membrane (Novex) which was probed
with a 1:5000 dilution of purified rabbit anti-DinB antibodies (a kind gift from Patricia Foster (30)) and
subsequently probed with a 1:5000 dilution of Goat Anti-Rabbit IgG (H+L)-AP Conjugate (BioRad).
Using the CDP-Star chemiluminescent assay (Applied Biosystems), the DinB proteins were visualized on
Carestream Biomax XAR film after various exposure times.

2.5.3

4-nitroquinolone-1-oxide survival assay
Cells (MG1655, EAW18, and EAW633) were grown in LB overnight at 37ºC. The next day, a

1/1000 dilution of each culture was grown to mid log phase (OD600 = 0.2), then stored on ice. These
cultures were then serially diluted by factors of ten down to 10-5. A spot (5 μL) of the OD 0.2 culture and
each dilution was plated on an agar plate containing 8 μM NQO. The plate was incubated at 37ºC for 18h.

2.5.4 Ciprofloxacin resistance assay
The assay was carried out as described in reference (9). Cells (MG1655, EAW18, EAW633,
EAW643) were grown in LB at 37ºC for 25h. For each culture, a 10-6 dilution was prepared. 150 L of
diluted cells were plated on a LB agar plate and incubated overnight at 37ºC to count for viable cells. The
mutagenesis assay was performed by plating 150 L of each saturated overnight culture (corresponding to
approximately 108 cells) on an LB agar plate containing 40 ng/mL ciprofloxacin. For each strain 5 plates
were prepared and incubated at 37 ºC.
On day one, all colonies of the LB agar plates were counted to determine the number of viable
cells that were originally present in each overnight culture. On day 4, colonies on the ciprofloxacin
containing plates were counted. These were interpreted as pre-existing mutations (9). Colonies were
counted again on day 8 and 13 and interpreted as resistant colonies formed as a result of mutagenesis
induced by ciprofloxacin. The numbers of new colonies appearing between days 4–8 and 8–13 were
calculated and normalised against the number of viable cells in each culture. The number of viable cells
as a function of time was determined using the count taken at day 1 and loss-of-viability rates measured
previously (9).

2.5.5

Fluorescence microscopy
Wide-field fluorescence imaging was performed on an inverted microscope (IX-81, Olympus

with a 1.49 NA 100x objective) in an epifluorescence configuration, as described previously (47).
Continuous excitation is provided using semidiode lasers (Sapphire LP, Coherent) of the wavelength 514
nm (150 mW max. output) and 568 nm (200 mW max. output). DnaX-mKate2 and DnaQ-mKate2 were
imaged using yellow excitation light (λ = 568 nm) at high intensity (2750 Wcm-2), collecting emitted light
between 610–680 nm (ET 645/75m filter, Chroma) on a 512 × 512 pixel EM-CCD camera (C9100-13,
Hamamatsu). For DinB-YPet and DinB-eYFP imaging, we used green excitation (λ = 514 nm) at lower
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power (160 Wcm-2) for DinB-YPet strains (EAW641 and EAW 643) and 60 Wcm-2 for the DinBYPet+DinB-eYFP strain EAW643 pPFB1188, collecting light emitted between 525–555 nm (ET540/30m
filter, Chroma).
Rapid acquisitions (movies of 300 × 34 ms frames, continuous excitation with 514 nm light)
were collected to characterise the motions of DinB-YPet and DinBD103N-YPet molecules, and to
determine the number of DinB-YPet molecules per cell. Time-lapse movies were recorded to visualise
changes in DinB-YPet expression and measure colocalisation with replisome markers. For EAW641 and
EAW643 cells, sets of three images were recorded (bright-field [34 ms exposure], YPet fluorescence [50
ms exposure]; mKate2 fluorescence [100 ms exposure]) at an interval of 5 min for 3h. All images were
analysed with ImageJ (65).

2.5.6

Flow cell designs
All imaging was carried out on cultures growing in home-built flow cells. Most imaging was

carried out in quartz-based flow cells, similar to those used in our previous study (47). These flow cells
were assembled from a no. 1.5 coverslip (Marienfeld, REF 0102222), a quartz top piece (45x20x1 mm)
and PE-60 tubing (Instech Laboratories, Inc.). Prior to flow-cell assembly, coverslips were silanized with
aminopropyltriethoxy silane (Sigma Aldrich, Alfa Aeser). First, coverslips were sonicated for 30 min in a
5M KOH solution to clean and activate the surface. The cleaned coverslips were rinsed thoroughly with
MilliQ water, then treated with a 5% (v/v) solution of amino-propyl-triethoxysilane in MilliQ water. The
coverslips were subsequently rinsed with ethanol and sonicated in ethanol for 20 seconds. Afterwards, the
coverslips were rinsed with MilliQ water and dried in a jet of N2. Silanised slides were stored under
vacuum prior to use.
To assemble each flow cell, polyethylene tubing (BTPE-60, Instech Laboratories, Inc.) was
glued (BONDiT B-482, Reltek LLC) into two holes that were drilled into a quartz piece. After the glue
solidified overnight, double-sided adhesive tape was stuck on two opposite sides of the quartz piece to
create a channel. Then, the quartz piece was stuck to an APTES-treated coverslip. The edges were sealed
with epoxy glue (5 Minute Epoxy, DEVCON home). Each flow cell was stored in a desiccator under mild
vacuum while the glue dried. Typical channel dimensions were 45 mm × 5 mm × 0.1 mm (length × width
× height).
Data shown in Figures 2–3 were collected in a three-channel PDMS-based flow cell. A
commercial PDMS kit (Dow Corning, SYLGARD 184 silicone elastomer kit) was used to obtain a 10:1
(polymer:curing agent) mixture. The mixed resin was poured in an aluminium mold that has three ridges,
creating PDMS blocks with channel dimensions (0.1 mm, 0.5 mm and 1.9 mm). After pouring, the
polymer was allowed to solidify at 65⁰C overnight. The next day, 1 mm holes were punched in the PDMS
block for the in- and outlet tubing. Then, the PDMS block was covalently attached to a clean glass
coverslip (KOH treated as above) by plasma treatment. After plasma bonding, PE60 tubing was pushed
into each hole. As a final step, the flow cell surface was silanised by pulling 5% (v/v in water) amino
propyl triethoxy silane solution through the channel with a syringe. The silanization reaction was allowed
to proceed for 15 min before the channels were flushed with MilliQ water.
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2.5.7

Imaging in flow cells
For all imaging experiments, cells were grown at 37⁰C in EZ rich defined medium (Teknova)

that contained 0.2% (w/v) glucose. EAW633, EAW641 and EAW643 cells were grown in the presence of
kanamycin (25 μg/mL), EAW643 pPFB1188 was grown in the presence of ampicillin (100 μg/mL) and
RW1594 was grown in the presence of chloramphenicol (25 μg/mL). Cells were loaded into flow cells,
allowed a few minutes to associate with the APTES surface, then loosely associated cells were removed
by pulling through fresh medium. The experiment was then initiated by either changing the input solution
to medium containing 30 ng/mL ciprofloxacin or 0.2 ng/ml MMS, or by irradiating cells in situ with 254
nm UV light from a mercury lamp (UVP) at a fluence of 30 J.m-2. In each case, medium was pulled
through the flow cell throughout the measurement using a syringe pump, at a rate of 50 μL/min.

2.5.8

Analysis of pol IV upregulation
We selected regions of images occupied by cells to obtain information about pol IV upregulation

upon ciprofloxacin treatment (>200 cells; all 5 min frames during the 3h experiment). MicrobeTracker
0.937 (84), a MATLAB script, was used to create cell outlines as regions of interest (ROI). We manually
curated cell outlines designated by MicrobeTracker to ensure accuracy and to ensure that only nonoverlapping, in-focus cells were selected for analysis. These ROI were imported in ImageJ 1.50i (85). The
cell outlines were then used to measure mean cell intensities, cell lengths and the number of foci per cell.
Parameters describing foci (number, positions and intensities) were obtained using a Peak Fitter plug-in,
described previously (47).

2.5.9

Analysis of colocalisation events of pol IV with replisomes
Foci were classed as colocalised if their centroid positions (determined using our peak fitter tool)

fell within 2 px (200 nm) of each other. We determined that for DinB-YPet–DnaX-mKate2 localisation
the background of pol IV foci expected to colocalise with replisomes purely by chance is ~4%. This was
calculated by taking the area of each cell occupied by replisome foci (including the colocalisation search
radius) and dividing by the total area of the cell. The value of 4% corresponds to the mean of
measurements made over >300 cells. As the number of pol IV foci changes in time, the proportion of
replisome foci expected to colocalise with pol IV foci by chance also changes in time. At the beginning of
the measurement, there are almost zero pol IV foci, thus there is close to zero chance that a replisome
focus will colocalise with a pol IV focus. At t = 30 min, chance colocalisation is expected to be 5% and at
t = 120 min, the chance for co-localisation 3%.

2.5.10 Analysis of pol IV copy numbers per cell
The number of pol IV molecules per cell and thus the intracellular concentration is extracted
from the change in integrated intensity under each cell outline during rapid acquisition photobleaching
measurements, as described previously (47). The intensity decay for each cell includes contributions not
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just from YPet bleaching, but also from cellular auto-fluorescence and background signals from the flow
cell surface. To obtain a background-free measure of the YPet photobleaching rate, we measured the
number of foci detected over hundreds of cells during bleaching. The number of foci over time followed a
single exponential decay with τ = 6 s. Returning to the integrated cell intensity decays, we found that
signals followed a two-exponential decay, with τ1 = 6 s and τ2 ≈ 60 s. Wild-type cells, expressing no YPet,
gave single-exponential decays with τ ≈ 60 s, indicating that the τ = 6 s decay seen for YPet-expressing
cells arises purely due to YPet bleaching. It was therefore possible to easily extract the YPet intensity
from the slower decaying auto-fluorescence and background by fitting with a two-exponential function.
First, the images were corrected for the electronic offset and flattened to correct for
inhomogeneity of the excitation beam. We then fit the cellular intensity decay with a two exponential
function f(x), fixing τ1 to 6 s1:
f(x) = A1 · exp(-x/τ1) + A2 · exp(-x/τ2).
For each cell, the amplitude A1 is an accurate measure of the mean YPet signal per pixel. Multiplying by
the cell area gives the integrated YPet intensity, which was used to determine the number of YPet
molecules per cell.
The mean intensity of individual YPet molecules was determined by analysing single-molecule
return events (see Supplementary figure 1). For each cell, the number of DinB-YPet molecules was then
calculated by dividing the integrated YPet intensity, measured by two-exponential fitting of cell-area
decays, by the mean single-molecule intensity. The concentration was calculated using the volume of each
cell, determined during cell outline assignation in MicrobeTracker.
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2.6

Supporting information legends

Supplementary Figure 1. Measurement of DinB and DinB-YPet molecules per cell in different
backgrounds. Western blots were developed using anti-DinB antibodies. In addition to DinB-specific
bands, a series of bands for cross-reacting species were observed. The slowest migrating of these was
used as an internal reference for the amount of cell extract loaded in each lane. (A) Calibration for DinB
loading. Lanes: i) molecular weight marker, ii) 8 ng DinB, iii) 4 ng DinB, iv) 2 ng DinB, v) 1 ng DinB,
vi) 0.5 ng DinB, vii) molecular weight marker. (B) Corresponding calibration plot: band intensity is
plotted against loaded DinB (ng). Lanes with 0.5 ng, 1 ng and 2 ng DinB were included in calibration
plot, 4 ng and 8 ng were excluded due to saturation. The intensities plotted for each band are the
integrated intensity of the DinB band divided by the integrated intensity of the reference band. Amounts
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of DinB present in cell extracts (C–F) were calculated from a line of best fit (y = 5.7773x; R2 = 0.72553).
(C) Western blot of extracts from untreated cells. Lanes: i) molecular weight marker, ii) FC1243 (ΔdinB),
iii) MG1655 (dinB+), iv) EAW633 (dinB-YPet), v) YG2247 (dinB+; F' plasmid - ΔdinB), vi) CC108
(dinB+; F' plasmid - dinB+), vii) molecular weight marker. Bands corresponding to full length DinB-YPet
are clearly visible in lane iv. A small amount of two DinB-containing fragments are also visible.
Fragment 1 corresponds to DinB+linker. Fragment 2 corresponds to DinB +/- one or two residues. (D)
Calculated molecules per cell for untreated cells (Western blot, panel C). Total DinB levels in EAW633
(DinB-YPet) cells are similar to wild-type DinB levels, although ~25% is proteolysed within the cells.
YG2247 have DinB at equivalent levels to MG1655, whereas, CC108 have tenfold higher levels than
MG1655. This is due to the fact that CC108 cells contain the F' plasmid, which provides a second copy of
dinB. Levels in CC108 may be somewhat underestimated due to saturation of DinB bands. (E) Two
Western blots of extracts from cells. Lanes from left Western blot: i) molecular weight marker, ii)
FC1243 (ΔdinB) untreated, iii) FC1243 (ΔdinB) ciprofloxacin-treated, iv) MG1655 (dinB+) untreated, v)
MG1655 (dinB+) ciprofloxacin-treated, vi) EAW633 (dinB-YPet) untreated, vii) EAW633 (dinB-YPet)
ciprofloxacin-treated, viii) molecular weight marker. Bands corresponding to full length DinB-YPet are
clearly visible in lane vi-vii. A small amount of two DinB-containing fragments are also visible. Lanes
from right Western blot: i) molecular weight marker, ii) YG2247 (dinB+) untreated, iii) YG2247 (dinB+;
F' plasmid - ΔdinB) ciprofloxacin-treated, iv) CC108 (dinB+; F' plasmid - dinB+) untreated, v) CC108
(dinB+) ciprofloxacin-treated, vi) molecular weight marker. (F) Calculated molecules per cell for
untreated and ciprofloxacin-treated cells (two Western blots, panel E). In untreated cells, DinB-YPet is
expressed at levels equivalent to wild-type DinB, however ~58% is proteolysed within the cells. In
comparison to MG1655, YG2247 expresses similar levels of DinB, whereas, CC108 have tenfold higher
expression levels. The band for CC108 is saturated, however, and thus likely to be underestimated. In
ciprofloxacin-treated EAW633 (DinB-YPet) cells, levels are similar to wild-type DinB levels, however
~31% is proteolysed within the cells. Comparing to MG1655, YG2247 expressed ~1.7 fold more DinB,
whereas, CC108 have fourfold higher expression levels. This however might be an underestimate due to
the saturated band.
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Supplementary Figure 2. Measurement of the number of DinB-YPet molecules per focus by analysis of
photobleaching trajctories. (A) Representative photobleaching trajectory showing bleaching of a single
DinB-YPet molecule. For each focus, the intensity within a 5 × 5 pixel selection box was monitored as a
function of time as foci photobleached. Each measurement was locally background-corrected by
subtracting the mean intensity within a 2 pixel-wide ring outside each focus. The red line indicates a fit of
intensity levels derived from change-point analysis (47). (B) Histogram of single-molecule intensities.
Once the majority of DinB-YPet in cells had photobleached, foci occasionally appeared as individual
molecules returned to the bright (fluorescent) state. These foci were fit with 2D Gaussian functions to
determine the integrated fluorescence intensities. The measured intensities were narrowly distributed,
with a mean value of 1850 arbitrary units. This value represents the mean intensity of a single DinB-YPet
molecule. (C–D) Histograms of intensities for DinB-YPet foci, 30 min (C) and 100 min (D) after addition
of ciprofloxacin. The initial intensities of foci were determined from photobleaching trajectories using
change-point analysis (47). This value was then divided by the single-molecule intensity 1850 to obtain
the number of molecules present in each focus.
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Supplementary Figure 3. Comparison of pol IV-replisome colocalisation in EAW641 and EAW643.
Foci located within 200 nm of each other were defined as being colocalised. (A) Graph indicating the
proportion of pol IV foci that contain a colocalised replisome focus in EAW641 cells (red line) and
EAW643 cells (black line). (B) Graph indicating the proportion of replisome foci that contain a
colocalised pol IV focus in EAW641 cells (red line) and EAW643 cells (black line). Shaded areas (A–B)
indicate the standard error of the proportion. The total number of cells analysed were not determined in
these measurements. We conservatively estimate that >300 cells were used in each measurement. The
DnaX-mKate2 dataset includes a total of 17005 DnaX-mKate2 foci and 12408 DinB-YPet foci. The
DnaQ-mKate2 dataset includes 7451 DnaQ-mKate2 foci and 3166 DinB-YPet foci.

Supplementary Figure 4. Colocalisation measurements for images of EAW643 cells recorded with a
longer (300 ms) exposure time. Foci located within 200 nm of each other were defined as being
colocalised. (A) Plot of the number of pol IV and replisome foci per EAW643 cell as a function of time.
Some cells were lost from the coverslip surface during the measurement. A total of 134 cells remained
bound and were analysed over the full course of the measurement. (B) Graph indicating the proportion of
replisome foci that contain a colocalised pol IV focus. (C) Graph indicating the proportion of pol IV foci
that contain a colocalised replisome focus. Error bars (B–C) indicate the standard error of the proportion.
The total number of cells analysed were not determined in these measurements. We conservatively
estimate that >300 cells were used in each measurement. The analysis includes a total of 7160 DnaXmKate2 foci and 1027 DinB-YPet foci.
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Supplementary Figure 5. Pol IV behaviour in cells expressing both DinB-YPet (from the dinB locus on
the chromosome) and DinB-eYFP (from the plasmid pPFB1188). (A) Representative microscope images
comparing yellow fluorescent protein signals in EAW643 (DinB-YPet only; top row) and EAW643
pPFB1188 (DinB-YPet + DinB-eYFP; bottom row) cells, 100 min after ciprofloxacin addition. The left
and right columns contain the same images, but with different intensity ranges displayed. (B)
Photobleaching trajectories for DinB foci in EAW643 pPFB1188 (DinB-YPet + DinB-eYFP) cells.
Trajectories were measured as illustrated in Supplementary figure 1. Derivation of the intensity of a
single YPet molecule (1850 arbitrary units) is shown in Supplementary figure 1B. The intensity of a
single eYFP molecule (1200 arbitrary units) was estimated based on the relative extinction coefficients
and quantum yields of YPet and eYFP (85).
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Supplementary Figure 6. Comparison of pol IV-replisome colocalisation in cells expressing labelled pol
IV from the chromosome (DinB-YPet), a plasmid (DinB-eYFP), or both. Foci located within 200 nm of
each other were defined as being colocalised. Measurements were made on cells treated with 30 ng/ml
ciprofloxacin for 60 min in the context of a flow cell. (A) Bar graph indicating the proportion of pol IV
foci that contain a colocalised replisome focus. (B) Bar graph indicating the proportion of replisome foci
that contain a colocalised pol IV focus. Bar colours (A–B) indicate cell type: EAW643 (blue), EAW643
pPFB1188 (red), EAW641 (green) and SSH001 pPFB1188 (yellow). Error bars indicate the standard
error of the proportion. The total number of cells analysed were not determined in these measurements.
We conservatively estimate that >300 cells were used in each measurement. The DnaX-mKate2 DinBYPet dataset includes a total of 1178 DnaX-mKate2 foci and 907 DinB-YPet foci. The DnaX-mKate2
DinB-YPet + DinB-eYFP dataset includes 1165 DnaX-mKate2 foci and 1264 DinB-YPet/DinB-eYFP
foci. The DnaQ-mKate2 DinB-YPet dataset includes a total of 739 DnaQ-mKate2 foci and 413 DinBYPet foci. The DnaQ-mKate2 DinB-YPet + DinB-eYFP dataset includes 386 DnaQ-mKate2 foci and 280
DinB-YPet/DinB-eYFP foci.
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Supplementary Figure 7. Increased rates of lysis in cells expressing DinB-eYFP from pPFB1188. (A)
Representative bright-field images of EAW643 cells (top two panels) and SSH001 pPFB1188 cells
(bottom two panels), 180 min after the addition of 30 ng/ml ciprofloxacin. Arrows indicate the positions
of cells that have lysed. (B) Bar graph showing the percentage of cells that lyse by the 180 min time-point
for MG1655, EAW643 and SSH001 pPFB1188 cells. The number of cells that were tracked were as
follows: MG1655, 102 cells; EAW643, 132 cells; SSH001 pPFB1188, 232 cells.
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Supplementary Figure 8. Intensity vs time trajectories for DinB-YPet signals in the vicinity of
replisomes in ciprofloxacin-treated EAW643 cells. 5×5 pixel regions of interest were placed at replisome
foci, then used to monitor fluctuations in DinB-YPet signals (see Fig 6A). A subset of 42 trajectories were
selected randomly from a total of 470 trajectories. To allow comparison with DinB-YPet singles in
lexA(Def) cells, where expression levels are too high to observe single-molecule foci, we present only a
portion of each trajectory, starting at a time-point (150 ms) where ~50% of DinB-YPet molecules have
already photobleached. In ciprofloxacin-treated EAW643 cells, DinB-YPet signals are frequently
elevated in the vicinity of replisomes for multiple frames, indicating long-lived binding events.
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Supplementary Figure 9. Intensity vs time trajectories for DinB-YPet signals in the vicinity of
replisomes in untreated lexA(Def) cells. 5×5 pixel regions of interest were placed at replisome foci, then
used to monitor fluctuations in DinB-YPet signals (see Fig 6A). A subset of 42 trajectories were selected
randomly from a total of 65 trajectories. A portion of each trajectory is presented, starting at a time-point
(150 ms) where ~50% of DinB-YPet molecules have already photobleached, allowing single-molecule
foci to be observed. In untreated lexA(Def) cells few events are visible in which the DinB-YPet is
elevated in the vicinity of replisomes for more than a single 34 ms frame, indicating few long-lived
binding events.
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Supplementary Figure 10. Comparison of pol IV-replisome colocalisation in cells treated with different
DNA-damaging agents: (A) 30 ng/ml ciprofloxacin, (B) 0.26 ng/ml methyl methanesulfonate, (C)
ultraviolet light (fluence = 30 J/m2, flux density = 3.3 W/m2, λ = 254 nm). Colocalisation (A–C) was
measured in two ways: the proportion of DinB-YPet foci that contain a colocalised DnaX-mKate2
(replisome) focus, and the proportion of DnaX-mKate2 foci that contain a colocalised DinB-YPet focus.
Shaded areas indicate the standard error of the proportion. All DNA-damaging agents produce a
distinctive drop in colocalisation 90–120 min after treatment. We conservatively estimate that >200 cells
were used in each measurement.
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Supplementary Figure 11. Time-lapse imaging of pol V-labelled EAW282 (dnaX-YPet umuC-mKate2)
cells following treatment with 40 ng/ml ciprofloxacin. We previously discovered that pol V is spatially
regulated: the UmuC protein accumulates at the cell membrane, until the active form pol V Mut (UmuD′2UmuC-RecA-ATP) is formed and released into the cytosol (47). This was monitored by observing the
change in cellular localisation of UmuC-mKate2 as a function of time. When cells are instead treated with
ciprofloxacin, UmuC-mKate2 goes through a very similar progression of localisation states. In the
example shown in this figure, UmuC-mKate2 is initially absent (0–1 h), then membrane associated (1.5-2
h), then cytosolic (2.5–3 h). The timing of these transitions varies from cell to cell. Typically, no UmuCmKate2 is visible until 45-90 min after ciprofloxacin treatment. From 45-150 min, UmuC-mKate2 is
membrane-associated. UmuC-mKate2 typically remains membrane-associated for approximately 30 min
before being released into the cytosol.

Supplementary Movie 1. Time-lapse imaging of pol IV up-regulation in response to ciprofloxacin
treatment. Cells were initially grown in rich medium in the absence of exogenous DNA damage. At t = 0
min, the flow cell inlet was switched to medium containing 30 ng/ml ciprofloxacin. At each field-of-view,
a bright-field image and a DinB-YPet fluorescence image were collected every 5 min for 180 min. Time
stamp indicates hours after ciprofloxacin addition.
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In many bacterial species, DNA damage triggers the SOS response; a pathway that regulates the
production of DNA repair and damage tolerance proteins, including error-prone DNA
polymerases. These specialised polymerases are capable of bypassing lesions in the template DNA, a
process known as translesion synthesis (TLS). Specificity for lesion types varies considerably
between the different types of TLS polymerases. TLS polymerases are mainly described as working
in the context of replisomes that are stalled at lesions or in lesion-containing gaps left behind the
replisome. Recently, a series of single-molecule fluorescence microscopy studies have revealed that
two TLS polymerases, pol IV and pol V, rarely colocalise with replisomes in Escherichia coli cells,
suggesting that most TLS activity happens in a non-replisomal context. In this review we re-visit
the evidence for the involvement of TLS polymerases in other pathways. A series of genetic and
biochemical studies indicates that TLS polymerases could participate in nucleotide excision repair,
homologous recombination and transcription. In addition, oxidation of the nucleotide pool, which is
known to be induced by multiple stressors, including many antibiotics, appears to favours TLS
polymerase activity and thus increases mutation rates. Ultimately, participation of TLS
polymerases within non-replisomal pathways may represent a major source of mutations in
bacterial cells and calls for more extensive investigation.

I drafted this review article on translesion DNA polymerases in Escherichia coli.
I edited the manuscript according to the review comments.
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3.1

Review article
Replication of the Escherichia coli genome is a fast and accurate process. On undamaged DNA,

the primary polymerase, DNA polymerase III, inserts close to 1000 nucleotides per second, with an error
rate of only one in one billion (1,2). Damaged DNA templates, however, lead to replication problems as
the primary polymerase is inhibited by the presence of lesions in the template DNA (3). Since cells are
frequently exposed to endogenous and exogenous sources of DNA damage, they have evolved error-free
repair pathways to remove and replace DNA lesions (4). Some lesions, however, escape these pathways
and are encountered by replication forks. Depending on conditions, this leads to either replication fork
arrest or re-priming and continued synthesis downstream of the lesion (known as lesion skipping) (3–12).
Both pathways lead to the accumulation of single-stranded DNA (ssDNA) gaps which are either repaired
or processed into double-strand breaks (DSBs) (8–10,13,14). DSBs are particularly toxic to cells (4). As
an overall consequence of DNA damage, the SOS response is triggered (15). The SOS response increases
the expression levels of many proteins involved in DNA repair mechanisms (9,15). The earliest SOS
genes to be induced participate in non-mutagenic DNA repair pathways. If damage is not resolved during
this stage, mutagenic pathways are initiated (16,17). Mutagenesis arises from the upregulation of
specialised DNA polymerases that are able to bypass lesions, a process known as translesion synthesis
(TLS) (3,4,19,20,5–11,18).
TLS polymerases generate mutations. In contrast to the primary polymerase, TLS polymerases
are capable of efficient lesion bypass. This activity is made possible by the architecture of their templatebinding sites, which are more open than that of the primary polymerase (21). This also, however, makes
TLS polymerases highly error-prone as they are less likely to discriminate between correct and incorrect
nucleotides which can lead to misincorporations. Insertion of the incorrect base can lead to a mutation
being established during subsequent rounds of replication (4).
Mutations caused by TLS polymerases acting on undamaged portions of DNA are called
untargeted mutations (22). Overexpression of TLS polymerases often leads to increased mutation rates in
the absence of damage, suggesting that a drastic increase in TLS polymerase concentration tilts the
balance towards TLS activity. For instance, E. coli DNA polymerase IV, encoded by the dinB gene, is an
error-prone polymerase and induces -1 frameshift mutations when highly overexpressed (23,24).
Similarly, overexpression of Bacillus subtilis DNA polymerase Pol Y1, encoded by yqjH, results in
increased mutagenesis in a rifampicin resistance assay (25,26). TLS polymerases increase the genetic
diversity of bacterial populations growing in the absence of external damage (27), implying that TLS
polymerases may produce untargeted mutations at a low, but significant, rate.
TLS polymerases are specialised because they can extend primed lesion-containing templates
(3,28). The incorporation of an incorrect base opposite the lesion can lead to mutation. This type of
mutation is called a targeted mutation (22,29). TLS polymerases carry out a variety of error-free and
mutagenic TLS activities (detailed below). It is important to note that in most cases the biological
context(s) for lesion bypass (stalled replisomes, ssDNA gaps, recombination intermediates etc.) remains
poorly understood.
TLS polymerases copy a variety of lesion-containing templates. DNA lesions originate from
endogenous or exogenous sources, for instance some antibiotics, other DNA damaging compounds (e.g.
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methyl methanesulfonate), or ultraviolet light (UV light)(3,17). Lesions can include chemically altered
nucleo-bases or changes in the sugar-phosphodiester backbone. Common lesions include abasic sites,
alkylated bases, oxidised bases and adducts to the N2 position of guanines (11). Certain DNA lesions are
only bypassed by a particular TLS polymerase, indicating that the active site of each TLS polymerase
differently accommodates different lesion types (21).
Ultraviolet light generates covalently cross-linked pairs of thymidine bases, most commonly
forming cyclobutane pyrimidine dimers (CPDs) and single cross-linked (6–4) photoproducts (4,29). In E.
coli, UV lesions are bypassed by DNA polymerase V (pol V) (30,31). This TLS polymerase is encoded
by umuDC and belongs to the Y-family polymerases (UmuC subfamily). Pol V is a highly error-prone
polymerase that is responsible for almost all UV-induced mutagenesis. When carrying out TLS at CPDs,
pol V frequently inserts the sequence GA opposite the TT-CPD lesion, rather than the canonical AA
(5,32–34). A second polymerase in E. coli, pol II (encoded by polB), plays a role in restarting replication
in UV-irradiated cells; cells lacking pol II show delayed recovery of DNA synthesis after irradiation
(17,35,36). The biochemical nature of this activity remains unclear. In B. subtilis Pol Y2 is essential for
UV-induced mutagenesis, whereas Pol Y1 is not (25). Polymerases of the UmuC subfamily appear to be
generally necessary for UV-induced mutagenesis (37–41). While deletion of E. coli dinB (encoding pol
IV) does not yield effects on UV survival, UV-induced mutagenesis or replication restart after UV arrest
(42), biochemical measurements indicate that pol IV is capable of error-free bypass of CPD lesions (43).
Alkylating agents, such as methyl methanesulfonate (MMS) modify nucleo-bases in DNA,
producing both cytotoxic and mutagenic effects (44). In E. coli pol IV contributes to survival upon MMS
treatment (44). This activity appears to stem from error-free bypass of MMS lesions. Pol V is involved in
error-prone bypass of the MMS-induced lesions N1-methyl-deoxyadenosine (1meA) and N3-methyldeoxycytosine (3meC) (45).
Certain compounds generate bulky adducts to the N2 position of deoxyguanosine (N2-dG), for
instance

benzo[a]pyrene,

nitrofurazone

(NFZ),

4-nitroquionoline

1-oxide

(4-NQO)

and

2-

acetylaminofluorene (22,46,47). TLS polymerases do not contribute equally to survival of N2
modifications. Escherichia coli pol V contributes to mutagenesis upon N-ethyl-N-nitrosourea
treatment(48), whereas, pols II and IV contribute greatly to 4-NQO survival (22,49,50).
N2acetylaminofluorene guanine adducts (N2-AAFdG) can be bypassed by pol II, often inducing -2
frameshift mutations (51). In cells carrying benzo[a]pyrene lesions, both pols IV and V have been shown
to be active using genetics and in vitro reconstitution assays, each contributing to both error-free TLS and
-1 frameshifts (52,53).
N2 adducts can also originate from methylglyoxal, a by-product of the glycolysis pathway (54).
These N2-(1-carboxyethyl)-2’-deoxyguanosine adducts (N2-CEdG) are accurately bypassed by pol IV
suggesting that in cells pol IV might frequently carry out error-free TLS on N2-dG adducts that arise
during normal metabolism. Moreover, bulky N2-N2-guanine cross-links are bypassed by pol IV with high
fidelity (55).
Modified nucleotide triphosphates may favour TLS polymerase activity. DNA lesions are also
induced by reactive oxygen species (ROS). For instance, guanine is often oxidised to 8-oxo-guanine
(56,57). Such oxidised nucleotides form altered DNA base pairs and are commonly mutagenic (57,58).

69

The amount of ROS in cells can vary considerably according to several factors, including for example
metabolic rates and oxygen concentrations. There is some evidence that in cells growing aerobically,
increased ROS levels lead to increased numbers of lesions (58). This, presumably, would cause an
increase in TLS activity. In fact, levels of pol V-dependent mutagenesis in E. coli appear to be markedly
higher in aerobic conditions than in anaerobic conditions (59). It is not clear, however, whether the extra
mutations that arise under aerobic conditions derive from targeted mutagenesis at oxidised base pairs or
whether the conditions favour untargeted mutagenesis. It has been directly demonstrated that pol IV
incorporates 8-oxo-dGs into the DNA (56). Whether pol V is similarly capable of incorporating oxidised
nucleotides requires further investigation.
Cellular stress is also known to increase ROS levels (60). For instance, ROS increasingly
accumulate in response to treatment with several antibiotics or in the case of thymine starvation and in
both cases strongly contribute to killing (61,62). The killing mechanism appears to depend on ROSinduced conversion of ssDNA regions into toxic DSBs (61,62). Stress-induced increases in ROS also
increase mutation rates and TLS polymerases are involved (56,62,63). It remains unclear, however, if this
involvement relates to incorporation of oxidised nucleotides into the DNA, mutagenic TLS at sites of
oxidised bases already present in the DNA, error-prone synthesis by TLS polymerases during break
repair, or some combination of the three. In general, the incorporation of non-canonical dNTPs into the
DNA by DNA polymerases is an important area that remains under-investigated.
Replicative vs post-replicative translesion synthesis. Two models have been proposed for TLS
activity upon encounters of replisomes with lesions on the leading strand (see Fig. 1A). In the most cited
model, known as replicative TLS, TLS polymerases assist stalled replisomes by exchanging for the
arrested pol III and bypassing the lesion (Heltzel et al. 2012; Fuchs and Fujii 2013; Scotland et al. 2015).
Following TLS, the polymerases exchange back, allowing pol III to resume replication. This model was
primarily built upon the results of in vitro reconstitution assays and led to the proposal of molecular
mechanisms invoking polymerase switching on the β clamp (65–69). In the other model, TLS
polymerases are involved in post-replicative translesion synthesis. Here the replisome is proposed to skip
over lesions (by re-priming downstream), creating lesion-containing gaps behind the replisome (43,70).
These gaps are templates for TLS polymerases, which bypass lesions and thus allow the gaps to be filled
(11,71,72).

70

Figure 1. Potential outcomes of replisome-lesion encounters. Schematic diagram describing commonly
envoked models for TLS triggered by the replisome encounters with a lesion on the leading strand (a) and
lagging strand (b).
Studies conducted in vitro have concluded that skipping of lagging strand lesions is an inherent
property of the replisome (see Fig. 1B) (73,74). In light of new observations that demonstrate that Pol III*
(three Pol III cores plus clamp loader complex, i.e. ′) exchanges readily at replication forks
(75,76), the conclusions of these studies may need to be revisited. The Higuchi and McInerney studies
demonstrated that lagging strand lesions did not block the progress of the replisome in bulk-level
biochemical assays. From this they each concluded that the replisome simply skips over lagging lesions.
In the absence of exogenous DNA damage, Pol III* exchanges readily in vivo (75,76). This opens an
alternative explanation for the Higuchi and McInerney data: the lagging strand polymerase actually
stalled at the lesion, but the stalled Pol III* was replaced by another molecule from the bulk. There are
only ~20 molecules of Pol III* available in each cell (75,76), thus exchange could easily become limiting
in the presence of damage. It would be of interest to examine the capacity of the replisome to skip lagging
strand lesions under dilute conditions, or in pre-assembled single-molecule assays, where exchange of Pol
III* would be limited.
TLS polymerases are involved in other DNA repair pathways.

Historically, error-prone

polymerases have mainly been examined in the context of the replisome. Several studies, however,
implicate the TLS polymerases are also involved in other DNA repair mechanisms, for instance,
transcription coupled repair (77–79), nucleotide excision repair (42,50) and homologous recombination
(80–83). Additionally, TLS polymerases play a role in adaptive mutagenesis (84–87).
In addition to DNA replication, DNA damage is also a hindrance to transcription. Lesioncontaining gaps on the template strand result in RNA polymerase stalling. Work by Cohen et al. revealed
that RNA polymerases stalled at gaps may recruit TLS polymerases to close the gap and allow

71

transcription to continue (see Fig. 2A). The group found that the E. coli transcription modulator NusA
genetically interacts with both Y-family polymerases pol IV and pol V (77,78). NusA physically interacts
with pol IV (79). NusA functions in both termination and antitermination of transcription and in both
cases is bound to the RNA polymerase (RNAP). In the Cohen transcription-coupled TLS model, NusA
recruits TLS polymerases to RNAPs stalled at gaps generated when the replisome encounters a lesion in
the nontranscribed strand (77). TLS polymerases could then fill the gap in the template strand and rescue
the stalled RNAP. In contrast, RNAPs stalled at lesions on the transcribed strain would be resolved by
transcription-coupled repair (77).

Figure 2. TLS polymerases are potentially involved in non-replisomal activities. Schematic diagrams
depicting TLS and/or primer exten- sion by TLS polymerases. (a) TLS polymerases rescue stalled
RNAPs. (b) TLS polymerases in nucleotide excision repair. (c) TLS polymerases in homologous
recombination
Nucleotide excision repair (NER) can remove a variety of bulky DNA lesions, leaving behind
ssDNA gaps which, in principle, could be substrates for TLS polymerases (see Fig. 2B). In fact, E. coli
pol IV is involved in both NER-dependent and -independent pathways in cells treated with 4-NQO (50).
Pol IV and NER are also proposed to work cooperatively on N2-N2-guanine interstrand DNA cross-links
(ICLs) (55). In another study, ICLs induced by exposure of cells to nitrogen mustard were proposed to be
repaired by pol II in concert with NER (88). The role of pol IV in processing of nitrogen mustard ICLs
has not yet been investigated.
Aside from NER, another major determinant of NQO survival is homologous recombination
(50). Although homologous recombination has been described as an error-free repair pathways, several
studies have proposed that TLS polymerases can participate in homologous recombination and make the
process error-prone (see Fig. 2C) (63,89). In vitro experiments demonstrated that E. coli pol IV can
proficiently extend D-loops (83). Interestingly, synthesis at D-loops has markedly lower fidelity than at
standard primed-template structures. At D-loops, pol II appears to be proficient in correcting errors
introduced by pol IV, presumably due to its exonuclease function. Consequently, pol II is proposed to
supresses error-prone recombination (83). Similar to pol IV, DNA polymerase I (pol I) is less accurate at
RecA-mediated recombination intermediates (90). This suggests that certain polymerases might generally
be error-prone at these unstable recombination intermediates which might be driving error-prone
recombination and, conceivably, could represent a major determinant in the development of antibiotic
resistance through mutation (90).
Single-molecule microscopy reveals that TLS polymerases mainly act away from replisomes.
Considering TLS polymerases being involved in several DNA repair pathways, we investigated if TLS
polymerases predominantly act in the vicinity of replisomes using single-molecule imaging in live E. coli
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cells (91,92). Single molecule microscopy allows TLS polymerase activity to be observed as individual
TLS polymerase molecules bind to DNA or replisomes and dissociate.
Using the SOS-inducing agents ciprofloxacin, UV light and MMS, we showed that the
concentration of pol IV increases upon damage induction (91). The increase in concentration was
correlated with cell filamentation rate and increased pol IV binding activity at DNA. In contrast to the
textbook model, we found that pol IV mainly binds away from replisomes suggesting that the majority of
pol IV activity could be non-replisomal. Furthermore, pol IV molecules bound in the vicinity of
replisomes were often close to, rather than at, replisomes. These results, and those of others (93), support
the model of post-replicative TLS, although do not completely exclude the possibility that pol IV is
involved in replicative TLS. Since pol IV mostly binds away from replisomes, pol IV might
predominantly work in other pathways such as transcription (77), nucleotide excision repair (42,50) and
homologous recombination (80–82,90) as proposed in several studies. In a microscopy study in which
cells were treated with NQO or nalidixic acid, pol IV foci were been shown to colocalise with certain
RecA structures and also with DSBs, supporting the idea that pol IV is involved in DSB repair (80). It is
important to note, however, that in this study pol IV was expressed at somewhat higher levels than in
wild-type cells. The pol IV colocalisation with RecA agglomerates was observed at a relatively late stage
of the DNA damage response, around 180 min after damage induction. It would be of considerable
interest to repeat these measurements with higher time resolution, to determine if pol IV acts at RecA
structures earlier in the SOS response.
We have also investigated the regulation of pol V and its role in replicative translesion synthesis
upon UV damage (92). Pol V is a highly error-prone polymerase and thus underlies several stages of
temporal and spatial regulation. After activation, pol V has little activity at replisomes and rather binds
away from replisomes, similar to pol IV. However, in a recA(E38K) mutant, where pol V is constitutively
activated in the absence of damage, many pol V molecules are bound at replisomes. In recA(E38K) UV
irradiation however, additional binding sites away from replisomes open for pol V. Since pol IV binds at
RecA structures upon SOS induction, it would be of interest to determine whether it also works on
recombination intermediates.
The third TLS polymerase, pol II, is different to pol IV and V in that it has an exonuclease
function. Pol II has been shown to suppress the error-prone activity of pol IV at recombination
intermediates, presumably due to pol II proof-reading errors introduced by pol IV. To date, live cell
single-molecule studies on pol II have not yet been published. It would be interesting to know whether
pol II shows a different behaviour to pol IV and V especially because of pol II’s exonuclease activity.
Conclusions. Single-molecule live cell imaging reveals that 90% of pol IV foci and 95% of pol V foci
form at sites on the DNA that are spatially distinct from replisomes (91,92). Of the remaining 5–10% of
foci, many appear close to replisomes rather than at replisomes. The data appear to indicate that TLS
polymerases frequently participate in mechanisms other than replicative TLS. Based on other studies,
these extra-replisomal activities could include post-replicative TLS, incorporation of oxidised dNTPs,
rescue of stalled RNA polymerase complexes or participation in NER or homologous recombination.
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Under many conditions the killing of bacterial cells by antibiotics is potentiated by damage induced
by reactive oxygen species (ROS). In most bacteria, ROS primarily target biomolecules such as
proteins and DNA. Damage to DNA, particularly in the form of double-strand breaks (DSBs), is a
major contributor to cell death. DNA polymerase IV (pol IV), an error-prone DNA polymerase
produced at elevated levels in cells experiencing DNA damage, has been implicated both in ROSdependent killing and in DSB repair (DSBR). Here, we show using single-molecule fluorescence
microscopy that ROS-induced DSBs promote pol IV activity in two ways. First, exposure to the
DNA-damaging antibiotics ciprofloxacin and trimethoprim triggers an SOS-mediated increase in
intracellular pol IV concentration that is strongly dependent on both ROS and DSBR. Second, in
cells that constitutively express pol IV, co-treatment with a ROS mitigator dramatically reduces the
number of DSBs as well as pol IV foci formed, indicating a role of pol IV in the repair of ROSinduced DSBs.

I carried out and analysed all in vivo single-molecule experiments and plate reader
assays. I was involved in strain construction, plate-based survival assays and the
preparation of the manuscript.
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4.1

Significance
Many antibiotics induce an accumulation of reactive oxygen species (ROS) in bacterial cells.

ROS-induced damage to DNA, in particular formation of double-strand breaks (DSBs), potentiates killing
by several bactericidal antibiotics. Here we used single-molecule fluorescence microscopy to reveal new
links between ROS-induced DSBs and the activity of error-prone DNA polymerase IV (pol IV). We
found that antibiotic-induced up-regulation of pol IV production requires active formation of DSB
intermediates and can be supressed by ROS mitigators. The formation of pol IV foci, which reflect DNAbinding events, also requires DSB repair. Our findings support a major role for pol IV in DSB
intermediates and reveal new details of how antibiotic treatment can potentially drive the development of
antibiotic resistance in bacteria.

4.2

Main
Many antibiotics induce the accumulation of reactive oxygen species (ROS) within bacterial

cells (1–4). These highly reactive molecules cause widespread damage to biomolecules. It is becoming
clear that secondary DNA lesions induced by ROS, such as double-strand breaks (DSBs) (5,6) and
oxidized nucleotides (7,8), potentiate killing by bactericidal antibiotics. This phenomenon of secondary
lesion formation, which has been described for several antibiotic classes with different primary modes of
action, is known as a common killing mechanism (8–15). A well-studied model of the common killing
mechanism is the fluoroquinolone antibiotic ciprofloxacin, a DNA gyrase inhibitor, for which killing is
strongly potentiated by ROS accumulation (12). A second well-studied model of the common killing
mechanism is trimethoprim (13), an antibiotic that inhibits folic acid production and consequently induces
thymineless death (TLD). Recent work indicates that TLD involves the accumulation of ROS, which lead
to the formation of DSBs (5).
Two mechanisms for ROS-induced DSB formation have been proposed in E. coli. The first
invokes oxidization of the cellular nucleotide pool, leading to increased incorporation of oxidized
nucleotide triphosphates (e.g. 8-oxo-dGTP) into the DNA, for instance, by DNA polymerase IV (7,16).
Subsequent initiation of base-excision repair (BER) creates single-stranded DNA (ssDNA) gaps. In cases
where BER is initiated at nearby sites, DSBs may be formed (7,15,16). Evidence for a second mechanism
of ROS-dependent DSB formation has emerged from a recent mechanistic study of TLD in Escherichia
coli (5,13). The ROS-driven potentiation of killing by both antibiotic treatment and TLD can be abrogated
through the addition of ROS mitigators to the culture medium (1,5,12). For example, dimethyl sulfoxide
(DMSO) and 2,2’-bipyridine (BiP), both, effectively mitigate the accumulation of antibiotic-induced ROS
(5,17). Using microscopy to quantify ssDNA gaps and DSBs in cells undergoing TLD, Hong and coworkers discovered that thymine starvation initially leads to the accumulation of ssDNA gaps, which are
subsequently converted to DSBs in an ROS-dependent process (5). In cells treated with ROS mitigators,
gaps were not converted to DSBs and thymine starvation was largely abolished (5). For ciprofloxacin, a
DNA gyrase inhibitor, a second, ROS-independent pathway exists in which gyrase-stabilized cleavage
complexes dissociate, creating a DSB directly (9–11,18).
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Several lines of evidence implicate pol IV in ROS-dependent DSB formation and processing.
Pol IV efficiently incorporates 8-oxo-dGTP into DNA in vitro (7). Cells over-expressing pol IV exhibit
ROS-dependent lethality (7,16,19). Similarly, cells lacking pol IV and pol V are partially protected
against killing by ampicillin under conditions where ROS concentrations are increased (7). These
observations suggest that pol IV promotes the formation of DBSs due to the BER-mediated removal of
closely spaced 8-oxo-dGTPs incorporated by pol IV (16). Other studies indicate that pol IV has a role in
the repair of DSBs (20,21,30,31,22–29): First, pol IV physically interacts with the RecA recombinase and
RecA nucleoprotein filaments (RecA*); a key player in DSB repair (DSBR) (26,32). This interaction
might facilitate pol IV to function in strand exchange (33). Second, fluorescently labelled pol IV
colocalizes with RecA extensively at sites of induced DSBs when expressed from a low-copy plasmid
(27). Similarly, in cells treated with ciprofloxacin, pol IV highly colocalizes with RecA* structures (32).
Third, genetic studies reveal that the gene encoding pol IV, dinB, is required for both induced and
spontaneous error-prone DSBR (20–25). Fourth, intermediates of DSBR known as recombination Dloops are efficiently utilized as substrates by pol IV in vitro (28,34).
Interestingly, the mutagenic potential of pol IV is modulated by UmuD and the recombinase
RecA (26,29–31). UmuD induces error-free synthesis of pol IV (26), promoting long-lived association of
pol IV with the DNA (32). Following UmuD cleavage, pol IV however operates error-prone (26) and pol
IV association with DNA is inhibited (32). Furthermore, pol IV operates in an error-prone manner in
recombination intermediates in vitro (29). Error-prone activity of pol IV in recombination intermediates
might be induced due to the interaction of pol IV with RecA (26,29). Beyond this, RecA promotes DNA
synthesis by pol IV in replisomes in vitro (30). In the presence of RecA, pol IV can also bypass alkylation
lesions more efficiently (31). In addition, RecA nucleoprotein formation on single-stranded DNA is a
major trigger for SOS induction and thus increased pol IV expression (35). For some antibiotics, it has
however been shown that the SOS response is mostly triggered following DSB processing by RecBCD
(36,37). Notably, upon induction of the SOS response, the cellular concentration of pol IV increases
significantly (38,39). Despite these observations, it remains unclear if pol IV primarily works in
recombination intermediates or in the context of replisomes in cells.
Here, we used single-molecule fluorescence microscopy to investigate whether ROS, and ROSmediated DSBs, influence pol IV expression and association with the nucleoid in cells. We used two
antibiotics which alter DNA replication and for which killing is known to involve ROS generation;
ciprofloxacin and trimethoprim (5,12). We further showed that DSB resection is necessary for the
formation of pol IV foci, even in cells expressing high concentrations of pol IV (constitutive SOS, lexA51
mutants, here: lexA[Def] mutants), suggesting that pol IV mainly operates on recombination
intermediates.

4.3
4.3.1

Results
ROS potentiate the expression levels and activity of pol IV
We set out to investigate the influence of antibiotic-induced ROS on pol IV activity by

monitoring fluorescently-tagged single pol IV molecules in cells. Toward that objective, we first
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compared pol IV expression levels and its dynamic behavior under normal conditions (no DMSO) and
ROS-mitigating conditions (DMSO added) in response to antibiotic treatment. Cells were treated with i)
ciprofloxacin alone, ii) ciprofloxacin and DMSO in combination, iii) trimethoprim alone or iv)
trimethoprim and DMSO in combination (Fig. 1, SI Appendix, Fig. 1A).

Figure 1. Pol IV concentration and activity following ciprofloxacin or trimethoprim
treatment under
normal conditions or ROS-mitigating conditions. (A) Fluorescence images showing cells expressing
DinB-YPet (Pol IV) at 0, 90 and 180 min (left to right) after ciprofloxacin-alone, ciprofloxacin-DMSO,
trimethoprim-alone or trimethoprim-DMSO treatment (top to bottom). Scale bar represents 5 µm. (B)
Concentration of DinB-YPet during stress. Mean cell brightness is plotted against time (ciprofloxacinalone: dark grey line, ciprofloxacin-DMSO: light grey line, trimethoprim-alone: magenta line,
trimethoprim-DMSO: light magenta line). At each time-point, data are derived from >100 cells. Grey
shaded error bands represent standard error of the mean. (C) Number of DinB-YPet foci per cell are
plotted against time (ciprofloxacin-alone: dark grey line, ciprofloxacin-DMSO: light grey line,
trimethoprim-alone: red line, trimethoprim-DMSO: light red line). At each time-point, data are derived
from >100 cells. Grey shaded error bands represent standard error of the mean.
Prior to live-cell imaging, we first established that cells expressing fluorescent protein fusions of
DinB,  (replisome marker) and UmuC (component of DNA polymerase V, pol V) exhibited wild-type
oxidative stress responses upon antibiotic treatment (ciprofloxacin or trimethoprim) administered either
alone or along with the ROS mitigator (DMSO) (SI Appendix, Fig. 2). In the presence of ROS, E. coli
cells induce the peroxide and/or superoxide stress responses in which expression of superoxide dismutase,
alkyl hydroperoxidase and Fe3+ enterobactin transporter genes are upregulated (reviewed in (3,4,40–44)).
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Therefore, we developed an assay to monitor expression of gfp from ROS-regulated and iron-responsive
promoters in cells treated with ciprofloxacin, trimethoprim or hydrogen peroxide (as a control). We
further tested if the addition of DMSO suppressed the accumulation of ROS (SI Appendix, Fig. 3, 4, 5).
For this purpose, we constructed three plasmids that express GFP (fast-folding GFP, sf-gfp (45)) from the
ROS-regulated promoters of sodA (notably regulated by superoxides/redox active compound via SoxRS
and by the iron (Fe2+) concentration via Fur (4,45), SI Appendix, Fig. 3A), ahpC (regulated by OxyR
(4,42,43), SI Appendix, Fig. 4A) or fepD (regulated by Fur pathway; iron homeostasis (44), SI Appendix,
Fig. 5A). Following hydrogen peroxide treatment, the addition of DMSO reduced the expression of the
GFP reporter from the plasmid-based sodA and fepD promoters by 30% (30 mM hydrogen peroxide at t =
8 h, SI Appendix, Fig. 3C, 4D). This reduction in GFP signal is not due to DMSO quenching fluorescence
(SI Appendix, Fig. 6). Increased expression from the ahpC promotor was delayed by ~3 h (30 and 100
mM hydrogen peroxide, SI Appendix, Fig. 4D). For ciprofloxacin-treated cells, the addition of DMSO
reduced expression from the fepD promotor by 50% (5, 10, 20 and 40 ng/mL at t = 8 h, SI Appendix, Fig.
5B). For trimethoprim-treated cells, the addition of DMSO reduced the expression from the ahpC and
fepD promotors by 50% (0.1 and 0.3 μg/mL at t = 8 h, SI Appendix, Fig. 4B, 5B). Together, these results
indicate that (i) ciprofloxacin and trimethoprim generate ROS in cells (consistent with previous work
(5,46)) and (ii) DMSO reduced the expression from ROS-sensitive promoters, following hydrogen
peroxide, ciprofloxacin and trimethoprim treatment, implying that ROS levels were effectively reduced
by the addition of DMSO.
Following antibiotic addition, we recorded time-lapse movies capturing fluorescence from
Escherichia coli cells expressing a functional, YPet fusion of the DinB gene from its native promoter (SI
Appendix, Fig. 1B, C, Materials and Methods) (39,47). We then monitored pol IV concentrations by
measuring the fluorescence intensity of DinB-YPet within cells in the presence or absence of DMSO (2%
v/v) and monitored DNA binding activities by counting the number of pol IV foci per cell. Treatment
with ciprofloxacin resulted in cell filamentation accompanied by a clear increase in DinB-YPet intensity,
indicating an increase in the intracellular DinB-YPet concentration (seven-fold increase from 140 to 990
DinB-YPet fluorescence, Fig. 1A, B; SI Appendix, Fig. 7). In a previous study (39), following
ciprofloxacin treatment, cells exhibited a similar increase in DinB-YPet concentration; an increase in
intracellular DinB-YPet (pol IV) concentrations was measured from 6 ± 1 nM prior to treatment (standard
error of the mean, SE) to 34 ± 3 nM (SE) 180 min after ciprofloxacin addition. Interestingly, in this
present study, we showed that inclusion of DMSO led to a significant reduction in the expression level of
DinB-YPet in ciprofloxacin-treated cells. DMSO was added at the concentration previously tested (SI
Appendix, Fig. 3, 4, 5). 180 min after ciprofloxacin addition in the presence of DMSO, cellular DinBYPet intensities were only four-fold higher than basal levels (intensity increase from 100 to 454, Fig. 1A,
B). This final intensity corresponds to a concentration of DinB-YPet equalling 19 ± 2 nM (SE, see
Materials and Methods), corresponding to a reduction of about 15 nM of ciprofloxacin-induced pol IV.
Treatment with trimethoprim alone led to a significant increase in DinB-YPet fluorescence; 180 min after
trimethoprim addition, the mean fluorescence intensity increased by more than four-fold (fluorescence
intensity increase from 135 to 557, Fig. 1A, B), corresponding to a final intracellular pol IV concentration
of 23 ± 2 nM. Inclusion of DMSO led to a significant reduction in trimethoprim-induced pol IV up-
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regulation; cellular DinB-YPet fluorescence intensities increased only slightly from 113 to 209,
corresponding to a final pol IV concentration of 9 ± 2 nM. Thus, for both antibiotics, addition of DMSO
resulted in a significant reduction in the steady state levels of pol IV in response to treatment.
Cells exhibit distinct pol IV foci when individual DinB-YPet molecules bind to DNA and thus
experience decreased diffusional mobility (48). Since cells expressing fluorescently tagged catalytically
dead pol IV molecules do not exhibit foci (39), the foci observed in response to antibiotic treatment
represent pol IV molecules engaged in catalytic functions. Prior to the addition of ciprofloxacin, cells
contained on average 0.6 ± 0.2 foci per cell (SE) in the absence of DMSO, and 0.4 ± 0.1 foci per cell in
the presence of DMSO (Fig. 1C). Following treatment with ciprofloxacin alone, the number of foci
steadily increased. By 180 min, cells had 4.2 ± 1.1 foci per cell. Upon ciprofloxacin-DMSO treatment,
cells contained 1.8 ± 0.4 foci per cell; a > 50% reduction compared to ciprofloxacin-alone measurements.
Prior to the addition of trimethoprim, cells contained on average 0.5 ± 0.1 foci (SE) in the absence of
DMSO and 0.4 ± 0.1 foci in the presence of DMSO. Trimethoprim-alone treatment induced a slight
increase in the number of DinB-YPet foci with 0.9 ± 0.2 per cell (SE) at 180 min. This is lower than the
number of foci observed for ciprofloxacin-DMSO treatment (1.8 ± 0.4 per cell), despite the measured pol
IV concentration being marginally higher after trimethoprim-alone treatment (Fig. 1C). Strikingly, cells
treated with both trimethoprim and DMSO did not show any increase in DinB-YPet foci after
trimethoprim addition (0.5 ± 0.1 foci per cell at 180 min; Fig. 1C). Together, these results demonstrate
that for cells treated with ciprofloxacin or trimethoprim, addition of DMSO supresses the drug-induced
increases in DinB-YPet concentration, as well as the binding of pol IV to DNA, as evidenced by a
reduction in the number of DinB-YPet foci. Importantly, the concentration of pol IV and its extent of
DNA-binding are not directly correlated as the trimethoprim-alone and ciprofloxacin-DMSO treatments
induced similar DinB-YPet concentrations, but different numbers of DinB-YPet foci.

4.3.2

ROS-induced double-strand breaks trigger the SOS response
Reasoning that the decreased induction of dinB-YPet expression in cells co-treated with DMSO

likely resulted from attenuation of the SOS response, we repeated the time-lapse experiments (SI
Appendix, Fig. 1B, C) on cells that carried an SOS-reporter plasmid, in which GFP is expressed from the
SOS-inducible sulA promoter (pUA66 PsulA-gfp; fast-folding GFP, gfpmut2 (49)). In the absence of any
antibiotic treatment, cells exhibit very low fluorescence intensity, consistent with the repression of the
sulA promoter in the absence of exogenously applied DNA damage (Fig. 2A, ‘0 min’). SOS levels were
similarly low for cells grown in the presence of DMSO. Cells exhibited robust SOS induction upon
treatment with ciprofloxacin as evidenced by the increase in GFP fluorescence in the 180 min time
window after addition of ciprofloxacin (170 fold induction, Fig. 2B). Consistent with our hypothesis,
SOS induction was strongly inhibited upon inclusion of DMSO during ciprofloxacin treatment (13 fold
induction at 180 min; Fig. 2B). A similar reduction in ROS and SOS levels has been observed in cells
following co-administration of ciprofloxacin with another ROS mitigator, N-acetylcysteine (51). Cells
exposed to trimethoprim exhibited a delay in SOS induction, however, even in this case, high levels of
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SOS induction (100 fold induction) were supressed by the addition of DMSO (2 fold induction for
combined treatment with trimethoprim and DMSO; Fig. 2B). Notably, the addition of a different ROS
mitigator, 2,2’-bipyridine (BiP, 0.35 mM, 0.5 x MIC (5)), similarly supressed the induction of the SOS
response (Fig. 2). These results were also confirmed using plate-reader assays (SI Appendix, Fig. 8).

Figure 2. PsulA-gfp expression levels (SOS response levels) following ciprofloxacin or trimethoprim
treatment under normal or ROS-mitigating conditions in different genetic backgrounds. (A) Fluorescence
images showing the expression of GFP from a SOS reporter plasmid (PsulA-gfp) at 0, 60, 120 and 180 min
(left to right) after ciprofloxacin-alone, ciprofloxacin-DMSO, ciprofloxacin-alone in ΔrecB,
trimethoprim-alone, trimethoprim-DMSO or trimethoprim-BiP treatment (top to bottom). Scale bar
represents 5 µm. (B) GFP expression levels from the sulA promotor during stress. Mean cell intensity is
plotted against time (ciprofloxacin-alone: dark grey line, ciprofloxacin-DMSO: light grey line,
ciprofloxacin in ΔrecB: purple, dotted line, trimethoprim-alone: red line, trimethoprim-DMSO: light red
line, trimethoprim-BiP: rose-colored, dashed line). At each time-point, data are derived from >100 cells.
Grey shaded error bands represent standard error of the mean.

We reasoned that the suppression of SOS by ROS mitigators might reflect a reduction in the
formation and processing of DSBs. Cells lacking recB fail to induce SOS upon treatment with nalidixic
acid, suggesting that end-resection products formed by RecBCD might be sites of SOS induction (36,37).
Since ciprofloxacin and nalidixic acid both target DNA gyrase (9,11,51), we repeated the GFP reporter
measurements in cells lacking recB (SSH111, ΔrecB PsulA-gfp) to determine if SOS induction by
ciprofloxacin is also dependent on DSB processing. The deletion of recB strongly inhibited the SOS
response following ciprofloxacin treatment (0.4 fold induction at 180 min in comparison to recB+, Fig. 2,
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SI Appendix, Fig. 9). While recB deletions are known to reduce survival in cells treated with ciprofloxacin
(52), we observed that most cells lacking recB continued to grow and divide during the 180 min timelapse measurement (SI Appendix, Fig. 7, 9), indicating that the lack of SOS induction observed for
ciprofloxacin-treated recB-deficient cells did not stem from gross inhibition of all cellular functions. Plate
reader assays did not reveal a sustained increase in cell mass for recB deletion cells following
ciprofloxacin treatment (SI Appendix, Fig. 8A, last column), suggesting that the initial growth observed by
microscopy stagnates soon after the 180 min observation window.

Figure 3. Number of MuGam-PAmCherry foci per cell following ciprofloxacin or trimethoprim
treatment under normal conditions or ROS-mitigating conditions in different genetic backgrounds. (A)
Fluorescence signal from MuGam-PAmCherry at 0.003% L-arabinose: Maximum projections over 100
ms x 200 frames showing MuGam-PAmCherry foci. From left to right: MuGam signal after 2 h treatment
with ciprofloxacin, ciprofloxacin + DMSO, trimethoprim, trimethoprim + DMSO, no damage. (B)
Percentage of cells containing MuGam foci: 0 foci (light grey), 1 focus (grey), 2-4 foci (amber) and > 4
foci (red). Cells were treated with ciprofloxacin (n = 125), ciprofloxacin + DMSO (n = 127),
trimethoprim (n = 138), trimethoprim + DMSO (n = 146), or experienced no damage (n = 140). (C) Mean
number of MuGam foci per cell. Cells were treated with ciprofloxacin (n = 125), ciprofloxacin + DMSO
(n = 127), trimethoprim (n = 138), trimethoprim + DMSO (n = 146), or experienced no damage (n = 140).
The error bars represent standard error of the mean over the number of cells. * for p < 0.05; ** for p <
0.01.
To more directly investigate if ROS create DSBs following ciprofloxacin and trimethoprim
treatment, we imaged cells expressing a fluorescent fusion of the DSB reporter MuGam (53) to the
photoactivatable mCherry protein (PAmCherry1 (54), SI Appendix, Fig. 1A, C). MuGam-PAmCherry

87

was expressed from a plasmid (Fig. 3A). For these single-molecule microscopy experiments, expression
of MuGam was induced using 0.003% L-arabinose at MuGam expression levels that had minimal effects
on survival upon drug treatment (SI Appendix, Fig. 10). In the absence of antibiotic, cells exhibited 0.3 ±
0.1 MuGam foci per cell with 74% of cells containing no foci (Fig. 3b, c). Two hours after ciprofloxacin
treatment, cells contained increased number of MuGam foci per cell (4.9 ± 0.3 foci with 1.6% of cells
containing no foci, Fig. 3C). Consistent with DMSO mitigating ROS, DMSO addition reduced the
number of MuGam foci per cell (2.2 ± 0.2 foci with 21% of cells containing no foci, Fig. 3C), indicating
a significant contribution of ROS to the formation of DSBs during ciprofloxacin treatment. In agreement
with a previous study (5), we observed that trimethoprim treatment generates DSBs (1.9 ± 0.1 MuGam
foci with 22% of cells containing no foci, Fig. 3C). These DSBs are ROS-induced as the addition of
DMSO prevents the formation of these DSBs (0.5 ± 0.1 foci with 59% of cells containing no foci, Fig.
3C). In contrast, in a recent study using sub-inhibitory concentrations of ciprofloxacin, reactive oxygen
species do not induce additional DSBs (57).
Taken together our measurements indicate that antibiotic-induced ROS generate DSBs and
potentiate the SOS response. Furthermore, SOS induction levels are dependent on recB DSB processing
in cells treated with ciprofloxacin. Together the results are consistent with a model in which the SOS
response is triggered or potentiated in antibiotic-treated cells via ROS-induced DSBs, leading to increased
levels of pol IV in cells.

4.3.3

Double-strand break resection creates substrates for pol IV
Having established conditions under which ROS create a majority of DSBs in cells as well as

binding sites for pol IV upon antibiotic treatment, we next set out to characterize pol IV behavior during
DSBR in response to antibiotic treatment. To that end, we tested if pol IV primarily forms foci following
DSB resection, suggestive of pol IV having a major role in DSBR. Therefore, we examined the extent of
DinB-YPet focus formation in ciprofloxacin and trimethoprim treated cells, comparing backgrounds that
permitted (recB+) or prevented (ΔrecB) DSB processing. Additionally, we monitored the formation of
DinB-YPet foci while using DMSO to modulate the number of antibiotic-induced DSBs (Fig. 3). To
separate effects on focus formation from effects on DinB-YPet expression, these measurements were
carried out in a lexA(Def) background (56) (dinB-YPet dnaX-mKate2 lexA[Def]). These cells
constitutively express DinB-YPet at levels consistent with SOS induced levels, even in the absence of
DNA damage (39). To capture DinB-YPet binding events on the time-scale of seconds, we recorded burst
acquisitions of the DinB-YPet signal (300 x 50 ms exposures taken every 100 ms, SI Appendix, Fig. 1A,
D).
Consistent with the results from our previous study (39), close to zero DinB-YPet foci were
observed in lexA(Def) cells in the absence of antibiotic (0.08 ± 0.05 foci per cell, Fig. 4). In contrast,
lexA(Def) cells treated with ciprofloxacin for 60 min exhibited clear foci (1.83 ± 0.15 foci per cell, Fig.
4B, C). Co-treatment with ciprofloxacin and DMSO yielded fewer foci (1.02 ± 0.13 foci per cell, Fig. 4
B, C). The deletion of recB resulted in a striking loss of DinB-YPet foci (0.23 ± 0.05 foci per cell, Fig. 4
B, C). lexA(Def) cells treated with trimethoprim for 60 min contained multiple DinB-YPet foci (2.6 ±
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0.18 foci per cell), whereas cells treated with both trimethoprim and DMSO contained few foci (0.19 ±
0.06). Trimethoprim-treated ΔrecB cells also contained very few foci (0.14 ± 0.05). Similar effects were
observed in lexA+ cells, although reductions in focus formation were conflated with reductions in DinBYPet expression levels (Fig. 1C). Taken together these results demonstrate that pol IV is normally active
at ROS-induced, RecBCD-processed DSBs in cells treated with ciprofloxacin or trimethoprim. Consistent
with this, we have demonstrated that pol IV co-localizes with RecA* features in cells treated with
ciprofloxacin (32).

Figure 4. Number of pol IV foci per cell in lexA(Def) cells following ciprofloxacin or trimethoprim
treatment under normal conditions or ROS-mitigating conditions. (A) Upper row: Average projection in
time (100 ms x 10 frames) showing DinB-YPet (pol IV) foci. Bottom row: Discoidal filtered projections.
Cells were treated for 60 min prior to imaging. (B) Percentage of cells containing pol IV foci: 0 foci (light
grey), 1 focus (grey), 2 foci (amber) and ≥ 3 foci (red). Cells were treated with ciprofloxacin (n = 106),
ciprofloxacin + DMSO (n = 109), ciprofloxacin in ΔrecB (n = 106), trimethoprim (n = 145), trimethoprim
+ DMSO (n = 102), trimethoprim in ΔrecB (n = 94) experienced no damage for wild-type (n = 85) and
ΔrecB (n = 99). (C) Number of DinB-YPet foci per cell. Error bars represent standard error of the mean.
Number of cells included in analysis: n(ciprofloxacin) = 106, n(ciprofloxacin-DMSO) = 109,
n(ciprofloxacin in ΔrecB) = 106, n(trimethoprim) = 145, n(trimethoprim-DMSO) = 102, n(trimethoprim
in ΔrecB) = 94, n(untreated recB+) = 85, n(untreated ΔrecB) = 99. * for p < 0.05; ** for p < 0.01.
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In a previous study (39), we showed that pol IV primarily forms foci away from replisomes,
indicating that pol IV has a minor role in facilitating replication restart of stalled replisomes. To
investigate if these non-replisomal pol IV foci are ROS-induced, we next determined the percentage of
DinB-YPet foci that form in the vicinity of replisomes (fluorescent protein fusion of the pol III τ-subunit,
τ -mKate2). For each experiment, when recording the DinB-YPet signal in recB+ cells, we also recorded
the position of τ -mKate2 as in the previous study (39). Ciprofloxacin treatment, which rapidly halts DNA
synthesis (57,58), causes 10% of pol IV foci to bind near replisomes (39). Here we observed that the
inclusion of DMSO dramatically increased the relative colocalization of DinB-YPet with replisomes in
both lexA+ and lexA(Def) cells treated with ciprofloxacin (SI Appendix, Fig. 11, 12). For long-lived pol IV
foci (detectable within a 10 s average projection image, Fig. 5B, right panel) in the lexA(Def)
background, 80% of foci colocalized with replisomes under ciprofloxacin-DMSO conditions (Fig. 5B).
This is consistent with the addition of DMSO having removed the vast majority of non-replisomal
substrates for pol IV-dependent DNA synthesis. This observation appears to be consistent with a recent
proposal that ROS-mitigation reduces rates of pol IV-dependent mutagenesis (55). For lexA(Def) cells
treated with trimethoprim, addition of DMSO abolished long-lived pol IV foci entirely (Fig. 5A, C).

Figure 5. Measuring the colocalization of pol IV and replisomes following ciprofloxacin or trimethoprim
treatment ± DMSO in lexA(Def) cells. (A) DinB-YPet activity at replisomes in lexA(Def) cells. Cells were
treated for 60 min prior to imaging. Merged images showing DinB-YPet foci in green and -mKate2 foci
in magenta following ciprofloxacin-alone (n = 106), ciprofloxacin-DMSO (n = 109), trimethoprim-alone
(n = 145) and trimethoprim-DMSO (n = 102) treatment (from left to right). White arrow points at
colocalization event (white focus). Data were collected over three biologically independent experiments.
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Scale bar represents 5 µm. (B) Colocalization percentages of pol IV foci that bind at replisomes (green
bars) and colocalization percentages of replisomes that contain a pol IV focus (magenta bars) for cells
treated with ciprofloxacin-alone (left) or ciprofloxacin-DMSO (right). Colocalization was measured with
sets of pol IV foci that last 1, 3, 5 and 10 s. Error bars represent the standard error of the mean. (C)
Colocalization percentages of pol IV foci that bind at replisomes (green bars) and colocalization
percentages of replisomes that contain a pol IV focus (magenta bars) for cells treated with trimethoprimalone (left) or trimehtoprim-DMSO (right). Colocalization was measured with sets of pol IV foci that last
1, 3, 5 and 10 s. Error bars represent the standard error of the mean.

4.3.4

ROS do not promote pol V activity
Finally, we explored if ROS-induced DSBs promote a change in the binding activity of the other

major error-prone polymerase pol V (UmuDʹ2C) in real time (59). Since pol V is also a member of the
SOS regulon (35), we use a lexA(Def) background (RW1286, umuC-mKate2 dnaX-YPet lexA[Def]) to
separate effects on focus formation from effects on UmuC-mKate2 expression.
UmuC foci might form at two stages during the activation of pol V Mut at RecA* filaments and
when active pol V Mut complexes synthesize DNA. As before, lexA(Def) cells were treated for 60 min
with ciprofloxacin-alone, ciprofloxacin-DMSO, trimethoprim-alone or trimethoprim-DMSO (SI
Appendix, Fig. 1A). Burst acquisitions of the UmuC-mKate2 signal were recorded (SI Appendix, Fig. 1D,
300 x 50 ms exposures taken every 100 ms).
Few UmuC-mKate2 foci were observed in the absence of antibiotic in lexA(Def) cells (about
0.32 ± 0.08 foci per cell, SI Appendix, Fig. 12). In lexA(Def) cells treated with ciprofloxacin or
trimethoprim for 60 min, foci were clearly visible (ciprofloxacin: 1.24 ± 0.16 foci per cell; trimethoprim
1.39 ± 0.21 foci per cell). In both cases, co-treatment with DMSO had little effect on the number of
UmuC-mKate2 foci (ciprofloxacin-DMSO: 0.99 ± 0.12 foci per cell; trimethoprim-DMSO 1.26 ± 0.16
foci per cell) or on the overall levels of UmuC-mKate2 fluorescence in the cells. Thus in contrast to the
effects observed for pol IV, the addition of DMSO had little effect on the formation of UmuC foci.
Interestingly, in lexA+ cells, which express SOS normally, trimethoprim treatment (with or without
DMSO) did not lead to the formation of pol V (SI Appendix, Fig. 13A, C). Consistent with this, cleavage
of UmuD to UmuD′ was far less efficient in trimethoprim-treated cells than in ciprofloxacin-treated cells
(compare SI Appendix, Fig. 14B, D). This suggests that RecA* structures that induce SOS (i.e. increase in
the expression levels of SulA and pol IV) may be different from those that mediate the formation of pol V
through UmuD cleavage. This result is discussed further below and warrants further investigation.

4.4
4.4.1

Discussion
ROS-mediated DSBs induce high intracellular concentrations of pol IV
We observed that ROS mitigators reduced levels of SOS induction, and thus, pol IV

concentrations, adding to a growing body of evidence linking ROS and mutational resistance to
antibiotics (14,50,60,61). ROS mitigators reduced the number of MuGam foci per cell, indicative of fewer
DSBs being formed. ROS accumulation is a major trigger for SOS induction in trimethoprim treated cells
and is mediated through RecBCD-dependent resection of ROS-induced DSBs. When a ROS mitigator is
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including during treatment, the SOS response is not induced even though ssDNA regions are likely to be
generated by trimethoprim-induced TLD (5,62,63). Thus, the formation of double-strand breaks is
essential for SOS induction in trimethoprim-treated cells. During thymine starvation, ssDNA regions are
converted to DSB due to ROS activity (5). Our results indicate that a similar pathway is at play in
trimethoprim-treated cells as previously proposed (5).
In ciprofloxacin-treated cells, the deletion of recB almost fully inhibited the SOS response.
Ciprofloxacin and nalidixic acid both target DNA gyrase (9,11,52). It was previously observed that
induction of SOS by the antibiotic nalidixic acid was completely blocked in cells that carried a recB
mutation and were therefore incapable of processing DSBs through the RecBCD end-resection nuclease
complex (36,37). This implies that SOS induction is also primarily triggered by DSB processing in
nalidixic acid-treated cells. Consistent with this result, we showed here that the SOS response in
ciprofloxacin-treated cells is recB-dependent, consistent with a requirement for DSB processing. Cells
lacking recB still exhibit very low levels of SOS induction, which could arise from RecA structures
assembled on ssDNA regions or by alternative DSB end-resection pathways, for instance via a RecJdependent pathway proposed previously (64,65)
Our findings raise the question of whether ssDNA gaps truly represent the major source of SOS
induction in E. coli. Under our conditions, DSB processing – most often induced by ROS – acts as the
major trigger of the SOS response. The results presented here highlight a need that further studies are
necessary to fully understand the regulation of the SOS response, in particular the role RecA* structures
formed on ssDNA gaps versus DSBs (54,66–68). The observation by Hong et al. that ssDNA gaps are
converted to DSBs under conditions of thymine starvation (5), highlights ROS-dependent gap-to-break
conversion as a potential complicating factor in studies that seek to differentiate events that take place at
gaps from those that take place at breaks.

4.4.2

DSB processing is critical for the formation of pol IV foci
We showed that the processing of ROS-induced DSBs promotes DinB-YPet focus formation.

The observations are consistent with a model in which ROS-induced DSBs promote pol IV activity by
inducing the SOS response and by generating substrates for pol IV in the form of recombination
intermediates.
Few DinB-YPet foci were observed in cells treated with a combination of trimethoprim and
DMSO. Based on events that occur during the analogous process of TLD (5,62), treatment with
trimethoprim should induce the formation of ssDNA gaps in the wake of the replisome. In the presence of
ROS these would be rapidly converted to DSBs, whereas under ROS mitigated conditions the gaps would
persist. The low extent of focus formation observed under trimethoprim-DMSO conditions implies that
pol IV rarely acts at these ssDNA gaps.
Following ciprofloxacin treatment, cells exhibited reduced numbers of DinB foci under low ROS
conditions. However, ciprofloxacin also induces the formation of end-stabilized DNA-gyrase complexes,
which halt DNA synthesis, slowing down cell growth (57,58). When deleting recB, and thus blocking
DSB resection at both ROS-induced and ROS-independent DSBs, cells exhibited a very low number of
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DinB foci, equivalent to numbers present in the absence of damage. Moreover, the colocalization of
DinB-YPet with replisomes was substantially increased in the presence of DMSO. It is possible that
replisome-proximal DinB-YPet foci, that are insensitive to ROS, reflect pol IV molecules that are
recruited to replisomes that have stalled at end-stabilized DNA-gyrase complexes.

4.4.3

Pol V is not activated by ROS-induced damage
In contrast to the observations made for pol IV, mitigation of ROS produces only a marginal

effect on pol V levels in ciprofloxacin-treated cells. Pol V levels barely increase following trimethoprim
treatment. Thus unlike pol IV, the repair of ROS-induced DSBs does not directly lead to increased levels
of pol V. One possibility is that the mechanisms of SOS induction are different during trimethoprim and
ciprofloxacin treatments, with the RecA* structures formed during trimethoprim treatment being
insufficient for the up-regulation of pol V. A second and perhaps more likely possibility is that the RecA*
structures that trigger LexA cleavage (and thus SOS induction) are different from those that trigger
UmuD cleavage (and thus pol V activation). In this scenario, ciprofloxacin treatment may produce both
types of RecA* structure, whereas trimethoprim induces only the form competent for SOS induction. In
this case, poor cleavage of UmuD would be expected to prevent the accumulation of UmuC due a
previously identified system of targeted proteolysis, which limits UmuC accumulation in the absence of
UmuD′2 (69).
Interestingly, the formation of pol V foci was not affected by adding DMSO to supress DSB
formation. This implies that DSBR intermediates are not major substrates for pol V in ciprofloxacin- or
trimethoprim-treated cells. In a previous study, we observed that pol V rarely colocalizes with replisomes
(48). Together our observations hint at a potential division of labor between pols IV and V, with pol IV
often acting at DSBR intermediates and pol V acting at other, as yet unidentified structures, which may
include ssDNA gaps or daughter strand gap repair intermediates.

4.5
4.5.1

Materials and Methods
Strain construction
EAW102 is E. coli K-12 MG1655 ΔrecB and was constructed using λRED recombination. The

kanamycin resistance marker in EAW102 was removed via FLP-FRT recombination (70) using the
plasmid pLH29 to obtain kanamycin sensitive HG356.
SSH091, SSH111 and MEC030 (dinB+ lexA+ recB+ + pUA66-sulA-gfp, dinB+ lexA+
ΔrecB::FRT + pUA66-sulA-gfp and recA730 sulA- + pUA66-sulA-gfp) were created by transforming
MG1655, EAW102 and EAW287 with pUA66-sulA-gfp (49).
RW1286 is E. coli MG1655 umuC-mKate2 dnaX-YPet sulA-::kanR lexA51(Def)::CmR and was
made in two steps: first the wild-type sulA+ gene of EAW282 was replaced with sulA-::kan by P1
transduction from EAW13 (47), to create EAW282 sulA-; then lexA51(Def) malB::Tn9 was transferred
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from DE406 (71) into EAW282 sulA- by P1 transduction, selecting for chloramphenicol resistance. To
confirm the presence of the lexA(Def) genotype, colonies were then screened for high levels of RecA
expression by Western blotting with anti-RecA antibodies (72).
EAW1144 is E. coli K-12 MG1655 dinB-YPet dnaX-mKate2 sulA- lexA51(Def) ΔrecB and was
constructed in three steps: sulA- FRT-Kan-FRT was P1 transduced in EAW643 (KanS) using a P1 lysate
grown on EAW13 to obtain the strain EAW1134. The Kan cassette was removed using pLH29 (70).
Then, lexA51(Def) malB::Tn9 was transduced into EAW1134 using a P1 lysate grown on DE406 to
obtain the strain EAW1141. Finally, ΔrecB FRT-KanR-FRT was transduced into EAW1141using P1
lysate grown on EAW102 to obtain EAW1144. All mutations introduced were confirmed by PCR.
The pBAD-MuGam vector (pEAW1159) was constructed using a PCR-amplified muGam gene
fragment (us=GGATATCCATATGGCTAAACCAGCAAAACGTA consisting of a NdeI site and the
beginning of the muGam gene, and MuGam ds= GCGAATTCTTAAATACCGGCTTCCTGTTCA
consisting of an EcoRI site and the end of the muGam gene) from EAW727 (MG1655 Founder (73) Δe14
with chromosomal muGam-gfp in the attTn7 site). EAW727 was constructed by transducing muGam-gfp
into Founder Δe14 using a P1 lysate grown on SMR14350 (54). The PCR product was digested with NdeI
and EcoRI and inserted into pBAD NdeI which was cut with the same enzymes. pBAD NdeI is
pBAD/Myc-HisA (Invitrogen) that has been mutated to add a NdeI site in place of the original NcoI site.
All other NdeI sites were filled in before the mutagenesis. The resulting plasmid was directly sequenced
to confirm presence of wt muGam gene
The pBAD-MuGam-PAmCherry vector (pEAW1162) was constructed by using two PCR
fragments: 1. NdeI-MuGam-linker-EcoRI generated from pEAW1159 using the following PCR primers:
MuGam us=GGATATCCATATGGCTAAACCAGCAAAACGTA consisting of a NdeI site and the
beginning

of

the

muGam

gene,

and

MuGam

ds

no

stop

link=

GGATATCGAATTCGCCAGAACCAGCAGCGGAGCCAGCGGAAATACCGGCTTCCTGTTCAAA
TG consisting of an EcoRI site, an 11aa linker, and the end of the muGam gene without a stop codon. The
PCR product was digested with NdeI and EcoRI. 2. EcoRI-PAmCherry-HindIII generated from pBADPAmCherry-mCI

(54)

using

the

following

PCR

primers

PAmCherry

usEco

=

GGATATCGAATTCATGGTGAGCAAGGGCGAGGAG consisting of an EcoRI site and the beginning
of

mCherry,

and

PAmCherry

dsHind=

GGATATCAAGCTTTTACTTGTACAGCTCGTCCAT

consisting of a HindIII site and the end of the mCherry gene. The PCR product was digested with EcoRI
and HindIII. Both PCR products were ligated to pBAD NdeI that had been digested with NdeI and
HindIII. The resulting plasmid was directly sequenced to confirm the presence of muGam-PAmCherry.
Table 1. Strains used in this study.
Strain

Relevant Genotype

Parent strain

Source/technique

MG1655
EAW102
HG356

dinB+ dnaX+ recB+ lexA+
ΔrecB::KanR
ΔrecB::FRT
+
dinB lexA+ recB+ + pUA66sulA-gfp

MG1655
MG1655

published (74)
Lambda Red recombination
EAW102
Transformation of MG1655
with pUA66-PsulA-gfp (49)

SSH091

94

MG1655

SSH111
EAW18
RW120
RW546

dinB+ lexA+ ΔrecB::FRT +
pUA66-PsulA-gfp
ΔdinB::KanR
recA+ sulA+
lexA ΔumuDC::CmR
recA+ sulAlexA51(Def) ΔumuDC::CmR

MG1655

Transformation of HG356
with pUA66-PsulA-gfp (49)
published (39)

RW118

published (75)

RW542

published (76)

HG356

RW880

ΔumuDC::CmR

MG1655

JJC5945
EAW642
EAW633

dnaX-YPet::KanR
dnaX-mKate2::KanR
dinB-YPet::KanR
dinB-YPet::FRT dnaXmKate2::KanR
umuC-mKate2::KanR
umuC-mKate2::FRT dnaXYPet::KanR

MG1655
MG1655
MG1655

Transduction of MG1655
with P1 grown on RW120
(75)
published (47)
published (39)
published (39)

EAW633

published (39)

MG1655

published (47)

JJC5945

published (47)

EAW13

sulA-::KanR

MG1655

published (47)

EAW282 sulA-

umuC-mKate2::FRT dnaXYPet::FRT sulA-::KanR

EAW282

EAW643
EAW191
EAW282

RW1286
RW1594
EAW1134
EAW1141

EAW1144
EAW287
MEC030
MG1655 +
pEAW1162
MG1655 + pSTBsodA-gfp
MG1655 +
pCJH0008
MG1655 +
pCJH0009

umuC-mKate2::FRT dnaXYPet::FRT sulA-::KanR
lexA51(Def)::CmR
dinB-YPet dnaX-mKate2 sulA::KanR lexA51(Def)::CmR
dinB-YPet::FRT dnaXmKate2::FRT sulA-::KanR
dinB-YPet::FRT dnaXmKate2::FRT sulA-::FRT
lexA51(Def)::CmR
dinB-YPet::FRT dnaXmKate2::FRT sulA-::FRT
lexA51(Def)::CmR ΔrecB::KanR
recA730 sulA-::FRT
recA730 sulA- + pUA66-PsulAgfp

EAW282
sulARW1588
EAW643
EAW1134

EAW1141
MG1655
EAW287
KanS

pBAD-MuGam-PAmCherry

MG1655

PsodA-sf-gfp

MG1655

PahpC-sf-gfp

MG1655

PfepD-sf-gfp

MG1655
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Transduction of EAW282
with P1 grown on EAW13
(47)
Transduction of EAW282
sulA- with P1 grown on
DE406 (71)
published (39)
Transduction of EAW643
with P1 grown on EAW13
Transduction of EAW1134
with P1 grown on DE406
(71)
Transduction of EAW1141
with P1 grown on EAW102
published (47)
Transformation of EAW287
with pUA66-PsulA-gfp (50)
Transformation of MG1655
with pBAD-MuGamPAmCherry
Transformation of MG1655
with pSTB-sodA-gfp
Transformation of MG1655
with pQCJH0008
Transformation of MG1655
with pCJH0009

4.5.2

ROS reporter fusions construction
Three promoters of genes regulated by changes in ROS or iron levels were cloned and fused to

the sf-gfp gene (45) into a pQBI63 plasmid (Qbiogene). Briefly, upstream regions of sodA gene
(consisting of the 284 nt intergenic region of rhaT and sodA ) regulated by soxS and Fur (4,41), or ahpC
gene (- 372 to -1 nt of ATG) regulated by OxyR (4,42,43), or fepD gene (-170 to -1 nt of ATG) regulated
by Fur (44), were amplified and cloned into the pQBI63 plasmid using BglII/NheI restriction enzyme to
generate respectively pSTB-sodA-gfp, pCJH0008 and pCJH0009. All constructions were confirmed by
sequencing.

4.5.3

DNA damaging agent sensitivity assay
Cells were grown in EZ glucose medium overnight at 37ºC. The next day, a dilution 1/1000 of

each culture was grown in EZ glucose (at 37ºC, 150 rpm) until reaching mid log phase (OD 600 = 0.3). Six
aliquots of 300 L of each culture were transferred in 24 microplates. The first aliquot was used as
control of no treatment, 2% DMSO (282 mM, 0.2 x MIC (5)), 30 ng/mL ciprofloxacin, 30 ng/mL
ciprofloxacin + 2% DMSO, 1 g/mL trimethoprim or 1 g/mL trimethoprim + 2% DMSO were added in
the others. Samples of 150 uL were taken at 0 and 60 min; samples at 0 h were taken just before
treatment. Each sample was serial diluted in PBS by factor ten down to 10-6 and dilutions 10-1 to 10-6 were
spotted on fresh LB plates (Difco brand). Plates were incubated overnight at 37ºC in the dark.

4.5.4

Survival assay following MuGam-PAmCherry expression
To test the effect of MuGam-PAmCherry expression levels on lethality following ciprofloxacin

and trimethoprim exposure, seven cells cultures were set up, expressing different levels of MuGamPAmCherry from a pBAD plasmid. Cells cultures 1-7 (each 1 mL) were grown in EZ glycerol medium in
the presence of ampicillin (100 g/mL) and different L-arabinose concentrations (0, 0.001, 0.003, 0.01,
0.03, 0.1%) and cell culture 8 (1 mL) was grown EZ glucose medium in the presence of ampicillin
(100 g/mL) in overnight at 37ºC, 950 rpm. The next day, a 10/1000 dilution of each culture (final
volume of 1.5 mL) was grown under the same conditions as over-night growth for 3 h. Each culture was
split in three and no drug, 30 ng/mL ciprofloxacin or 1 g/mL trimethoprim was added. These cultures
were grown (at 37ºC, 950 rpm) for 2 h. Then, cultures were spin down (5 min; 5,000 g) and cell pellets
were resuspended in 0.5 mL corresponding EZ medium; centrifugation and resuspension was carried out
three times. Each cell culture was serial diluted in PBS by factor ten down to 10-5 and dilutions 10-1 to 105

were spotted on fresh LB plates containing 100 g/mL ampicillin (Difco brand). Plates were incubated

overnight at 37ºC in the dark. For each condition, biological triplicates were performed. From these
experiments, an L-arabinose concentration of 0.003% was chosen for fluorescence microscopy
experiments because this L-arabinose concentration showed no drastic decrease in survival compared to
the sample grown in the presence of glucose.
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4.5.5

Plate reader assay
Cells were grown in EZ glucose medium overnight at 37ºC. The next day, a dilution 10/1000 of

each culture was grown in EZ glucose (at 37ºC, 950 rpm) for 3 h. These cultures were diluted to 1/200.
Then, 10 μL of these diluted cultures were added to a total volume of 200 μL medium in each well of a
96-well plate. These 200 μL of media contained antibiotic, or hydrogen peroxide, and/or ROS mitigators
(final concentration: 5, 10, 20 and 40 ng/mL ± 2% DMSO or ± 0.35 mM BiP; 0.1, 0.3, 1 and 3 μg/mL ±
2% DMSO or ± 0.35 mM BiP; 30, 100, 300 and 500 mM hydrogen peroxide [H2O2] ± 2% DMSO). For
experiments with antibiotics and/or ROS mitigators, antibiotics and/or ROS mitigators were added just
before cells were added. For experiments with hydrogen peroxide, hydrogen peroxide was added
subsequently after cells were added. For each well, absorbance (OD600) is measured every 30 min over 17
h or 18 h. The fluorescence signal was measured at each time point (λexcitation = 470 ± 15 nm, λemission = 515
± 20 nm). For cells carrying PsulA-gfp, experiments were carried out in 96-well plates from Nalge Nunc
International (no. 265301). For cells carrying PsodA-sf-gfp, PahpC-sf-gfp or PfepD-sf-gfp, experiments
were carried out in 96-well plates from Thermo Scientific (no. 165305). The experiments were carried out
using the CLARIOstar plate reader (BMG Labtech; settings: orbital reading 4 mm (for 96-well plates
from Nalge Nunc International) or 2 mm (for 96-well plates from Thermo Scientific), orbital shaking at
200 rpm, at 37 ºC).
Cell cultures were also serial diluted and plated on LB agar plates in order to calculate the
number of cells added to each well. To each well, when adding wild-type cells, 105 – 106 cells were added
at the beginning of the experiment. For experiments when adding ΔrecB cells, 105 cells were added at the
beginning of the experiment.

4.5.6

Fluorescence microscopy
For all experiments except for experiments including imaging of MuGam-PAmCherry (Fig. 3),

wide-field fluorescence imaging was conducted on an inverted microscope (IX-81, Olympus with a 1.49
NA 100x objective) in an epifluorescence configuration (47). Continuous excitation is provided using
semidiode lasers (Sapphire LP, Coherent) of the wavelength 514 nm (150 mW max. output) and 568 nm
(200 mW max. output). -mKate2 in EAW643 and UmuC-mKate2 in EAW282 were imaged using yellow
excitation light (λ = 568 nm) at high intensity (2750 Wcm-2), collecting emitted light between 610–680
nm (ET 645/75m filter, Chroma) on a 512 × 512 pixel EM-CCD camera (C9100-13, Hamamatsu). Images
of UmuC-mKate2 in RW1286 were recorded at 275 Wcm-2. For DinB-YPet imaging of EAW643, we
used green excitation (λ = 514 nm) at 160 Wcm-2 collecting light emitted between 525–555 nm
(ET540/30m filter, Chroma). For DinB-YPet imaging of RW1594, cells were imaged at 51 Wcm-2. YPet imaging (EAW282, RW1286) was performed at 51 Wcm-2. Cells carrying the SOS reporter plasmid
pUA66-sulA-gfp (SSH091, SSH111) were imaged at 16 Wcm-2.
For experiments including imaging of MuGam-PAmCherry (Fig. 3), imaging was conducted on
an inverted microscope (Nikon Eclipse-Ti), equipped with a 1.49 NA 100× objective and a 512 ×
512 pixel2 Photometrics Evolve CCD camera (Photometrics, Arizona, US). NIS-Elements equipped with
JOBS module was used to operate the microscope (Nikon, Japan). Continuous excitation is provided
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using semidiode lasers of the wavelength 405 nm (OBIS, Coherent, 200 mW max. output) and 568 nm
(Sapphire LP, Coherent, 200 mW max. output). MuGam-PAmCherry was imaged by simultaneous
illumination with the activation laser 405 nm (1–5 W cm–2) and 568 nm readout laser (540 W cm–2), a
PALM (photoactivation localization microscopy) acquisition protocol, collecting emitted light from 590
nm (ET590LP, Chroma).
Two-color time-lapse movies were recorded to visualize if DinB-YPet foci overlap with mKate2 foci (EAW643). Sets of three images were recorded (bright-field [34 ms exposure], mKate2
fluorescence [100 ms exposure], YPet fluorescence [50 ms exposure]) at an interval of 10 min for 3 h. To
measure colocalization between UmuC-mKate2 with the replisome marker -YPet (EAW282), we
recorded time-lapse movies at the same intervals but different exposures for the replisome marker (brightfield [34 ms exposure], mKate2 fluorescence [100 ms exposure], YPet fluorescence [500 ms exposure]).
Burst acquisitions of DinB-YPet (movies of 300 × 50 ms frames taken every 100 ms light at 514
nm) were collected, subsequently to each burst acquisition, an image of -mKate2 (568 nm) was taken
(imaging sequence for RW1594). With this imaging sequence, we analysed activity of DinB-YPet at
replisomes. RW1286 was imaged similarly; we recorded burst acquisitions of UmuC-mKate2 (568 nm)
followed by a snapshot of -YPet (514 nm). All images were analysed with ImageJ (77).
The MuGam-PAmCherry imaging acquisition was recorded as a set of two acquisitions, 1.
bright-field image (100 ms exposure), 2. PAmCherry fluorescence [simultaneous illumination with the
activation laser 405 and 568 nm readout laser for 200 frames each with 100 ms exposure]). This protocol
was only executed once for a field-of-view to minimize laser damage. Consequently, before and after
antibiotic treatment shows a new set of cells. Images taken after antibiotic addition were recorded
following 2 h of antibiotic treatment.

4.5.7

Flow cell designs
All imaging experiments were carried out in home-built quartz-based flow cells. These flow cells

were assembled from a no. 1.5 coverslip (Marienfeld, REF 0102222, for imaging on IX-81, Olympus) or
(Marienfeld, REF 0107222, for imaging on Nikon Eclipse-Ti), a quartz top piece (45x20x1 mm) and PE60 tubing (Instech Laboratories, Inc.). Prior to flow-cell assembly, coverslips were silanized with (3aminopropyl)triethoxysilane (APTES, from Alfa Aeser). First, coverslips were sonicated for 30 min in a
5M KOH solution to clean and activate the surface. The cleaned coverslips were rinsed thoroughly with
MilliQ water and then treated with a 5% (v/v) solution of APTES in MilliQ water. The coverslips were
subsequently rinsed with ethanol and sonicated in ethanol for 20 seconds. Afterwards, the coverslips were
rinsed with MilliQ water and dried in a jet of N2. Silanized slides were stored under vacuum prior to use.
To assemble each flow cell, polyethylene tubing (BTPE-60, Instech Laboratories, Inc.) was
glued (BONDiT B-482, Reltek LLC) into two holes that were drilled into a quartz piece. After the glue
solidified overnight, double-sided adhesive tape was stuck on two opposite sides of the quartz piece to
create a channel. Then, the quartz piece was stuck to an APTES-treated coverslip. The edges were sealed
with epoxy glue (5 Minute Epoxy, PARFIX). Each flow cell was stored in a desiccator under mild
vacuum while the glue dried. Typical channel dimensions were 45 mm × 5 mm × 0.1 mm (length × width
× height).
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4.5.8

Preparation of cell cultures for microscopy
The day before each experiment, for all experiments, an over-night culture was grown from a

freezer stock for each cell culture. Cells that did not carry the MuGam-PAmCherry plasmid were grown
at 37⁰C in EZ rich defined medium (Teknova) that contained 0.2% (w/v) glucose. All strains that have a
KanR cassette were grown in the presence of kanamycin (20 μg/mL). Cells that carried the MuGamPAmCherry plasmid were grown at 37⁰C in EZ rich defined medium (Teknova) that contained 0.2% (w/v)
glycerol and 0.001% L-arabinose, in the presence of ampicillin (100 μg/mL).
At the day of the experiment, for all imaging experiments excluding imaging of MuGam fusion,
cells were grown at 37⁰C in EZ rich defined medium (Teknova) that contained 0.2% (w/v) glucose. All
strains that have a KanR cassette were grown in the presence of kanamycin (20 μg/mL). Cultures used for
imaging under ROS-mitigating conditions were grown in the presence of the particular mitigator used for
the experiment (DMSO [2% v/v, 282 mM, 0.2 x MIC (5)] or BiP [0.35 mM, 0.5 x MIC (5)], culture time
~3 h for recB+ lexA+, ~4 h for ΔrecB lexA+ and ~6 h for ΔrecB lexA[Def]). For imaging experiments of the
MuGam fusion, cells were grown at 37⁰C in EZ rich defined medium (Teknova) that contained 0.2%
(w/v) glycerol and 0.001% L-arabinose. All strains were grown in the presence of ampicillin
(100 μg/mL). Cultures used for imaging under ROS-mitigating conditions were grown in the presence of
DMSO [2% v/v, 282 mM, 0.2 x MIC (5)] for ~3 h culture time.

4.5.9

Imaging in flow cells
Cells were loaded into flow cells (SI Appendix, Fig. 1A), allowed a few minutes to associate with

the APTES surface, then loosely associated cells were removed by pulling through fresh medium. The
experiment was then initiated by adding either an antibiotic alone or in combination with DMSO to the
medium (30 ng/ mL ciprofloxacin, 30 ng/ mL ciprofloxacin with 2% (v/v) DMSO, 1 μg/mL trimethoprim,
1 μg/mL trimethoprim with 2% (v/v) DMSO or 1 μg/mL trimethoprim with 0.35 mM BiP). Throughout
the experiment, medium was pulled through the flow cell using a syringe pump, at a rate of 50 μL/min.
For each condition, triplicate measurements were recorded.

4.5.10

Analysis of cell filamentation, concentrations, SOS induction level and

number of foci
We selected single cells to obtain information about SOS induction, DinB and UmuC levels
upon UV irradiation (>100 cells for every time point). MicrobeTracker 0.937 (78), a MATLAB script,
was used to create cell outlines as regions of interest (ROI). We manually curated cell outlines designated
by MicrobeTracker at t = 0 min (time point of antibiotic addition) and at 30 min time intervals until 180
min. By obtaining cell outlines manually, we ensure accuracy and purely select non-overlapping, in-focus
cells for analysis. These ROI were imported in ImageJ 1.50i. The cell outlines were then used to measure
mean cell intensities, cell lengths and the number of foci per cell. Parameters describing foci (number,
positions and intensities) were obtained using a Peak Fitter plug-in, described previously (39,47). Prior to
determining DinB-YPet foci UmuC-mKate2 per cell from burst acquisition movies in lexA(Def), average
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projections in time were curated from frame 1 to 101 (10 x 100 ms = 1 s). Prior to determining MuGamPAmCherry foci per cell from burst acquisition movies, maximum projections in time were curated over
the entire movie, capturing all binding events of MuGam-PAmCherry.
Using information of mean cell brightness derived from DinB-YPet expressing cells, we also
calculated DinB-YPet concentrations of cells grown in the absence or presence of antibiotic. In a previous
study (39), we calculated the DinB-YPet concentration which correlates with a certain mean cell
brightness (in the absence of ciprofloxacin: 6 ± 1 nm [SE]; 180 min after ciprofloxacin treatment: 34 ± 3
nM [SE]). We utilized these values to calculate the DinB-YPet concentration for ciprofloxacin ± DMSO
or trimethoprim ± DMSO treated cells.

4.5.11

Analysis of colocalization events
Foci were classed as colocalized if their centroid positions (determined using our peak fitter tool)

fell within 2.18 px (218 nm) of each other. When treating with ciprofloxacin, we determined that for
DinB-YPet–-mKate2 localization the background of DinB foci expected to colocalize with replisomes
purely by chance is ~4% at 180 min. This was calculated by taking the area of each cell occupied by
replisome foci (including the colocalization search radius) and dividing by the total area of the cell. The
value of 4% corresponds to the mean of measurements made over 121 cells. Since the foci density of
replisomes stays fairly constant following ciprofloxacin treatment, the chance colocalization of DinBYPet foci with -mKate2 is ~4% during the experiment (39). Chance colocalization of -mKate2 with
DinB-YPet is however not constant over time because most cells contain no pol IV foci in the absence of
any DNA damage. Chance colocalization is close to zero at 0 min; at 60 min, chance colocalization is
~5%; at 120 min, chance colocalization is ~3%. Moreover, chance colocalization of -mKate2 with DinBYPet is overall reduced under ROS-mitigating conditions due to a reduced number of foci per cell
(chance colocalization close to zero at 0 min; at 120 min, ~2%). Chance colocalization of -mKate2 with
DinB-YPet in trimethoprim-treated cells amounts to ~1% from 60-90 min (close to zero before 60 min).
Under ROS-mitigating conditions, chance colocalization is always close to zero because the number of
pol IV foci per cell does not increase post treatment as well as cell size (Fig. 1).
The chance colocalization of UmuC-mKate2 with -YPet is similar to the chance colocalization
of DinB-YPet with -mKate2 (chance colocalization: ~4%). The expected colocalization of -YPet with
UmuC-mKate2 by background is close to zero until 90 min. UmuC-mKate2 is neither upregulated nor
released from the membrane (SI Appendix, Fig. 13A). Chance colocalization is ~3% at 180 min after
ciprofloxacin treatment and ~2% after the combinational treatment of ciprofloxacin/DMSO.

4.5.12

Western blotting
Overnight E. coli LB cultures of RW120/pRW154 and RW546/pRW154 (75) were diluted 1 to

100 in fresh LB with appropriate antibiotics and grown to mid-log (~OD 0.5, ~3 hrs). Aliquots were then
taken for the untreated samples. Either ciprofloxacin (30 ng/mL) or trimethoprim (1 µg/mL) was added to
the remaining culture and incubated with or without the addition of 2% DMSO. Samples were taken at 1,
2 and 3 hours. Whole cell extracts were made by centrifuging 1.5 mL of culture and adding 90 µl of
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sterile deionized water and 30µL of NuPAGE LDS sample buffer (4X) (Novex, Life Technologies) to the
cell pellet. Five cycles of freeze/thaw on dry ice and in a 37⁰C water bath were performed to lyse the
cells. Extracts were boiled for 5 minutes prior to loading. Samples were run on NuPAGE 4-12% Bis-Tris
gels (Novex Life Technologies) and transferred to Invitrolon PVDF (0.45 µm pore size) membranes
(Novex Life Technologies). Membranes were incubated with anti-UmuD antibodies (1:5,000 dilution) at
room temperature overnight. Then the membranes were incubated with goat anti-rabbit IgG (H+L)
alkaline phosphatase conjugate (1:10,000 dilution) (BIO-RAD). Subsequently, the membranes were
treated with the CDP-Star substrate (Tropix). Membranes were then exposed to BioMax XAR film
(Carestream) to visualize UmuD protein bands.

101

4.6

Supplementary Information Text and Legends

Sequence of pBAD-MuGam-PAmCherry (pEAW1162).
AAGAAACCAATTGTCCATATTGCATCAGACATTGCCGTCACTGCGTCTTTTACTGGCTCTTCT
CGCTAACCAAACCGGTAACCCCGCTTATTAAAAGCATTCTGTAACAAAGCGGGACCAAAGC
CATGACAAAAACGCGTAACAAAAGTGTCTATAATCACGGCAGAAAAGTCCACATTGATTAT
TTGCACGGCGTCACACTTTGCTATGCCATAGCATTTTTATCCATAAGATTAGCGGATCCTACC
TGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATACCCGTTTTTTGGGCTAACAGGAGGA
ATTAACATATGGCTAAACCAGCAAAACGTATCAAGAGTGCCGCAGCGGCTTATGTGCCACA
AAACCGCGATGCGGTGATTACCGATATTAAACGCATCGGGGATTTACAGCGCGAAGCATCA
CGTCTGGAAACGGAAATGAATGATGCCATCGCGGAAATTACGGAGAAATTTGCGGCCCGGA
TTGCACCGATTAAAACCGATATTGAAACCCTTTCAAAAGGCGTTCAGGGATGGTGTGAAGCG
AACCGCGACGAACTGACGAACGGCGGCAAAGTGAAGACGGCGAATCTTGTCACCGGTGATG
TATCGTGGCGGGTCCGTCCACCATCAGTAAGTATTCGTGGTATGGATGCAGTGATGGAAACG
CTGGAGCGTCTTGGCCTGCAACGCTTTATTCGCACGAAGCAGGAAATCAACAAGGAAGCGA
TTTTACTGGAACCGAAAGCGGTCGCAGGCGTTGCCGGAATTACAGTTAAATCAGGCATTGAG
GATTTTTCTATTATTCCATTTGAACAGGAAGCCGGTATTTCCGCTGGCTCCGCTGCTGGTTCT
GGCGAATTCATGGTGAGCAAGGGCGAGGAGGATAACATGGCCATCATTAAGGAGTTCATGC
GCTTCAAGGTGCACATGGAGGGGTCCGTGAACGGCCACGTGTTCGAGATCGAGGGCGAGGG
CGAGGGCCGCCCCTACGAGGGCACCCAGACCGCCAAGCTGAAGGTGACCAAGGGTGGCCCC
CTGCCCTTCACCTGGGACATCCTGTCCCCTCAATTCATGTACGGCTCCAATGCCTACGTGAAG
CACCCCGCCGACATCCCCGACTACTTTAAGCTGTCCTTCCCCGAGGGCTTCAAGTGGGAGCG
CGTGATGAAATTCGAGGACGGCGGCGTGGTGACCGTGACCCAGGACTCCTCCCTGCAGGAC
GGTGAGTTCATCTACAAGGTGAAGCTGCGCGGCACCAACTTCCCCTCCGACGGCCCCGTAAT
GCAGAAGAAGACCATGGGCTGGGAGGCCCTCTCCGAGCGGATGTACCCCGAGGACGGCGCC
CTGAAGGGCGAGGTCAAGCCGAGAGTGAAGCTGAAGGACGGCGGCCACTACGACGCTGAG
GTCAAGACCACCTACAAGGCCAAGAAGCCCGTGCAGCTGCCCGGCGCCTACAACGTCAACC
GCAAGTTGGACATCACCTCACACAACGAGGACTACACCATCGTGGAACAGTACGAACGTGC
CGAGGGCCGCCACTCCACCGGCGGCATGGACGAGCTGTACAAGTAAAAGCTTGGGCCCGAA
CAAAAACTCATCTCAGAAGAGGATCTGAATAGCGCCGTCGACCATCATCATCATCATCATTG
AGTTTAAACGGTCTCCAGCTTGGCTGTTTTGGCGGATGAGAGAAGATTTTCAGCCTGATACA
GATTAAATCAGAACGCAGAAGCGGTCTGATAAAACAGAATTTGCCTGGCGGCAGTAGCGCG
GTGGTCCCACCTGACCCCATGCCGAACTCAGAAGTGAAACGCCGTAGCGCCGATGGTAGTGT
GGGGTCTCCCCATGCGAGAGTAGGGAACTGCCAGGCATCAAATAAAACGAAAGGCTCAGTC
GAAAGACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCCTGAGTAGGACAAA
TCCGCCGGGAGCGGATTTGAACGTTGCGAAGCAACGGCCCGGAGGGTGGCGGGCAGGACGC
CCGCCATAAACTGCCAGGCATCAAATTAAGCAGAAGGCCATCCTGACGGATGGCCTTTTTGC
GTTTCTACAAACTCTTTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAGAC
AATAACCCTGATAAATGCTTCAATAATATTGAAAAAGGAAGAGTATGAGTATTCAACATTTC
CGTGTCGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCACCCAGAAACGC
TGGTGAAAGTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGA
TCTCAACAGCGGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCA
CTTTTAAAGTTCTGCTATGTGGCGCGGTATTATCCCGTGTTGACGCCGGGCAAGAGCAACTC
GGTCGCCGCATACACTATTCTCAGAATGACTTGGTTGAGTACTCACCAGTCACAGAAAAGCA
TCTTACGGATGGCATGACAGTAAGAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACA
CTGCGGCCAACTTACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCAC
AACATGGGGGATCATGTAACTCGCCTTGATCGTTGGGAACCGGAGCTGAATGAAGCCATAC
CAAACGACGAGCGTGACACCACGATGCCTGTAGCAATGGCAACAACGTTGCGCAAACTATT
AACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTGGATGGAGGCGGATA
AAGTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTG
GAGCCGGTGAGCGTGGGTCTCGCGGTATCATTGCAGCACTGGGGCCAGATGGTAAGCCCTCC
CGTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTATGGATGAACGAAATAGACAGA
TCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAACTGTCAGACCAAGTTTACTCATAT
ATACTTTAGATTGATTTAAAACTTCATTTTTAATTTAAAAGGATCTAGGTGAAGATCCTTTTT
GATAATCTCATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCGT
AGAAAAGATCAAAGGATCTTCTTGAGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAAC
AAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCGGATCAAGAGCTACCAACTCTTTTTC
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CGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTCCTTCTAGTGTAGCCGTAG
TTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTA
CCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTT
ACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAG
CGAACGACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTC
CCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCA
CGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTC
TGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAG
CAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCG
TTATCCCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGCTGATACCGCTCGCCGC
AGCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCCTGATGCGG
TATTTTCTCCTTACGCATCTGTGCGGTATTTCACACCGCATAtaTGGTGCACTCTCAGTACAAT
CTGCTCTGATGCCGCATAGTTAAGCCAGTATACACTCCGCTATCGCTACGTGACTGGGTCAT
GGCTGCGCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGG
CATCCGCTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGTGTCAGAGGTTTTCACCG
TCATCACCGAAACGCGCGAGGCAGCAGATCAATTCGCGCGCGAAGGCGAAGCGGCATGCAT
AATGTGCCTGTCAAATGGACGAAGCAGGGATTCTGCAAACCCTATGCTACTCCGTCAAGCCG
TCAATTGTCTGATTCGTTACCAATTATGACAACTTGACGGCTACATCATTCACTTTTTCTTCA
CAACCGGCACGGAACTCGCTCGGGCTGGCCCCGGTGCATTTTTTAAATACCCGCGAGAAATA
GAGTTGATCGTCAAAACCAACATTGCGACCGACGGTGGCGATAGGCATCCGGGTGGTGCTC
AAAAGCAGCTTCGCCTGGCTGATACGTTGGTCCTCGCGCCAGCTTAAGACGCTAATCCCTAA
CTGCTGGCGGAAAAGATGTGACAGACGCGACGGCGACAAGCAAACATGCTGTGCGACGCTG
GCGATATCAAAATTGCTGTCTGCCAGGTGATCGCTGATGTACTGACAAGCCTCGCGTACCCG
ATTATCCATCGGTGGATGGAGCGACTCGTTAATCGCTTCCATGCGCCGCAGTAACAATTGCT
CAAGCAGATTTATCGCCAGCAGCTCCGAATAGCGCCCTTCCCCTTGCCCGGCGTTAATGATT
TGCCCAAACAGGTCGCTGAAATGCGGCTGGTGCGCTTCATCCGGGCGAAAGAACCCCGTATT
GGCAAATATTGACGGCCAGTTAAGCCATTCATGCCAGTAGGCGCGCGGACGAAAGTAAACC
CACTGGTGATACCATTCGCGAGCCTCCGGATGACGACCGTAGTGATGAATCTCTCCTGGCGG
GAACAGCAAAATATCACCCGGTCGGCAAACAAATTCTCGTCCCTGATTTTTCACCACCCCCT
GACCGCGAATGGTGAGATTGAGAATATAACCTTTCATTCCCAGCGGTCGGTCGATAAAAAA
ATCGAGATAACCGTTGGCCTCAATCGGCGTTAAACCCGCCACCAGATGGGCATTAAACGAGT
ATCCCGGCAGCAGGGGATCATTTTGCGCTTCAGCCATACTTTTCATACTCCCGCCATTCAGAG
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Fig. S1. Experimental design. (A) Experimental setup. Cells are loaded in a flow-cell and immobilized on
a positively charged aminopropyl silane glass surface. Cells were imaged before and after antibiotic
exposure ± ROS mitigator. Time-lapse movies were recorded to follow the cellular response. Burst
acquisitions were recorded to follow the dynamic behavior of fluorescent protein fusion constructs in
cells. (B) Time-lapse movies were recorded over 3 h following the cellular response to antibiotic
exposure. An image was taken every 10 min. At t = 0 min, the first image was taken and subsequently
antibiotic-containing media was flowed into the flow cell. A total number of 19 frames were recorded.
(C) Burst acquisition videos were recorded at specific time-points before or after antibiotic addition.
Movies of MuGam- PAmCherry were recorded using continuous excitation, containing 200 frames at 100
ms exposure. (D) Burst acquisition movies of DinB-YPet or UmuC-mKate2 were recorded using noncontinuous excitation, containing 300 frames at 50 ms exposure followed by 50 ms dark time.
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Fig. S2. Survival of strains to ciprofloxacin and trimethoprim in EZ medium. Survival assays using
ciprofloxacin or trimethoprim normal or ROS-mitigating condition (+ DMSO). Cell cultures (MG1655
[wild-type], dinB-YPet dnaX-mKate2, ΔdinB, umuC-mKate2 dnaX-YPet and ΔumuDC) were grown in EZ
glucose medium to exponential growth phase (OD600 = 0.2-0.3). Then, culture were split in 6 before, one
sample was used as control, 2% DMSO, 30 ng/mL ciprofloxacin, 30 ng/mL ciprofloxacin + DMSO, 1
g/mL trimethoprim or or 1 g/mL trimethoprim + 2% DMSO were added in the others and grown for 60
min. Before the treatment and after 60 min samples were taken and serial diluted by factor ten down to
10-6. Dilutions 10-1 to 10-6 of each culture were spotted on fresh LB plates, incubated in the dark overnight
at 37ºC before the image were captured. Images selected are resentative of a biological triplicate. Cells
constructs used in this study (dinB-YPet dnaX-mKate2 and umuC-mKate2 dnaX-YPet) exhibit a similar
phenotype to MG1655.
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Fig. S3. PsodA-gfp expression levels wild-type cells. For each strain, 104 – 106 cells were added to each
well at the beginning of the experiment. Measurements of absorbance (OD600) and fluorescence intensity
(a.u.) were carried out every 30 min over 17 h. For (A)-(C): upper row shows absorbance (OD600) and
bottom row illustrates intensity values/ OD600, consistent with expression levels. Error bars represent
standard error of the mean over three independent biological replicates. (A) sodA is regulated by SoxRS.
Superoxides oxidize the Fe-S clusters of the SoxR transcription factor, promoting transcription of soxS
and sodA. Then, SoxS also acts as a transcription factor for sodA. For cells carrying PsodA-gfp, superoxides
then trigger the expression of GFP from the sodA promotor. (B) Comparison of normal growth condition
with ciprofloxacin treatment ± ROS mitigator for wild-type cells. First column: normal growth conditions
(wild-type: dark grey; ΔrecB: orange) or + 2% DMSO (wild-type: grey); second column: ciprofloxacin
treatment of wild-type cells (5 ng/mL: black; 10 ng/mL: grey; 20 ng/mL: blue; 40 ng/mL: orange); third
column: ciprofloxacin + 2% DMSO treatment of wild-type cells (same color coding as second column).
(C) Comparison of normal growth condition with trimethoprim treatment ± ROS mitigator for wild-type
cells. First column: as (A) first column; second column: trimethoprim treatment of wild-type cells (0.1
μg/mL: black; 0.3 μg/mL: grey; 1 μg/mL: blue; 3 μg/mL: orange); third column: trimethoprim + 2%
DMSO treatment of wild-type cells (same color coding as second column). (D) Comparison of normal
growth condition with hydrogen peroxide (H2O2) treatment ± ROS mitigator for wild-type cells. First
column: as (A) first column; second column: H2O2 treatment of wild-type cells (30 mM: black; 100 mM:
grey; 300 mM: blue; 500 mM: orange); third column: H2O2 + 2% DMSO treatment of wild-type cells
(same color coding as second column).
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Fig. S4. PahpC-gfp expression levels wild-type cells. For each strain, 104 – 106 cells were added to each
well at the beginning of the experiment. Measurements of absorbance (OD600) and fluorescence intensity
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(a.u.) were carried out every 30 min over 17 h. For (A)-(C): upper row shows absorbance (OD600) and
bottom row illustrates intensity values/ OD600, consistent with expression levels. Error bars represent
standard error of the mean over three independent biological replicates. (A) ahcP is transcriptionally
regulated by OxyR. Oxidation of OxyR cysteines induces transcription and expression of ahcPC. For
cells carrying PahcP-gfp, oxidative stress triggers the expression of GFP from the ahcP promotor. (B)
Comparison of normal growth condition with ciprofloxacin treatment ± ROS mitigator for wild-type
cells. First column: normal growth conditions (wild-type: dark grey; ΔrecB: orange) or + 2% DMSO
(wild-type: grey); second column: ciprofloxacin treatment of wild-type cells (5 ng/mL: black; 10 ng/mL:
grey; 20 ng/mL: blue; 40 ng/mL: orange); third column: ciprofloxacin + 2% DMSO treatment of wildtype cells (same color coding as second column). (C) Comparison of normal growth condition with
trimethoprim treatment ± ROS mitigator for wild-type cells. First column: as (A) first column; second
column: trimethoprim treatment of wild-type cells (0.1 μg/mL: black; 0.3 μg/mL: grey; 1 μg/mL: blue; 3
μg/mL: orange); third column: trimethoprim + 2% DMSO treatment of wild-type cells (same color coding
as second column). (D) Comparison of normal growth condition with hydrogen peroxide (H2O2)
treatment ± ROS mitigator for wild-type cells. First column: as (A) first column; second column: H2O2
treatment of wild-type cells (30 mM: black; 100 mM: grey; 300 mM: blue; 500 mM: orange); third
column: H2O2 + 2% DMSO treatment of wild-type cells (same color coding as second column).
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Fig. S5. PfepD-gfp expression levels wild-type cells. For each strain, 104 – 106 cells were added to each
well at the beginning of the experiment. Measurements of absorbance (OD600) and fluorescence intensity
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(a.u.) were carried out every 30 min over 17 h. For (A)-(C): upper row shows absorbance (OD600) and
bottom row illustrates intensity values/ OD600, consistent with expression levels. Error bars represent
standard error of the mean over three independent biological replicates. (A) fepD is regulated by Fur.
Under high iron conditions, transcriptional repressor Fur inhibits of fepD transcription. Under low iron
conditions, in the presence of oxidative damage, Fur is de-repressed and fepD is transcribed. For cells
carrying PfepD-gfp, oxidative stress triggers the expression of GFP from the fepD promotor. (B)
Comparison of normal growth condition with ciprofloxacin treatment ± ROS mitigator for wild-type
cells. First column: normal growth conditions (wild-type: dark grey; ΔrecB: orange) or + 2% DMSO
(wild-type: grey); second column: ciprofloxacin treatment of wild-type cells (5 ng/mL: black; 10 ng/mL:
grey; 20 ng/mL: blue; 40 ng/mL: orange); third column: ciprofloxacin + 2% DMSO treatment of wildtype cells (same color coding as second column). (C) Comparison of normal growth condition with
trimethoprim treatment ± ROS mitigator for wild-type cells. First column: as (A) first column; second
column: trimethoprim treatment of wild-type cells (0.1 μg/mL: black; 0.3 μg/mL: grey; 1 μg/mL: blue; 3
μg/mL: orange); third column: trimethoprim + 2% DMSO treatment of wild-type cells (same color coding
as second column). (D) Comparison of normal growth condition with hydrogen peroxide (H2O2)
treatment ± ROS mitigator for wild-type cells. First column: as (A) first column; second column: H2O2
treatment of wild-type cells (30 mM: black; 100 mM: grey; 300 mM: blue; 500 mM: orange); third
column: H2O2 + 2% DMSO treatment of wild-type cells (same color coding as second column).
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Fig. S6. DMSO has no effect on GFP fluorescence in vivo. (A) Fluorescence images of recA730 cells
carrying the SOS reporter plasmid (PsulA-gfp) in the absence of DMSO (left) and in the presence of DMSO
(right). Scale bar represents 5 µm. (B) SulA expression levels. Mean cell brightness is plotted for recA730
cells grown in the absence and presence of DMSO. Error bars represent standard error of the mean from n
> 100 cells.
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Fig. S7. Scatter plots of cell-size from time-lapse imaging. White points indicate individual data-points,
while blue-to-red contours indicate frequencies of observations. Blue areas indicate regions of the plot
containing few data points; red areas indicate regions containing a large number of data points.
Frequencies were normalized at each time-point to the maximum value at that time-point with dark blue =
0 and dark red = 1. We conservatively estimate that >100 cells were used in each measurement. (A)
EAW643 cells (dinB-YPet dnaX-mKate2) treated with ciprofloxacin-alone. (B) EAW643 cells (dinB-YPet
dnaX-mKate2) treated with ciprofloxacin-DMSO. (C) EAW643 cells (dinB-YPet dnaX-mKate2) treated
with trimethoprim-alone. (D) EAW643 cells (dinB-YPet dnaX-mKate2) treated with trimethoprimDMSO. (E) SSH091 cells (MG1655 PsulA-gfp) treated with ciprofloxacin-alone. (F) SSH091 cells
(MG1655 PsulA-gfp) treated with ciprofloxacin-DMSO. (G) SSH091 cells (MG1655 PsulA-gfp) treated with
trimethoprim-alone. (H) SSH091 cells (MG1655 PsulA-gfp) treated with trimethoprim-DMSO. (I) SSH091
cells (MG1655 PsulA-gfp) treated with trimethoprim-BiP. (J) SSH111 cells (ΔrecB PsulA-gfp) treated with
ciprofloxacin.
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Fig. S8. PsulA-gfp expression levels in wild-type and ΔrecB cells. For each strain, 104 – 106 cells were
added to each well at the beginning of the experiment. Measurements of absorbance (OD600) and
fluorescence intensity (a.u.) were carried out every 30 min over 18 h. For (A)-(C): upper row shows
absorbance (OD600) and bottom row illustrates intensity values/ OD600, consistent with expression levels.
Error bars represent standard error of the mean over three independent biological replicates. (A)
Comparison of normal growth condition with ciprofloxacin treatment ± ROS mitigator for wild-type cells
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or ΔrecB. First column: normal growth conditions (wild-type: dark grey; ΔrecB: orange), + 2% DMSO
(wild-type: grey) or 0.35 mM BiP (wild-type: green); second column: ciprofloxacin treatment of wildtype cells (5 ng/mL: black; 10 ng/mL: grey; 20 ng/mL: blue; 40 ng/mL: orange); third column:
ciprofloxacin + 2% DMSO treatment of wild-type cells (same color coding as second column); forth
column: ciprofloxacin + 0.35 mM BiP treatment of wild-type cells (same color coding as second column);
fifth column: ciprofloxacin treatment of ΔrecB cells (same color coding as second column). (B)
Comparison of normal growth condition with trimethoprim treatment ± ROS mitigator for wild-type cells
or ΔrecB. First column: as (A) first column; second column: trimethoprim treatment of wild-type cells
(0.1 μg/mL: black; 0.3 μg/mL: grey; 1 μg/mL: blue; 3 μg/mL: orange); third column: trimethoprim + 2%
DMSO treatment of wild-type cells (same color coding as second column); forth column: trimethoprim +
0.35 mM BiP treatment of wild-type cells (same color coding as second column); fifth column:
trimethoprim treatment of ΔrecB cells (same color coding as second column). (C) Comparison of normal
growth condition with hydrogen peroxide (H2O2) treatment ± ROS mitigator for wild-type cells. First
column: as (A) first column; second column: H2O2 treatment of wild-type cells (30 mM: black; 100 mM:
grey; 300 mM: blue; 500 mM: orange); third column: H2O2 + 2% DMSO treatment of wild-type cells
(same color coding as second column).
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Fig. S9. PsulA-gfp expression levels following ciprofloxacin-alone treatment in ΔrecB vs. MG1655 (wildtype). (A) Fluorescence images showing the expression of GFP from a SOS reporter plasmid (PsulA-GFP)
from 0-110 min at intervals of 10 min and 120 min after ciprofloxacin addition in ΔrecB. Scale bar
represents 5 µm. (B) Fluorescence images showing the expression of GFP from a SOS reporter plasmid
(PsulA-GFP) at 120 min after ciprofloxacin addition in wild-type cells, MG1655. Scale bar represents 5
µm.
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Fig. S10. Plate-based survival assays using ciprofloxacin or trimethoprim at different MuGamPAmCherry expression levels. Cells carrying a pBAD plasmid for MuGam-PAmCherry expression were
grown in EZ glycerol in the presence of ampicillin at different L-arabinose concentrations (0, 0.001,
0.003, 0.01, 0.03, 0.1% wt/vol) or in EZ glucose in order to inhibit expression from the pBAD plasmid.
These cultures were split in three to perform two survival assays and a 'no damage' control. For the
survival assays, antibiotic was added to these cultures (30 ng/mL ciprofloxacin or 1 μg/mL trimethoprim),
then, cell cultures were grown for 2 h. For the control, cells were grown in the absence of antibiotic for
2 h. After 2 h of growth, cultures were centrifuged and resuspended in glucose or glycerol containing
media (x 3) to remove the antibiotic. These cultures were serial diluted in PBS by factor ten down to 10-5
and spotted onto LB agar plates containing 100 g/mL ampicillin. At an L-arabinose concentration of
0.003% (orange box), no drastic decrease in survival was observed in comparison to the sample grown in
EZ glucose.
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Fig. S11. Measuring colocalization of pol IV with replisomes following ciprofloxacin or trimethoprim
treatment in the absence or presence of ROS mitigators. (A) Merged images showing DinB-YPet (pol IV)
foci in green and -mKate2 (replisome) foci in magenta at 0, 90 and 180 min (left to right) for
ciprofloxacin-alone or ciprofloxacin-DMSO treatment (top to bottom). White arrows indicate
colocalization events (white foci). Scale bar represents 5 µm. (B) Merged images showing DinB-YPet
(pol IV) foci in green and -mKate2 (replisome) foci in magenta at 0, 90 and 180 min (left to right) for
trimethoprim-alone or trimethoprim-DMSO treatment (top to bottom). White arrows indicate
colocalization events (white foci). Scale bar represents 5 µm. (C) Colocalization measurements following
ciprofloxacin-alone treatment over 180 min: percentage of pol IV foci that are bound at replisomes (green
line), percentage of replisomes that contain a pol IV focus (magenta line). Grey shaded error bands
represent the standard error of the mean from six biological replicates together. Measurements are from
>300 cells per time point. (D) Colocalization measurements following ciprofloxacin-DMSO treatment
over 180 min: percentage of pol IV foci that are bound at replisomes (green line), percentage of
replisomes that contain a pol IV focus (magenta line). Grey shaded error bands represent the standard
error of the mean from four biological replicates together. Measurements are from >100 cells per time
point. (E) Colocalization measurements following trimethoprim-alone treatment over 180 min: percentage
of pol IV foci that are bound at replisomes (green line), percentage of replisomes that contain a pol IV
focus (magenta line). Grey shaded error bands represent the standard error of the mean from three
biological replicates together. Measurements are from >100 cells per time point. (F) Colocalization
measurements following trimethoprim-DMSO treatment over 180 min: percentage of pol IV foci that are
bound at replisomes (green line), percentage of replisomes that contain a pol IV focus (magenta line).
Grey shaded error bands represent the standard error of the mean from three biological replicates
together. Measurements are from >100 cells per time point.
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Fig. S12. Measuring the number of pol V foci per cell following ciprofloxacin or trimethoprim treatment
under normal conditions or ROS-scavenging conditions in lexA(Def) cells. (A) UmuC-mKate2 activity at
replisomes in lexA(Def) cells. Cells were treated for 60 min prior to imaging. Upper row: unfiltered image
of an average projection showing UmuC-mKate2 foci that last >1 s (from left to right: ciprofloxacin,
ciprofloxacin-DMSO, trimethoprim, trimethoprim-DMSO). Bottom row: merged image showing UmuCmKate2 foci in magenta and -YPet foci in green (from left to right: ciprofloxacin, ciprofloxacin-DMSO,
trimethoprim, trimethoprim-DMSO). Scale bar represents 5 µm. (B) Number of UmuC-mKate2 foci per
cell of foci that last > 1 s. Error bars represent standard error of the mean. Number of cells included in
analysis: n(ciprofloxacin) = 97, n(ciprofloxacin-DMSO) = 109, n(untreated) = 87. (C) Binding behavior
of UmuC-mKate2 at replisomes after ciprofloxacin-alone or ciprofloxacin-DMSO treatment. Mean
average autocorrelation function (ciprofloxacin-alone: dark grey line, ciprofloxacin-DMSO: light grey
line). Error bar represents standard error of the mean. We conservatively estimate that >400 trajectories
from >400 replisomes were used in each measurement. (D) Number of UmuC-mKate2 foci per cell. Error
bars represent standard error of the mean. Number of cells included in analysis: n(trimethoprim) = 102,
n(trimethoprim-DMSO) = 120, n(untreated) = 87. (E) Binding behavior of UmuC-mKate2 at replisomes
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after trimethoprim-alone or trimethoprim-DMSO treatment. Mean average autocorrelation function
(trimethoprim-alone: magenta line, trimethoprim-DMSO: light magenta line). Error bar represents
standard error of the mean. We conservatively estimate that >550 trajectories from >550 replisomes were
used in each measurement.
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Fig. S13. UmuC concentration and activity following ciprofloxacin or trimethoprim treatment under
normal conditions or ROS-scavenging conditions. (A) Images showing UmuC-mKate2 (pol V) signal at
0, 90 and 180 min (left to right) for ciprofloxacin-alone, ciprofloxacin-DMSO treatment or trimethoprimalone treatment (top to bottom). Scale bar represents 5 µm. (B) Merged images showing UmuC-mKate2
(pol V) foci in magenta and -YPet (replisome) foci in magenta at 0, 90 and 180 min (left to right).
Colocalized foci would appear as white foci. Scale bar represents 5 µm. (C) Concentration of UmuCmKate2 during stress. Mean cell brightness is plotted against time (ciprofloxacin-alone: dark grey line,
ciprofloxacin-DMSO: light grey line, trimethoprim-alone: magenta line). At each time-point, data are
derived from >100 cells. Grey shaded error bands represent standard error of the mean. (D)
Colocalization measurements following ciprofloxacin-alone treatment over 180 min: percentage of UmuC
foci that are bound at replisomes (magenta line), percentage of replisomes that contain a UmuC focus
(green line). Grey shaded error bands represent the standard error of the mean from three biological
replicates together. Measurements are from >100 cells per time point. (E) Colocalization measurements
following ciprofloxacin-DMSO treatment over 180 min: percentage of UmuC foci that are bound at
replisomes (magenta line), percentage of replisomes that contain a UmuC focus (green line). Grey shaded
error bands represent the standard error of the mean from three biological replicates together.
Measurements are from >100 cells per time point.
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Fig. S14. Western blots with anti-UmuD antibodies measuring levels of UmuDʹ. For each lane, 30 μL of
lysate were loaded from cultures at OD600 0.5. All strains used are ΔumuDC expressing UmuDC from a
low-copy number plasmid (pRW154). After treatment, time points were taken at 1, 2, 3 h. (A) Western
blot of recA+ lexA+ cells (RW120): untreated, treated with ciprofloxacin or ciprofloxacin + 2% DMSO.
(B) Western blot of recA+ lexA+ cells: untreated, treated with trimethoprim or trimethoprim + 2% DMSO.
(C) Western blot of recA+ lexA51(Def) cells (RW546): untreated, treated with ciprofloxacin or
ciprofloxacin + 2% DMSO. (D) Western blot of recA+ lexA51(Def) cells: untreated, treated with
trimethoprim or trimethoprim + 2% DMSO.
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4.8

Additional data

4.8.1

Recombination mediator protein RecF inhibits pol IV binding at replisomes
In cells, TLS and homologous recombination proteins are involved in repairing single-stranded

gaps and double-strand breaks (1–5). It has been proposed that, initially following, SOS induction, TLS
has preference over homologous recombination due to the time-limiting step of the D-loop formation
(1,6). After the formation of recombinant ssDNA strands however, gaps are primarily repaired via
homologous recombination (1). In agreement, a recA mutant with slower kinetics of RecA* filament
formation, in comparison to wildtype recA, showed increased TLS levels (7). Similarly, cells lacking
recF exhibited an increase in TLS levels. In addition, RecF often binds at replisomes in response to DNA
damage (Chapter 6), suggesting that RecF may decrease TLS levels at the replisome.
In this sub-chapter, the colocalisation percentage of pol IV with replisomes was measured in
recF+ and recF cells, following ciprofloxacin-DMSO treatment. Time-lapse movies were recorded
following ciprofloxacin-DMSO treatment (3 h time-lapse movies, an image was taken every 10 min). In
recF+ cells, a strong dip in colocalisation was observed at 30 min after ciprofloxacin addition (Chapter
4.6, Figure S11); fewer pol IV foci were bound in the vicinity of replisomes. In recF cells,
colocalisation of pol IV with replisomes did not decline directly after ciprofloxacin addition in
comparison to wild-type recF cells (Figure 6). No drop in colocalisation was observed. When measuring
colocalisation of replisomes with pol IV foci, deleting recF leads to an increase in colocalisation directly
after damage induction. From 40 min, colocalisation is slightly decrease compared to wild-type recF
(Figure 6).

Figure 6. Colocalisation measurement of pol IV with replisomes in recF+ (black) and recF (orange).
Cells were treated with ciprofloxacin-DMSO over 3 h. Left: percentage of pol IV bound at replisomes.
Right: percentage of replisomes that contain a pol IV focus. Data points for recF experiments are an
average over duplicates, data points for recF+ experiments are an average over triplicates. Error bars
represent the standard deviation of the mean.
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In conclusion, the deletion of the recombination mediator protein RecF increases the activity of
pol IV at replisomes within the first 30 min after ciprofloxacin addition. These results suggest that during
this period RecF activity inhibits replisomal pol IV activity, consistent with RecF having a role at
replisomes (Chapter 6). In the future, it would be interesting to conduct similar experiments in an either
recO or recR deletion background.

4.8.2

Materials and Methods

Microscopy, flow cell design and data analysis
All experimental procedures (i.e. imaging in flow cell) were carried out as described in Chapter
4.5 Materials and Methods.
Strain construction
Table 4.2. Strains used in this sub-chapter.
Strain

Relevant Genotype

Parent strain

Source/technique

MG1655

dinB+ dnaX+ recB+ lexA+

-

published (8)

EAW643

dinB-YPet::FRT dnaX-

EAW633

published (9)

EAW643

Transduction of EAW643

mKate2::KanR
SSH102

dinB-YPet::FRT dnaXmKate2::FRT ΔrecF::KanR

KanS with P1 grown on
EAW629 (10)

4.8.3
1.
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Modulation of DNA polymerase IV activity by
UmuD and RecA* observed by single-molecule
time-lapse microscopy
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DNA polymerase IV (pol IV) is expressed at increased levels in Escherichia coli cells suffering high
levels of DNA damage. In a recent single-molecule imaging study, we demonstrated that elevating
the pol IV concentration is not sufficient to provide access to binding sites on the nucleoid,
suggesting that other factors may recruit pol IV to its substrates once the DNA becomes damaged.
Here we extend this work, investigating the proteins UmuD and RecA as potential modulators of
pol IV activity. UmuD promotes long-lived association of pol IV with the nucleoid, whereas its
cleaved form, UmuDʹ, which accumulates in DNA-damaged cells, inhibits binding. In agreement
with proposed roles for pol IV in homologous recombination, up to 40% of pol IV foci colocalise
with a probe for RecA* nucleoprotein filaments in ciprofloxacin-treated cells. A hyperactive RecA
mutant, recA(E38K), allows pol IV to bind the nucleoid even in the absence of exogenous DNA
damage. In vitro, RecA(E38K) forms RecA*-like structures that can recruit pol IV, even on doublestranded DNA, consistent with a physical interaction between RecA and pol IV. Together, the
results indicate that UmuD and RecA modulate the binding of pol IV to its DNA substrates, which
frequently coincide with RecA* structures.

I carried out and analysed all in vivo single-molecule experiments and plate reader
assays. I was involved in strain construction, SPR experiments and the preparation of
the manuscript.
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5.1

Introduction
DNA polymerase IV (pol IV), encoded by dinB, is one of three specialised DNA polymerases

that are produced at increased levels in Escherichia coli cells suffering DNA damage (1). In vitro, DNA
polymerase IV is capable of translesion synthesis (TLS) on a variety of different lesion-containing DNA
substrates (2–9). The most commonly proposed function for pol IV within cells is TLS at stalled
replication forks, which may help to maintain chromosomal replication in cells experiencing DNA
damage (10,11). However, in the cell, the majority of binding sites for pol IV on the nucleoid appear
distal to replisome markers (12). There is significant evidence that pol IV participates in other pathways,
including recombinational repair (13–19) and transcription-coupled TLS (20–23).
Single-molecule time-lapse imaging of fluorescently tagged pol IV in live Escherichia coli cells
revealed that various DNA-damaging agents (ciprofloxacin, UV light and methyl methanesulfonate
[MMS]) up-regulate the production of pol IV and create binding sites for pol IV on the nucleoid (12).
Only 10% of the pol IV binding events (pol IV foci) occurred in the vicinity of replisomes. At late time
points during the SOS response (90–100 min after damage induction) pol IV continued to form foci but
no longer colocalised with replisomes, even at low levels. This led to the hypothesis that replisome access
might be controlled by protein–protein interactions that change around 90–100 min after the induction of
SOS. The results also suggest that pol IV function is focused primarily on events that occur away from
the replication fork. The recruitment of pol IV to the processivity factor  strongly depends on the source
of DNA damage (24), indicating that the type of DNA lesion and changes in metabolism may affect
which repair pathway(s) pol IV participates in (9).
The UmuD protein and its cleaved form UmuD′ have a potential role in regulating pol IV
activity in cells (25). The auto-cleavage of UmuD to the shorter form UmuD′ is induced by the cellular
recombinase RecA, in particular RecA nucleoprotein filaments (denoted RecA*). UmuD cleavage (26–
28) has long been understood to be a key step in the activation of the highly mutagenic enzyme DNA
polymerase V (pol V) Mut (UmuD′2C-RecA-ATP; (29)). Several lines of evidence suggest that the
conversion of UmuD to UmuD′ might also regulate the activity of pol IV in E. coli (25). Far-Western
blots and co-purification experiments indicate that pol IV interacts with UmuD2 and UmuD′2, but not the
heterodimer UmuDD′ (25). Overexpression of pol IV induces high rates of –1 frameshift mutations in
cells, that can be supressed by co-overexpression of UmuD, but not co-overexpression of UmuD′ (25).
Furthermore, UmuD and UmuD′ overexpression reduced frequencies in an adaptive mutagenesis assay
compared to an empty vector; overproduction of UmuD even lowered frequencies to equivalent levels of
a catalytically dead dinB mutant (25). These observations have led to the proposal that UmuD status
regulates the mutagenic activity of pol IV-dependent DNA synthesis. Despite these advances, it remains
unclear if UmuD or UmuD′ solely affects the fidelity of pol IV, or if UmuD and UmuD′ might also
regulate the DNA-binding activity of pol IV as a means to modulate pol IV-dependent mutagenesis.
A series of live-cell studies indicate that pol IV operates in the repair of double-strand breaks
(DSBs) (15,19,30–34). Reducing DSB formation (by mitigating the destructive effects of reactive oxygen
species) or introducing defects in the end-resection of double-strand breaks (recB mutation) greatly
reduces the number of pol IV foci formed in cells treated with ciprofloxacin or trimethoprim (35). At end-
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resected DSBs, RecA nucleoprotein filaments facilitate repair through homologous recombination (36),
suggesting that pol IV should colocalise with RecA* structures in cells engaged in DSB repair. A series
of observations support this notion. Pol IV forms a physical interaction with RecA in vitro and this
interaction modulates the fidelity of pol IV-dependent DNA synthesis (5,25,37). This interaction is
proposed to provide pol IV with the ability to participate in DNA synthesis during RecA-dependent strand
exchange reactions (38). In a fluorescence microscopy study (34), pol IV was shown to colocalise with
RecA structures in vivo. However, the RecA-GFP probe that was used to observe RecA localisation does
not differentiate between active forms of RecA (i.e. RecA*) and inactive forms, such as storage structures
(39). Furthermore, this RecA-GFP (recA4155-gfp) probe is deficient in recombination, SOS induction and
UV survival (40). It therefore remains unclear whether RecA* structures, such as those that form as
intermediates of recombination, represent major or minor substrates for pol IV in cells. With the recent
development of a RecA*-specific probe, PAmCherry-mCI (39), we are now in a position to measure pol
IV–RecA* colocalisation directly in a time-resolved manner.
In this work, we set out to test the following: 1. whether the UmuD cleavage status affects the
extent of pol IV focus formation and pol IV colocalisation with a replisome marker and/or the lifetimes of
pol IV molecules binding to its substrates, and 2. whether pol IV predominantly binds at RecA*
structures. We use the drug ciprofloxacin, a DNA gyrase inhibitor, that induces DSBs upon treatment
(41). Using single-molecule live-cell imaging, we demonstrated that the binding of pol IV to the nucleoid
is promoted by full-length UmuD in cells treated with the DNA damaging antibiotic ciprofloxacin. In
contrast, UmuD′ diminishes pol IV binding. We observed that a large proportion of pol IV foci (up to
40%) colocalise with a RecA* marker in ciprofloxacin-treated cells. The recA(E38K) mutation (also
known as recA730), which constitutively produces RecA*-like activity (42–44), promotes the binding
activity of pol IV to the nucleoid, even in the absence of DNA damage. We further showed that pol IV
physically interacts with RecA(E38K), which forms RecA*-like structures on single-stranded as well as
double-stranded DNA, suggesting that pol IV might also associate with these RecA*-like structures in
cells. These findings provide evidence for regulatory roles for both UmuD and RecA in modulating the
binding activity of pol IV in E. coli cells. RecA* structures that likely mark sites of on-going DSB repair
appear to serve as major binding sites for pol IV in live cells treated with ciprofloxacin.

5.2
5.2.1

Results
Deletion of umuDC increases pol IV- colocalisation
In a previous study, we carried out time-lapse measurements on E. coli cells treated with DNA

damaging agents (12). We found that the colocalisation of pol IV foci with replisome markers started at
~10% prior to treatment, and dropped to < 5% (i.e. baseline levels) at a time-point 90–100 after the onset
of treatment. In a separate study, we observed that pol V (UmuC-mKate2) enters the cytosol and forms
foci on the nucleoid at this same 90 min time-point (45). This spatial re-distribution of the UmuC-mKate2
marker required cleavage of UmuD to UmuD′. The similar timing of the changes in pol IV and pol V
localisation, together with established links between pol IV activity and UmuD/UmuD′ status described
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above, led us to hypothesise that UmuD cleavage and/or formation of pol V at the 90 min time-point
alters the colocalisation of pol IV with replisome markers.
To investigate the effect of pol V and/or its precursors (UmuD and UmuC) on the extent of pol
IV focus formation and colocalisation with a replisome marker, we constructed two strains: i) dinB-YPet
dnaX-mKate2 umuDC+ (EAW643, (12)) and ii) dinB-YPet dnaX-mKate2 umuDC (SSH007). The dnaXmKate2 allele encodes for a fluorescent fusion of the τ clamp loader protein, serving as a marker for the
replisome, τ-mKate2. We previously showed that the fluorescent protein fusion of DinB-YPet is fully
functional, yielding pol IV-dependent mutagenesis activity upon ciprofloxacin treatment in both dnaX+
and dnaX-mKate2 cells (12,35).
Time-lapse movies were recorded for each strain after treatment with ciprofloxacin (30 ng mL–
). At t = 0 min, images of the DinB-YPet signal and τ-mKate2 signal (replisome marker) were recorded

1

for untreated cells. Directly after t = 0, ciprofloxacin was introduced to the flow cell and a time-lapse was
recorded over a period of 3 h. We previously showed that a catalytically dead mutant DinB(D103N)-YPet
does not form foci under these imaging conditions (12). This suggests that the DinB-YPet foci we
normally detect are formed as DinB-YPet binds to the nucleoid and carries out DNA synthesis, at which
point its diffusion is slowed sufficiently to produce a single-molecule focus. From the time-lapse movies,
the numbers of DinB-YPet foci per cell, reflective of pol IV binding to the nucleoid (12), were
determined at 0, 30, 60, 90 and 120 min time points (Fig 1). Colocalisation between DinB-YPet foci and
-mKate2 foci was also monitored. In order to enhance diffusional contrast in our images we used longer
exposure times when capturing DinB-YPet signal (300 ms) than in our previous study (50 ms; (12). We
nonetheless recorded a complementary set of colocalisation measurements with the shorter exposure time
of 50 ms in order to better capture transient foci and allow for more direct comparison with our previous
results (Fig S1).

136

Figure 1. Number of DinB foci per cell and colocalisation measurements between DinB and τ in different umuDC mutants following ciprofloxacin treatment. (A)
Upper panel: Number of DinB foci per cell in umuDC+ at 300 ms exposures. Error bar represents standard error of the mean for n > 100 cells. Middle panel: Colocalisation
percentage of DinB with DnaX (green bars) in umuDC+. Time points are binned over 30 min. Error bar represents standard error of the mean between biological triplicates.
Lower panel: Colocalisation percentage of DnaX with DinB (magenta bars) in umuDC+. Time points are binned over 30 min. The other columns represent the same
measurements as in (A), except from the cell strains (B) umuDC, (C) umuDC + UmuD(K97A) expressed from a plasmid, and (D) umuDC + UmuDʹ expressed from a
plasmid.
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We first monitored pol IV behaviour in cells expressing wild-type levels of UmuD and UmuC
(EAW643, Table 1). Cells exhibited very few pol IV foci prior to ciprofloxacin treatment (Fig 1A, upper
panel), as observed previously (12). After ciprofloxacin addition, the number of pol IV foci per cell
increased to an average of 0.1 foci per cell from 60 min, i.e. one in ten cells exhibited a pol IV focus.
Consistent with our previous observations (12), the percentage of pol IV foci that colocalised with mKate2 dropped markedly between the 90 min and 120 min time-points (Fig 1A, middle panel). From 0–
90 min after ciprofloxacin addition, 5% of pol IV foci colocalised with the replisome marker . From
120–150 min this decreased to < 2%. These values are somewhat lower than those we reported previously
(10% dropping to < 5%) and is attributable to the longer image exposure times used in the current study
(Fig S1). The percentage of  foci that contained a pol IV focus followed a similar trend (Fig 1A, lower
panel); from 0–90 min after ciprofloxacin addition, 0.5% of  foci contained a pol IV focus, dropping to
~0.1% (indistinguishable from chance colocalisation) from 120–150 min.
We next examined the effect of deleting the umuDC operon (and thus eliminating UmuD and
UmuC) on the number of pol IV foci and the extent of colocalisation with  foci (SSH007, Table 1).
From 30 min, 10–15% of pol IV foci colocalised with replisomes. Compared to umuDC+ cells, ΔumuDC
cells exhibited a three-fold increase in the number pol IV foci per cell with ~0.3 foci per cell from 60 min
after ciprofloxacin addition (Fig 1B, upper panel). Moreover, deletion of umuDC led to a three-fold
increase in the percentage of pol IV foci that colocalise with a  focus (Fig 1B, middle panel).
Interestingly, pol IV- colocalisation now persisted above 10% for the 90, 120 and 150 min time points.
The percentage of  foci that contained a pol IV focus was also elevated in the ΔumuDC background (Fig
1B, lower panel). From 30 min, 2–4% of  foci contained a pol IV focus. Compared to umuDC+ cells, this
represents a six- to eight-fold increase in colocalisation.
Taken together, the time-lapse imaging results show that cells lacking umuDC exhibit an
increase in the number of pol IV foci per cell, accompanied by enhanced pol IV- colocalisation during
the late SOS response (90–120 min). In cells lacking umuDC, the maximum extent of pol IV-
colocalisation is 15%. This suggests that in cells lacking UmuD and UmuC, replisomes still do not
represent the major binding substrate for pol IV.

5.2.2

Cleavage state of UmuD affects the binding behaviour of pol IV
The increased numbers of pol IV foci and increased pol IV- colocalisation in ΔumuDC than in

umuDC+ cells could manifest through two scenarios: 1. the deletion of the umuDC operon, which encodes
for pol V, eliminates competition between pol IV and pol V for binding sites on the nucleoid. 2. a subunit
of pol V has a regulatory effect on pol IV focus formation and pol IV- colocalisation. It has been shown
previously that UmuD2 and UmuD′2 physically interact with pol IV and modulate its mutagenic activity
(25). To that end, we tested if UmuD or UmuD′ affect the extent of pol IV focus formation and the
colocalisation between pol IV with , in the absence of UmuC (and thus pol V).
We constructed two strains, both of which include the dinB-YPet and dnaX-mKate2 alleles: i)
umuDC (SSH007) expressing the non-cleavable UmuD(K97A) protein from a low-copy plasmid
(SSH007 + pJM1243), and ii) SSH007 expressing the ‘cleaved’ UmuD′ protein from a low-copy plasmid
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(SSH007 + pRW66). The amount of UmuD(K97A) and UmuD′ produced from each plasmid is 4–5-fold
higher than UmuD expressed from its native chromosomal locus (39,46). Time-lapse analysis was
repeated as described above.
We first explored the effects of expressing the non-cleavable UmuD(K97A) mutant in dinB-YPet
dnaX-mKate2 umuDC cells (SSH007 + pJM1243, Table 1). At the 90 min time point, cells contained on
average 0.6 pol IV foci per cell — a six-fold increase over umuDC+ cells (Fig 1C, upper panel). This
sixfold increase in pol IV foci per cell was accompanied by a three-fold increase in colocalisation with the
replisome marker -mKate2 (Fig 1C, middle panel). From 30 min after damage induction, 13% of pol IV
foci overlapped with a  focus. This colocalisation remained relatively constant during the later stages of
the SOS response; colocalisation did not drop below 9% from 90–120 min as observed in umuDC+ cells.
These observations reveal that UmuD(K97A), and by inference uncleaved UmuD, promote the binding of
pol IV to DNA and do not limit pol IV- colocalisation beyond 90 min.
During the later stages of the SOS response (90 min after SOS induction), UmuD is cleaved to
UmuD′ (47). To explore the effects of UmuD′ on pol IV behaviour, we imaged umuDC cells expressing
UmuD′ directly from a plasmid (SSH007 + pRW66, Table 1). These cells produced ~0.1 DinB-YPet foci
per cell at 60 min (Fig 1D, upper panel), similar to umuDC+ cells. In the cells expressing UmuD′,
colocalisation of pol IV with  was generally low, but highly variable (Fig 1D, middle panel). Two large
spikes in colocalisation were apparent at the 30 and 90 min time points. However, due to the low number
of foci available for analysis at these time-points, there was very large error associated with these values.
No spikes in colocalisation were observed when measuring the proportion of  foci that contained a pol
IV focus (Fig 1D, lower panel). Importantly, the colocalisation of pol IV with  decreased to < 1% after
90 min (Fig 1D, middle panel). Similarly, the percentage of  foci that contained a pol IV focus drops
between the 90 and 120 min time points (Fig 1D, lower panel). From 30–90 min, ~1% of  foci contained
a pol IV focus. By 120 min < 0.1% of  foci contained a pol IV focus. Overall, the introduction of UmuD′
into umuDC cells restores rates of focus formation and colocalisation with the replisome marker  to
near wild-type (umuDC+) levels.
Taken together, the time-lapse imaging results show that the presence of non-cleavable UmuD
results in an increase in nucleoid binding by pol IV, accompanied by increased pol IV- colocalisation
during the late SOS response (90–120 min). Strikingly, UmuD′ suppresses the formation of pol IV foci,
also limiting pol IV- colocalisation. These results suggest that UmuD cleavage represents a biochemical
switch that alters aspects of pol IV activity. Importantly, these effects were apparent in the absence of
UmuC, ruling out the possibility that the drop in pol IV colocalization with replisomes at 90 min occurs
because of competition for substrates between pols IV and V.

5.2.3

UmuD(K97A) but not UmuDʹ promotes long-lived pol IV binding events
Time-lapse imaging revealed differences in pol IV activity in umuDC variants with respect to the

number of foci per cell and pol IV- colocalisation. We noted that in the various DinB-YPet images the
foci formed in different strains appeared to exhibit differences in both intensity and shape (Figs 2A–D,
first row; 300 ms exposures). For the umuDC+ (Fig 2A), ΔumuDC (Fig 2B) and UmuD′-expressing cells
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(Fig 2D), most foci were relatively faint and diffuse. In contrast, cells expressing UmuD(K97A) produced
brighter, and much more distinct, pol IV foci. Reasoning that these differences might reflect differences
in the nature of pol IV interactions with the substrates, we next measured the binding lifetime of pol IV at
these sites. Image sets were recorded during three periods following the addition of ciprofloxacin: 20–45
min, 55–85 min and 120–180 min. For each time interval and each strain (EAW643, SSH007, SSH007 +
pJM1243, SSH007 + pRW66; Table 1), burst acquisitions of the DinB-YPet signal were recorded
(300 images of 34 ms exposure time, total length of 10.2 s). Subsequently, a corresponding image of the
replisome marker τ-mKate2 was collected (see Fig S2B for imaging sequence).

Figure 2. Binding activity of DinB at and away from replisomes in different umuDC mutants. (A)
Upper panel: Images of DinB and DnaX signal in umuDC+. Left: Projection of DinB signal consistent
with 300 ms exposure times. Right: Merged images of discoidal filtered DinB (green) and DnaX signal
(magenta). Second panel from the top: Exemplary trajectory showing DinB activity at replisomes in
umuDC+. Third panel from the top: Mean autocorrelation function showing DinB activity at replisomes
in umuDC+ at 25–45 (light grey line), 55–85 (grey line) and 120–150 min (black line). Error bars
represent standard error of the mean over > 100 trajectories. Bottom panel: Components of the
autocorrelation function for DinB at replisomes in umuDC+ showing short (< 0.03 s, grey), medium (0.3
s, light green) and long components (1.7 s, dark green). The error bars for long and medium components
were extracted from the fit error using the two-exponential fit (Suppl. Fig 1G, H). The error bar from the
short components is equivalent to the standard error of the mean from the mean autocorrelation function
at lag time 0s. (B) similar to (A), however in umuDC. (C) similar to (A), however in umuDC +
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UmuD(K97A) expressed from a plasmid. (D) similar to (A), however in umuDC + UmuDʹ expressed
from a plasmid.
For the umuDC+, ΔumuDC and UmuD′-expressing cells, intensity trajectories collected at the
positions of  foci predominantly exhibited short-lived binding events (Fig 2, second row). Cells
expressing UmuD(K97A), on the other hand, often produced long-lived pol IV binding events. To
comprehensively assess the binding lifetimes of pol IV with respect to the UmuD status at sites of the
replisome marker, mean autocorrelation functions were calculated for foci within each strain (Fig 2, third
row; Fig S2). This approach allows us to extract characteristic timescales of signal fluctuations within
intensity trajectories, which reflect the lifetimes of binding and dissociation events. Exponential fitting of
each mean autocorrelation function gave time constants of  = < 0.03, 0.3 and 3.3 s, reflecting short-,
medium-, and long-lived binding events (Fig S2). For each strain and time interval after ciprofloxacin
addition, the relative proportions of these binding events are plotted in Fig 2 (fourth row).
For both umuDC+ and umuDC cells, most pol IV binding at  positions appeared to be shortlived (Figs 2A, B). In the early stages of ciprofloxacin exposure (25–45 min) the components of the
autocorrelation function were 80% short-lived (< 0.03 s, shorter than a frame of 34 ms), 10% medium
(0.3 s) and 10% long-lived (3.3 s). In the later stages, (120–150 min), the proportion of medium-long
lived events increased to 40%. In cells expressing UmuD(K97A) long-lived events were much more
common: by the 120–150 min period medium and long-lived events comprised 80% of the
autocorrelation function (Fig 2C). In stark contrast, cells expressing UmuD′ produced almost exclusively
short-lived events (Fig 2D). UmuD′ appeared to supress the medium and long-lived pol IV binding events
that occur in wild-type umuDC+ background following ciprofloxacin treatment.
Taken together, the results indicate that UmuD(K97A) promotes long-lived DNA binding by pol
IV, whereas UmuD′ inhibits binding. The deletion of umuDC only marginally increases the binding
lifetime of pol IV compared to umuDC+. The results demonstrate that the binding of pol IV to its
substrates on the nucleoid is modulated by UmuD and UmuD′ in cells, independently of pol V formation
(i.e. in cells lacking UmuC).

5.2.4

Pol IV binds frequently at RecA* structures
Like UmuD and UmuD′, the RecA recombinase modulates the mutagenic activity of pol IV

(14,17). In vitro, DNA synthesis by pol IV is error-prone when operating on D-loop substrates that mimic
recombination intermediates (14,17). Pol IV is known to participate in error-prone DSB repair under a
variety of circumstances (13–19,31,33). In vitro, RecA also facilitates DNA synthesis by pol IV in
replisomes (37). However, it remains to be determined whether pol IV binds at RecA* in vivo.
We determined whether pol IV colocalises with RecA* structures by visualising the localisations
of fluorescent pol IV (DinB-YPet) and a RecA* marker PAmCherry-mCI; a red fluorescent protein fusion
of a monomeric C-terminal fragment of the λ repressor that retains the ability to bind RecA* in cells (39).
We carried out this analysis in SSH092 cells treated with ciprofloxacin — a potent inducer of DSBs
(41,48) through reactive oxygen species-dependent and -independent pathways (49). Live-cell
photoactivatable localisation microscopy (PALM) of SSH092 cells treated with ciprofloxacin was
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performed by collecting images in both channels every 5 min over a period of 3 h following introduction
of ciprofloxacin at time point t = 0 min. At each time point, a new field-of-view was recorded.

Figure 3. Colocalisation measurement between DinB and mCI after ciprofloxacin treatment. (A)
Merged images of discoidal filtered DinB-YPet (green) and PAmCherry-mCI (magenta) at 55, 70, 100
and 155 min after ciprofloxacin addition. (B) Colocalisation percentage of DinB with mCI. Time points
are binned over 30 min. Error bar represents standard deviation of biological quadruplicates.
Following ciprofloxacin treatment, cells typically contained multiple mCI foci (Fig 3A). At later
time points, some cells contained more elongated “bundle” structures as described previously (39). We
next determined the percentage of DinB-YPet foci that colocalised with mCI foci and bundle-like
structures (Fig 3B). Prior to the introduction of ciprofloxacin, mCI foci were rarely formed in cells during
normal metabolism (< 0.1 mCI foci per cell) consistent with our previous study (39). Unsurprisingly, we
did not detect colocalisation of pol IV with the RecA* probe in untreated cells. Upon introduction of
ciprofloxacin to the flow chamber, colocalisation remained low during the early phase of the SOS
response (i.e., between 0–45 min after treatment). From 45 min after the introduction of ciprofloxacin, pol
IV exhibited extensive colocalisation (10–40%) with mCI in cells. This extensive colocalisation persisted
into the late stages of SOS (up to 180 min after treatment). We have previously noted that most of the
mCI foci form at locations distal to the replisome in UV-irradiated cells (39). Notably, pol IV foci also
mainly form at sites distinct from replisome markers.

5.2.5

RecA* promotes the binding of pol IV to the nucleoid
Having observed that a large proportion of pol IV colocalises with the RecA* probe mCI, we

next set out to determine whether RecA* structures could recruit pol IV to the DNA. To isolate the effects
of RecA* formation from other effects introduced by exogenous DNA damage, we utilised a RecA
mutant, RecA(E38K), which is able to constitutively induce SOS and high rates of pol V-dependent
mutagenesis in cells (42–44,50), suggestive of RecA* structures being formed in the absence of
endogenous DNA damage.
Using surface plasmon resonance (SPR) as previously described (39), we observed that
RecA(E38K) forms filaments on ssDNA in vitro (Figs S3A, B). Stable association of RecA(E38K)
required the presence of ATPγS suggesting that RecA(E38K) forms filaments (Fig S3B). Additionally,
RecA(E38K) filaments on ssDNA are competent to cleave LexA (Fig S4), suggesting that RecA(E38K)
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forms RecA*-like structures on ssDNA (28,51). However, in the absence of DNA damage, we expect
exposed ssDNA substrates for RecA(E38K) binding to occur infrequently. Therefore, we additionally
tested whether constitutive SOS signalling may occur due to constitutive RecA(E38K)-dsDNA filament
formation. To that end, we tested the ability of RecA(E38K) to form filaments on a 60-mer dsDNA
substrate. We found that RecA(E38K) binds readily to dsDNA (Figs S3C, D) and that incubation of
dsDNA plasmid substrates with RecA(E38K) promoted LexA cleavage (Fig S4), indicating that
RecA(E38K) also forms RecA*-like structures on dsDNA (28,51).
Together, these results allowed us to establish conditions where we could now probe the binding
of pol IV to constitutive RecA filaments, even in the absence of exogenous DNA damage, in live cells.
We carried out single-molecule imaging of dinB-YPet dnaX-mKate2 cells carrying wild-type or mutant
alleles of lexA (encoding the SOS-response repressor LexA) and recA (encoding the recombinase RecA).
Three strains were examined: i) cells with wild-type lexA and recA alleles (EAW643, dinB-YPet dnaXmKate2 lexA+ recA+, Table 1), ii) cells that constitutively express high levels of DinB-YPet (and all other
SOS-induced proteins) even in the absence of exogenous DNA damage (51); RW1594, dinB-YPet dnaXmKate2 lexA[Def] recA+, Table 1) and iii) cells that both produce high levels of DinB-YPet and
constitutively formed RecA*-like structures (RW1598, dinB-YPet dnaX-mKate2 lexA[Def] recA[E38K],
Table 1) (42–44,50). Although cells carrying the recA(E38K) allele are constitutive for SOS induction,
our previous study of UmuC-mKate2 cells suggested that this induction only operates at ~50% of
maximum – expression of UmuC-mKate2 could be further induced by UV irradiation, whereas this was
not the case for lexA(Def) cells (45) We therefore included the additional lexA(Def) allele in RW1598 so
that the intracellular concentration of pol IV would match that of RW1594 cells.
We set out to determine if the presence of RecA*-like structures formed by RecA(E38K) is
sufficient to recruit pol IV to the nucleoid in cells. We recorded burst acquisitions of DinB-YPet motions
in the three strains (300 images of 34 ms exposure time, total length of 10.2 s). For each movie, a
corresponding image of the replisome marker τ-mKate2 was also captured (see Figs S2A, B for imaging
sequence). As expected, cells with wild-type lexA and recA alleles produced few pol IV foci (Fig 4A)
(12). Cells that carried the SOS-constitutive lexA(Def) allele and the wild-type recA allele produced a
relatively high level of DinB-YPet signal, but produced few foci (Fig 4B) (12). This result is consistent
with our previous study in which we concluded that binding is triggered by the presence of damage on the
DNA, as opposed to mass action-driven exchange brought on by increased intracellular concentrations of
pol IV (12). In contrast to both recA+ strains, cells carrying both the lexA(Def) allele and the RecA*constitutive recA(E38K) allele produced both high DinB-YPet signal and readily visible foci (Fig 4C).
These results suggest two possibilities. First, in the absence of ciprofloxacin-induced double strand
breaks, lexA(Def) recA(E38K) cells might produce some kind of DNA structures that serve as substrates
for pol IV (and are not present in lexA(Def) cells carrying wild-type RecA). Second, nucleoid-associated
RecA(E38K) assemblies might themselves acts as binding sites for pol IV in recA(E38K) cells.
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Figure 4. Binding activity of DinB at and away from replisomes in different lexA and recA mutants.
(A) Images of DinB and DnaX signal in lexA+ recA+. Left: Projection of DinB signal consistent with 300
ms exposure times. Right: Merged images of discoidal filtered DinB (green) and DnaX signal (magenta).
(B) similar to (A), however in lexA(Def) recA+. (C) similar to (A), however in lexA(Def) recA(E38K). (D)
Left: DinB signal at a replisome in lexA+ recA+. Right: DinB signal away from replisome in lexA+ recA+.
(E) Left: DinB signal at a replisome in lexA(Def) recA+. Right: DinB signal away from replisome in
lexA(Def) recA+. (F) Left: DinB signal at a replisome in lexA(Def) recA(E38K). Right: DinB signal away
from replisome in lexA(Def) recA(E38K). (G) Mean autocorrelation function showing DinB activity at
replisomes in lexA+ recA+ (black line), lexA(Def) recA+ (grey line) and lexA(Def) recA(E38K) (green line).
Error bars represent standard error of the mean over > 100 trajectories. (H) Mean autocorrelation function
showing DinB activity away from replisomes in lexA+ recA+ (black line), lexA(Def) recA+ (grey line) and
lexA(Def) recA(E38K) (green line). Error bars represent standard error of the mean > 100 trajectories.
We therefore directly tested whether RecA(E38K) interacts with pol IV on filaments assembled
dsDNA in vitro. Using an identical SPR experimental setup as described above, we assembled
RecA(E38K) on a 60-mer dsDNA substrate (Figs S3C, D). We found that pol IV associates with
RecA(E38K)-ATPγS filaments formed on dsDNA (Fig S3E), producing a much stronger response than
measurements in which pol IV was exposed to dsDNA in the absence of RecA(E38K) (Fig S3F).
Unfortunately, despite our attempts to further optimise the assay, non-specific binding of pol IV to the
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chip surface hampered our attempts to extract binding parameters from the sensorgrams. Nevertheless,
these results clearly demonstrate that the association of pol IV with the nucleoid is promoted by the
presence of RecA*-like structures.
Returning to the live-cell single-molecule data, we next examined fluctuations in the DinB-YPet
signals that occur as pol IV binds to, or dissociates from, binding sites on the nucleoid. We monitored pol
IV binding events within cells, both close to and away from  foci. Intensity trajectories for DinB-YPet in
lexA+ recA+ cells and lexA(Def) recA+ cells predominantly showed short-lived spikes (< 1s; Figs 4D, E),
indicative of transient pol IV binding events (milliseconds timescale). In contrast, trajectories for DinBYPet in lexA(Def) recA(E38K) cells often included binding events that were much longer lived (1–10 s,
Fig 4F), indicative of pol IV binding to its target for longer periods (seconds timescale).
To comprehensively assess pol IV binding lifetimes across all intensity trajectories, mean
autocorrelation functions were calculated for each set of trajectories (Figs S2D–F). Fitting of each
autocorrelation function give time constants  = < 0.03, 0.4 and 6.0 s, reflecting short-, medium-, and
long-lived binding events (Figs 4G, H; S2G, H). For lexA+ recA+ cells in the absence of ciprofloxacin,
only 1% of  positions showed evidence of pol IV binding events (Fig 4G, right panel). The normalised
mean autocorrelation function for lexA+ recA+ cells was of low amplitude (0.16 at Δt = 1 frame, Fig 4G,
black line), indicative of there being relatively few long-lived binding events at replisomes across the
different trajectories (12). The lexA(Def) recA+ background marginally increased pol IV binding activity
with 5% of  foci showing by DinB-YPet binding (Fig 4G, right panel) (12). The autocorrelation function
remained of low amplitude (0.3 at Δt = 1 frame, Fig 4G, grey line), indicating that few long-lived pol IV
binding events occurred at  positions in the lexA(Def) recA+ background. In contrast, lexA(Def)
recA(E38K) cells exhibited a strong increase in pol IV binding activity, both close to and away from 
foci; 31% of  positions had a pol IV binding event (Fig 4G, right panel). The amplitude of the
autocorrelation function was also increased (0.4 at Δt = 1 frame, Fig 4G, green line), indicating that longlived binding events occurred close to replisome markers much more frequently. The decay rate of the
autocorrelation function had two longer timescale components (Fig 4G, right panel: τm = 0.4 s with an
amplitude of 15% and τl = 6.0 s with an amplitude of 29%), suggesting that pol IV typically binds near 
foci for periods of a few seconds in the recA(E38K) background. When analysing the binding behaviour
of pol IV away from  positions in these three backgrounds, similar results were obtained (Fig 4H).

5.3

Discussion
In this study, we arrived at four conclusions: i) UmuD promotes the binding of pol IV to the

nucleoid, at replisomal and non-replisomal sites; ii) UmuD′ inhibits the binding of pol IV to the nucleoid,
at both replisomal and non-replisomal sites; iii) pol IV frequently colocalises with the RecA* probe mCI;
iv) RecA*-like structures strongly promote the binding of pol IV to the DNA. These results lead us to
infer that RecA*-like structures can recruit pol IV to the nucleoid, where pol IV might associate with the
RecA* filaments. Following ciprofloxacin treatment, this pol IV-RecA* interaction might recruit pol IV
to carry out repair synthesis at DSB repair intermediates. Furthermore, the RecA* mediated cleavage of
UmuD, a biochemical switch that has long been known to regulate pol V activation, also regulates the
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binding of pol IV to the nucleoid. The results provide direct evidence for both RecA and UmuD acting as
regulatory factors for pol IV in vivo, as proposed previously (5,14,17,25,37).

5.3.1

UmuD2 and UmuD′2 as regulators of pol IV
A previous study suggested that both UmuD2 and UmuD′2 bind to pol IV and modulate its

mutagenic activity (25). Moreover, in vitro experiments have suggested that full-length UmuD binds to
the replicative polymerase, α, and destabilises its interaction with the sliding clamp, β, thus facilitating
other polymerases, such as pol IV, to access the replisome (52,53).
Here we show that UmuD(K97A) increases the number of pol IV foci and increases the binding
time of pol IV at the nucleoid. The increased binding time of pol IV in the presence of umuD(K97A)
could be caused by a pol IV-UmuD(K97A) complex binding to the nucleoid; the existence of a pol IVUmuD(K97A) complex needs to be further tested in the future. In contrast, UmuD′ inhibits nucleoid
binding by pol IV. Reasons for this inhibition of binding could be UmuD′ binding to pol IV sites or the
formation of a pol IV- UmuD′ complex might impact pol IV binding to the nucleoid. During the first
stage of the SOS response, most UmuD is present as full-length UmuD2 (45). This would promote longlived binding of pol IV to DNA and support high-fidelity DNA synthesis. Based on rates of pol IVdependent DNA synthesis measured in vitro (3–5 nt s–1; (54)), binding events lasting a few seconds, such
as those observed during this study, could permit the incorporation of tens of nucleotides. In cells lacking
umuDC, the operon encoding for pol V, we observed increased colocalisation between pol IV and the
replisome marker, however nucleoid-binding was shorter-lived than in cells expressing UmuD(K97A).
These effects of UmuD and UmuD′ were observed in strains lacking UmuC, indicating that the changes in
replisome colocalization and nucleoid-binding lifetime did not arise from differences in competition for
binding sites with pol V. Effects observed might be exaggerated in the backgrounds used because
UmuD(K97A) and UmuD′ were produced from plasmids at 4–5-fold higher levels than being expressed
from the chromosome (39,46).
This work allows us to propose the following model for pol IV activity in the context of the SOS
response. Cells experiencing extensive DNA damage trigger the full extent of the SOS response, leading
to the formation of UmuD′ at late time points after DNA damage. At this point, the cell enters a
mutagenic phase. The highly error-prone polymerase pol V Mut becomes active and pol IV, now in the
absence of UmuD, introduces –1 frameshift mutations. At the same time pol IV binding becomes
infrequent and short-lived in the presence of UmuD′, consistent with an earlier observation that UmuD′
reduces the frequency of adaptive mutagenesis (25). Thus, while pol IV is error-prone in the presence of
UmuD′, mutagenesis would be kept in check by pol IV having reduced access to substrates. This
mechanism of UmuD cleavage restricting mutagenesis is in line with the multiple mechanisms that have
evolved to restrict the mutagenic activity of pol V (55). Interestingly, colocalization between pol IV and 
is highest in cells that lack UmuD and UmuC altogether (ΔumuDC). One possibility is that in wild-type
umuDC+ cells pol V competes with pol IV for binding to replisome-proximal binding sites, however this
explanation seems unlikely for two reasons: 1. pol IV- colocalization is low in cells that express UmuD′,
but lack UmuC and therefore cannot produce pol V (Fig 1D); 2. fluorescently labelled pol V colocalises
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with replisomes even less frequently than pol IV does (45). Another explanation, which is more consistent
with the data, is that the accumulation of UmuD′ in response to treatment with DNA damaging agents
inhibits the binding of pol IV at replisome-proximal sites in wild-type (umuDC+) cells.

5.3.2

Pol IV binds to RecA* structures
The high degree of colocalisation we observed between pol IV and the RecA* probe when

treating with ciprofloxacin, together with the binding of pol IV to RecA*-like structures in vitro and in
vivo, adds to a growing body of evidence supporting the participation of pol IV in homologous
recombination (13–19,30,31,33). In ciprofloxacin-treated cells, pol IV colocalises with the RecA* probe
(this study) far more frequently than it colocalises with the replisome marker  (12). Ciprofloxacin is a
DNA gyrase inhibitor, which generates DSBs (41) and rapidly halts DNA synthesis (56,57). Defects in
DSB processing strongly suppress both pol IV up-regulation and focus formation (35). Interestingly, in
vitro, pol IV is capable of associating with RecA(E38K)-ATPγS filaments formed on dsDNA. These
filaments are competent of LexA cleavage, indicative of RecA*-like activity. In vivo in the absence of
DNA damage, pol IV forms foci in a recA(E38K) mutant background, suggestive of pol IV binding to
RecA(E38K) filaments, which presumably form predominantly on dsDNA. In wild-type cells, an
interaction between pol IV and RecA* may well facilitate the recruitment of pol IV to homologous
recombination intermediates, or indeed any substrates where amenable RecA* structures form.
The results presented here indicate that in ciprofloxacin-treated cells pol IV primarily forms foci
at sites of RecA* structures. Together with the observation that inhibition of DSB resection almost
completely eliminates pol IV focus formation in ciprofloxacin-treated cells (35), this suggests that pol IV
predominantly acts at double-strand break repair intermediates in ciprofloxacin-treated cells, where its
most likely role is the extension of D-loops during repair synthesis (14,17,37). The association of pol IV
with RecA has also been observed outside the context of RecA* structures (25) and is proposed to
stimulate pol IV-dependent TLS in vitro (5). Further research is required to determine whether the pol IVRecA* interaction plays a role in modulating pol IV activities within pathways other than double-strand
break repair.
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5.4

Experimental procedures

5.4.1

Strain construction, plasmid construction and transformations
SSH007 is a two-colour strain (dinB-YPet dnaX-mKate2 umuDC) derived from EAW643

(dinB-YPet dnaX-mKate2). It was made by replacing the wild-type umuDC+ gene of EAW643 with
umuDC::CmR from RW880 via P1 transduction. Colonies were selected by testing for chloramphenicol
resistance.
To investigate the influence of UmuD mutants on pol IV activity, SSH007 was complemented
with plasmids that express UmuD(K97A) (pJM1243) or UmuDʹ (pRW66).
SSH092 was made by transformation; EAW633 (dinB-YPet) carries the pJMuvrA-PAmCherrymCI vector (see Supplementary Notes for sequence). The PAmCherry-mCI gene block was
commercially synthesised and the sequence was verified (IDT gene block). The gene block was
introduced into pSC101 (46) using the ApaI and SacII restriction sites.
RW1598 was made by P1 transduction of recA730 srlD300::Tn10 from RW244 into RW1594,
selecting for TetR. Colonies were then screened for constitutive UmuD cleavage using Western blotting.
recA and srlD are about 90% linked.
pJM1243 was made by chemically synthesizing an E.coli codon optimised umuD(K97A)
gene that was cloned into the low-copy spectinomycin resistant vector, pSC101 (46), as HindIII-EcoRI
fragment. UmuD(K97A) expression is LexA-regulated. Similarly, pRW66 was made by introducing the
umuDʹ gene into pSC101 (46).
Table 1. Strains used in this study.
Strain

Relevant Genotype

MG1655

dinB+ umuDC+ lexA+recA+

RW1594

dinB-YPet dnaX-mKate2 sulA::kanR
lexA(Def) Cm

Parent strain

Source/technique

-

(58)

RW1588

(12)

-

(59)

R

RW244

recA(E38K) srlD300::Tn10

RW1598

dinB-YPet dnaX-mKate2 sulA::kanR

RW1594

R

lexA(Def)::Cm recA(E38K)

Transduction of RW1594 with P1
grown on RW244

srlD300::Tn10
EAW633

dinB-YPet::kanR

EAW643

dinB-YPet::FRT dnaXR

MG1655

(12)

EAW633

(12)

+

mKate2::kan lexA
RW880

umuDC::CmR

MG1655

(35)

SSH007

dinB-YPet::FRT dnaX-

EAW643

Transduction of EAW643 with P1

mKate2::kanR lexA+

grown on RW880

umuDC::CmR
SSH007 +

dinB-YPet::FRT dnaX-

pJM1243

mKate2::kanR lexA+

SSH007

Transformation of SSH007 with
pJM1243
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umuDC::CmR (chr) +
UmuD(K97A) (pl)
SSH007+

dinB-YPet::FRT dnaX-

pRW66

mKate2::kanR lexA+

SSH007

Transformation of SSH007 with
pRW66

umuDC::Cm (chr) + UmuDʹ (pl)
R

SSH092

dinB-YPet::kanR (chr) +

EAW633

PAmCherry-mCI (pl)

5.4.2

Transformation of EAW633 with
pJMuvrA-PAmCherry-mCI (39)

Fluorescence microscopy and imaging protocols
For all experiments except for experiments including imaging of PAmCherry-mCI, wide-field

fluorescence imaging was performed on an inverted microscope (IX-81, Olympus with a 1.49 NA 100×
objective) in an epifluorescence configuration, as described previously (45). Continuous excitation is
provided using semidiode lasers (Sapphire LP, Coherent) of the wavelength 514 nm (150 mW max.
output) and 568 nm (200 mW max. output). τ-mKate2 was imaged using yellow excitation light (λ = 568
nm) at high intensity (2750 W cm–2), collecting emitted light between 610–680 nm (ET 645/75m filter,
Chroma) on a 512 × 512 pixel2 EM-CCD camera (C9100-13, Hamamatsu). For DinB-YPet time-lapse
imaging, we used green excitation (λ = 514 nm) at lower power (240 W cm–2), collecting light emitted
between 525–555 nm (ET540/30m filter, Chroma).
For experiments including imaging of PAmCherry-mCI, imaging was conducted on an inverted
microscope (Nikon Eclipse-Ti), equipped with a 1.49 NA 100× objective and a 512 × 512 pixel2
Photometrics Evolve CCD camera (Photometrics, Arizona, US). NIS-Elements equipped with JOBS
module was used to operate the microscope (Nikon, Japan). Continuous excitation is provided using
semidiode lasers of the wavelength 405 nm (OBIS, Coherent, 200 mW max. output), 514 nm (Sapphire
LP, Coherent, 150 mW max. output) and 568 nm (Sapphire LP, Coherent, 200 mW max. output). DinBYPet was imaged using green excitation (λ = 514 nm) at lower power (~2200 W cm–2), collecting light
emitted between 535–550 nm (ET535/30m filter, Chroma). PAmCherry-mCI was imaged by
simultaneous illumination with the activation laser 405 nm (1–5 W cm–2) and 568 nm readout laser (540
W cm–2), a PALM (photoactivation localisation microscopy) acquisition protocol, collecting emitted light
from 590 nm (ET590LP, Chroma).
Burst acquisitions (movies of 300 × 34 ms frames, continuous excitation with 514 nm light; each
frame at 80 W cm–2) were collected to characterise DinB-YPet binding kinetics; followed by a set of two
images (bright-field [34 ms exposure]; mKate2 fluorescence [100 ms exposure]). Data were recorded
from 20–45 min, from 55–85 min and from 120–180 min after ciprofloxacin treatment (30 ng mL–1).
Time-lapse movies were recorded to visualise changes in DinB-YPet binding activity and measure
colocalisation with the replisome marker. Sets of three images were recorded (bright-field [34 ms
exposure], YPet fluorescence [50 ms exposure]; mKate2 fluorescence [100 ms exposure]) at an interval of
10 min for 3 h. All images were analysed with ImageJ (60).
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Time-sampling of DinB-YPet and PAmCherry-mCI expressing cells were performed as follows:
First, the bright-field image was taken with 100 ms exposure time. Then, a PALM acquisition protocol
(simultaneous illumination with the activation laser 405 [1–5 W cm–2] and 568 nm readout laser [540 W
cm–2] for 200 frames taken every 100 ms) was used to image PAmCherry-mCI. Third, DinB-YPet was
detected using 512 nm laser (50 ms exposure time at ~2200 W cm–2). The experiment was performed over
3 h, time points were sampled at an interval of 5 min. At each time point, a new field-of-view was
sampled to minimise laser-induced damage.
To image DinB-YPet and PAmCherry-mCI, sets of three acquisitions were recorded (bright-field
[100 ms exposure], YPet fluorescence [50 ms exposure]; PAmCherry fluorescence [simultaneous
illumination with the activation laser 405 and 568 nm readout laser for 200 frames each with 100 ms
exposure]). This protocol was only executed once for a field-of-view to minimise laser damage.
Consequently, each time point shows a new set of cells. The experiment was conducted over 3 h, an
image was taken every 5 min.

5.4.3

Flow cell design
All imaging was carried out on cultures growing in home-built flow cells. Imaging was carried

out in quartz-based flow cells, similar to those used in our previous study (12). These flow cells were
assembled from a no. 1.5 coverslip (Marienfeld, reference number 0102222 or 0107222), a quartz top
piece (45 × 20 × 1 mm3) and PE-60 tubing (Instech Laboratories, Inc.). Prior to flow cell assembly,
coverslips were silanized with aminopropyltriethoxy silane (APTES; Alfa Aeser). First, coverslips were
sonicated for 30 min in a 5 M KOH solution to clean and activate the surface. The cleaned coverslips
were rinsed thoroughly with MilliQ water, then treated with a 5% (v/v) solution of APTES in MilliQ
water. The coverslips were subsequently rinsed with ethanol and sonicated in ethanol for 20 s.
Afterwards, the coverslips were rinsed with MilliQ water and dried in a jet of N2. Silanised slides were
stored under vacuum prior to use.
To assemble each flow cell, polyethylene tubing (BTPE-60, Instech Laboratories, Inc.) was
glued (BONDiT B-482, Reltek LLC) into two holes that were drilled into a quartz piece. After the glue
solidified overnight, double-sided adhesive tape was stuck on two opposite sides of the quartz piece to
create a channel. Then, the quartz piece was stuck to an APTES-treated coverslip. The edges were sealed
with epoxy glue (5 Minute Epoxy, DEVCON home and Epoxy Adhesive, 5 Minute Everyday, PARFIX).
Each flow cell was stored in a desiccator under mild vacuum while the glue dried. Typical channel
dimensions were 45 × 5 × 0.1 mm.

5.4.4

Setup of flow cell experiments
For all imaging experiments, cells were grown at 37 °C in EZ rich defined medium (Teknova)

that contained 0.2% (w/v) glucose. EAW643, RW1594 and RW1598 cells were grown in the presence of
kanamycin (25 μg mL–1), SH001 cells were grown in the presence of chloramphenicol (25 μg mL–1),
SSH007 cells carrying pJM1243 or pRW66 were grown in the presence of spectinomycin (50 μg mL–1).
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Cells carrying PAmCherry-mCI were also grown in the presence of spectinomycin (50 μg mL–1). Cells
were loaded into flow cells, allowed a few minutes to associate with the APTES surface, then, loosely
associated cells were removed by pulling through fresh medium. The experiment was then initiated by
switching the medium to a medium that contains 30 ng mL–1 ciprofloxacin (for cells carrying plasmids:
50 μg mL–1 spectinomycin was added). A flow rate of 50 μL min–1 was applied during the experiment to
allow a constant nutrient and oxygen supply by using a syringe pump.

5.4.5

Proteins
The wild-type E. coli RecA protein was purified as described (61). The RecA concentration was

determined using the extinction coefficient 280 = 2.23 × 104 M-1 cm-1 (61).
The E. coli RecA(E38K) protein was purified as previously described (62) with the following
modifications. After washing the protein pellet with R buffer plus 2.1 M ammonium sulfate, the pellet
was resuspended in R buffer plus 1 M ammonium sulfate. The sample was loaded onto a butyl-Sepharose
column and washed with 1.5 column volumes of R buffer plus 1 M ammonium sulfate. It was then eluted
with a linear gradient from R buffer plus 1 M ammonium sulfate to R buffer, carried out over 5 column
volumes. Peak fractions were identified by SDS-PAGE analysis and pooled. The protein was loaded onto
a hydroxyapatite column as done previously, but with the linear gradient from 10–500 mM P buffer. The
fractions were dialyzed against R buffer plus 50 mM KCL and 1 mM dithiothreitol three times. The
fractions were loaded onto a Source 15S column and washed with R buffer plus 50 mM KCl and 1 mM
dithiothreitol until the UV trace receded from peak. Next, the pool was loaded onto a Source 15Q column
and eluted with a linear gradient from 0.05–1 M KCl over 25 column volumes. Peak fractions were
identified as above and pooled. A DEAE-Sepharose column was not used. Protein in this pool was
precipitated by the addition of equal volume of 90% saturated ammonium sulfate. The precipitate was
stirred and then spun down at 13,000 rpm for 30 min. The pellet was resuspended in R buffer plus 1 M
ammonium sulfate, stirred for an hour, and then spun down again. This protein was loaded onto a butylSepharose column and eluted in a gradient from R buffer and 1 M ammonium sulfate to R buffer. The
fractions were identified, pooled, and concentrated using GE Vivispin 20 10K MWCO centrifuge filter
concentrating units. The protein was flash frozen in liquid nitrogen and stored at –80 °C. The
concentration was determined as above. No exonuclease or other endonuclease activities were detected.
Pol IV (dinB) coding sequence was cloned into NcoI and BamHI sites of pET16b to generate a
native pol IV expression construct. E. coli strain Turner/pLysS (Novagen) carrying the expression
construct was grown in LB medium supplemented with 20 μg/ml chloramphenicol and 100 μg ml–1
ampicillin. Expression of pol IV was induced by adding IPTG to 1 mM and growing for 3-4 h at 30oC.
Collected cells (~20 g) were resuspended in 50 mL of lysis buffer (50 mM Tris-HCl, pH 7.5, 1 M NaCl,
10% sucrose, 2 mM DITHIOTHREITOL, 1 mM EDTA and protease inhibitor cocktail). Cells were lysed
by lysozyme (2 mg/mL) and the clarified extract was collected following centrifugation at 15000 x g for
30 min. Pol IV was then precipitated by ammonium sulfate added to 30% saturation and stirring for 10
min. The precipitate was subjected to gel-filtration in GF-buffer (20 mM Tris-HCl, pH 7.5, 1 M NaCl, 0.1
mM EDTA, 1 mM DITHIOTHREITOL) using a GE Healthcare Superdex-75 XK-26/60 gel filtration
column. Pol IV fractions were pooled, dialyzed overnight in PC-buffer (20 mM Tris-HCl, pH 7.5, 0.1

153

mM EDTA 1 mM DITHIOTHREITOL, 10% glycerol), containing 200 mM NaCl and then subjected to
phosphocellulose chromatography (P-11, Whatman). After washing extensively with PC-buffer + 200
mM NaCl, pol IV was eluted with a linear gradient of 200–500 mM NaCl. Fractions containing native pol
IV (> 99% pure) were pooled and stored at –70 °C.

5.4.6

Surface Plasmon Resonance (SPR) experiments
SPR experiments were conducted on BIAcore T200 istrument (GE Healthcare) using

streptavidin (SA) coated sensor chips, probing the formation of RecA structures (assembled from
RecA[E38K]) on ssDNA and dsDNA. Experiments were carried out at 20 °C at a flow rate of 5 μL min–1.
As described previously (39), SA chips were activated and stabilised, single-stranded biotinylated 71-mer
poly-dT oligonucleotide bio-(dT)71 was immobilised, followed by RecA(E38K) filament assembly (Figs
S3A, B). RecA(E38K) filaments were assembled on bio-(dT)71 by injecting 1 μM RecA(E38K) in
SPRRecA(E38K) buffer (20mM Tris-HCl, pH 8.0, 10 mM KCl, 10 mM MgCl2, 0.005% surfactant P20 and
0.5 mM dithiothreitol) supplemented with 1 mM adenosine 5’-(-thio) triphosphate (ATPγS) at 10 μL
min–1 for 400 s. Similarly, biotinylated dsDNA was immobilised (as previously described (39)), followed
by RecA(E38K) filament assembly (Figs S3C, D). RecA(E38K) filaments were assembled on dsDNA
(sequence: 5’-TCC TTT CGT CTT CAA AGT TCT AGA CTC GAG GAA TTC TAA AGA TCT TTG
ACA GCT AGC CAG-3’, 5’ end is biotinylated) by injecting 1 μM RecA(E38K) in SPRRecA(E38K) buffer
(20mM Tris-HCl, pH 8.0, 10 mM KCl, 10 mM MgCl2, 0.005% surfactant P20 and 0.5 mM dithiothreitol)
supplemented with 0.5 mM ATPγS at 5 μL min–1 for 500 s. Then, SPRRecA(E38K) supplemented with 0.5 or
1 mM ATPγS buffer was flowed in at 5 μL min–1 for 2,500 s, in order to stabilise the formed filaments.
From 3,000 s, 1 μM RecA(E38K) in SPRRecA(E38K) buffer supplemented with 0.5 mM ATPγS was injected
at a flow rate of 5 μL min–1 for 4,200 s.
Pol IV association with RecA(E38K)-dsDNA filaments was observed by injecting 0.65 μM pol
IV in SPRRecA(E38K) buffer supplemented with 0.5 mM ATPγS for 220 s at 5 μL min–1, monitoring pol IV
association (Fig S3E). From 220 s, buffer containing 0.5 mM ATPγS was flowed in at 5 μL min–1 and
fast dissociation of pol IV was observed. Similarly, pol IV association with dsDNA was monitored,
giving a lower response curve (Fig S3F). We also observed non-specific binding of pol IV to the chip
surface, making it impossible to measure binding kinetics of pol IV.
The surface was regenerated as previously reported (39). Furthermore, the SPR signal were
corrected using a flow cell without immobilised bio-(dT)71 or dsDNA and corrected for the amount of
immobilised RecA(E38K) (39). Ghodke et al. utilised this assay to monitor the binding kinetics of mCI
at RecA-ssDNA filament (39).

5.4.7

DNA substrates for ATPase and LexA cleavage assay
M13mp18 cssDNA was purified as previously described (63), and M13mp18 cdsDNA was

prepared as previously described (63–65). The M13mp18 nicked dsDNA (from here onward called
pEAW951) was prepared by nicking with DNaseI according to manufacturer’s recommendations. All
DNA concentrations are given in terms of total nucleotides.
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5.4.8

ATPase assay
ATP hydrolysis of wild-type RecA and RecA(E38K) on nicked cdsDNA was measured using a

spectrophotometric enzyme assay (66,67). ATP regeneration from phosphoenolpyruvate and ADP was
coupled to the oxidation of NADH, which was monitored by the decrease in absorbance of NADH at 380
nm. 380-nm light was used so that the signal remained within the linear range of the spectrophotometer
during the experiment. The assays were carried out on a Varian Cary 300 dual beam spectrophotometer
equipped with a temperature controller and a 12-position cell changer. The cell path length and band pass
were 0.5 cm and 2 nm, respectively. The NADH extinction coefficient at 380 nm of 1.21 mM–1 cm–1 was
used to calculate the rate of ATP hydrolysis.
The reactions were carried out at 37 °C in a buffer containing 25mM Tris-Ac (80% cation, pH
7.5), 3 mM potassium glutamate, 10 mM magnesium acetate, 5% (w/v) glycerol, 1mM dithiothreitol, an
ATP regeneration system (10 units ml–1 pyruvate kinase, 3 mM phosphoenolpyruvate), and a coupling
system (2 mM NADH and 10 units ml–1 lactate dehydrogenase). The concentration of DNA (pEAW951
nicked cdsDNA) was 5 µM. One cuvette was a blank control that contained everything except the DNA
(volume compensated with TE). The nicked cdsDNA, buffer, and ATP regeneration system were
preincubated at 37 °C

for 10 min before addition of 3 mM ATP and 3 µM wild-type RecA or

RecA(E38K). Data collection was then begun.

5.4.9

LexA cleavage assay
The cleavage of LexA was performed essentially as previously described (28). Reaction

mixtures (125µl) contained 40 mM Tris-HCl, pH 8.0, 10 mM MgCl2, 30 mM NaCl, 2 mM dithiothreitol,
3 µM of M13mp18 circular single-stranded DNA or pEAW951 nicked circular double-stranded DNA, 3
mM ATPS, LexA, and RecA as noted. Reactions were incubated at 37 °C for 10 min before addition of
LexA. The reaction products were separated and visualized by 15% SDS-PAGE stained with Coomassie
blue.

5.4.10

Analysis of colocalisation events of pol IV with replisomes
Foci were classed as colocalised if their centroid positions (determined using our peak fitter tool)

fell within 2.18 pixels (218 nm) of each other (68). For colocalisation analysis, we binned the data in 30
min intervals for a larger sample size per time point due to low numbers of pol IV foci per cell at
exposures of 300 ms. We determined that for DinB-YPet–τ-mKate2 localisation the background of pol IV
foci expected to colocalise with replisomes purely by chance is ~4%. This was calculated by taking the
area of each cell occupied by replisome foci (including the colocalisation search radius) and dividing by
the total area of the cell. The value of 4% corresponds to the mean of measurements made over > 300
cells. As the number of pol IV foci changes in time, the proportion of replisome foci expected to
colocalise with pol IV foci by chance also changes in time. At an exposure time of 50 ms, there are
almost zero pol IV foci at the beginning of the measurement, thus there is close to zero probability that a
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replisome focus will colocalise with a pol IV focus by chance. At t = 30 min, chance colocalisation is
expected to be 5% and at t = 120 min, the chance colocalisation is expected to be 3%. At an exposure
time of 300 ms, the number of pol IV foci per cell never exceeds ~0.6 foci per cell, thus the level of
colocalisation expected to occur by chance is close to zero.

5.4.11

Analysis of pol IV binding kinetics
Replisome localisations were determined by identifying and fitting peaks from τ-mKate2

images. From the corresponding burst acquisition movie, the DinB-YPet signal at replisomes was plotted
against time (trajectories of DinB-YPet activity at replisomes) from 20–45 min, from 55–85 min and from
120–180 min after ciprofloxacin treatment (Fig S2C). These were divided into trajectories that give and
not give pol IV binding events (Figs S2D, E). From this, the percentage of replisomes (τ-mKate2 foci)
that are visited by DinB-YPet molecules (Fig 4G, right panel) is calculated.
Only trajectories that have pol IV binding events were then used to separate pol IV binding
kinetics. The autocorrelation function was applied to each of these trajectories giving signal similarities as
a function of the lag time, a method that identifies time-dependent fluctuations in signal dependent on
binding and dissociation of molecules. When applying the autocorrelation function to a DinB-YPet
trajectory, the correlation of this trajectory with its time delayed copy is generated for various lag times.
With zero lag time, the normalised correlation of a trajectory with itself is 1. The correlation of a
trajectory with its time delayed copy, however, gives autocorrelation values that range from 0–1
depending on signal fluctuations. DinB-YPet molecules that are statically bound show no fluctuations in
the DinB-YPet fluorescence signal over time, consistent with the signal being correlated in time.
Consequently, the autocorrelation is between 0–1 for lag times after zero. In contrast, DinB-YPet
molecules that are transiently associated show many fluctuations in the DinB-YPet fluorescence signal
over time. The signal is not correlated in time and results in zero autocorrelation for lag times after zero.
For each time window (20–45 min, 55–85 min and 120–180 min), the mean autocorrelation
function output was calculated to determine the average of DinB-YPet binding kinetics. The fast decay at
t = 0 s corresponds to short components. From t > 0 s, the curve was fitted with a two-exponential
function where medium or short components were identified (y=y0+A1·e-x·τ1+A2·e-x·τ2). Using the in vitro
experimentally determined rate of nucleotide incorporation of pol IV as a guide (3–5 nt s–1 (54)), the
short, medium and long components are translated to no binding/short-lived binding (unproductive
binding), binding events that are sufficient for the insertion of 1–2 nucleotides or ~8.5 nucleotides,
respectively.
Pol IV binding activity away from replisomes was determined as described above. Pol IV
trajectories were, however sampled, from average projections of pol IV burst acquisitions in time
(average projection over 100 frames, exposure time for each frame was 34 ms; total exposure 3.4 s; see
Fig 2, upper row).
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5.4.12

Analysis of colocalisation events of pol IV with mCI
To measure colocalisation between pol IV and mCI, we first created a maximum projection of

each PAmCherry-mCI movie. Similar to the colocalisation analysis performed for pol IV with replisomes,
foci were classed as colocalised if their centroid positions fell within 218 nm of each other. Chance
colocalisation of pol IV with mCI is close to zero at 0 min. Chance colocalisation is increased from 50
min with ~4%. At 100 min, the chance colocalisation is ~15%.
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5.5

Supplementary Notes and Figures

Sequence of pJMuvrA-PAmCherry-mCI vector:
AAGCTGGAAGATCTTCCCTGGCACGACAGGTTTCCCGACTGGAAAGCGGGCAGTGAGCGCA
ACGCAATTAATGTGAGTTAGCTCACTCATTAGGCACCCCAGGCTTTACACTTTATGCTTCCGGC
TCGTATGTTGTGTGGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGCTATGACCATGA
TTACGCCAAGCGCGCAATTAACCCTCACTAAAGGGAACAAAAGCTGGGTACCGGGCCCCCCC
TCGAGGTCGACTTCCGGGAAACAAACCTGGCCAGACATTGTTACACAACACTCCGGGTAATG
CATTCCAATACTGTATATTCATTCAGGTCAATTTGTGTCATAATTAACCGTTTGTGATCGGATCC
AGCACCATGCCACCGGGCAAAAAAGCGTTTAATCCGGGAAAGCATATGGTGAGCAAGGGCGA
GGAGGATAACATGGCCATCATTAAGGAGTTCATGCGCTTCAAGGTGCACATGGAGGGGTCCGT
GAACGGCCACGTGTTCGAGATCGAGGGCGAGGGCGAGGGCCGCCCCTACGAGGGCACCCAG
ACCGCCAAGCTGAAGGTGACCAAGGGTGGCCCCCTGCCCTTCACCTGGGACATCCTGTCCCC
TCAATTCATGTACGGCTCCAATGCCTACGTGAAGCACCCCGCCGACATCCCCGACTACTTTAA
GCTGTCCTTCCCCGAGGGCTTCAAGTGGGAGCGCGTGATGAAATTCGAGGACGGCGGCGTGG
TGACCGTGACCCAGGACTCCTCCCTGCAAGACGGTGAGTTCATCTACAAGGTGAAGCTGCGC
GGCACCAACTTCCCCTCCGACGGCCCCGTAATGCAGAAGAAGACCATGGGCTGGGAGGCCCT
CTCCGAGCGGATGTACCCCGAGGACGGCGCCCTGAAGGGCGAGGTCAAGCCGCGCGTGAAG
CTGAAGGACGGCGGCCACTACGACGCTGAGGTCAAGACCACCTACAAGGCCAAGAAGCCCG
TGCAGCTGCCCGGCGCCTACAACGTCAACCGCAAGTTGGACATCACCTCACACAACGAGGAC
TACACCATCGTGGAACAGTACGAACGTGCCGAGGGCCGCCACTCCACCGGCGGCATGGACGA
GCTGTACAAGGAGCTCGCTGCAGGTGGCGGCGGCGGCTCCGGCAGCCATATGTATGAGTACC
CTGTTTTTTCTCATGTTCAGGCAGGGATGTTCTCACCTGAGCTTCGCACCTTTACCAAAGGTGA
TGCGGAGCGCTGGGTAAGCACAACCAAAAAAGCCAGTGATTCTGCATTCTGGCTTGAGGTTG
AAGGTAATTCCATGACCACACCAACAGGCTCCAAGACAAGCTTTCCTGACGGAATGTTAATTC
TCGTTGACCCTGAGCAGGCTGTTGAGCCAGGTGATTTCTGCATTGCCCGCCTTGGGGGTGATG
AGTTTACCTTCGCGAAACTGATCCGCGATAGCGGTCAGGTGTTTTTACAACCACTGAACCCAC
AGTACCCAATGATCCCATGCAATGAGAGTTGTTCCGTTGTGGGGAAAGTTATCGCTAGTCAGT
GAGCGGCCGCGAATTCGAAGTTCCTATAGTTTCTAGAGAATAGGAACTTCGATCTTTAGAAAA
ACTCATCGAGCATCAAATGAAACTGCAATTTATTCATATCAGGATTATCAATACCATATTTTTGA
AAAAGCCGTTTCTGTAATGAAGGAGAAAACTCACCGAGGCAGTTCCATAGGATGGCAAGATC
CTGGTATCGGTCTGCGATTCCGACTCGTCCAACATCAATACAACCTATTAATTTCCCCTCGTCA
AAAATAAGGTTATCAAGTGAGAAATCACCATGAGTGACGACTGAATCCGGTGAGAATGGCAA
AAGCTTATGCATTTCTTTCCAGACTTGTTCAACAGGCCAGCCATTACGCTCGTCATCAAAATCA
CTCGCATCAACCAAACCGTTATTCATTCGTGATTGCGCCTGAGCGAGACGAAATACACGATCG
CTGTTAAAAGGACAATTACAAACAGGAATCGAATGCAACCGGCGCAGGAACACTGCCAGCGC
ATCAACAATATTTTCACCTGAATCAGGATATTCTTCTAATACCTGGAATGCTGTTTTCCCGGGGA
TCGCAGTGGTGAGTAACCATGCATCATCAGGAGTACGGATAAAATGCTTGATGGTCGGAAGAG
GCATAAATTCCGTCAGCCAGTTTAGTCTGACCATCTCATCTGTAACATCATTGGCAACGCTACC
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TTTGCCATGTTTCAGAAACAACTCTGGCGCATCGGGCTTCCCATACAATCGATAGATTGTCGCA
CCTGATTGCCCGACATTATCGCGAGCCCATTTATACCCATATAAATCAGCATCCATGTTGGAATT
TAATCGCGGGCGCGAGCAAGACGTTTCCCGTTGAATATGGCTCATAACACCCCTTGTATTACTG
TTTATGTAAGCAGACAGTTTTATTGTTCATGATGATATATTTTTATCTTGTGCAATGTAACATCAG
AGATTTTGAGACACAACGTGGCTTTCCCCGCCCGCCCGATCCCCGGGTACCGAGCTCGAATTT
CGACCAATTCGAAGTTCCTATACTTTCTAGAGAATAGGAACTTCCCGCGGTGGAGCTCCAATT
CGCCCTATAGTGAGTCGTATTACGCGCGCTCACTGGCCGTCGTTTTACAACGTCGTGACTGGG
AAAACCCTGGCGTTACCCAACTTAATCGCCTTGCAGCACATCCCCCTTTCGCCAGCTGGCGTA
ATAGCGAAGAGGCCCGCACCGATCGCCCTTCCCAACAGTTGCGCAGCCTGAATGGCGAATGG
GACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGC
TACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTC
GCCGGAAGATCTTCCAATTCCCGACAGTAAGACGGGTAAGCCTGTTGATGATACCGCTGCCTT
ACTGGGTGCATTAGCCAGTCTGAATGACCTGTCACGGGATAATCCGAAGTGGTCAGACTGGA
AAATCAGAGGGCAGGAACTGCTGAACAGCAAAAAGTCAGATAGCACCACATAGCAGACCCG
CCATAAAACGCCCTGAGAAGCCCGTGACGGGCTTTTCTTGTATTATGGGTAGTTTCCTTGCATG
AATCCATAAAAGGCGCCTGTAGTGCCATTTACCCCCATTCACTGCCAGAGCCGTGAGCGCAGC
GAACTGAATGTCACGAAAAAGACAGCGACTCAGGTGCCTGATGGTCGGAGACAAAAGGAAT
ATTCAGCGATTTGCCCGAGCTTGCGAGGGTGCTACTTAAGCCTTTAGGGTTTTAAGGTCTGTTT
TGTAGAGGAGCAAACAGCGTTTGCGACATCCTTTTGTAATACTGCGGAACTGACTAAAGTAGT
GAGTTATACACAGGGCTGGGATCTATTCTTTTTATCTTTTTTTATTCTTTCTTTATTCTATAAATTA
TAACCACTTGAATATAAACAAAAAAAACACACAAAGGTCTAGCGGAATTTACAGAGGGTCTA
GCAGAATTTACAAGTTTTCCAGCAAAGGTCTAGCAGAATTTACAGATACCCACAACTCAAAGG
AAAAGGACTAGTAATTATCATTGACTAGCCCATCTCAATTGGTATAGTGATTAAAATCACCTAG
ACCAATTGAGATGTATGTCTGAATTAGTTGTTTTCAAAGCAAATGAACTAGCGATTAGTCGCTA
TGACTTAACGGAGCATGAAACCAAGCTAATTTTATGCTGTGTGGCACTACTCAACCCCACGAT
TGAAAACCCTACAAGGAAAGAACGGACGGTATCGTTCACTTATAACCAATACGCTCAGATGAT
GAACATCAGTAGGGAAAATGCTTATGGTGTATTAGCTAAAGCAACCAGAGAGCTGATGACGA
GAACTGTGGAAATCAGGAATCCTTTGGTTAAAGGCTTTGAGATTTTCCAGTGGACAAACTATG
CCAAGTTCTCAAGCGAAAAATTAGAATTAGTTTTTAGTGAAGAGATATTGCCTTATCTTTTCCA
GTTAAAAAAATTCATAAAATATAATCTGGAACATGTTAAGTCTTTTGAAAACAAATACTCTATG
AGGATTTATGAGTGGTTATTAAAAGAACTAACACAAAAGAAAACTCACAAGGCAAATATAGA
GATTAGCCTTGATGAATTTAAGTTCATGTTAATGCTTGAAAATAACTACCATGAGTTTAAAAGG
CTTAACCAATGGGTTTTGAAACCAATAAGTAAAGATTTAAACACTTACAGCAATATGAAATTG
GTGGTTGATAAGCGAGGCCGCCCGACTGATACGTTGATTTTCCAAGTTGAACTAGATAGACAA
ATGGATCTCGTAACCGAACTTGAGAACAACCAGATAAAAATGAATGGTGACAAAATACCAAC
AACCATTACATCAGATTCCTACCTACATAACGGACTAAGAAAAACACTACACGATGCTTTAACT
GCAAAAATTCAGCTCACCAGTTTTGAGGCAAAATTTTTGAGTGACATGCAAAGTAAGTATGAT
CTCAATGGTTCGTTCTCATGGCTCACGCAAAAACAACGAACCACACTAGAGAACATACTGGCT
AAATACGGAAGGATCTGAGGTTCTTATGGCTCTTGTATCTATCAGTGAAGCATCAAGACTAAC
AAACAAAAGTAGAACAACTGTTCACCGTTACATATCAAAGGGAAAACTGTCCATATATGCACA
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GATGAAAACGGTGTAAAAAAGATAGATACATCAGAGCTTTTACGAGTTTTTGGTGCATTCAAA
GCTGTTCACCATGAACAGATCGACAATGTAACAGATGAACAGCATGTAACACCTAATAGAACA
GGTGAAACCAGTAAAACAAAGCAACTAGAACATGAAATTGAACACCTGAGACAACTTGTTAC
AGCTCAACAGTCACACATAGACAGCCTGAAACAGGCGATGCTGCTTATCGAATCAAAGCTGC
CGACAACACGGGAGCCAGTGACGCCTCCCGTGGGGAAAAAATCATGGCAATTCTGGAAGAA
ATAGCGCTTTCAGCCGGCAAACCTGAAGCCGGATCTGCGATTCTGATAACAAACTAGCAACAC
CAGAACAGCCCGTTTGCGGGCAGCAAAACCCGTGGGAATTAATTCCCCTGCTCGCGCAGGCT
GGGTGCCAAGCTCTCGGGTAACATCAAGGCCCGATCCTTGGAGCCCTTGCCCTCCCGCACGAT
GATCGTGCCGTGATCGAAATCCAGATCCTTGACCCGCAGTTGCAAACCCTCACTGATCCGCAT
GCCCGTTCCATACAGAAGCTGGGCGAACAAACGATGCTCGCCTTCCAGAAAACCGAGGATGC
GAACCACTTCATCCGGGGTCAGCACCACCGGCAAGCGCCGCGACGGCCGAGGTCTTCCGATC
TCCTGAAGCCAGGGCAGATCCGTGCACAGCACCTTGCCGTAGAAGAACAGCAAGGCCGCCA
ATGCCTGACGATGCGTGGAGACCGAAACCTTGCGCTCGTTCGCCAGCCAGGACAGAAATGCC
TCGACTTCGCTGCTGCCCAAGGTTGCCGGGTGACGCACACCGTGGAAACGGATGAAGGCAC
GAACCCAGTGGACATAAGCCTGTTCGGTTCGTAAGCTGTAATGCAAGTAGCGTATGCGCTCAC
GCAACTGGTCCAGAACCTTGACCGAACGCAGCGGTGGTAACGGCGCAGTGGCGGTTTTCATG
GCTTGTTATGACTGTTTTTTTGGGGTACAGTCTATGCCTCGGGCATCCAAGCAGCAAGCGCGTT
ACGCCGTGGGTCGATGTTTGATGTTATGGAGCAGCAACGATGTTACGCAGCAGGGCAGTCGC
CCTAAAACAAAGTTAAACATCATGAGGGAAGCGGTGATCGCCGAAGTATCGACTCAACTATCA
GAGGTAGTTGGCGTCATCGAGCGCCATCTCGAACCGACGTTGCTGGCCGTACATTTGTACGGC
TCCGCAGTGGATGGCGGCCTGAAGCCACACAGTGATATTGATTTGCTGGTTACGGTGACCGTA
AGGCTTGATGAAACAACGCGGCGAGCTTTGATCAACGACCTTTTGGAAACTTCGGCTTCCCC
TGGAGAGAGCGAGATTCTCCGCGCTGTAGAAGTCACCATTGTTGTGCACGACGACATCATTCC
GTGGCGTTATCCAGCTAAGCGCGAACTGCAATTTGGAGAATGGCAGCGCAATGACATTCTTGC
AGGTATCTTCGAGCCAGCCACGATCGACATTGATCTGGCTATCTTGCTGACAAAAGCAAGAGA
ACATAGCGTTGCCTTGGTAGGTCCAGCGGCGGAGGAACTCTTTGATCCGGTTCCTGAACAGGA
TCTATTTGAGGCGCTAAATGAAACCTTAACGCTATGGAACTCGCCGCCCGACTGGGCTGGCGA
TGAGCGAAATGTAGTGCTTACGTTGTCCCGCATTTGGTACAGCGCAGTAACCGGCAAAATCGC
GCCGAAGGATGTCGCTGCCGACTGGGCAATGGAGCGCCTGCCGGCCCAGTATCAGCCCGTCA
TACTTGAAGCTAGACAGGCTTATCTTGGACAAGAAGAAGATCGCTTGGCCTCGCGCGCAGAT
CAGTTGGAAGAATTTGTCCACTACGTGAAAGGCGAGATCACCAAGGTAGTCGGCAAATAATG
TCTAACAATTCGTTCAAGCCGACGCCGCTTCGCGGCGCGGCTTAACTCAAGCGTTAGATGCAC
TAAGCACATAATTGCTCACAGCCAAACTATCAGGTCAAGTCTGCTTTTATTATTTTTAAGCGTG
CATAATAAGCCCTACACAAATTGGGAGATATATCATGAAAGGCTGGCTTTTTCTTGTTATCGCA
ATAGTTGGCGAAGTAATCGCAACATCCGCATTAAAATCTAGCGAGGGCTTTACT
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Supplementary Figure S1. Colocalisation analysis using 50 ms exposures for DinB-YPet and
number of DinB-YPet and τ-mKate2 foci per cell. (A) Upper row: colocalisation of DinB with DnaX.
Left plot compares umuDC+ (black line) with ΔumuDC (green line). Middle plot compares umuDC+
(black line) with ΔumuDC + UmuD(K97A) expressed from plasmid (green line). Right plot compares
umuDC+ (black line) with ΔumuDC + UmuDʹ expressed from plasmid (green line). Bottom row:
colocalisation of DnaX with DinB. Left plot compares umuDC+ (black line) with ΔumuDC (green line).
Middle plot compares umuDC+ (black line) with ΔumuDC + UmuD(K97A) expressed from plasmid
(green line). Right plot compares umuDC+ (black line) with ΔumuDC + UmuDʹ expressed from plasmid
(green line). Error bars represent standard error of the mean between at least biological triplicates. (B)
Number of DinB (upper plot) and DnaX foci per cell (bottom plot) in umuDC+ (black line), ΔumuDC (red
line), ΔumuDC + UmuD(K97A) (yellow line) and ΔumuDC + UmuDʹ (blue line) after ciprofloxacin
treatment. Error bars represent standard error of the mean for n > 100 cells.
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Supplementary Figure S2. Burst acquisitions and analysis. (A) Experimental setup. Cells are loaded in
a flow cell and immobilised on a positively charged APTES glass surface. Cells were imaged before
addition of ciprofloxacin and 25–45, 55–85 and 120–150 min after addition. (B) Burst acquisition
sequence. Movies of DinB-YPet were recorded. The movies contain 300 frames at an exposure of 50 ms
taken every 100 ms. Subsequently, an image of the τ-mKate2 channel is taken at an exposure time of 100
ms. (C) Exemplary intensity trajectories showing DinB-YPet binding at replisomes. (D) Histogram of
DinB-YPet intensities at replisomes. From cut-off to 0: replisomes with no DinB-YPet binding. From cutoff to higher intensities: replisomes with DinB-YPet binding. (E) Grouping of trajectories. Trajectories
that show no DinB-YPet binding at replisomes are excluded from the analysis. Trajectories that show
DinB-YPet binding at replisomes are used for the analysis. (F), The mean autocorrelation function is
obtained from single autocorrelation function. Each autocorrelation function stems from single intensity
trajectories of a DinB-YPet binding event at replisomes. (G), Determining components of autocorrelation
functions. The mean autocorrelation function is plotted in black. The autocorrelation function has shortlived components which consist of noise, short-lived and transient binding events (light grey line). Slower
components retrieved from longer-lived events are fitted with a two-exponential fit (green line) which
consist of medium and slow decorrelation events consistent with binding events. (H), Components of the
autocorrelation function are plotted in a bar graph. Long, medium and short components are indicated by
different colours: long (dark green), medium (light green), short (light grey). The error bars for long and
medium components were extracted from the fit error using the two-exponential fit. The error bar from
the short-lived components is equivalent to the standard error of the mean from the mean autocorrelation
function at lag time 0 s.

162

Supplementary Figure S3. Sensorgram showing RecA(E38K) filament assembly on ssDNA and
dsDNA in order to probe interactions with pol IV. (A) Sensorgram showing the immobilisation of
ssDNA, (dT)71, on the SA chip surface (association: dark grey phase; immobilised ssDNA: light grey
phase). (B) Following ssDNA immobilisation, buffer containing 1 μM RecA(E38K) (+ 1 mM ATPγS)
was flowed into the flow cell, at t = 0 min for 400 s. During this period, RecA(E38K) associated with
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ssDNA (blue phase), forming a RecA(E38K) filament. At 400 s, buffer containing 1 mM ATPγS was
flowed into the flow cell. RecA(E38K) dissociates from the surface (yellow phase). From 1,400 s, RU
units are constant, consistent with stabilised RecA(E38K) filaments. (C) Sensorgram showing the
immobilisation of dsDNA on the SA chip surface (association: dark grey phase; immobilised dsDNA:
light grey phase). (D) Following dsDNA immobilisation, buffer containing 1 μM RecA(E38K) (+ 0.5 mM
ATPγS) was flowed into the flow cell, at t = 0 min for 500 s. During this period, RecA(E38K) associated
with ssDNA (blue phase), forming a RecA(E38K) filament. From 500 – 3,000 s, buffer containing 0.5 or
1 mM ATPγS was flowed into the flow cell (yellow phase). From 3,000 – 7,200 s, buffer containing 1 μM
RecA(E38K) (+ 0.5 mM ATPγS) was flowed into the flow cell to allow for more RecA(E38K) to
associate with the dsDNA. (E) Sensorgram showing the association of pol IV with RecA(E38K)
structures formed on dsDNA. At t = 0 s, 0.65 uM pol IV (+ 0.5 mM ATPγS) was flowed into the flow cell
for 220 s and association of pol IV was observed (green phase). At t = 220 s, buffer containing 0.5 mM
ATPγS was flowed into the flow cell (yellow phase). (F) Sensorgram showing the association of pol IV
with dsDNA. At t = 0 s, 0.65 uM pol IV (+ 0.5 mM ATPγS) was flowed into the flow cell for 220 s and
association of pol IV was observed (green phase). At t = 220 s, buffer containing 0.5 mM ATPγS was
flowed into the flow cell (yellow phase). Lower response units are recorded than for the association of pol
IV with RecA(E38K) structures on dsDNA.
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Supplementary Figure S4. RecA(E38K) forms RecA*-like structures on circular dsDNA. (A)
RecA(E38K) readily binds to dsDNA. In six separate reactions, either RecA(E38K) or wild-type RecA
was incubated at 37 ˚C with nicked circular dsDNA (cdsDNA), ATP, and an ATP regeneration system.
(B) LexA Cleavage Assays. Reaction mixtures contained 40 mM Tris-HCl at pH 8.0, 10 mM MgCl2, 30
mM NaCl, 2 mM dithiothreitol, 3 µM circular single-stranded DNA (cssDNA) or nicked circular doublestranded DNA (cdsDNA), 3 mM ATPS, LexA, and RecA as noted. Reactions were incubated at 37˚C for
10 minutes before addition of UmuD or LexA. The reaction products were separated and visualized by
15% SDS-PAGE stained with Coomassie blue. Lane 1 contains a protein ladder while subsequent groups
of three lanes contain the same reaction mixture sampled at 0, 20, and 40 minutes. On cssDNA,
RecA(E38K) and wild-type RecA form RecA* structures. On cdsDNA however, RecA(E38K) forms
RecA*-like structures in contrast to wildtype RecA.
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In bacteria, genetic recombination is a major mechanism for DNA repair. The RecF, RecO and
RecR proteins are proposed to initiate recombination by loading the RecA recombinase onto DNA.
However, the biophysical mechanisms underlying this process remain poorly understood. Here we
used genetics and single-molecule fluorescence microscopy to investigate whether RecF and RecO
function together, or separately, in live Escherichia coli cells. We identified conditions in which
RecF and RecO functions are genetically separable. Single-molecule imaging revealed key
differences in the spatiotemporal behaviours of RecF and RecO. RecF foci frequently colocalize
with replisome markers. In response to DNA damage, colocalization increases and RecF dimerizes.
The majority of RecF foci are dependent on RecR. Conversely, RecO foci occur infrequently, rarely
colocalize with replisomes or RecF and are largely independent of RecR. In response to DNA
damage, RecO foci appeared to spatially redistribute, occupying a region close to the cell
membrane. These observations indicate that RecF and RecO have distinct functions in the DNA
damage response. The observed localization of RecF to the replisome supports the notion that RecF
helps to maintain active DNA replication in cells carrying DNA damage.

I carried out and analysed all in vivo single-molecule experiments. I was involved in
strain construction and the preparation of the manuscript and, reviewer responses.
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6.1

Introduction
DNA damage and nucleotide depletion impede DNA replication and occasionally cause

single-strand gaps to be left in the wake of the replisome. These postreplicative gaps meet one of several
fates: 1. Gap filling by polymerases (1) 2. Homology directed repair synthesis involving template
switching (2–5) or 3. Conversion to potentially lethal double strand breaks that may be resolved by DNA
recombination (4,6). In bacteria, the majority of postreplicative gaps are thought to be resolved by
recombinational DNA repair via the RecFOR pathway (7,8).
The RecFOR pathway is mediated by the recombination mediator proteins - RecF, RecO and
RecR. Their proposed function is to facilitate the loading of RecA onto single stranded DNA (ssDNA) by
displacing the single-stranded DNA binding protein SSB (9–12). The recF, recO and recR genes form a
putative epistasis group (5,13–21). This grouping is supported by several findings: 1. an identical level of
increased sensitivity to UV irradiation when one of these functions is absent (22) 2. almost identical
deficiencies in DNA repair and recombination (23) 3. the joint suppression of mutant alleles of all three
genes by certain mutations in the recA gene (14,24); and 4. the existence of a gene in bacteriophage λ that
eliminates the requirement for all three genes in λ recombination (17,18). These observations have helped
to perpetuate a misconception that the RecFOR pathway features a RecFOR complex (7,25). However,
despite extensive examination, evidence for a RecFOR complex – even one formed transiently – is
lacking.
The cohesiveness of a putative recFOR epistasis group begins to fray further upon closer
examination of in vivo observations. First, many bacterial species lack a gene for RecF, but virtually all
bacteria appear to have genes encoding RecR and one of two variants of RecO (25,26). Second, there are
clear instances where the phenotype of a mutation in one of the recFOR genes diverges from the others
(27–32). In B. subtilis, RecF protein recruitment to repair foci is preceded by the appearance of RecO
protein by several minutes (33). RecF is not essential, although its absence leads to a delayed increase in
RecA foci formation when DNA is damaged (34).
The RecO and RecR proteins function together and are both necessary and sufficient for the
nucleation of RecA on SSB-coated ssDNA in vitro (11,35). Further, RecO and RecR are essential for the
formation of RecA foci in vivo (34). The RecO protein contains an oligonucleotide-binding fold (OBfold) in its N-terminal domain and binds both ssDNA and dsDNA (36,37). In a RecA independent
manner, RecO catalyses the annealing of complementary oligonucleotides and can also catalyse invasion
of duplex DNA by a complementary ssDNA (37,38). The RecR protein has no known intrinsic enzymatic
activities and exhibits poor functional conservation across bacteria. EcRecR does not bind DNA, whereas
the RecR homologs in Deinococcus radiodurans and B. subtilis both bind to DNA (39,40). In E. coli,
there is an apparent competition between RecF and RecO for RecR binding that may involve an
interaction of both RecF and RecO with the C-terminal TOPRIM domain of RecR (41,42). RecR
increases the apparent affinity of both RecO and RecF for DNA (11,43,44). Stimulation of RecA loading
onto SSB-bound ssDNA does not occur in the presence of either RecO or RecR protein alone; it requires
the formation of the RecOR complex (7,11,35). The RecOR-facilitated nucleation of RecA filaments onto
SSB-coated ssDNA (RecAOR nucleation) is limited by access of RecOR to ssDNA, and requires an
interaction of RecO with the C-terminus of SSB (45). The EcRecR protein also forms a complex with
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RecF in vitro (11,43,44). As in the case of RecO, RecR increases the apparent affinity of RecF for DNA
(11,43,44).
RecF is an SMC-like protein, exhibiting structural similarity with the head domain of the
eukaryotic Rad50 protein, as well as sequence similarity to the head domains of the eukaryotic SMC
proteins (46). However, RecF lacks the long coiled-coil domains of Rad50. RecF belongs to the ATPbinding cassette (ABC) ATPase family of proteins, and it has the Walker A, Walker B, and signature
motifs characteristic of that family. ATP binding triggers RecF dimerization (46). The RecF protein
(functioning in complex with RecR) cannot serve as a RecA loader (44). In vitro, RecFR binds randomly
to dsDNA and can act as a barrier to RecA filament extension (44). RecF can also facilitate RecA
filament extension on ssDNA by antagonizing the activity of the RecX inhibitor (47). Addition of RecF
protein has a neutral or inhibitory effect on RecOR function (11,35,41,45,47), consistent with competition
between RecF and RecO for RecR binding that may involve an interaction with the C-terminal TOPRIM
domain of RecR (41,42). A RecF enhancement to RecOR-mediated loading has been observed when SSB
is present in large excess (7). RecF can also have a positive effect on RecOR-mediated RecA loading
when the interaction between RecO and SSB is abolished by utilizing an SSB mutant lacking the RecO
interaction site in the SSB C-terminal tail (8). However, the latter two situations are unlikely to be
physiologically relevant and the RecFR complex may well possess a function distinct from RecOR.
Given the complex and overlapping phenotypes, we set out to document the spatial and temporal
behaviours of fluorescently tagged RecF and RecO proteins in live E. coli cells in response to DNA
damage. RecR fusions caused a complete loss of RecR function and were not further perused. Our
observations provide insights into the intracellular localizations of RecF and RecO and reveal that the two
proteins rarely interact with each other in cells during the DNA damage response.

6.2

Materials and Methods

6.2.1 Strain construction
EAW670 is E. coli K-12 MG1655 recF-YPet. The 3′ end of the recF gene includes the promotor
sequence for the gyrB gene downstream. We thus preserved the last 129 bp of recF and inserted an
altered recF gene fused to sequences encoding YPet upstream (including mutant FRT-Kanamycin
resistance-wt FRT cassette) using λRED recombineering. Positive colonies were selected for kanamycin
resistance. The fusion gene recF-YPet encodes RecF, a C-terminal twelve amino acid spacer, followed by
YPet. We similarly constructed EAW779, E. coli K-12 MG1655 recF-mKate2.
EAW814 is E. coli K-12 MG1655 recO-YPet. This construct was also made by λRED
recombineering and contains a 3′ end duplication of recO gene (last 124 bp). This gene duplication is
downstream of an altered recO gene fused to sequences encoding YPet (including mutant FRTKanamycin resistance-wt FRT cassette). EAW672 (E.coli K-12 MG1655 recO-mKate2) was constructed
similarly.
EAW673 is E. coli K-12 MG1655 recR-mKate2(SL). The fusion gene recR-mKate2(SL) encodes
RecR, a C-terminal eleven amino acid spacer, followed by mKate2 (including mutant FRT-Kanamycin
resistance-wt FRT cassette). This construct was also made by λRED recombineering and contains a 3′ end

173

duplication of recR gene (last 247 bp). EAW897 (E. coli K-12 MG1655 recR-mKate2(LL)) and EAW898
(E. coli K-12 MG1655 recR-YPet(LL)) were constructed similarly except that they contain a twenty amino
acid spacers.
EAW642 is E. coli K-12 MG1655 dnaX-mKate2. The fusion gene dnaX-mKate2 encodes DnaX,
a C-terminal eleven amino acid spacer, followed by mKate2 (including mutant FRT-Kanamycin
resistance-wt FRT cassette).
EAW676 (recF-YPet recO-mKate2) is a two-colour strain derived from EAW672 (recOmKate2). The kanamycin resistance marker in EAW672 was removed via FLP-FRT recombination using
the plasmid pLH29 (48) to obtain kanamycin sensitive EAW672. EAW676 was then constructed by
replacing the recF gene of EAW672 with recF-YPet, a FRT-Kanamycin resistance-wt FRT cassette and
the 3’ end duplication of recF using λRED recombineering. Colonies were selected for kanamycin
resistance.
EAW762 (recO-mKate2 dnaX-YPet) is derived from the kanamycin sensitive parent strain
EAW672 (recO-mKate2). To construct EAW762, λRED recombination was used to replace the dnaX gene
of EAW672 with dnaX-YPet and a mutant FRT-kanamycin resistance-wt FRT cassette. Colonies were
selected for kanamycin resistance. CJH0015 (recF-mKate2 dnaX-YPet) was constructed just as EAW762;
the kanamycin sensitive EAW670 was infected with the P1 phage grown on JJC5945 (dnaX-YPet). We
selected colonies for kanamycin resistance.
Deletion strains were constructed using λRED recombination, pKD46 was used for the λRED
recombinase production and then removed from the strains (49). We created the following strains:
EAW629 (recF), EAW114 (recO) and EAW669 (recR). EAW788 was constructed using λRED
recombination. We used pBLW24 (43) as a template to fuse the region encoding for recF(K36R) to the
RT-Kanamycin resistance-wt FRT cassette. In all cases, deletion mutants and the recF(K36R) mutant
maintain 3′ portions of each gene in order to preserve promoter sequences for genes downstream.
Colonies were selected for kanamycin resistance. EAW214 (araBAD) and HH020 (recA) were used in
previous studies (50,51).
Using λRED recombineering, we deleted recF, recR and recA in kanamycin sensitive EAW670
(recF-YPet). We produced EAW824 (recF-YPet recO), SSH068 (recF-YPet recR) and SSH070 (recFYPet recA). By analogy, deletion strains expressing RecO-mKate2 were constructed: EAW822 (recOmKate2 recF), EAW697 (recO-mKate2 recR) and SSH067 (recO-mKate2 recA). We selected for
kanamycin resistance.
To investigate the dependency of RecF on RecO, we created the two-colour strain EAW828
(recO-mKate2 dnaX-YPet recF). The kanamycin sensitive parent strain EAW762 was transduced with a
P1 phage lysate grown on EAW629. Colonies were selected for kanamycin resistance. EAW826 (recFmKate2 dnaX-YPet recO) was constructed in a similar manner, transducing CJH0015 with a P1 phage
lysate grown on EAW114.
We further constructed a pair of two-colour strains (SSH114: recF-mKate2 dnaX-YPet
dnaB8[Ts], SSH115: recO-mKate2 dnaX-YPet dnaB8[Ts]) that have a temperature-sensitive dnaB allele
(52,53). The dnaB8 allele encodes DnaB A130V (53). These strains were used to monitor the behaviours
of RecF, DnaX, and RecO under conditions where DNA replication is blocked (by shifting to the non-
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permissive temperature, 42°C) soon after inducing UV damage. SSH114 constructed by transducing the
parent strain, CJH0015 (recF-mKate2 dnaX-YPet dnaB+), with a P1 phage lysate grown on WX31.
Similarly, SSH115 was made by transducing EAW762 (recO-mKate2 dnaX-YPet dnaB+) with a P1 phage
lysate grown on WX31. We also transduced the dnaB8(Ts) allele into MG1655 to produce HG362.
HG362 was used to confirm the temperature sensitivity of all constructs in the MG1655 background
(Supplementary Figure S14).
The two strains expressing either the fluorescent protein mKate2 (HG012) or YPet (HG013)
were used to investigate if the fluorescent proteins themselves form foci after UV irradiation
(Supplementary Figure S16). These two strains were produced by transforming either pBAD-LinkermKate2 (for HG012) or pBAD-Linker-YPet (for HG013) into E. coli K-12 MG1655. The construction of
these fluorescent proteins fused to a linker was previously published (54).
All constructs were confirmed by PCR and sequencing as required.
Table 6.1. Strains used in this study.
Strain

Relevant Genotype

MG1655
EAW629
EAW114
EAW669
EAW20
EAW788
HH020
EAW670
EAW779
EAW814
EAW672
EAW676

recF+ recO+ dnaX+
recF::kan
recO::kan
recR::kan
recA::kan
recF(K36R)::kan
recA::kan
recF-YPet::kan
recF-mKate2::kan
recO-YPet::kan
recO-mKate2::kan
recF-YPet::FRT recO-mKate2::kan

Parent
strain
MG1655
MG1655
MG1655
MG1655
EAW629
MG1655
EAW629
EAW629
EAW114
EAW114
EAW672

EAW824

recF-YPet::FRT recO::kan

EAW114

SSH068

recF-YPet::FRT recR::kan

EAW670

SSH070

recF-YPet::kan recA::kan

EAW670

EAW822

recO-mKate2::FRT recF::kan

EAW629

EAW697

recO-mKate2::FRT recR::kan

EAW672

SSH067

recO-mKate2::FRT recA::kan

EAW672

JJC5945
CJH0015

dnaX-YPet::kan
recF-mKate2::FRT dnaX-YPet::kan

MG1655
EAW672

EAW762

recO-mKate2::FRT dnaX-YPet::kan

EAW672

EAW826

recF-mKate2::FRT dnaX-YPet::FRT
recO::kan
recO-mKate2::FRT dnaX-YPet::FRT
recF::kan
recR-mKate2::kan (Short Linker, 11
a.a.)
recR-mKate2::kan (Long Linker,20

CJH0015

EAW828
EAW673
EAW897
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Source/technique

EAW669

(55)
Lambda Red recombination
Lambda Red recombination
Lambda Red recombination
Lambda Red recombination
Lambda Red recombination
(50)
Lambda Red recombination
Lambda Red recombination
Lambda Red recombination
Lambda Red recombination
Transduction of EAW672 with P1
grown on EAW670
Transduction of EAW114 with P1
grown on EAW670
Transduction of EAW672 with P1
grown on EAW669
Transduction of EAW672 with P1
grown on HH020
Transduction of EAW629 with P1
grown on EAW672
Transduction of EAW672 with P1
grown on EAW669
Transduction of EAW672 with P1
grown on HH020
from Bénédicte Michel
Transduction of EAW672 with P1
grown on JJC5945
Transduction of EAW672 with P1
grown on JJC5945
Transduction of CJH0015 with P1
grown on EAW669
Transduction of EAW672 with P1
grown on EAW629
Lambda Red recombination

EAW669

Lambda Red recombination

EAW762

EAW898
EAW642
EAW214
CJH0004

a.a.)
recR-YPet::kan (Long Linker,20 a.a.)
dnaX-mKate2::kan
araBAD
dnaX-YPet::FRT araBAD::kan

EAW669
MG1655
MG1655
JJC5945

CJH0014

recF-mKate2::FRT araBAD::kan

EAW779

CJH0010

recF-YPet::FRT araBAD::kan

EAW670

UB2

recO-mKate2::FRT araBAD::kan

EAW672

CJH0072

recO-YPet::FRT araBAD::kan

EAW814

EAW1116

EAW676

HG012

recF-YPet::FRT recO-mKate2::FRT
araBAD::kan
dnaB8(Ts)::kan
recF-mKate2::FRT dnaX-YPet::FRT
dnaB8(Ts)::kan
recO-mKate2::FRT dnaX-YPet::FRT
dnaB8(Ts)::kan
Linker-mKate2 (plasmid)

HG013

Linker-YPet (plasmid)

MG1655

HG362

dnaB8(Ts)::kan

MG1655

WX31
SSH114
SSH115

AB1157
CJH0015
EAW762
MG1655

Lambda Red recombination
Lambda Red recombination
(51)
Transduction of JJC5945 with P1 grown
on EAW214
Transduction of EAW779 with P1
grown on EAW214
Transduction of EAW770 with P1
grown on EAW214
Transduction of EAW672 with P1
grown on EAW214
Transduction of EAW814 with P1
grown on EAW214
Transduction of EAW676 with P1
grown on EAW214
(52)
Transduction of CJH0015 with P1
grown on WX31
Transduction of EAW762 with P1
grown on WX31
Transformation of MG1655 with pBADLinker-mKate2 (54)
Transformation of MG1655 with pBADLinker-YPet (54)
Transduction of MG1655 with P1 grown
on WX31

6.2.2 Growth curves
Wild-type cells, deletion mutants and protein fusion constructs were grown in LB at 37ºC in a
microplate reader at a medium shaking rate (Biotek model Synergy2). Growth was monitored by
measuring the optical density at a wavelength of 600 nm (OD600) over 10h. For each strain, a biological
quadruplet was recorded. To determine the growth of each strain, the average OD600 of the quadruplets
and the corresponding standard deviation were plotted over time.

6.2.3 Fitness of fusion strain constructs
Cell fitness was determined for each fusion strain using a modified growth competition assays
described by Lenski et al. (56). In general, this two-colour colony assay is based on the colour difference
of Ara+ and Ara- colonies on tetrazolium arabinose indicator plates (TA plates). Ara– colonies typically
are red coloured, while Ara+ colonies are white. Ara+ and Ara– cells can be counted and thus fitness in a
mixed population of two strains can be assessed. Using this two-colour colony assay, the fitness of each
fusion protein construct was measured in comparison to the parental strain that has the native gene instead
of the fusion construct.
In preparation for the assay, individual overnight cultures of Ara– and Ara+ cells were grown in 3
mL LB at 37ºC. The next day, a mixed culture of Ara– and Ara+ cells was set up at a 1:1 ratio by volume.
To start the experiment, 3 mL of medium was inoculated with 30 L of the mixed culture and grown at
37ºC. Fitness was assessed over the period of 72 h; cells were serial diluted in PBS at 0, 24, 48 and 72 h.
The dilutions were spread on plates containing TA plates and incubated at 37ºC for 16h before counting.
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We performed this assay competing Ara+ cells of each fusion protein construct with Ara– cells of the
corresponding parental strain and vice versa. We carried out triplicate measurements for each
combination to determine the red and white percentage of the total population.

6.2.4 UV survival assay
Cells were grown in LB overnight at 37ºC. The next day, a 1/100 dilution of each culture was
grown in LB medium (at 37ºC, 150 rpm) until reaching mid-log phase (OD600 = 0.2). Cell cultures were
then serial diluted in PBS by factors of ten down to 10-5 and 10 L of each dilution was spotted in
duplicates onto two LB plates. One of the plates was exposed to 60 J/m2 UV light using a cross linker
(Spectrolinker model XL1000 UV). The other was used as a no-exposure control. Unexposed and
exposed plates were incubated at 37ºC in the dark for 16h. Images of plates were acquired with LAS4000
imager in digitalization mode (GE healthcare).

6.2.5 SOS induction using mytomycin C
To investigate the levels of SOS induction in each fusion strain, we performed the βgalactosidase assay (Miller assay (57)) using a plasmid that expresses β-galactosidase from the SOSinducible promoter for the recN gene (pEAW362)(58). Cells were grown in LBAmp media (100 g/mL
ampicillin) overnight at 37ºC and 150 rpm. The next day, a 1/100 dilution of the overnight cultures (total
volume = 10 mL) was grown in LBAmp medium (at 37ºC, 150 rpm) until reaching an OD600 of 0.2-0.4.
Two aliquots of 3mL culture were taken. Mitomycin C was added to one 3mL culture (to 0.2 g/ml) and
the other 3 mL culture was used as a control. The MMC-treated and untreated cells were grown for 2h,
then 1 mL of each culture was centrifuged and the pellet resuspended in Z buffer (0.06M sodium
phosphate dibasic heptahydrate, 0.04M sodium phosphate monobasic, 0.01M potassium chloride, 0.001M
magnesium sulfate, pH 7.0). Levels of SOS induction were determined by β-galactosidase assay (Miller)
and were expressed as fold induction. Fold induction was determined by dividing the β-galactosidase
activity of cells exposed to mitomycin C by the activity of the untreated cells.

6.2.6 DNA damaging agent sensitivity assay
Cells were grown in LB overnight at 37ºC. The next day, a 1/100 dilution of each culture was
grown in LB medium (at 37ºC, 150 rpm) until reaching mid log phase (OD600 = 0.2). Cell cultures were
then serially diluted in PBS by factors of ten down to 10-5. Serial dilutions were spotted (spot volume 10
L) on fresh LB plates and LB plates containing DNA damaging agent (which were protected from light).
DNA damaging agents were added at the following concentrations: 5 M NFZ, 3 g/mL MMC, 0.3 M
bleomycin, 0.1 g/mL trimethoprim, 7.5 ng/mL ciprofloxacin or 5 mM hydroxyurea. Plates were
incubated at 37ºC for 16h in the dark. Images of plates are acquired with LAS4000 imager in
digitalization mode (GE healthcare).
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6.2.7 Temperature sensitivity assay
Cells were grown in LB overnight at 37ºC. The next day, a 1/100 dilution of each culture was
grown in LB medium (at 37ºC, 150 rpm) until reaching mid log phase (OD600 = 0.2). Cell cultures were
then serially diluted in PBS by factors of ten down to 10-5. Serial dilutions were spotted (spot volume
10 L) on fresh LB plates. Plates were incubated at either 37ºC or 42ºC for 16h in the dark.

6.2.8 SOS induction using DNA damaging agents
To compare the levels of SOS induction in deletion mutants with wild-type cells, we used cells
that carry a vector for GFP expression from the SOS-inducible promoter of recN (pEAW903). Cells
carrying the empty vector pET21A were used as a control. Cultures were grown in LB Amp medium at
37ºC while shaking at 150 rpm until reaching mid log phase (OD600 = 0.2). For each strain, 200 L of
cultures were transferred into a 96 well microplate (Corning model black plate Costar). One culture was
left untreated; the other culture was incubated with 0.5 g/mL mitomycin C, 10 M nitrofurazone, 0.4
M bleomycin, 15 g/mL trimethoprim, 10 ng/mL ciprofloxacin, or 200 mM hydroxyurea. The 96 well
microplate containing the untreated and treated cells was kept at 37ºC for 10h while medium shaking
using a microplate reader (Biotek model Synergy2). The optical density (absorbance at 600 nm) and the
fluorescence intensity (excitation 485 nm – emission 510 nm) were measured every 10min. Cells carrying
the empty vector and also untreated cells were expected to emit a low intensity fluorescence signal. Cells
treated with DNA damaging agents that were carrying the SOS reporter plasmid were expected to emit a
high intensity fluorescence signal due to the expression of GFP. For each strain and condition (treated or
untreated), the expression level of the PrecN-GFP was calculated at each time point as followed. We
divided the fluorescence signal gained from cells carrying the SOS reporter plasmid by their optical
density and subtracted the fluorescence signal gained from cells carrying the empty vector by their optical
density. We recorded triplicates for each condition. From these triplicates, two plots were generated. The
average level of SOS induction and standard deviation were calculated and plotted as a function of time.
The global SOS response over 10h was illustrated as violin plots with identical max width using R
software. Data are compiled from triplicate measurements. The median value is represented with a black
dot along the vertical axis of each violin plot.

6.2.9 Fluorescence microscopy
For all microscopy data except for those comparing dnaB alleles and some controls
(Supplementary Figure S13, S15-S17), wide-field fluorescence imaging was conducted on an inverted
microscope (IX-81, Olympus with a 1.49 NA 100x objective) in an epifluorescence configuration.
Continuous excitation is provided using semidiode lasers (Sapphire LP, Coherent) of the wavelength
514 nm (150 mW max. output) and 568 nm (200 mW max. output). RecF-mKate2 and RecO-mKate2
(CJH0015, EAW672, EAW676, EAW697, EAW762, EAW822, EAW826, EAW828, SSH067) were
imaged using yellow excitation light (λ = 568 nm) at high intensity (2750 Wcm-2 at EM gain 300),
collecting emitted light between 610–680 nm (ET 645/75m filter, Chroma) on a 512 × 512 pixel EMCCD camera (C9100-13, Hamamatsu). For RecF-YPet, RecO-YPet and DnaX-YPet imaging, we used

178

green excitation (λ = 514 nm) at either lower (16 Wcm-2 at EM gain 300) or higher laser power (160
Wcm-2 at EM gain 300) for RecF-YPet and RecO-YPet strains (EAW670, EAW676, EAW814, EAW824,
SSH068, SSH070) and 60 Wcm-2 for the DnaX-YPet strains (CJH0015, EAW762, EAW826, EAW828),
collecting light emitted between 525–555 nm (ET540/30m filter, Chroma).
For the comparison of dnaB alleles, data were recorded on a Nikon Ti2-E microscope with a
heated stage insert. Continuous excitation was provided by the same setup as described above. In all
experiments including a temperature shift from 30⁰C to 42⁰C, RecF-mKate2 and RecOmKate2(CJH0015, EAW762, SSH114, SSH115) were also imaged using yellow excitation light (λ = 568
nm) at high intensity (2750 Wcm-2 at EM gain 100), collecting emitted light between 610–680 nm,
(ET654/75m filter, Chroma) on a 512 × 512 pixel EM-CCD camera (C9100-13, Hamamatsu). DnaX-YPet
(CJH0015, EAW762, SSH114, SSH115) was imaged using green excitation (λ = 514 nm) at lower
(60 Wcm-2 at EM gain 255), collecting light emitted between 525–555 nm (ET540/30m filter mounted in
Nikon Ti2 Filter Cubes, Chroma).
Burst acquisitions (movies of 300 × 34ms frames, continuous excitation with 514 nm light) were
collected to characterise the motions of RecF-YPet and RecO-YPet molecules, and to determine the
number of RecF-YPet and RecO-YPet molecules per cell. Single-colour time-lapse movies were recorded
to visualise RecF-YPet or RecO-mKate2 binding to DNA (EAW670, EAW672, EAW697, EAW779,
EAW814, EAW822, EAW824, SSH067, SSH068, SSH070). A set of two-images was recorded at an
interval of 10min for 3h, UV irradiating just after the first image was taken (bright-field [34ms exposure],
YPet fluorescence [100ms exposure] or bright-field [34ms exposure], mKate2 fluorescence [100ms
exposure]). Two-colour time-lapse movies were recorded to visualise if RecF-YPet and RecO-mKate2
(EAW676) bind to DNA as a complex. Sets of three images were recorded (bright-field [34ms exposure],
mKate2 fluorescence [100ms exposure], YPet fluorescence [100ms exposure]) at an interval of 10min for
3h. To measure colocalization between RecF-mKate2 or RecO-mKate2 with the replisome marker
(CJH0015, EAW762, EAW826, EAW828, SSH114, SSH115), we recorded time-lapse movies at the same
intervals but different exposures for the replisome marker (bright-field [34ms exposure], mKate2
fluorescence [100ms exposure], YPet fluorescence [500ms exposure]). All images were analysed with
ImageJ (59).

6.2.10 Flow cell designs
All imaging experiments were carried out in home-built quartz-based flow cells (62). These flow
cells were assembled from a no. 1.5 coverslip (Marienfeld, REF 0102222), a quartz top piece (45x20x1
mm) and PE-60 tubing (Instech Laboratories, Inc.). Prior to flow-cell assembly, coverslips were silanised
with aminopropyltriethoxy silane (Alfa Aeser). First, coverslips were sonicated for 30min in a 5M KOH
solution to clean and activate the surface. The cleaned coverslips were rinsed thoroughly with MilliQ
water and then treated with a 5% (v/v) solution of amino-propyl-triethoxysilane (APTES) in MilliQ water.
The coverslips were subsequently rinsed with ethanol and sonicated in ethanol for 20 seconds.
Afterwards, the coverslips were rinsed with MilliQ water and dried in a jet of N2. Silanised slides were
stored under vacuum prior to use.
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To assemble each flow cell, polyethylene tubing (BTPE-60, Instech Laboratories, Inc.) was
glued (BONDiT B-482, Reltek LLC) into two holes that were drilled into a quartz piece. After the glue
solidified overnight, double-sided adhesive tape was stuck on two opposite sides of the quartz piece to
create a channel. Then, the quartz piece was stuck to an APTES-treated coverslip. The edges were sealed
with epoxy glue (5 Minute Epoxy, PARFIX). Each flow cell was stored in a desiccator under mild
vacuum while the glue dried. Typical channel dimensions were 45 mm × 5 mm × 0.1 mm (length × width
× height).

6.2.11 Imaging in flow cells
For imaging experiments in a dnaB+ background, cells were grown at 37⁰C in EZ rich defined
medium (Teknova) that contained 0.2% (w/v) glucose (62). All strains that have a kanR cassette were
grown in the presence of kanamycin (20 μg/mL). Cells were loaded into flow cells, allowed a few
minutes to associate with the APTES surface, then loosely associated cells were removed by pulling
through fresh medium. The experiment was then initiated by irradiating cells in situ with 254 nm UV light
from a mercury lamp (UVP) at a fluence of 10 J·m-2. Throughout the experiment, medium was pulled
through the flow cell using a syringe pump, at a rate of 50 μL/min.
For imaging experiments conducted at the dnaB8(Ts) non-permissive temperature, cells were
grown at 30⁰C in EZ rich defined medium (Teknova) that contained 0.2% (w/v) glucose (62). All strains
have a kanR cassette, and thus, were grown in the presence of kanamycin (20 μg/mL). Cells were loaded
into flow cells as described above, at 30⁰C. Following acquisition of data at the first time point (t = 0
min), the temperature was rapidly ramped up to 42⁰C. After 3 min, the stage reached a temperature of 3941⁰C. Following this, cells were irradiated in situ with a brief pulse of 254 nm light (10 J·m-2) through a
quartz window in the flow cell. The temperature of the stage stabilized at 42⁰C within 5 minutes
following the first acquisition, and was maintained constant at this value for the rest of the experimental
time line. Throughout the experiment, medium was pulled through the flow cell using a syringe pump, at
a rate of 50 μL/min.

6.2.12 Analysis of cell filamentation, RecF and RecO levels and foci per cell
We selected single cells to obtain information about RecF and RecO levels upon UV irradiation
(>100 cells for every time point). MicrobeTracker 0.937 (60), a MATLAB script, was used to create cell
outlines as regions of interest (ROI). We manually curated cell outlines designated by MicrobeTracker
before UV irradiation and at intervals of 30min up to 120min after UV irradiation. By obtaining cell
outlines manually, we ensure accuracy and purely select non-overlapping, in-focus cells for analysis.
These ROI were imported in ImageJ 1.50i. The cell outlines were then used to measure mean cell
intensities, cell lengths and the number of foci per cell. Parameters describing foci (number, positions and
intensities) were obtained using a Peak Fitter plug-in, described previously (61,62).
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6.2.13 Analysis of colocalization events
It has been shown that freely moving molecules diffuse quickly (D ≈ 10 μm2/s), whereas, DNAbound molecules diffuse much slower (D ≈ 10-5 μm2/s) (63,64). The imaging conditions (34ms or 100ms
exposures) used here separate freely diffusing molecules from bound molecules due to the difference in
their diffusion behaviour; a focus represents a DNA bound molecule, diffusive molecules increase the
background signal.
Foci were classed as colocalized if their centroid positions (determined using our peak fitter tool)
fell within 2.18 px (218 nm) of each other. We determined that for RecF-mKate2–DnaX-Pet localization
the background of RecF foci expected to colocalize with replisomes purely by chance is ~4% when
imaging at 37⁰C. This was calculated by taking the area of each cell occupied by replisome foci
(including the colocalization search radius) and dividing by the total area of the cell. The value of 4%
corresponds to the mean of measurements made over >200 cells. Since the foci density of replisomes
stays fairly constant after UV irradiation, the chance colocalization of RecF-mKate2 foci with DnaXYPet is ~4%. Similarly, the chance colocalization of RecO-mKate2 with DnaX-YPet is ~4% before and
after UV irradiation. Similarly, chance colocalization is ~4% for RecF with DnaX and RecO with DnaX
in dnaB8(Ts) and dnaB+ at 30⁰C. After UV irradiation, at 42⁰C, in dnaB+, chance colocalization of RecF
with DnaX and RecO with DnaX is also ~4%. In contrast, chance colocalization of RecF with DnaX and
RecO with DnaX decreases in dnaB8(Ts) at the non-permissive temperature (42⁰C) after UV irradiation.
Chance colocalization is ~0.5% at 90min.
At 37⁰C, in dnaB+ cells, the chance colocalization of DnaX-YPet with RecF-mKate2 is similar to
chance colocalization with replisomes due to a similar foci density before and after UV irradiation
(chance colocalization ~4%, >100 cells). The chance colocalization of RecO-mKate2 with RecF-YPet is
~4% following UV irradiation. At 30⁰C, in dnaB+ and dnaB8(Ts), chance colocalization of DnaX-YPet
with RecF-mKate2 is ~2% because half the number of RecF foci per cell are detected. In dnaB+, chance
colocalization is also ~2% after UV irradiation at 42⁰C. In dnaB8(Ts), chance colocalization however
drops after UV irradiation at the non-permissive temperature as the number of RecF foci per cell declines.
At 90 min, chance colocalization is ~0.5%.
In dnaB+ and dnaB8(Ts) under all conditions, there are <0.3 RecO foci per cell before UV
irradiation, thus there is close to zero chance that a replisome focus or RecF focus will colocalize with a
RecO focus by chance. At 30min, in dnaB+ at 37⁰C and 42⁰C, chance colocalization is expected to be
<1% and at 120min, the chance for co-localization 1%. In dnaB8(Ts), chance colocalization is close to
zero when imaging at 30⁰C as well as after UV irradiation at the non-permissive temperature because
<0.3 foci per cell are detected.

6.2.14 Analysis of RecF and RecO copy numbers per cell
The number of RecF-YPet and RecO-YPet molecules and thus the physiological concentration
of RecF and RecO are extracted from the integrated fluorescence signal under each cell outline during
time series experiments. Each cell exhibits an intensity decay which is composed of YPet bleaching,
cellular auto-fluorescence and background fluorescence (62). Exciting with a higher laser power (160
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Wcm-2), Escherichia coli MG1655 cells, expressing no YPet, exhibit auto fluorescence equivalent to ~2.5
YPet molecules which we corrected for. The background fluorescence was negligible (equivalent to < 1
YPet molecule). After correcting for auto-fluorescence, the integrated fluorescence signal under each cell
outline corresponds to the fluorescence signal of intracellular YPet molecules.
Images were corrected for the electronic offset and flattened to correct for inhomogeneity of the
excitation beam (inhomogeneity was small at a laser power of 160 Wcm-2; the brightest part at the centre
of the image was 12% more intense than at the corners). For each cell, the mean YPet signal per pixel of
the first frame from the time series experiments was extracted. The mean YPet signal multiplied by the
cell area gives the integrated YPet intensity, which was used to determine the number of YPet molecules
per cell.
The mean intensity of individual YPet molecules was determined by analysing single-molecule
return events (Supplementary Figure S5), as previously described (62). For each cell, the number of
RecF-YPet or RecO-YPet molecules was then calculated by dividing the mean YPet signal of the first
frame from the burst acquisition experiments by the mean single-molecule intensity. The cellular
concentration was calculated using the cell volume of each cell, determined during cell outline
assignation in MicrobeTracker.

6.2.15

Autocorrelation analysis and simulation of intensity versus time

trajectories
Within the rapid acquisition movies, intensity fluctuations within regions of cells corresponding
to RecF or RecO foci were monitored as a function of time. The resulting intensity versus time
trajectories contain information on the binding and dissociation behaviours of RecF and RecO,
convoluted with photobleaching effects (which cause an exponential loss of signal as a function of time)
and noise (which by definition is not correlated in time). To gain information on the binding and
dissociation behaviours of RecF and RecO we calculated the autocorrelation functions for all trajectories
recorded and determined the mean autocorrelation for each particular set of conditions. The averaged
autocorrelation function contained three major components. Fast decorrelation occurred on the time scale
of the integration time due to noise and transient binding event (s < 0.034s). The exponential decay in the
autocorrelation curve was fitted starting from lag time 0.034s (after the initial fast decorrelation) with
single and double exponential-decay functions. Two major component timescales were present in the
remainder of the autocorrelation curve (m = 0.3s for RecF-YPet and RecO-YPet, l = 1.5s for RecF-YPet
and 2.2s for recO-YPet, Supplementary Figure S4). The amplitude of each component (as, am, al)
represents the weight for each autocorrelation components. Error bars for as were derived from the
standard deviation of the error mean for each average autocorrelation function at lag time 0.034s. Error
bars for am and al were derived from the fit error.
An increase in signal intensity within foci, such as that observed upon dimerization of RecF, will
cause an increase in the signal-to-noise ratio within trajectories. When the autocorrelation curve is
determined, this will manifest as a reduction in the fast-decorrelating component. To determine what
effect a two-fold increase in focus intensity would have during autocorrelation analysis, we produced
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simulated trajectories in which complexes containing either one or two fluorescent molecules
photobleached, bound to DNA, and dissociated from DNA. Simulations were run in Matlab 2012a using
custom-written code (Appendix PDF). The simulator is comprised of three sub-routines. In the first subroutine, binding/dissociation trajectories are generated for a complex (representing RecF or RecF2 binding
to DNA). When bound, the complex produces signal (I = 1). When unbound it produces none (I = 0).
Binding and dissociation times are determined by randomly sampling user-defined distributions of kon and
koff. In the second sub-routine, similar trajectories are produced for individual molecules binding to each
complex. In the third sub-routine, photobleaching trajectories are produced for each molecule in the
simulation, by drawing randomly from a user-defined distribution of bleaching rates τbleach. The three
signals are then combined such that a molecule only produces signal when it is bound to the complex, the
complex is bound to DNA and the molecule has not yet photobleached. Poissonian noise is added to the
signal for each molecule according to a user-defined signal-to-noise parameter. Averaging is used to
appropriately reduce noise when multiple molecules are bound. The key input parameters for simulation
are: Nmol/comp, the maximum number of molecules that can bind to each complex; kon(complex), the on-rate
for complex binding to DNA; koff(complex), off-rate for complex dissociation from DNA; kon(molecule),
on-rate for molecule binding to complex; koff(molecule), off-rate for molecules dissociating from
complex; τbleach, the mean photobleaching rate for molecules. Using this code, simulations were run for
complexes that permanently contained either one or two molecules (of RecF), keeping all other
parameters constant. The autocorrelation functions for one-molecule and two-molecule trajectories were
compared.

6.3

Results

6.3.1 recF and recO mutant phenotypes diverge depending upon DNA damaging
agent
The recF and recO genes (along with recR) have been grouped to reflect the very similar
phenotypes displayed by mutants lacking the function of the encoded proteins. We set out to
systematically investigate the phenotype of mutations in these two genes, exploring a range of DNA
damaging agents with different modes of action. To generate DNA damage, we treated cell cultures
separately with nitrofurazone (NFZ), mitomycin C (MMC), bleomycin (bleo), ciprofloxacin (cipro),
hydroxyurea (HU) and trimethoprim (TMP). We did not further explore the effects of ultraviolet light
exposure, as the original observation of phenotypic equivalence with this stressor (22) has been
repeatedly reproduced in our laboratories and many others. The sensitivity of the mutant strains EAW629
(recF), EAW114 (recO), EAW669 (recR), and EAW788 (recF[K36R]) to each DNA damaging
agent was tested using a spot plate dilution assay. The mutants were compared to the wild type strain
MG1655 (wild-type), which is the genetic background into which all gene mutations were introduced.
In these trials, three patterns emerged. First, in some cases, there was no evident difference
between the recF and recO phenotype, congruent with previous reports on UV-induced damage. When
cells were challenged with NFZ or MMC, the strains carrying deletions in any of the three genes
displayed an approximately equal degree of sensitivity (Figure 1A). In the second pattern, recO
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produced results that diverged from wild-type, while recF did not. When cells were exposed to
bleomycin or trimethoprim, the strains recO and recR were approximately 10-fold more sensitive than
the wild-type cells or a strain lacking recF (Figure 1B). Third and finally, strains with a recF deletion
uniquely diverged from the wild-type phenotype in some cases. When cells were exposed to ciprofloxacin
or HU, the recF strain was more resistant (up to 2 logs for ciprofloxacin and about 1 log for HU,
depending on the concentration of stressor) (Figure 1C). We also investigated the contribution of the
RecF ATPase activity to the recF phenotype, using the RecF ATPase deficient mutant (recF[K36R]).
Interestingly, cells with the recF(K36R) mutation were more resistant to ciprofloxacin but not to HU
(Figure 1C). Altogether, the results reveal several DNA damaging conditions in which the recO and
recF mutations produce quite different phenotypes.
We set out to determine if the difference between the recF and recO phenotypes to the
different DNA damaging agents was also reflected in a difference in SOS induction. We used a plasmid
expressing GFP from the SOS-inducible promoter for the recN gene, pEAW903 (pPrecN-gfp)(65).
Deletion strains of recF and recO carrying pPrecN-gfp were grown to exponential phase and treated with
the various DNA damaging agents (NFZ, MMC, bleo, cipro, HU or TMP). We then monitored GFP
expression for 10 hours. Exposure to NFZ induced little or no PrecN-gfp expression in the wild-type cells
and moderate expression (~18 000 R.F.U.) in recF and recO cells (Figure 1D). Exposure to bleo,
cipro or TMP triggered similar SOS induction profiles for all three strains (~ 40,000 R.F.U with bleo or
cipro and ~12,000 R.F.U with TMP). Exposure to HU or MMC showed a slight reduction in PrecN-gfp
expression in recF or recO mutants relative to wild-type cells (~12 000 R.F.U vs ~20 000 R.F.U. for
HU; ~45 000 R.F.U vs ~ 58 000 R.F.U for MMC). Overall, we found differences in recF and recO
phenotypes suggesting that RecF and RecO might have distinct functions. We thus chose to further
investigate RecF and RecO behaviour on the single-molecule level in live Escherichia coli cells.

184

Figure 1. Cells lacking recF and recO present differences in sensitivity to DNA damaging agents. (A),
(B) and (C) Spot plate dilution assays of MG1655 (wild-type), EAW629 (recF), EAW114 (recO),
EAW669 (recR), EAW788 (recF[K36R]). Cells grown to exponential phase (OD600 ~0.2) were serial
diluted to the dilution 10-5. Serial dilutions were spotted on LB agar and LB agar supplemented with the
indicated DNA damaging agent. Plates were incubated overnight at 37C. Images show a representative
experiment of independent triplicates. (A) Sensitivity of cells exposed to 5 M NFZ or 3 g/mL MMC.
The sensitivities to NFZ and MMC are almost identical for recF, recO, recR and recF(K36R) strains
(recF and recF(K36R) are slightly more resistant than recO, recR to NFZ). (B) Sensitivity of cells
exposed to 0.3 M bleo or 0.10 g/mL TMP. recO, recR are ~10 times more sensitive to bleo in
comparison to wild-type, recF and recF(K36R) mutants. (C) Sensitivity of cells exposed to 7.5 ng/mL
cipro or 5 mM HU. Deletion of recF confers resistance to cipro and HU. The ATPase deficient recF
mutant (recF[K36R]) confers resistance to cipro. (D) Expression of the SOS reporter fusion PrecN-gfp
over a period of 10h in wild-type (blue), recF (green) and recO strains (red). Cells grown to
exponential phase (OD600 ~0.2) were exposed to 10 M NFZ (downwards facing triangle), 0.5 g/mL
MMC (star-shaped), 0.4 M bleo (square), 15 g/mL TMP (diamond), 10 ng/mL cip (pentagon) or 200
mM HU (upwards facing triangle). Untreated cells (grey circle) were used as a control. The expression of
PrecN-gfp per cell is expressed in relative fluorescent units (R.F.U). Upper three panels show the PrecNgfp average expression as function of time for wt (left, blue), recF (middle, green) and recO (right,
red). Error bars represent the standard deviation of biological triplicates. Lower panel, violin plot
representing the global expression of PrecN-gfp, the central dot indicates the median value.
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6.3.2

RecF and RecO have different DNA binding behaviours and respond

differently to UV irradiation
To characterise the spatiotemporal behaviour of the RecF and RecO proteins in live E. coli cells,
we constructed functional fluorescent protein fusions of the RecF and RecO proteins to the yellow
fluorescent protein (YPet) and the red fluorescent protein (mKate2) (Figure 2A, Materials and methods,
Table 1). The activity of the RecO and RecF fusion proteins, as well as the DnaX-YPet fusion used in
this work, was validated in vivo in several ways (Supplementary Figure S1). Briefly, all constructs used
in the present study harbour similar growth, fitness, UV sensitivity and SOS induction level compared to
the WT. A number of RecR fusion proteins were also constructed (Table 1). However, the fusions caused
a complete loss of RecR function upon UV exposure (Supplementary Figure S1), and further work on
them was not pursued.
The functional fusion constructs of the RecF and RecO proteins allowed us to generate a series
of two colour strains to examine RecF and RecO within the same cell, or to examine either of these
proteins in concert with the replisome. We also constructed a series of strains in which single deletions of
recO, recF, recR or recA, as appropriate, were transduced into the strains encoding various fusion
proteins and combinations of fusion proteins (Table 1). This was done to allow examination of the effects
of such deletions on fusion protein behaviour and colocalization.
To investigate the spatiotemporal regulation of RecF and RecO proteins, we imaged singlecolour strains (encoding recF-mKate2, recF-YPet, recO-mKate2 or recO-YPet) in home-built flow-cells
under continuous flow of oxygenated media throughout the experiment at 37˚C using a custom-built
single molecule fluorescence microscope (62). Cells were irradiated with a pulse of UV light (10 J/m2)
immediately after t = 0min and imaged for 3h after UV irradiation. In these experiments, we set out to
measure three properties: 1. Stoichiometry; 2. Binding lifetime and 3. Intracellular localization. We used
two different single-molecule imaging modes to extract these measurements. First, burst acquisitions
(movies of 300 x 34ms, continuous excitation) enabled us to extract information on binding lifetimes, and
perform photobleaching experiments used to measure stoichiometry. To measure changes in intracellular
localization, we performed time-lapse imaging by collecting a snapshot of the cells every 10min for three
hours after UV-irradiation. We also recorded a bright-field image at each time-point. All fluorescence
images were recorded with single-molecule sensitivity, allowing us to observe RecF and RecO fusions
binding to DNA (Figure 2B).
When recording time-lapse data in the absence of DNA damage, we observed punctate foci of
RecF-YPet, consistent with RecF-YPet molecules binding to DNA (Figure 2C). On average, cells
contained 2.2 ± 0.2 RecF-YPet foci (Figure 2D). Similarly, RecF-mKate2 cells contain 1.7 ± 0.1 foci per
cell (Supplementary Figure S2). We then investigated the binding behaviour of RecF-YPet more
closely. Using burst acquisition measurements, we observed RecF-YPet molecules binding to DNA while
others were freely diffusing (Figure 3A). We extracted fluorescence intensity trajectories from binding
events that lasted several hundreds of milliseconds (>150 trajectories) (Supplementary Figure S3).
Trajectories featured prominent bleaching steps due to the continuous exposure to excitation light, each
step representing a single YPet molecule that has bleached. The distribution of intensity steps was used to
determine the intensity equivalent to one RecF-YPet molecule (Supplementary Figure S3). Knowing the
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intensity of a single RecF-YPet molecule, we determined that RecF foci predominantly contain one
molecule per focus in undamaged cells (Figure 3C). Brighter foci could correspond to oligomers of RecF
(i.e. dimers, trimers…) or multiple RecF monomers producing overlapping foci.

Figure 2. Construction and single-molecule imaging of RecF and RecO fusion constructs. (A)
Construction of EAW670 (recF-YPet) and EAW814 (recO-YPet) as well as EAW779 (recF-mKate2) and
EAW672 (recO-mKate2). The recF or recO gene of E. coli K12 MG1655 was modified using λRED
recombineering so that RecF or RecO is expressed as a fusion with a fluorescent protein YPet or mKate2.
(B) Detection of DNA-bound molecules in single-molecule fluorescence images. Molecules of fusion
proteins that are not bound to DNA will diffuse quickly (D ≈ 10 μm2/s for a typical cytosolic protein) and
thus signals from individual molecules will blur over the entire cell in our images (34ms or 100ms
exposures). Molecules of fusion proteins that are bound to DNA, however, experience greatly reduced
motion and thus appear as punctate foci. Because of this diffusional contrast, it is possible to detect
individual molecules of RecF and RecO fusion proteins when bound to DNA. (C) Time-lapse imaging of
RecF-YPet and RecO-mKate2 in response to UV irradiation. Cells were UV irradiated in a flow cell
directly after t = 0min. Images were taken from time-lapse experiments before UV irradiation (0min) and
after UV irradiation (30min, 60min time-points). Scale bar: 5 m. (D) Histograms showing the number of
RecF-YPet and RecO-mKate2 foci per cell in response to UV irradiation. Bright-field images were used
to determine the position of cells within different fields of view. The number of foci per cell were counted
for each cell and plotted in a histogram. We plotted these histograms for the time-point before UV
irradiation (0min) and several time-points following UV irradiation (10, 30, 60 and 90min). The mean
over the number of foci per cell is depicted in each histogram for each time-point. The number of cells
that went into each histogram is indicated as n.
Intensity traces were further used to investigate the time scale on which RecF-YPet molecules
are bound to DNA (Supplementary Figure S4). To investigate the time scale of binding events, we
utilised autocorrelation analysis, a method that identifies time-dependent fluctuations in signal which are
also dependent on binding and dissociation of molecules. When applying the autocorrelation function to a
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RecF-YPet trajectory, the correlation of this trajectory with its time delayed copy is generated for various
lag times. With zero lag time, the normalized correlation of a trajectory with itself is one. After zero lag
time, RecF-YPet molecules that are statically bound would give autocorrelation values between zero and
one depending on the signal-to-noise. However, RecF-YPet molecules that are transiently associated
show zero autocorrelation. Autocorrelation analysis can thus be used to identify major components of
binding events. We generated an average over all autocorrelation functions for each condition (before and
after UV irradiation) which was then used to extract information on the overall binding behaviour (Figure
3D, Supplementary Figure S4). The averaged autocorrelation function contained three major
components reflecting multiple time-dependent processes present in the signal. The first was a fast
decorrelation occurring on the time scale of the integration time (an individual camera frame exposure,
one frame of the burst acquisition) attributable to noise as well as, transient binding events that occur
within the time resolution of imaging. This fast decorrelation component is hereafter referred to as the
short component (s < 0.034s). Fitting the averaged autocorrelation curve starting from lag time 0.034s
(after the initial fast decorrelation) with single and double exponential-decay functions indicated that
there were two major component timescales present in the remainder of the autocorrelation curve
(Supplementary Figure S4 shows two-exponential fit). In both undamaged as well as damaged cells (30
– 60min after UV), the fluorescence signal decayed according to two timescales: medium corresponding
to 0.3s (m) and long corresponding to 1.5s (l) reflecting longer-lived binding events. The amplitudes of
these decay functions in the autocorrelation function for RecF-YPet are 53% short (as), 12% medium (am)
and 35% long (al).
Our experiments also enabled us to further determine the cellular concentration of RecF-YPet.
Knowing the intensity of a single YPet molecule from our trajectories, we calculated that there were 18.1
± 0.7 molecules of RecF-YPet per cell (standard deviation STD = 5.5; n = 71 cells) (Supplementary
Figure S5), equivalent to a RecF-YPet concentration of 5.4 ± 0.2 nM (Materials and methods). From
the above measurements (18 molecules per cell, two foci, one molecule per focus), we concluded that
~11% of RecF-YPet molecules were bound to DNA at any given moment in the absence of DNA
damage.
We undertook the same measurements for EAW814 (recO-YPet) and EAW672 (recO-mKate2).
RecO foci were much less common than RecF foci. Using time-lapse measurements (100ms exposure),
we determined that only three in ten cells have a RecO-mKate2 focus (Figure 2D). Consistent with these
measurements, cells expressing a RecO-YPet fusion (EAW814) contain on average 0.4 ± 0.04 foci per
cell (Supplementary Figure S2). Burst acquisition measurements showed that most RecO-YPet
molecules are diffusive and a RecO-YPet molecule binds to DNA only occasionally (Figure 3B). These
RecO-YPet foci contain one molecule per focus (Figure 3C, Supplementary Figure S3). RecO-YPet
binding events were then analysed using autocorrelation analysis. The components of the autocorrelation
function were 75% short (as, s < 0.034s), 13% medium (am, m = 0.3s) and 12% long (al, l = 2.2s)
(Figure 3E and F, Supplementary Figure S4). We further determined that cells have 12.2 ± 0.6 RecOYPet molecules per cell (STD = 5.9; n = 98 cells), corresponding to a RecO-YPet concentration of 3.7 ±
0.2 nM (Supplementary Figure S5). With only 0.3 foci per cell and 12 RecO-YPet molecules per cell,
only ~2% of RecO molecules are DNA bound at any given moment in the absence of any cellular stress.
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Next, we investigated the behaviour of RecF and RecO fusions in cells damaged with 10Jm-2 of
UV light. Using time-lapse measurements, we observed that cells filament after acquiring UV induced
DNA damage, beginning approximately 30min after UV irradiation (Supplementary Figure S6A). We
further determined the mean pixel intensities within cell boundaries (mean cell intensity) to identify
possible changes in the concentration of RecF-YPet upon DNA damage induction. We found that the
mean cell intensity is constant during the experiment, indicating that the concentration of RecF-YPet
remains constant throughout the experiment (Supplementary Figure S6B). As cells grow into filaments,
more RecF-YPet molecules bind to DNA (Figure 2C and D), for instance, cells have approximately six
RecF-YPet foci per cell at 90min. We calculated the focus density (foci per cell area) using the time-lapse
data. Even though the number of binding sites increases for RecF-YPet, the focus density is constant
before and after UV irradiation as the number of binding sites increases proportionally with the increase
in cell length (Supplementary Figure S6C). In contrast to untreated cells however, RecF-YPet foci
contain approximately two molecules per focus starting 30min after UV irradiation (Figure 3A and C).
This suggests that RecF forms a dimer, a molecular form previously characterized (46,66–68), in response
to UV irradiation. From autocorrelation analysis, we identified that more RecF molecules seem to bind
slightly longer to DNA 30-60min after UV irradiation. The components of the autocorrelation function
are 38% short (as, s < 0.034s), 12% (am, m = 0.3s) medium and 50% long (al, l = 1.5s) (Figure 3D and
F). There are (at least) two possible explanations for the difference in RecF binding behaviour between
untreated and UV-irradiated cells. More RecF molecules may bind on the longer timescale to DNA after
UV-irradiation. Alternatively, the formation of RecF-YPet dimers observed after UV is associated with an
increase in focus intensity. This increase in intensity causes an increase in the signal-to-noise ratio for
RecF foci which then decreases the rapid (short) component of the autocorrelation curve. Analysis of
simulated data suggests that the second case is likely (Supplementary Figure S7, Materials and
methods). With RecF forming a dimer and cells exhibiting a constant focus density and mean cell
intensity, ~22% of RecF-YPet molecules are DNA bound after damage induction. This is a two-fold
increase compared to untreated cells and is driven primarily by dimerization of RecF rather than an
increase in the density of binding sites on the DNA.
As observed for cells expressing RecF fusion proteins, cells carrying RecO fusion constructs
grow into filaments upon UV irradiation (Figure 2C, Supplementary Figure S6A). The mean cell
intensity derived from the fusion proteins stays constant over time (Supplementary Figure S6B)
suggesting no change in the cellular concentration of RecO. As cells grow into filaments upon UV
irradiation, cells contain more RecO foci (Figure 2C and D, Supplementary Figure S2) while the focus
density remains constant over time (Supplementary Figure S6C). In contrast to RecF-YPet foci, RecOYPet foci consist of only one molecule per focus and thus are monomeric before and after UV damage
(Figure 3B and C). UV irradiation results in a small increase in the number of long-lived RecO foci; the
components of the autocorrelation function were 62% short (as, s < 0.034s), 20% (am, m = 0.3s) medium
and 18% long (al, l = 2.2s) (Figure 3E and F). Since the focus density and mean cell brightness are
constant and RecO foci are still monomeric after UV irradiation, ~2% of RecO-YPet molecules are DNA
bound both before and after DNA damage induction.
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Figure 3. Binding behaviour of RecF-YPet and RecO-YPet to chromosomal DNA. (A) Average
projection over time of RecF-YPet signal and representative time traces for RecF-YPet binding to DNA
(continuous illumination with 34ms exposure times over 300 frames). Average projections stem from
burst acquisition movies before UV exposure and 60min after UV exposure. The projection was made
over 10 x 34ms. Scale bar: 5 m. (B) Average projection over time of RecO-YPet signal and
representative time traces for RecO-YPet binding to DNA (continuous illumination with 34ms exposure
times over 300 frames). Average projections stem from burst acquisition movies before UV exposure and
60min after UV exposure. The projection was made over 10 x 34ms. Scale bar: 5 m. (C) Histogram
showing the number of RecF-YPet and RecO-YPet molecules per focus before UV exposure and 3060min after UV exposure. For the number of RecF-YPet molecules per focus before UV irradiation, 161
trajectories were samples. For the number of RecF-YPet molecules per focus upon UV irradiation, 285
trajectories were samples. To determine the number of RecO-YPet molecules per focus, 32 trajectories
were sampled before UV exposure and 61 trajectories after UV exposure. For further explanation see
Supplementary Figure S3. (D) Autocorrelation function obtained for RecF-YPet binding events before
and after UV exposure. For further explanation see Supplementary Figure S4. (E) Autocorrelation
function obtained for RecO-YPet binding events before and after UV exposure. For further explanation
see Supplementary Figure S4. (F) Components of the autocorrelation for RecF-YPet and RecO-YPet
binding to DNA. Components of the autocorrelation function for RecF-YPet before and after UV
exposure are long (1.5s), medium (0.3s) and short (<0.034s). For RecO-YPet, components are split in
long (2.2s), medium (0.3s) and short (<0.034s). Error bars for long and medium components are derived
from the exponential fit (Supplementary Figure S4), error bars for short events stem from the standard
error of the mean at lag time 0s.

6.3.3 RecF and RecO exhibit different spatiotemporal behaviour
We further defined the spatiotemporal behaviour of RecF and RecO in response to UV damage.
This was achieved through two-colour time-lapse imaging of EAW676 (recF-YPet recO-mKate2). Cells
were irradiated with a UV dose of 10J/m2 directly after t = 0min and imaged for a period of 3h after UV
irradiation. Images were recorded once every 10min (Figure 4A and D).
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When analysing the spatial localization of RecF in response to DNA damage, we examined
whether foci localize within the inner part of the cell or closer to the membrane (focus position along the
cellular width). We plotted histograms of the RecF foci position with respect to the short axis of the cell
(i.e. width) prior to damage induction, as well as 30min and 90min after UV irradiation (Figure 4B). The
centre spline of the cell (a line drawn down the long axis) is at 0 μm, the cell membrane is at 0.5 μm and 0.5 μm. We found that RecF foci localize predominantly within the inner part of the cell before and after
UV irradiation. The vast majority of the RecF foci were located within 0.2 μm of the cell centre. To
further characterize the spatiotemporal localization of RecF throughout the experiment, we used a tool
that yields information on the distributions of sparse fluorescence signals by averaging signals across
cross-sections of many cells (69). The resulting data are referred to as line scans and represent the average
fluorescence intensity across the short axis of the cell. Prior to analysis, we enhanced the focus intensity
and reduced the background signal using digital filters (61). High intensity areas within cells thus
represent foci and other high-spatial frequency features. Using our time-lapse data, this tool plots a 2D
contour plot showing the spatiotemporal behaviour of RecF-YPet following the SOS response (Figure
4C). The cell width is given in micrometres, whereas, the mid-cell position is at 0 μm and the dashed red
line indicates the signal of a membrane binding protein, LacY (61). High focus abundance is shown by
red coloured areas in the localization map; low focus abundance is illustrated by blue coloured areas. We
found that RecF foci are localized to the inner part of the cell before and after damage induction. This
localization behaviour has previously been found for replisome markers following UV irradiation (69).

Figure 4. Spatiotemporal behaviour of RecF-YPet and RecO-mKate2 following UV treatment. (A) Timelapse imaging of RecF-YPet in response to UV irradiation. Cells were UV irradiated in a flow cell
directly after t = 0min. Images were taken from time-lapse experiments before UV irradiation (0min) and
after UV irradiation (30min, 90min time-points). Scale bar: 5 m. (B) Histogram showing the localization
of RecF foci along the short axis of the cell. Histograms are derived from ~100 cells at each time point
(for exact numbers see Figure 2). The centre spline of the cell (a line drawn down the long axis) is at
0 m, the cell membrane is at 0.5 m and -0.5 m. (C) 2D contour plot showing the spatiotemporal
behaviour of RecF-YPet following the SOS response. The cell width is given in micrometres, the mid-cell
position is at 0 m and the dashed red line indicates the signal of a membrane binding protein, LacY.
High focus abundance and other high-spatial frequency features are shown by red coloured areas in the
localization map; low focus abundance is illustrated by blue coloured areas. (D) Time-lapse imaging of
RecO-mKate2 in response to UV irradiation. For further description see (A). Scale bar: 5 m. (E)
Histogram showing the localization of RecO foci along the short axis of the cell. For further description
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see (B). (F) 2D contour plot showing the spatiotemporal behaviour of RecO-mKate2 following the SOS
response. For further description see (C).
We also investigated the spatiotemporal behaviour of RecO. In comparison with RecF, RecO
produces a broader distribution around 0 μm prior to UV irradiation (Figure 4E). After UV irradiation,
the distribution broadened further. At 30min, more foci were localized closer to the membrane. At 90min,
most RecO foci were localized in proximity to the membrane. Two broader peaks appeared at the -0.3 μm
and 0.3 μm position, with relatively few foci found at the 0 μm position. When plotting the 2D contour
plot showing the spatiotemporal behaviour of RecO-mKate2, we observed that the distribution broadened
30-50min after damage induction, corresponding closely to the time when cells begin to grow into
filaments (Figure 4F). This reveals that RecO usually binds at positions closer to the membrane
following the SOS response, likely excluded from the nucleoid.

6.3.4 RecF and RecO foci localize differently with respect to replisome markers
Due to strong differences in the spatiotemporal behaviour of RecF and RecO, we wished to
determine if there was any indication that RecF and RecO formed a complex in vivo, as indicated by a
sharing of chromosomal binding sites. We determined the percentage of RecF foci that colocalized with
RecO foci and the percentage of RecO foci that colocalized with RecF foci following the SOS response.
For colocalization analysis, we selected foci for each of the proteins that are each labelled with a different
fluorescent protein (i.e. RecF-YPet and RecO-mKate2, Figure 5A). We defined two foci (i.e. a RecF and
a RecO focus) as colocalized if their centroid positions were within 218 nm of each other (Figure 5B and
C). This distance corresponds to the maximum colocalization distance observed between two replisome
probes, which are expected to be highly colocalized (62). To conduct colocalization analysis of RecF and
RecO, we used the two-colour time-lapse data of EAW676 (recF-YPet recO-mKate2) inducing UV
damage directly after t = 0min.
In undamaged cells, only 0.5% of RecF foci also contained a RecO focus (chance colocalization
<1%, Materials and methods) while 5% of RecO foci had a coincident RecF focus (chance
colocalization ~4%, Materials and methods) (Figure 5D). Note that the calculated frequency of chance
colocalization takes into account the fact that many cells do not have RecO foci, but most have RecF foci.
After exposure to 10 J/m2 UV, the percentage of RecF foci that are coincident with a RecO focus slightly
increased to ~2% at 40min after damage induction. The colocalization of RecO with RecF increased to
12% at 30-40min followed by a gradual drop in colocalization to 5% at 50min. Following the SOS
response, the colocalization of RecF with RecO was just above the level calculated for chance
colocalization, whereas colocalization of RecO with RecF is slightly above chance in the 10-50min time
interval. Our data clearly suggest that RecF and RecO have predominantly distinct binding sites both
before and after exposure to UV, and provide no evidence for a RecFOR complex.
We further examined if RecF and RecO localized to the replisome. We performed two-colour
time-lapse experiments and colocalization analysis by imaging CJH0015 (recF-mKate2 dnaX-YPet) and
EAW762 (recO-mKate2 dnaX-YPet) as described above (UV dose: 10 J/m2 just after t = 0min; images
were taken every 10min for 3h after UV, experiments were conducted at 37˚C).
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We observed that the colocalization of RecF with the replisome marker DnaX-YPet was quite
significant, both before and after UV irradiation (Figure 5E). Before damage induction, colocalization of
RecF with the replisome marker was 22% (chance colocalization ~4%, Materials and methods).
Similarly, 20% of replisome foci contained a RecF focus (chance colocalization ~4%, Materials and
methods). After UV irradiation, the percentage of RecF foci that contained a replisome focus peaked at
30% at 30min. This peak was followed by a gradual decline in colocalization, and at 120min after UV
irradiation only 15% of RecF foci overlapped with a replisome focus. The colocalization of replisomes
with RecF followed the same trend upon UV irradiation. At 30min, 27% of replisome foci contained a
RecF focus. At 120min, 13% of replisome foci had a RecF focus. RecF appeared to be recruited to
replisomes directly after UV exposure. In general, RecF displayed relatively high colocalization with
replisome markers, suggesting that RecF function often involves action at, or near, replisomes.

Figure 5. Colocalization measurements of RecF/RecO, RecF/replisomes and RecO/replisomes. (A)
Exemplary selection of RecF-YPet and RecO-mKate2 foci. Selection boxes indicate selected foci for
recF-YPet and RecO-mKate2. Scale bar: 3 m. (B) Diagram of area shells used for colocalization
analysis. As colocalization is a radial measurement, histograms of colocalization distances are constructed
using bins of linearly increasing area rather than distance. A colocalization radius of 218 nm was used for
all measurements since two replisome components colocalize within this colcoalisation radius. (C)
Montage of two-colour images shown in (A). RecF-YPet foci appear in green and RecO-mKate2 foci
appear in magenta. Upper panel: Colocalization percentages for RecF-YPet with RecO-mKate2 are
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determined from selected foci in the RecF-YPet channel (green circles) that colocalize to the same
position with RecO-mKate2 foci from the other channel (magenta crosses). Lower panel: The opposite is
shown to determine colcoalisation percentages of RecO-mKate2 (magenta circles) with RecF-YPet (green
crosses). Scale bar: 3 m. (D) Colocalization measurements of RecF-YPet with RecO-mKate2 in
response to 10 J/m2 UV. Merged images of RecF-YPet (green signal) and RecO-mkate2 (magenta signal)
are shown before UV irradiation and after UV irradiation (30min and 60min). Colocalization was
measured over >300 cells. The percentage of RecF-YPet foci that contain a RecO-mKate2 focus is plotted
as a green line plot over 180min at intervals of 10min. Similarly, the colocalization of RecO-mkate2 with
RecF-YPet is plotted as a magenta line plot. Scale bar: 5 m. (E) Colocalization measurements of RecFmKate2 with DnaX-YPet (replisomes) in response to 10 J/m2 UV. Merged images of RecF-mKate2
(magenta signal) and DnaX-YPet (green signal) are shown before UV irradiation and after UV irradiation
(30min and 60min). The percentage of RecF-mKate2 foci that contain a DnaX-YPet focus is plotted in
green, the percentage of DnaX-YPet that colocalize with RecF-mKate2 is depicted with a magenta line
plot (n > 300 cells). Scale bar: 5 m. (F) Colocalization measurements of RecO-mKate2 with DnaXYPet (replisomes) in response to 10 J/m2 UV. Merged images of RecO-mkate2 (magenta signal) and
DnaX-YPet (green signal) are shown before UV irradiation and after UV irradiation (30min and 60min).
Colocalization of RecF-mKate2 with DnaX-YPet is illustrated by a green line plot; colocalization of
DnaX-YPet with RecO-mKate2 is presented by a magenta line plot (n > 300 cells). Scale bar: 5 m.
In contrast to colocalization measurements between RecF and replisomes, RecO rarely bound at
sites of replisomes (Figure 5F). In undamaged cells, 10% of RecO foci colocalized with replisomes
(chance colocalization ~4%, Materials and methods); 4% of replisome foci contained a RecO focus
(chance colocalization ~1%, Materials and methods). Colocalization between RecO and replisomes
progressively decreased after UV irradiation; only 3% of RecO foci contained a replisome focus at
120min, a level below that expected by chance. Thus, the vast majority of RecO foci (97%) are spatially
distinct from replisomes. The percentage of replisomes containing a RecO molecule remained at 3-4%
throughout the experiment, constantly just above the level calculated for chance colocalization. This
suggests that RecO binding sites, and sites of action, rarely correspond with replisomes in cells.

6.3.5 RecF and RecO function independently of each other
To investigate if RecF and RecO act independently, we first determined the number of RecF foci
in recO cells and the number RecO foci in recF cells at 37˚C. A slower cell filamentation rate is
associated with a slower increase in the number of foci. In these experiments, we used cell filamentation
as a proxy for SOS induction.
In the absence of DNA damage, we found that the deletion of recO did not affect the number of
RecF foci (Figure 6A, Supplementary Figure S8). After damage induction, cells lacking recO
filamented slower than wild-type cells. A subset of cells within the population were static and did not
grow into filaments (Supplementary Figure S10). The mixed population of slowly filamenting cells and
static cells produced a broad distribution in cell length beginning about 30min after UV irradiation. We
further observed that the number of RecF-YPet foci in recO cells increased slower than in recO+ cells
(Supplementary Figure S11). This result agrees with our previous observation that the increase in cell
length is associated with an increase in number of foci (i.e. the focus density is constant, Supplementary
Figure S6).
The deletion of recF marginally lowered the number of RecO foci before UV irradiation
(Supplementary Figure S9). Cells lacking recF also filamented slower than wild-type cells upon UV
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treatment. However, we did not detect a static population that does not grow into filaments as seen for
cells lacking recO (Supplementary Figure S10). The number of RecO foci in recF increases steadily
as cells grow into filaments, remaining just slightly lower than in wild-type cells (Supplementary Figure
S12).
To determine if the activity of RecF at replisomes is independent of RecO and vice versa, we
conducted colocalization measurements for RecF and replisomes in the recO background as well as
RecO and replisomes in the recF background. Time-lapse experiments (10 J/m2 directly after 0min, at
37˚C) and colocalization measurements were conducted as described above.

Figure 6. Colocalization measurements of RecF with replisomes in recO and RecO with replisomes in
recF. (A) Histograms showing the number of RecF-YPet foci per cell in recO (green) and recO+ (blue)
under normal growth conditions. Bright-field images were used to determine the position of cells within
different fields of view. The number of foci per cell were counted for each cell and plotted in a histogram.
The mean over the number of foci per cell is given in each histogram. The number of cells included in
each histogram is also indicated as n. (B) Histograms showing the number of RecO-mKate2 foci per cell
in recF (pink) and recF+ (grey) under normal growth conditions. Bright-field images were used to
determine the position of cells within different fields of view. The number of foci per cell were counted
for each cell and plotted in a histogram. The mean over the number of foci per cell is given in each
histogram. The number of cells included in each histogram is also indicated as n. (C) Colocalization
measurements of RecF-mKate2 with DnaX-YPet (replisomes) in recO following 10 J/m2 UV. The
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percentage of RecF-mKate2 foci that contain a DnaX-YPet focus is plotted in green, the percentage of
DnaX-YPet that colocalize with RecF-mKate2 is depicted with a magenta line plot (n > 100 cells). The
colocalization of RecF-mKate2 with DnaX-YPet in recO+ (magenta scatter plot) and the colocalization of
DnaX-YPet with RecF-mKate2 in recO+ (green scatter plot) is also plotted for each time-point as in
Figure 5E. (D) Colocalization measurements of RecO-mKate2 with DnaX-YPet (replisomes) in recF
following 10 J/m2 UV. The percentage of RecO-mKate2 foci that contain a DnaX-YPet focus is plotted in
green, the percentage of DnaX-YPet that colocalize with RecO-mKate2 is depicted with a magenta line
plot (n > 100 cells). The colocalization of RecO-mKate2 with DnaX-YPet in recF+ (magenta scatter plot)
and the colocalization of DnaX-YPet with RecO-mKate2 in recF+ (green scatter plot) is also plotted for
each time-point as in Figure 5F.
Colocalization measurements of RecF with the replisome in recO cells returned higher extents
of colocalization while retaining the trend observed for wild-type cells (Figure 6C). In the absence of
damage, 35% of RecF foci were colocalized with a replisome. At 30min, colocalization peaked at 40%
followed by a slow decrease in colocalization (chance colocalization ~4%). From 90min, 14% of RecF
foci were coincident with a replisome focus. When measuring colocalization between the replisome and
RecF in recO, 16% of replisomes had a RecF focus bound before UV irradiation, which is slightly lower
than in wild-type cells (chance colocalization ~4%). After UV irradiation, colocalization marginally
increased to 18% at 30min, followed by a slight drop to 13% at 90min.
The deletion of recF only marginally changed the colocalization behaviour of RecO with
replisomes. In the absence of damage, 9% of RecO foci contained a replisome focus (Figure 6D) as seen
for wild-type cells. During the experiment, the percentage of RecO foci that contained a replisome stays
on average at ~8% which was just above chance (chance colocalization ~4%). In the recF+ background,
the small degree of RecO-replisome colocalization present in the absence of damage dropped below
chance after UV irradiation. This drop did not appear to occur in the recF background. We then
measured the colocalization of replisomes with RecO foci; 0.5% of replisomes contained a RecO focus in
the absence of damage. The colocalization percentage stayed low following the SOS response. From
60min, only 2% of replisomes contained a RecO focus (chance colocalization <1%).
Thus, independently of RecO, RecF is recruited to replisomes directly after UV irradiation while
the number of RecF foci per cell slowly increases. Similarly, the number of RecO foci per cell increases
upon UV irradiation independently of RecF. In recF+ and recF, RecO predominantly binds at sites that
are spatially distinct from replisomes, in both untreated and UV-irradiated cells.

6.3.6 RecF and RecO form foci only under conditions of active DNA replication
Recombination via the RecFOR pathway is thought to be the major mechanism for the resolution
of post-replicative ssDNA gaps in bacteria. We reasoned that if the majority of RecF and RecO foci
observed in our experiments represent proteins engaged in post-replicative gap repair, then blocking DNA
replication should reduce the number of RecF and RecO foci. To test this hypothesis, we first constructed
strains that carry a temperature sensitive dnaB allele in place of the wild-type allele (52,53): SSH114
(recF-mKate2 dnaX-YPet dnaB8[Ts]) and SSH115 (recO-mKate2 dnaX-YPet dnaB8[Ts]). Next, we
conducted two-colour time-lapse experiments in which we observed the ability of tagged RecF and RecO
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proteins to form foci in UV-irradiated cells following a rapid jump from the permissive to the nonpermissive temperature (Figure 7; Supplementary Figure S13, S14). To that end, we first collected data
at the permissive temperature at the first time point (t = 0 min, T = 30˚C). Following this acquisition, cells
were irradiated with a UV-dose of 10 J·m-2 and imaged every 10 minutes for 2 hours. In these
experiments, the stage temperature changed from 30 to 42⁰C within 5 minutes, such that the temperature
of the flow cell was maintained at 42⁰C for all time points but the first (Figure 7A). Additionally, we
repeated these experiments with cells carrying the wild-type dnaB allele.

Figure 7. Number of DnaX-YPet, RecF-mKate2 and RecO-mKate2 foci per cell in replicating cells
(dnaB+) and cells experiencing replication blocking (dnaB8[Ts]). (A) Experimental design. First image is
taken at 30˚C (0min) when no UV image is yet induced. Then, the temperature is ramped up to 42˚C. UV
damage is induced at 3-4min. 42˚C are reached at 5min and hold until the end of the experiment, at
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120min. (B) Histograms showing the number of DnaX-YPet foci per cell in dnaB+ (light grey) and
dnaB8(Ts) (green) before UV exposure, at 30˚C (0min) and after UV exposure at 42˚C (30min and
90min). Bright-field images were used to determine the position of cells within different fields of view.
The number of foci per cell were counted for each cell and plotted in a histogram. The mean over the
number of foci per cell is given in each histogram. The number of cells included in each histogram is also
indicated as n. (C) Histograms showing the number of RecF-mKate2 foci per cell in dnaB+ (light grey)
and dnaB8(Ts) (blue) before UV exposure, at 30˚C (0min) and after UV exposure at 42˚C (30min and
90min). Bright-field images were used to determine the position of cells within different fields of view.
The number of foci per cell were counted for each cell and plotted in a histogram. The mean over the
number of foci per cell is given in each histogram. The number of cells included in each histogram is also
indicated as n. (D) Histograms showing the number of RecO-mKate2 foci per cell in dnaB+ (light grey)
and dnaB8(Ts) (dark grey) before UV exposure, at 30˚C (0min) and after UV exposure at 42˚C (30min
and 90min). Bright-field images were used to determine the position of cells within different fields of
view. The number of foci per cell were counted for each cell and plotted in a histogram. The mean over
the number of foci per cell is given in each histogram. The number of cells included in each histogram is
also indicated as n.
From the time-lapse images we then measured the number of DnaX foci per cell as a proxy for
active DNA replication forks. As expected, both wild-type and temperature sensitive cells exhibited
identical number of DnaX-YPet foci (dnaB+: 2.65 ± 0.11, dnaB8(Ts): 2.29 ± 0.16) prior to UV irradiation
at the permissive temperature (Figure 7B). Following UV damage, whereas both dnaB8(Ts) and dnaB+
cells exhibited classic cell filamentation that accompanies the triggering of the SOS response
(Supplementary Figure S13). The number of DnaX foci per cell decreased in dnaB8(Ts) while the
number of DnaX foci increased in dnaB+ cells (Figure 7B, Supplementary Figure S13). At 90min after
irradiation, cells contain on average 0.80 ± 0.23 DnaX foci in the dnaB8(Ts) background and 4.19 ± 0.54
DnaX foci in the dnaB+ background. The loss of replisomes detected in the dnaB8(Ts) cells at the nonpermissive temperature is consistent with the inability of this DnaB mutant to maintain processive
replication at the non-permissive temperature.
The number of RecF and RecO foci per cell was comparable between the two dnaB backgrounds
(RecF: 0.95 ± 0.07 in dnaB+, 1.32 ± 0.09 in dnaB8[Ts]; RecO: 0.14 ± 0.04 in dnaB+, 0.24 ± 0.07 in
dnaB8[Ts], Figure 7C, D). Notably, the colocalization of RecF with replisomes was 1.5 fold higher in
dnaB8(Ts) cells (36%) compared to dnaB+ cells (24%) (Supplementary Figure S15; chance
colocalization ~4% in both cases, see Materials and methods). Strikingly, the colocalization of RecO
with replisomes increased from 5% in dnaB8(Ts) cells to 20% in dnaB8(Ts) cells (chance colocalization
~4% in both cases, see Materials and methods). The enhanced co-localization of RecF and RecO with
the replication forks may reflect the weaker helicase activity of DnaB8 compared to DnaB (53).
Irradiating with UV and increasing the temperature led to a reduction of RecF foci in dnaB8(Ts)
cells (Figure 7C, Supplementary Figure S13) mirroring the previously observed reduction in DnaX foci
(Figure 7B). By the 90 min time-point, dnaB8(Ts) cells contained on average only 0.40 ± 0.20 RecF foci
per cell, compared with 2.71 ± 0.45 foci for dnaB+ cells under the same conditions. A similar trend was
observed for RecO foci (Figure 7D). By the 90 min time-point, dnaB8(Ts) cells contained on average
only 0.26 ± 0.18 RecO foci per cell, compared with 0.6 ± 0.2 foci for dnaB+ cells under the same
conditions.
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Our data demonstrate that UV irradiation leads to an increase in DnaX, RecF and RecO foci per
cell in dnaB+ cells. Whereas RecF is often found at replisomes, most RecO molecules reside at sites away
from the replisome. Loss of replisomes is accompanied by an overall loss of RecF and RecO binding sites
in cells. These findings lead us to suggest that whereas RecF may play a role at the replisome, RecO
instead acts on substrates that are generated and left behind in the wake of the replisome - consistent with
its proposed role in post-replicative gap repair.

6.4

Discussion
The epistatic relationship of the recF, recO, and recR genes has led to the expectation that the

proteins function together, perhaps forming a complex or forming multiple complexes in a temporal order
at one location. Here, we examined this hypothesis by obtaining a high-resolution description of the
spatial and temporal organisation of RecF and RecO in cells following DNA damage. The evidence
points to several key differences in the behaviour of RecF and RecO in cells. We found that the RecF
protein spends most of its time near the centre of the nucleoid, often colocalizing with the replisome. This
is true both before and after exposure to a UV challenge. The formation of RecF foci is strikingly
dependent on DNA replication. In contrast, the RecO protein is usually found closer to the nucleoid/cell
periphery, and RecO foci are rarely coincident with replisomes. The formation of RecO foci, however, is
also dependent on DNA replication. In all of our experiments, RecF and RecO rarely colocalized with
each other. The spatial and temporal properties of RecF and RecO foci imply differences in function. A
distinction in function is also brought forward in phenotypic differences observed when cells are
challenged with a broad range of DNA damaging agents. The results indicate that, irrespective of
phenotypic similarities documented in earlier work, the RecF and RecO proteins have distinct functions in
recombinational repair.
The RecOR complex is both necessary and sufficient for facilitating the nucleation of RecA
filaments on SSB-coated ssDNA (7,11,35,45). The observation that RecO foci are usually found at some
distance from replisomes might be consistent with a role in loading RecA protein at DNA post-replicative
gaps and/or double-strand breaks spatially separated from replisomes. Additional support for a role in
post-replicative gap repair comes from the observation that DNA replication is required for the UVinduced increase in the number of RecO foci. It is interesting to note that this same region of the cell in
which RecO foci form plays host to large bundles of RecA, which are proposed to mediate double-strand
break repair (6,70,71). The RecO localizations detected in our work may reflect intermediates formed
during RecA loading during the DNA damage response. Unfortunately it is not yet possible to
simultaneously image fluorescently tagged RecO and RecA due to technical limitations; RecA is present
at 105–106 molecules per cell (72–75) and thus bleed-through from fluorescently tagged RecA floods the
RecO channel. Alternative probes for RecA may alleviate this limitation in the future.
RecF can enhance RecOR-mediated RecA loading under certain (non-physiological) conditions
in vitro (7,8), a clear role in this process in vivo has however not been demonstrated. We found no
evidence supporting these observations under physiological conditions in live cells. RecF foci did not
colocalize with RecO foci. Instead RecF frequently localized to replisomes, suggesting a potential RecF
function at or near the replisome. Indeed, RecF foci are strongly dependent on the presence of active
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replication forks. A replisome-associated role for RecF is not an entirely new concept (76). RecF and
RecR are required in vivo to recover replication after fork stalling, to prevent DNA degradation at stalled
forks, and to complete ongoing replication (76). We also detected dimerization of RecF upon UV
irradiation. RecF dimerization is required for fork recovery after UV irradiation in E. coli (67). The
present results more directly tie RecF to a possible role at the replisome and are in line with the proposal
that the effects of recF deletion on recombination may well stem from problems that arise at the
replication fork (76).
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6.5

Supplementary data

Supplementary Figure S1. Functionality assays for fusion protein constructs. (A) Growth curves of
single-colour strains carrying the protein fusions RecF-YPet, RecF-mKate2, RecO-YPet, RecO-mKate2
or DnaX-YPet, as well as two-colour strains expressing RecO-mKate2 RecF-YPet, RecF-mKate2 DnaXYPet or RecO-mKate2 DnaX-YPet. wild-type, recF and recO strains were used as controls. Cells were
grown in LB at 37C over a period of 10h. Growth curves are averaged over biological quadruplets while
error bars represent the standard deviation. No growth defects were observed. (B) Fitness of single protein
fusion constructs (RecF-YPet, RecF-mKate2, RecO-YPet, RecO-mKate2 or DnaX-YPet) and two-colour
protein fusion construct (RecO-mKate2 RecF-YPet). For each construction, two growth competition
assays were performed. First, the strain Ara+ of each protein fusion construct was compared to wild-type
Ara- (EAW214). Second, the strain Ara- of each fusion protein construct was compare to the wild-type
Ara+ (MG1655). The assay was started with 50% of each of the two strains in the population mixture. For
each of the two competing strains, the percentage cell population was determined at t = 0, 24, 48 and 72h.
Black lines represent Ara+ strains, red lines represent Ara- strains. Strains were indicated by symbol
shape (wild-type: circle, RecF-YPet: upwards facing triangle, RecF-mKate2: downwards facing triangle,
RecO-YPet: cross, RecO-mKate2: square, DnaX-YPet: diamond, RecO-mKate2 RecF-YPet: pentagone).
Fusion protein constructs exhibit similar fitness to wild-type cells. (C) UV survival assays. Cells grown in
LB to exponential phase were serial diluted and spotted on two LB plates. One plate was exposed to 60
J/m2 the other was used as a control for unexposed cells. Plates were incubated overnight at 37C. Images
show a representative experiment of independent triplicates. Strains expressing RecF-YPet, RecF-
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mKate2, RecO-YPet, RecO-mKate2, DnaX-YPet exhibit similar sensitivity to UV like wild-type. RecR
fusions and DnaX-mKate2 fusion constructs were sensitised and showed similar sensitivity to recR
upon UV exposure. (D) Bar graphs showing the fold induction of the SOS reporter fusion PrecN-lacZ
(pEAW362) in MG1655 (wild-type), EAW20 (recA), EAW629 (recF), EAW670 (recF-YPet),
EAW779 (recF-mKate2), EAW114 (recO), EAW814 (recO-YPet), EAW672 (recO-mKate2), JJC5945
(dnaX-YPet) and EAW676 (recO-mKate2 recF-YPet). Cells carrying PrecN-lacZ were grown in LBAmp at
37C until reaching exponential phase. Cultures were split; one subculture was treated with 0.25 g/mL
mitomycin C inducing the SOS reponse, the other was used as a control. After 2h of growth at 37C,
expression of PrecN-lacZ was measured by the -galactosidase assay. The SOS induction level (fold
induction) was determined by dividing the -galactosidase activity from the MMC treated culture by the
-galactosidase activity from the untreated control. The standard deviations across biological triplicates
are indicated with error bars.

Supplementary Figure S2. Single-molecule imaging of RecF-mKate2 and RecO-YPet fusion constructs.
Histograms showing the number of RecF-mKate2 and RecO-YPet foci per cell in response to UV
irradiation. Bright-field images were used to determine the position of cells within different fields of
view. The number of foci per cell were counted for each cell and plotted in a histogram. We plotted these
histograms for the time-point before UV irradiation (0min) and several time-points following UV
irradiation (10, 30, 60 and 90min). The mean over the number of foci per cell is depicted in each
histogram for each time-point. The number of cells included in each histogram is also indicated as n.
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Supplementary Figure S3. Burst acquisitions and analysis at 160 Wcm-2. (A) Experimental setup. Cells
are loaded in a flow-cell and immobilised on a positively charged aminopropyl silane glass surface. Cells
were images before UV exposure and 30-60min after UV exposure. UV exposure was conducted in flowcells. (B) Burst acquisition sequence. Movies of RecF-YPet or RecO-YPet were recorded. The movies
contain 300 frames at 34ms recorded at continuous excitation. (C) Exemplary average projection of one
RecF-YPet movie. The average projection originates from one burst acquisition movie before UV
exposure. The projection was made over 10 x 34ms. Two exemplary intensity trajectories are plotted
showing RecF-YPet binding to DNA. Scale bar: 5 m. (D) Histrogram of bleaching step intensities. The
histogram was fit with the Kernel density estimation function (orange line) to determine the bleaching
step of a single YPet molecule with x1 = 107.3, x2 = 2x1 and x3 = 3x1. The intensity of a single YPet
molecule was used to determine the number of RecF-YPet and RecO-YPet molecules per focus in Figure
3C.
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Supplementary Figure S4. Burst acquisitions and analysis at 16 Wcm-2. (A) Experimental setup. Cells are loaded in a flow-cell and immobilised on a positively charged
aminopropyl silane glass surface. Cells were images before UV exposure and 30-60min after UV exposure. UV exposure was conducted in flow-cells. (B) Burst acquisition
sequence. Movies of RecF-YPet or RecO-YPet were recorded. The movies contain 300 frames at an exposure of 34ms. (C) Exemplary average projections of one RecF-YPet
movie before UV exposure and one movie after UV exposure. The average projection was made over 10 x 34ms. One exemplary intensity trajectories is plotted showing
RecF-YPet binding to DNA before UV exposure and one trajectory that stems from a burst acquisition post UV exposure. Scale bar: 5 m. (D) Mean autocorrelation function
is obtained from single autocorrelation function. Each autocorrelation function stems from single intensity trajectories of binding events. (E) Determining components of
autocorrelation functions. The autocorrelation function is plotted in black. The autocorrelation function has fast components which consist of noise, short-lived and transient
binding events (light blue line). Slower components are fitted with a two exponential fit (dark blue line) which consist of medium and slow decorrelation events consistent
with binding events. (F) Components of the autocorrelation function are plotted in a bar graph. Slow, medium and fast components are indicated by shades of blue: slow (dark
blue), medium (blue), fast (light blue). The error bars for slow and medium components were extracted from the fit error using the two exponential fit. The error bar from the
fast components is equivalent to the standard error of the mean from the mean autocorrelation function at lag time 0s.
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Supplementary Figure S5. RecF-YPet and RecO-YPet molecules per cell. (A) Histogram of the number
of RecF-YPet molecules per cell (blue) and RecO-YPet molecules per cell (grey) under normal growth
conditions. The mean, standard error of the mean, standard deviation and number of cells (n = 71 for
RecF-YPet; n = 98 for RecO-YPet) are depicted in each histogram. (B) Histogram of the cell length for
EAW670 (recF-YPet, blue) and EAW814 (recO-YPet, grey) under normal growth conditions. The mean,
standard error of the mean, standard deviation and number of cells (n = 71 for RecF-YPet; n = 98 for
RecO-YPet) are depicted in each histogram.
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Supplementary Figure S6. Scatter plots of cell-size and fluorescence signal parameters from time-lapse
imaging of cells expressing RecF-YPet (EAW670) or RecO-mKate2 (EAW672).White points indicate
individual data-points, while blue-to-red contours indicate frequencies of observations. Blue regions
indicate regions with few data points and red regions indicate regions with a large number of data points.
Frequencies were normalised at each sampled time-point to the maximum at each time-point. (A)
Distribution of cell length over time following UV irradiation directly after t = 0min. Fusion constructs
grow into filaments at the same filamentation rate when exposed to UV light. (B) Mean pixel intensity
within cell boundaries. Changes in the mean cell intensity over time would indicate changes in the
concentration of either RecF-YPet or RecO-mKate2. After UV exposure, mean cell intensities for cells
expressing RecF-YPet or RecO-mKate2 stays constant indicating that the concentration of each protein
stays constant as cells grow into filaments. (C) Density of RecF-YPet and RecO-mKate2 foci per cell,
measured as the number of foci per cell area in m2. The foci density for RecF-YPet and RecO-mKate2
stays relatively constant in response to UV damage. The density of RecF-YPet foci has a slight dip at
30min after UV irradiation exactly when nucleoids compact and colocalisation with replisomes is
increased. The foci density of RecF-YPet foci is overall higher than the density of RecO-mKate2 foci
since cells contain more RecF-YPet foci per cell then RecO-mKate2 foci (Figure 2D).
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Supplementary Figure S7. Autocorrelation analysis of simulated rapid-acquisition data. To determine
what effect the dimerization of a protein would have on the autocorrelation analysis of rapid-acquisition
movies, simulated data were generated. Intensity versus time trajectories were generated for two types of
complexes: one containing one molecule per complex (representing RecF-YPet), and one containing two
molecules per complex (representing [RecF-YPet]2). Custom Matlab code (Appendix PDF) was used to
simulate a scenario in which each complex binds to and dissociates from DNA, while the pool of
available fluorescent proteins photobleaches. Signal is only generated when a complex is bound, the
complex contains a molecule, and the molecule has not yet photobleached, analogous to focus formation
in the experimental data. User-defined parameters are described within the code. For the displayed
simulation the parameters were set as follows: frames = 100; signal = 1; bkg = 3; max_sites_mol1 = 1;
max_sites_mol2 = 2; complexes = 1000; mol_per_complex = 10; fracunbndt0 = 0; Kon_complex =
0.00001; Koff_complex = 0.03; StoN_mol1 = 3; Tbleach_mol1 = 50; Kon_mol1 = 0.00001; Koff_mol1 =
0.00001; StoN_mol2 = 3; Tbleach_mol2 = 50; Kon_mol2 = 0.00001; Koff_mol2 = 0.00001.
Autocorrelation functions were calculated as for the experimental data (Materials and Methods).
Comparing the autocorrelation function for the simulated data (above) against that for the experimental
data (Figure 3D) it is clear that dimerization of RecF (Figure 3C) would be sufficient to explain the
increase in autocorrelation observed after UV-irradiation of cells.
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Supplementary Figure S8. Time-lapse images of RecF-YPet in wild type, recA, recR and recO. Time-lapse images are shown at 0, 30, 60, 90 and 120min after UV
irradiation. Cell outlines indicate the boundaries of single cells. In wild type cells, the number of RecF-YPet foci increases as cells filament. In a recA background, cells do
not grow into filaments and lose their RecF-YPet foci in response to UV damage. In a recR background, cells either do not grow into filaments or filament slower than wild
type cells. Cells that do not filament lose their RecF-YPet foci, whereas, cells that slowly filament have some foci. In a recO background, cells either do not grow into
filaments or filament slower than wild type cells. All recO cells contain RecF-YPet foci. Scale bar: 5 m.
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Supplementary Figure S9. Time-lapse images of RecO-mKate2 in wild type, recA, recR and recF. Time-lapse images are shown at 0, 30, 60, 90 and 120min after UV
irradiation. Cell outlines indicate the boundaries of single cells. In wild type cells, the number of RecO-mKate2 foci increases as cells filament. In a recA background, cells
do not grow into filaments and lose their RecO-mKate2 foci in response to UV damage. In a recR background, cells either do not grow into filaments or filament slower than
wild type cells. All recR cells contain RecO-mKate2 foci. In a recF background, cells either do not grow into filaments or filament slower than wild type cells. All recF
cells contain RecO-mKate2 foci. Scale bar: 5 m.
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Supplementary Figure S10. Scatter plots of cell length over time from time-lapse imaging of cells expressing RecF-YPet (EAW670) or RecO-mKate2 (EAW672) in
comparison to fusion constructs lacking recR (SSH068, EAW697), recA (SSH070, SSH067) and either recO (EAW824) or recF (EAW822). Cells were exposed to a single
UV dose directly after t = 0min. All contour plots have white points indicating individual data-points, while blue-to-red contours illustrate frequencies of observations. Blue
regions indicate regions with few data points and red regions indicate regions with a large number of data points. Frequencies were normalised at each sampled time-point to
the maximum at each time-point. (A) Fusion constructs that do have no deletion background grow into filaments at the same filamentation rate when exposed to UV light.
Same figure as Supplementary Figure S6. (B) Cells expressing RecF-YPet while lacking recO have two populations of cells post UV exposure, one does not grow while the
other slowly filaments. In contrast, cells expressing RecO-mKate2 mostly grow into filaments at a slower rate than wild type cells. (C) Cells lacking recR and expressing
either RecF-YPet or RecO-mKate2 have two populations of cells post UV exposure, one does not grow while the other slowly filaments. This behaviour is similar to cells
lacking recO (Supplementary Figure S10B). (D) Cells lacking recA and expressing either RecF-YPet or RecO-mKate2 either divide once and then do not grow or do not
grow at all post UV treatment.
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Supplementary Figure S11. Histograms of the number of RecF-YPet foci in wild type cells and cells lacking recA, recR or recO. Bright-field images were used to determine
the position of cells within different fields of view. The number of foci per cell were counted for each cell and plotted in a histogram. We plotted these histograms for the
time-point before UV irradiation (0min) and several time-points following UV irradiation (10, 30, 60 and 90min). The mean over the number of foci per cell is depicted in
each histogram for each time-point. The number of cells included in each histogram is also indicated as n. Wild-type cells contain more foci per cell as cells grow into
filaments. Cells lacking recA lose their RecF-YPet foci post UV exposure. Cells lacking recR contain less RecF-YPet foci under normal growth conditions (see
Supplementary Figure S8 for time-lapse images). Post UV, cells either lose their RecF foci or have some RecF foci. Cells lacking recO however slightly increase the
number of RecF foci until 90min after UV exposure.
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Supplementary Figure S12. Histograms of the number of RecO-mkate foci in wild type cells and cells lacking recA, recR or recF. Bright-field images were used to
determine the position of cells within different fields of view. The number of foci per cell were counted for each cell and plotted in a histogram. We plotted these histograms
for the time-point before UV irradiation (0min) and several time-points following UV irradiation (10, 30, 60 and 90min). The mean over the number of foci per cell is
depicted in each histogram for each time-point. The number of cells included in each histogram is also indicated as n. Corresponding time-lapse images are shown in
Supplementary Figure S9. Upon UV exposure, more wild type cells contain RecO-mKate2 foci while some still have zero foci. Most cells lacking recA contain no foci after
UV exposure. Cells lacking recR or recF however have more RecO foci after a single UV dose.
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Supplementary Figure S13. Experimental design and images (unfiltered and filtered) of CJH0015 (recFmKate2 dnaX-YPet dnaB+), EAW762 (recO-mKate2 dnaX-YPet dnaB+), SSH114 (recF-mKate2 dnaXYPet dnaB8(Ts)) and SSH115 (recO-mKate2 dnaX-YPet dnaB8(Ts)) at 0, 30 and 90min. (A)
Experimental design. First image is taken at 30˚C (0min) when no UV image is yet induced. Then, the
temperature is ramped up to 42˚C. UV damage is induced at 3-4min. 42˚C are reached at 5min and hold
until the end of the experiment, at 120min. (B) Images of recF-mKate2 dnaX-YPet dnaB+. Upper panel:
DnaX-YPet signal, raw images. Middle panel: RecF-mKate2 signal, raw images. Lower panel: Merged
images of RecF-mKate2 (magenta signal) and DnaX-YPet (green signal) are shown before UV
irradiation, at 30˚C, and after UV irradiation, at 42˚C (30min and 90min). Scale bar: 5 m. (C) Images of
recF-mKate2 dnaX-YPet dnaB8(Ts). Upper panel: DnaX-YPet signal, raw images. Middle panel: RecFmKate2 signal, raw images. Lower panel: Merged images of RecF-mKate2 (magenta signal) and DnaXYPet (green signal) are shown before UV irradiation, at 30˚C, and after UV irradiation, at 42˚C (30min
and 90min). Scale bar: 5 m. (D) Images of recO-mKate2 dnaX-YPet dnaB+. Upper panel: DnaX-YPet
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signal, raw images. Middle panel: RecF-mKate2 signal, raw images. Lower panel: Merged images of
RecF-mKate2 (magenta signal) and DnaX-YPet (green signal) are shown before UV irradiation, at 30˚C,
and after UV irradiation, at 42˚C (30min and 90min). Scale bar: 5 m. (E) Images of recO-mKate2 dnaXYPet dnaB8(Ts). Upper panel: DnaX-YPet signal, raw images. Middle panel: RecF-mKate2 signal, raw
images. Lower panel: Merged images of RecF-mKate2 (magenta signal) and DnaX-YPet (green signal)
are shown before UV irradiation, at 30˚C, and after UV irradiation, at 42˚C (30min and 90min). Scale bar:
5 m.
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Supplementary Figure S14. The non-permissive temperature of cells carrying the dnaB8(Ts) allele is
42C. Spot plate dilution assays of MG1655 (wild-type), HG362 (dnaB8[Ts]), CJH0015 (recF-mKate2
dnaX-YPet dnaB+), SSH114 (recF-mKate2 dnaX-YPet dnaB8[Ts]), EAW762 (recO-mKate2 dnaX-YPet
dnaB+) and SSH115 (recO-mKate2 dnaX-YPet dnaB8[Ts]). Cells grown to exponential phase (OD600
~0.2) were serial diluted to the dilution 10-5. Serial dilutions were spotted on LB agar. Plates were
incubated overnight either at 37C or 42C. Images show a representative experiment of independent
duplicates.
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Supplementary Figure S15. Experimental design and colocalisation measurements of CJH0015 (recFmKate2 dnaX-YPet dnaB+), EAW762 (recO-mKate2 dnaX-YPet dnaB+), SSH114 (recF-mKate2 dnaXYPet dnaB8(Ts)) and SSH115 (recO-mKate2 dnaX-YPet dnaB8(Ts)) at 0, 30 and 90min. Colocalisation
was measured over >300 cells. (A) Experimental design. First image is taken at 30˚C (0min) when no UV
image is yet induced. Then, the temperature is ramped up to 42˚C. UV damage is induced at 3-4min. 42˚C
are reached at 5min and hold until the end of the experiment, at 120min. (B) Colocalisation measurement
of RecF-mKate2 with DnaX-YPet in dnaB+. The percentage of RecF-mKate2 foci that contain a DnaXYPet focus is plotted as a magenta line plot over 120min at intervals of 10min. Similarly, the
colocalisation of DnaX-YPet with RecF-mKate2 is plotted as a green line plot. (C) Colocalisation
measurement of RecF-mKate2 with DnaX-YPet in dnaB8(Ts). The percentage of RecF-mKate2 foci that
contain a DnaX-YPet focus is plotted as a magenta line plot over 120min at intervals of 10min. Similarly,
the colocalisation of DnaX-YPet with RecF-mKate2 is plotted as a green line plot. (D) Colocalisation
measurement of RecO-mKate2 with DnaX-YPet in dnaB+. The percentage of RecO-mKate2 foci that
contain a DnaX-YPet focus is plotted as a magenta line plot over 120min at intervals of 10min. Similarly,
the colocalisation of DnaX-YPet with RecO-mKate2 is plotted as a green line plot. (E) Colocalisation
measurement of RecO-mKate2 with DnaX-YPet in dnaB8(Ts). The percentage of RecO-mKate2 foci that
contain a DnaX-YPet focus is plotted as a magenta line plot over 120min at intervals of 10min. Similarly,
the colocalisation of DnaX-YPet with RecO-mKate2 is plotted as a green line plot.
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Supplementary Figure S16. Colocalisation measurements of CJH0015 (recF-mKate2 dnaX-YPet dnaB+)
following ciprofloxacin treatment (30 ng/mL). Colocalisation was measured over >300 cells. The
percentage of RecF-mKate2 foci that contain a DnaX-YPet focus is plotted as a magenta line plot over
180min at intervals of 10min. Similarly, the colocalisation of DnaX-YPet with RecF-mKate2 is plotted as
a green line plot.
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Supplementary Figure S17. Time-lapse data of cells carrying a pBAD plasmid to express either YPet or mKate2. Expression is induced at low levels with 5·10-3% Larabinose. Cells were exposed to a UV dose of 10 J·m-2 directly after t = 0min. Images are shown at 0, 30, 60 and 90min. Upper panel: signal of cells expressing YPet. The
fluorescent protein YPet does not form foci after UV exposure. Bottom panel: signal of cells expressing mKate2. The fluorescent protein mKate2 does show some diffusive
signal after UV exposure, however, no foci. Scale bar: 5 m.

Supplementary Materials PDF contains the MATLAB codes used for ‘Autocorrelation analysis and simulation of intensity versus time trajectories’ (see Material and
methods).
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6.7
6.7.1

Additional data
RecF and RecO colocalise with the RecA probe mCI
In cells exposed to DNA damaging agents, the number of RecF and RecO binding sites are

increased as cells filament, as shown earlier in this chapter. RecF and RecO each have roles in loading of
the recombinase RecA. The mechanism of RecA loading is however still poorly understood. RecF has
been described to act as a catalyst for RecA loading while RecO seems to be more actively engaged in the
loading of RecA onto single-stranded DNA gaps or resected double-strand breaks.
To further investigate the roles of RecF and RecO in loading RecA, two-colour experiments
were conducted recording the signal of fluorescent fusions of either RecF or RecO and a RecA-binding
probe, mCI. The truncated bacteriophage  repressor mCI binds to RecA filaments formed on ssDNA
regions (1). Two-colour time-sampling experiments were carried out over a period of 3 h (acquisition
protocol: 1. bright-field; 100 ms exposure time; 2. PALM acquisition protocol for PAmCherry-mCI:
simultaneous illumination with the activation laser 405 [1-5 W/cm2] and 568 nm readout laser [540
W/cm2] for 200 frames, image cycle time 100 ms; 3. image of RecF-YPet or RecO-YPet signal: 50 ms
exposure time at ~2200 W/cm2). A new field-of-view was sampled at every 5 min. Cells were irradiated
with UV light (fluence =10 J/ m2), Directly after t = 0 min, cells were irradiated with 10 J/ m2.
Before UV irradiation, colocalisation of RecF and RecO with mCI is zero (Figure 8) because
mCI foci start to increasingly form subsequently after irradiation (1). After UV irradiation, the
colocalisation of RecF with mCi is increased with 27% colocalisation at 60 min (Figure 8). From 90 min,
fewer RecF foci localised in the vicinity of mCI foci with 9% at 115 min. In contrast, the colocalisation of
RecO with mCI is highly increased from 90 min (26% at 110 min, 42% at 180 min, Figure 8).

Figure 8. Colocalisation measurement of RecF with mCI (blue) and RecO with mCI (orange). Cells were
irradiated with 10 J/m2 directly after t = 0 min. Data points are an average over duplicates. Error bars
represent the standard deviation of the mean.
In conclusion, RecF foci colocalised with mCI foci from 10 – 90 min with ~10-25%
colocalisation, whereas, RecO foci predominantly overlapped with mCI foci from 90 min after UV
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exposure with ~13-42% colocalisation. These results are suggestive of two distinct phases for DNA
damage repair after UV irradiation with respect to the recombination mediator proteins RecF and RecO.
One possibility is that RecF may play a role in ssDNA gap repair, whereas, RecO might actually
participate in DSB repair. It would be of great interest to conduct similar experiments in deletion
backgrounds, such as recF, recO, recR etc., to gain further insights into the mechanism of RecA
loading.

6.7.2

Materials and Methods

Microscopy, flow cell design and data analysis
All experimental procedures (i.e. imaging in flow cell) were carried out as described in Chapter
6.2 Materials and Methods.
Strain construction
The plasmid pJM-mfd-PAmCherry-mCI was commercially synthesised (Aldevron), replacing
the uvrA promotor in pJM-uvrA-PAmCherry-mCI (Chapter 5) with the mfd promotor.
Table 2. Strains used in this sub-chapter.
Strain

Relevant Genotype

Parent strain

Source/technique

MG1655

dinB+ dnaX+ recB+ lexA+

-

published (2)

EAW670

recF-YPet::KanR

MG1655

published (3)

EAW814

recO-YPet::Kan

R

MG1655

published (3)

SSH104

recF-YPet:: KanR (chr)

EAW670

Transformation of EAW670

PAmCherry-mCI (pl, specR)

with pJM-mfd-PAmCherrymCI

SSH105

recO-YPet:: KanR (chr)

EAW814
R

PAmCherry-mCI (pl, spec )

Transformation of EAW814
with pJM-mfd-PAmCherrymCI
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pol VICE391 (RumAʹ2B) is a low-fidelity polymerase that promotes considerably higher levels of
spontaneous “SOS-induced” mutagenesis than the related E. coli pol V (UmuDʹ2C). The molecular
basis for the enhanced mutagenesis was previously unknown. Using single molecule fluorescence
microscopy to visualize pol V enzymes, we discovered that the elevated levels of mutagenesis are
likely due, in part, to prolonged binding of RumB to genomic DNA leading to its increased levels of
DNA synthesis compared to UmuC.
We have generated a steric gate pol VICE391 variant (pol VICE391_Y13A) that readily misincorporates
ribonucleotides into the E. coli genome and have used the enzyme to investigate the molecular
mechanisms of Ribonucleotide Excision Repair (RER) under conditions of increased
ribonucleotide-induced stress. To do so, we compared the extent of spontaneous mutagenesis
promoted by pol V and pol VICE391 to that of their respective steric gate variants. Levels of
mutagenesis promoted by the steric gate variants that are lower than that of the wild-type enzyme
are indicative of active RER that removes misincorporated ribonucleotides, but also
misincorporated deoxyribonucleotides from the genome.
Using such an approach, we confirmed that RNase HII plays a pivotal role in RER. In the absence
of RNase HII, Nucleotide Excision Repair (NER) proteins help remove misincorporated
ribonucleotides. However, significant RER occurs in the absence of RNase HII and NER. Most of
the RNase HII and NER-independent RER occurs on the lagging strand during genome
duplication. We suggest that this is most likely due to efficient RNase HI-dependent RER which
recognizes the polyribonucleotide tracts generated by pol VICE391_Y13A. These activities are critical
for the maintenance of genomic integrity when RNase HII is overwhelmed, or inactivated, as rnhB
or rnhB uvrA strains expressing pol VICE391_Y13A exhibit genome and plasmid instability in the
absence of RNase HI.

I carried out and analysed some in vivo single-molecule experiments. I was involved in
strain construction and the preparation of the manuscript.
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7.1

Introduction
Escherichia coli DNA polymerase V (pol V), a trimeric UmuD´2C complex (1), is a Y-family

polymerase (2) that is best characterized for its ability to promote damage-induced “SOS”-mutagenesis
(3, 4). The mutagenesis occurs during error-prone translesion synthesis (TLS) across lesions that would
otherwise block the cell’s replicase, DNA polymerase III (pol III) (5, 6). Because of its error-prone DNA
synthesis, pol V is subject to multiple levels of regulation (7). This includes LexA-regulated
transcriptional control; activated RecA*-mediated posttranslational modification; Lon- and ClpXPtargeted proteolysis; the need for additional specific protein-protein interactions; as well as spatial
regulation inside the cell. As a result, pol V activity is usually kept to a minimum, such that it is utilized
only when absolutely required.
However, in a lexA(Def) recA730 genetic background, in which the RecA730 (E38K) protein is in a
constitutively activated state (RecA*), virtually all of the regulation normally imposed on pol V activity
in a wild-type cell is circumvented, allowing error-prone pol V to replicate undamaged DNA. This leads
to a roughly 100-fold increase in so-called “SOS-dependent spontaneous mutagenesis” (8). It is believed
that this mutagenesis occurs, in part, due to the higher basal steady state levels of pol V in undamaged
recA730 strains compared to recA+ strains (~20 pol V molecules in a recA730 cell vs. one pol V molecule
in a recA+ cell (9)) that transiently compete with pol III for access to undamaged DNA (10). Studies with
lacZ reporter alleles suggest that this occurs primarily on the lagging strand during genome duplication
(11).
The intracellular levels of ribonucleotides in a cell are considerably higher (up to 1000-fold) than the
concentrations of the corresponding deoxyribonucleotides (12-14). It is now well established that the
main line of defense against errant misincorporation of ribonucleotides by DNA polymerases is a socalled “steric gate”, which usually comprises a single amino acid residue with a bulky side chain that
physically clashes with the 2´-OH of the incoming ribonucleotide to prevent its misincorporation into
DNA (15-17). Mutant DNA polymerases in which the bulky side chain of the steric gate amino acid has
been replaced with a much smaller moiety have been widely used to increase the levels of errant
ribonucleotides misincorporated into DNA and to elucidate the mechanism of their subsequent removal
during Ribonucleotide Excision Repair (RER) (18-23). Indeed, we previously utilized a steric gate pol V
mutant with a Y11A substitution in the catalytic UmuC subunit of the polymerase to investigate the
mechanisms of RER in E. coli (24, 25). In vitro studies with the pol V_Y11A mutant revealed that the
enzyme not only distinguishes poorly between ribo- and deoxyribonucleotides, but also exhibits low base
selectivity (24).

We therefore expected the pol V_Y11A mutant to promote high levels of SOS-

dependent mutagenesis in vivo. To our surprise, the level of mutagenesis was a fraction of that promoted
by wild-type pol V (24).

To explain these observations, we hypothesized that misincorporated

deoxyribonucleotides were removed by active RER triggered by the misincorporated ribonucleotides. We
further hypothesized that if all RER pathways were inactivated, pol V_Y11A-dependent mutagenesis
would be as high as (or even higher than) that promoted by wild-type pol V (26). On the basis of these
hypotheses, we discovered that RNase HII encoded by rnhB, provides the lead role in RER in E. coli,
while RNase HI (encoded by rnhA) and the Nucleotide Excision Repair proteins (encoded by uvrA, uvrB
and uvrC) provide back-up roles in the absence of RNase HII (26).
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Although E. coli pol V promotes significant levels of SOS-dependent spontaneous mutagenesis,
orthologs of pol V, such as polR1 (comprising MucAʹ2B and encoded by mucAB on R46/pKM101, and
used to increase the efficacy of mutagen detection in the “Ames-test”) (27), or pol VICE391 (comprising
RumAʹ2B and encoded by rumAB on R391/ICE391) (28, 29) are much more efficient at promoting SOSdependent spontaneous mutagenesis (30). Indeed, pol VICE391 is the most potent pol V mutator reported in
the literature to date (30).
We were therefore interested in recapitulating our earlier RER studies with the E. coli pol V_Y11A
using a steric gate mutant of pol VICE391 harboring a Y13A substitution in its catalytic RumB subunit. Our
initial studies suggest that pol VICE391 can bind to undamaged DNA more frequently, and for far longer,
than E. coli pol V. Our expectation was that the more potent pol VICE391_Y13A enzyme would potentially
increase the number of errantly misincorporated ribonucleotides into the E. coli genome and possibly
reveal additional pathways of RER. Our studies suggest that while RNase HII maintains its pivotal role
in RER, the increased load of ribonucleotides incorporated into the genome by pol VICE391_Y13A leads to
a greater dependency on RNase HI to protect E. coli from the deleterious effects of errant ribonucleotide
incorporation into its genome.

7.2

Materials and Methods

7.2.1

Bacterial Strains and Plasmids

Bacterial strains used in this study are described in Table 1. New strains were generated via
generalized transduction using P1vir (31). Where noted, the following antibiotics were used for selection;
zeocin (25 g/ml), kanamycin (50 g/ml), tetracycline (15 g/ml), chloramphenicol (20 g/ml),
ampicillin (100 g/ml) and spectinomycin (50 g/ml).
The E. coli strains used for the leading/lagging strand mutagenesis assay (see section 2.5 below) are
derivatives of RW698 (26), but carry a lacZ missense allele that allows for scoring of mutagenesis via
reversion to Lac+ by an A·T→T·A transversion (32), inserted into the phage λ attachment site in one of
the two orientations (Left and Right) with respect to the origin of replication (33). Recipient pairs of lacZ
integrants were transformed with low-copy-number plasmids expressing either wild-type pol VICE391
(pRW320), the pol VICE391_Y13A variant (pJM1282), or the control vector (pGB2), to measure
mutagenesis levels on the leading and lagging DNA strands.
Plasmids used in this study are described in Table 2. A low-copy-number plasmid, pJM1282,
expressing a Y13A steric gate variant of rumB was generated by synthesizing a BamHI to AccI fragment
(Genscript) containing the Y13A allele marked with a BssHII site into the corresponding sites of pRW320
(34). The mKate2-RumB containing plasmid, pJM1324, was constructed by sub-cloning an N-terminal
mKate2-RumB chimera (Genscript) into pRW320 from AleI to PmlI to generate pJM1324. Subsequently,
a fragment carrying the catalytically inactive D103A-E104A double mutation in rumB (Genscript) was
sub-cloned into pJM1324 from PmlI to AccI to generate pJM1347. In addition, a fragment carrying the clamp binding site mutant, Q358A-L361A-F364A in rumB (Genscript) was sub-cloned into pJM1324
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from MscI to NarI to generate pJM1350. A C-terminal umuC-mKate2 chimera was generated by
synthesizing a BamHI fragment containing the desired gene fusion and sub-cloned into the unique BamHI
site of pRW134 (34). One clone with umuC-mKate in the correct orientation was designated as pJM1334.
pJM1295, which expresses N-terminal His-tagged RumB_Y13A was generated by cloning a
synthesized XbaI-NcoI rumB fragment with the Y13A substitution (Genscript) into pHRB1 (35).

7.2.2

Quantitative spontaneous mutagenesis

E. coli cells were transformed with the one of the following plasmids and grown at 37°C overnight in
LB media containing spectinomycin: pGB2 (low-copy-number vector), or low-copy plasmids expressing pol
V (pRW134), pol V_Y11A steric gate mutant (pJM963), pol VICE391 (pRW320), or pol VICE391_Y13A steric
gate mutant (pJM1282). The following day, cells were isolated by centrifugation and resuspended in an equal
volume of SM buffer (31). To determine the number of spontaneously arising histidine revertant (His+)
mutants, (100 μl) cells were seeded upon Davis and Mingioli minimal agar plates (36) containing glucose
(0.4% wt/vol); agar (1.0% wt/vol); proline, threonine, valine, leucine and isoleucine (all at 100 μg/ml);
thiamine (0.25 μg/ml); and histidine (1 μg/ml). Spontaneously arising His+ mutants were counted after four
days growth at 37°C and are a direct measure of the spontaneous mutagenesis frequency since the number of
mutants that arise on each plate is dependent on the limiting amount of histidine present in the media,
independent of the number of cells seeded.

7.2.3

Western blotting to detect plasmid encoded UmuC and RumB proteins

Overnight cultures of RW584 harboring pRW134, pRW320, pJM1324, or pJM1334 were grown in LB
media containing 50 g/ml spectinomycin. The next day, the cultures were diluted 1:100 in fresh LB
containing spectinomycin and grown to mid-log (~OD 0.5) (~3 hrs). Whole cell extracts were made by
centrifuging 1.5 ml of culture and adding 90µl of sterile deionized water and 30 µl of NuPAGE LDS sample
buffer (4X) (Novex, Life Technologies) to the cell pellet. Cells were lysed by five cycles of freeze/thaw on
dry ice and in a 37°C water bath. Extracts were boiled for 5 minutes prior to loading. Samples were run on
NuPAGE 4-12% Bis-Tris gels (Novex Life Technologies) and transferred to Invitrolon PVDF (0.45 µm pore
size) membranes (Novex Life Technologies). Membranes were incubated with affinity purified polyclonal
rabbit anti-UmuC or rabbit anti-RumB antibodies (1:7,500 dilution) at room temperature overnight. Then the
membranes were incubated with goat anti-rabbit IgG (H+L) alkaline phosphatase conjugate (1:10,000
dilution) (BIO-RAD). Subsequently, the membranes were treated with the CDP-Star substrate (Tropix).
Membranes were then exposed to BioMax XAR film (Carestream) to visualize UmuC, or RumB protein
bands.

7.2.4

Expression and purification of pol VICE391_Y13A
Pol VICE391_Y13A was purified from RW644/ pARA1 /pJM1295 following the previously

published protocol for wild-type Pol VICE391 (35) as a custom service by scientists at Eurofins (Dundee,
United Kingdom).
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7.2.5

In vitro replication assays

Wild-type E.coli pol V (37), wild-type pol VICE391 (35), the steric gate variant pol VICE391_Y13A (this
manuscript), β-clamp, and γ-complex (37) were purified as previously described. All oligonucleotides
were synthesized by Lofstrand Laboratories (Gaithersburg, MD) and gel purified prior to use. The primer
used for the characterization of (mis)incorporation specificity of pol V variants has the following
sequences: 5A17M (5'-GAC AAA CAA CGC GAC A). The 5′-32P labeled primer was hybridized to
single stranded circular M13mp18 plasmid at a 1.5:1 molar ratio by heating the DNA mixtures in an
annealing buffer [50 mM Tris–HCl (pH 8), 50 µg/ml BSA, 1.42 mM 2-mercaptoethanol] for 10 min at
100°C followed by slow cooling to room temperature.
RecA (4 µM) (New England Biolabs, Ipswich, MA) was incubated with 0.25 µM 48-mer singlestranded oligonucleotide in the presence of 1 mM adenosine 5′[γ-thio]triphosphate (ATPγS, Biolog Life
Science Institute, Bremen, Germany) in the 1x reaction buffer [20 mM Tris-HCl pH 7.5, 8 mM MgCl2, 8
mM DTT, 80 µg/ml BSA, 4% glycerol] at 37°C for 5 min to form RecA nucleoprotein filament on
ssDNA (RecA*). Purified pol V polymerases (80 nM) were first combined with RecA* to form pol V
Mut complexes (37) and then added to the reaction mixture which had been pre-incubated for 3 min at
37°C. The reaction mixture contained 1 mM ATP, 50 µM dNTPs or rNTPs (added individually, or as a
mixtures), 2 nM primed ssDNA templates (expressed as primer termini), 100 nM (as tetramer) singlestranded binding protein (SSB, Epicentre Biotechnologies, Madison, WI, USA), 50 nM (as a dimer) βclamp and 5 nM γ-complex in the 1x reaction buffer. The reactions were incubated at 37°C for 0.5–
20 min, split into two and treated with either 0.3 M KCl, or 0.3 M KOH for 2 h at 55°C.
For processivity measurements, primer extension reactions were carried out essentially as described
above, except that the reaction mixtures contained primer-templates in sufficient excess (20-fold) over
polymerase and that RecA* was pre-formed on biotinylated 48-mer oligomers (UTTA: 5′-TCG ATA
CTG GTA CTA ATG ATT AAC GAC TTA AGC ACG TCC GTA CCA TCG-3′) linked to streptavidincoated agarose resin as previously described (38). Pol V Mut complexes were generated by incubation of
wild-type pol V and pol VICE391 with RecA* and isolated by centrifugation (37). As we have shown
previously (38), because pol V Mut deactivates after every round of primer extension and requires new
RecA* for reactivation, addition of a trap has no effect on pol V Mut and consequently, heparin was not
used in these experiments. In addition, less than 20% of the radiolabeled primer was utilized in the
reactions and therefore represents replication products generated from a single polymerase-primertemplate binding event (39).
All reactions were terminated by addition of an equal volume of loading buffer (97% formamide,
10 mM EDTA, 0.1% xylene cyanol, 0.1% bromophenol blue) and after heat-denaturation, the products
were immediately resolved by denaturing PAGE (8 M urea, 15% acrylamide), followed by visualization
using a Fuji image analyzer FLA-5100.
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7.2.6

Measurement of leading vs. lagging strand lacZ mutagenesis

Mutant frequencies were determined for 10-30 cultures for each strain (for 2 independent lacZ
integrants per orientation) inoculated in 2 ml LB containing 50 g/ml spectinomycin and grown with
agitation at 37°C. After overnight incubation the appropriate dilutions of the cultures were plated on
minimal-Lac plates to determine the number of Lac+ mutants and on minimal plates containing glucose to
determine the total cell count. Mutant frequencies were calculated by dividing the number of Lac+
mutants by the total number of cells. Table 3 presents the mean values of frequencies ± 95% confidence
intervals obtained from 3 independent experiments. The results for strains harboring control vector pGB2
were excluded from analyses due to negligible mutability in all tested genetic backgrounds.
Solid and liquid media were prepared as described in Fijalkowska and Schaaper (40), supplemented
with appropriate amino acids and antibiotics when required.

7.2.7

Fluorescence microscopy

Wide-field fluorescence imaging was conducted on an inverted microscope (IX-81, Olympus with a
1.49 NA 100x objective) in an epifluorescence configuration (9, 41). Continuous excitation is provided
using semidiode lasers (Sapphire LP, Coherent) at a wavelength of 514 nm (150 mW max. output) and
568 nm (200 mW max. output). Imaging of strains SSH118 and SSH119 were carried out on a Nikon Ti2E microscope. Excitation light was provided by the same setup as described above.

For all

measurements, the sample compartment and objective lens were heated to 37°C.
All mKate2 fusion proteins expressed from plasmids pJM1224, pJM1334, pJM1347, pJM1350
(Table 2), were imaged using yellow excitation light (λ = 568 nm) at 275 Wcm-2 (for colocalization
measurements, imaging of RumB mutants and molecules per cell measurements), collecting emitted light
between 610–680 nm (ET 645/75m filter, Chroma) on a 512 × 512 pixel EM-CCD camera (C9100-13,
Hamamatsu). For DnaX-YPet imaging, we used green excitation (λ = 514 nm) at 60 Wcm-2 (SSH038,
SSH040, SSH073, SSH074, SSH118, SSH119), collecting light emitted between 525–555 nm
(ET540/30m filter, Chroma). Burst acquisitions in undamaged recA730 cells movies of 300 frames, each
frame has 100 ms exposures followed by 50 ms dark time using 568 nm light) were collected to
characterize the effective binding lifetimes of UmuC-mKate2 (pJM1224) and mKate2-RumB (pJM1334)
as a function of foci number per cell.
Burst acquisitions (movies of 300 frames, each frame has 50ms exposures followed by 50ms dark
time using 568 nm light) were collected to characterize the motions of UmuC and RumB fused to mKate2
(including RumB mutants), and to determine the number of UmuC-mKate2 and mKate2-RumB
molecules per cell. Images of DnaX-YPet were recorded with 500 ms exposures, bright-field images
were recorded with 34ms exposures. All images were analyzed with ImageJ (42).
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7.2.8

Flow cell designs

All imaging experiments were carried out in home-built quartz-based flow cells (9). These flow cells
were assembled from a no. 1.5 coverslip (Marienfeld, REF 0102222), a quartz top piece (45x20x1 mm)
and PE-60 tubing (Instech Laboratories, Inc.). Prior to flow-cell assembly, coverslips were silanized with
aminopropyltriethoxy silane (Alfa Aesar). First, coverslips were sonicated for 30 min in a 5 M KOH
solution to clean and activate the surface. The cleaned coverslips were rinsed thoroughly with MilliQ
water and then treated with a 5% (v/v) solution of amino-propyl-triethoxysilane (APTES) in MilliQ water.
The coverslips were subsequently rinsed with ethanol and sonicated in ethanol for 20 s. Afterwards, the
coverslips were rinsed with MilliQ water and dried in a jet of N2. Silanized slides were stored under
vacuum prior to use.
To assemble each flow cell, polyethylene tubing (BTPE-60, Instech Laboratories, Inc.) was glued
(BONDiT B-482, Reltek LLC) into two holes that were drilled into a quartz piece. After the glue
solidified overnight, double-sided adhesive tape was adhered on two opposite sides of the quartz piece to
create a channel. Then, the quartz piece was affixed to an APTES-treated coverslip. The edges were
sealed with epoxy glue (5 Minute Epoxy, PARFIX). Each flow cell was stored in a desiccator under mild
vacuum while the glue dried. Typical channel dimensions were 45 mm × 5 mm × 0.1 mm (length × width
× height).

7.2.9

Imaging in flow cells

Cells were grown at 37ºC in EZ rich defined medium (Teknova) that contained 0.2% (wt/vol)
glucose. All strains were grown in the presence of spectinomycin (50 μg/ml). Cells were loaded into
flow cells, allowed a few minutes to associate with the APTES surface, then loosely associated cells were
removed by pulling through fresh medium that contained spectinomycin (50 μg/ml). Throughout the
experiment, medium was pulled through the flow cell using a syringe pump, at a rate of 50 μl/min.

7.2.10

Analysis of foci number per cell

Single cells were selected to obtain information about the number of UmuC and RumB foci present
in undamaged recA730 cells. MicrobeTracker 0.937 (43), a MATLAB script, was used to manually create
cell outlines as regions of interest (ROI). By manually outlining cells, we ensure accuracy and purely
select non-overlapping, in-focus cells for analysis. ImageJ 1.50i (42) was used to create average
projections of effective exposure times (0.1, 7.5, 15 and 45 s). A Peak Fitter plugin, as described
previously (9), was used to describe the position of each foci. The position of each defined foci was then
meshed with the previously defined cell ROIs to define the number of foci per cell.
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7.2.11

Analysis of UmuC and RumB copy numbers per cell

The number of UmuC-mKate2 and mKate2-RumB molecules and thus their concentration are
extracted from the integrated fluorescence signal under each cell outline during burst acquisition
experiments. Each cell exhibits an intensity decay which is comprised of mKate2 bleaching, cellular autofluorescence and background fluorescence. Exciting with a laser power of 275 Wcm-2, E. coli MG1655
cells, expressing no mKate2, exhibit no auto-fluorescence. The background fluorescence was negligible
(equivalent to <1 mKate2 molecule). The integrated fluorescence signal under each cell outline
corresponds to the fluorescence signal of intracellular mKate2 molecules.
Images were corrected for the electronic offset and flattened to correct for inhomogeneity of the
excitation beam (inhomogeneity was small at a laser power of 275 Wcm-2; the brightest part at the center
of the image was <10% more intense than at the corners). For each cell, the mean mKate2 signal per pixel
of the first frame from the time series experiments was extracted. The mean mKate2 signal multiplied by
the cell area gives the integrated mKate2 intensity, which was used to determine the number of mKate2
molecules per cell.
The mean intensity of individual mKate2 molecules was determined by analysing single-molecule
return events. For each cell, the number of UmuC-mKate2 and mKate2-RumB molecules was then
calculated by dividing the mean mKate2 signal of the first frame from the burst acquisition experiments
by the mean single-molecule intensity. The cellular concentration was calculated using the cell volume of
each cell, determined during cell outline assignation in MicrobeTracker (43).

7.2.12

Autocorrelation analysis

Intensity vs time trajectories for UmuC-mKate2 and mKate2-RumB were extracted from
fluorescence movies using ImageJ (42). Regions of interest were defined based on the positions of DnaXYPet foci. To capture and locally background correct mKate2 signals at these regions-of-interest, the
mean intensity within a 5x5 pixel selection box was measured, subtracting the signal from a two-pixel
ring placed around the box. This was repeated for each region-of-interest across each time-point of each
movie. The resulting intensity vs time trajectories, measured at each replisomal position, were imported
into MATLAB. The autocorrelation function of each trajectory was calculated using the xcorr routine.
The mean of these functions was determined for each set of data (UmuC-mKate2 or mKate2-RumB). In
parallel, a mean intensity trajectory was calculated for each data set, reflecting the photobleaching
kinetics. The autocorrelation function of this photobleaching curve was then calculated. To separate the
effects of photobleaching from other time-dependent signal fluctuations (protein dynamics), the mean
autocorrelation function for individual trajectories was divided by the autocorrelation function of the
photobleaching curve. To extract time constants from the signatures detected in the normalized
autocorrelation functions, the first 1 s of these signatures were fit with a single exponential decay
function.
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7.3

Results

7.3.1

pol V and pol VICE391 dependent spontaneous mutagenesis in dnaE+ and

dnaE915 strains
pol VICE391 is encoded by the rumAB genes, which were first cloned in 1993 from the IncJ plasmid,
R391 (28). Due to the fact that R391 spends much of its natural life cycle integrated into its host genome
(44), it has subsequently been renamed Integrating Conjugating Element 391 (ICE391). In its native ICE
environment, pol VICE391 promotes minimal levels of spontaneous SOS mutagenesis (45, 46). However,
when sub-cloned, pol VICE391 is a potent mutator that exhibits 3-5 fold higher levels of SOS-dependent
spontaneous mutagenesis compared to E. coli pol V (28, 30). The higher levels of mutagenesis could be
due to a variety of reasons, such as higher steady-state levels of pol VICE391 compared to E. coli pol V
within the cell, or reduced fidelity during replication of undamaged DNA. Another possibility that we
considered is that pol VICE391 might bind to undamaged DNA more efficiently than pol V, resulting in a
greater opportunity to compete with the cell’s replicase, pol III. To investigate this hypothesis further, we
compared the extent of pol V and pol VICE391-dependent mutagenesis in strains expressing a dnaE915
allele. dnaE915 (an A498T substitution in the -catalytic subunit of the pol III replicase) was first
characterized as a potential “antimutator” allele of dnaE (47). It was postulated that the dnaE915encoded mutant -catalytic subunit of pol III frequently dissociates from DNA allowing any 3ʹ-5ʹ
exonuclease, including the intrinsic proofreading domain of DNA polymerase II, to extrinsically
proofread mispaired bases at the abandoned 3′ primer terminus (48). However, the same strains become
“mutators” in the presence of SOS-induced error-prone pol V (49) which extends pol III terminal mispairs
and participates more efficiently in replication after pol III dissociation. Indeed, the level of pol Vdependent SOS mutagenesis increased roughly 3-fold between dnaE+ and dnaE915 strains (Fig. 1),
suggesting that pol V is not necessarily intrinsically less mutagenic than pol VICE391, but under
physiological conditions, it may have limited access to undamaged genomic DNA and/or does not
compete well with the wild-type -catalytic subunit of pol III. Conversely, there was no obvious
difference in the high levels of pol VICE391-dependent mutagenesis in dnaE+ and dnaE915 strains (Fig. 1),
supporting the idea that pol VICE391 may have better access to undamaged DNA and/or competes more
efficiently with the wild-type -catalytic subunit of pol III for access to the free 3′ primer termini, so as to
promote much higher levels of spontaneous SOS mutagenesis.
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Fig. 1. Comparison of pol V- and pol VICE391-dependent spontaneous mutagenesis in recA730
lexA51(Def) umuDC dnaE+ or dnaE915 strains. Strains were transformed with low copy plasmids
pGB2 (vector); pRW134 (umuDʹC); or pRW320 (rumAʹB). Cultures were grown overnight in LB plus
spectinomycin and processed as described in Materials and methods to measure reversion to histidine
prototrophy. The revertants were counted after incubation at 37ºC for 4 days. The data reported represent
the average number of His+ mutants per plate (with error bars indicating Standard Errors of the Mean
[SEM]). The numbers shown above the bars are the mean values calculated from the data obtained using
3 individual cultures per strain each plated on 5 plates, for a total of 15 plates per strain.

7.3.2

Fluorescent protein reporters and cellular concentrations

To test the hypothesis that pol VICE391 may have better access to undamaged DNA where it would
compete with the cell’s replisome, we used single-molecule time-lapse microscopy to directly visualize
fluorescently labelled pol V and pol VICE391 in live cells. We have previously used this technique to
visualize the localization of a chromosomally expressed UmuC-mKate2 fusion protein (9) and have now
extended these studies with plasmid encoded fluorescent constructs. So as to ensure the fusion constructs
were catalytically active, we first generated low-copy number plasmids expressing UmuD′ and mKate2
fused to either the N- or C- terminus of UmuC, along with analogous RumA′ and mKate2-RumB fusions.
These plasmids were introduced into E. coli RW584 (recA730 lexA51(Def) (umuDC)596::ermGT) and
the level of spontaneous mutagenesis assayed (Supplemental Fig. 1). Both N- and C- mKate2-RumB
fusions were highly proficient at promoting spontaneous mutagenesis. The N-terminal fusion construct,
pJM1324, promoted slightly higher levels of spontaneous mutagenesis than the untagged construct
(pRW320) and was accordingly chosen for further analysis. As expected, all pol V constructs gave much
lower levels of spontaneous mutagenesis than the pol VICE391 constructs. The highest level of mutagenesis
was observed when mKate2 was fused to the C-terminus of UmuC and as a consequence, pJM1334 was
used in the fluorescence assays.
Western blots using affinity purified anti-UmuC were initially used to compare steady-state levels of
the plasmid encoded untagged- and mKate2-tagged UmuC proteins (Supplemental Fig. 2). The level of
UmuC-mKate2 was ~20% of that observed for wild-type UmuC. These observations are consistent with
our earlier studies with chromosomally encoded umuC-mKate2, which also exhibited lower steady-state
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levels than wild-type UmuC protein (9). The lower level of mutagenesis promoted by plasmid encoded
UmuC-mKate2 compared to wild-type UmuC therefore equates to the lower steady-state levels of the
fusion protein compared to the wild-type UmuC protein, rather than a change in function of the fusion
protein compared to the wild-type protein.
Western blotting does not allow for ready comparison of steady-state UmuC-mKate2 and mKate2RumB concentrations. We therefore used single-molecule fluorescence microscopy to measure these
concentrations using an approach that has been described in detail previously (41). Briefly, the integrated
fluorescence intensity within each cell is measured within microscope images and normalized by the
mean intensity of a single molecule, which is extracted from photobleaching traces. We found that in
undamaged recA730 cells, steady-state levels of UmuC-mKate2 were ~3-fold higher than mKate2-RumB.
Specifically, cells that carried pJM1334 (UmuD′2 UmuC-mKate2) contained on average 315 ± 29
molecules of UmuC-mKate2 (STD = 296; n = 80 cells), whereas cells that carried pJM1324 (RumA′2
mKate2-RumB) contained 92 ± 11 molecules of mKate2-RumB (STD = 90; n = 65 cells). Taking account
cell volumes, which were measured from bright-field images, these values correspond to intracellular
concentrations of 40 ± 3 nM for mKate2-RumB and 101 ± 4 nM for UmuC-mKate2. Together, these
results indicate that in the recA730 background pol VICE391 supports higher levels of spontaneous
mutagenesis than pol V, despite its intracellular levels being lower than those of pol V. For the tagged
proteins, the intracellular concentration of mKate2-RumB (40 nM) is 2.5-fold lower than for UmuCmKate2 (101 nM).
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7.3.3 Number and longevity of UmuC and RumB foci in undamaged recA730 cells
As the intracellular concentrations did not explain the higher levels spontaneous mutagenesis
observed in pol VICE391-expressing cells, we next looked for evidence of increased polymerase activity. In
single-molecule fluorescence images, we would expect individual polymerase molecules to produce foci
as they bind to DNA. This phenomenon is well described and is commonly referred to as detection by
localization (50). As the polymerases bind to DNA, their diffusional motion becomes sufficiently slow
that they appear as static foci in images recorded on the millisecond timescale.

Fig.2. Effective exposure times and number of UmuC and RumB foci in undamaged recA730 cells.
A, Top panel: Focus longevity of UmuC-mKate2 foci. Bottom panel: Focus longevity of mKate2-RumB.
Scale bar 5 μm. Cells shown are representative of n>100 cells. B. Mean foci per cell over longer effective
exposure times. Over all projection lengths the mean number of mKate2-RumB foci per cell is similar to
the mean number UmuC-mKate2 foci per cell. n>100 cells. Error bars displayed indicate standard error of
the mean.
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To visualize fluorescently labelled pol V and pol VICE391, a bright field image was first acquired to
define the position of each recA730 ∆umuDC cell. Burst acquisition movies were then collected,
capturing fluorescence signals from UmuC-mKate2 or mKate2-RumB signals (300 cycles of 50 ms
exposure time followed by 50ms dark time, total length of movie = 30 s). For both UmuC-mKate2 and
mKate2-RumB, punctate foci were visible in most cells (Fig. 2). If foci appearing in our single-molecule
images correspond to DNA polymerases actively engaged in DNA synthesis, one would predict that
mutants that are defective for either DNA synthesis or impaired for substrate binding would fail to
produce foci. Indeed, a catalytically inactive mutant of RumB and a mutant of RumB that is defective for
binding to the -sliding clamp, each fused to mKate2 (pJM1347 and pJM1350, respectively) failed to
produce foci under conditions where the unaltered mKate2-RumB probe readily produced foci
(Supplemental Figure. 3). These observations support the notion that those foci seen in the recA730
∆umuDC cells represent catalytically functional pol V, or pol VICE391.
We next set out to quantify the number of UmuC-mKate2 and mKate2-RumB foci per cell as a
window into their polymerase activities. Visually comparing the UmuC-mKate2 and mKate2-RumB
movies, it appeared that mKate2-RumB foci were longer-lived than the UmuC-mKate2 foci. To gain
further insight into focus lifetimes, we quantified foci within average projections that captured different
lengths of time. We compared the number of foci that could be detected in the first frame of the movie
against projections of frames 1–3, 1–10, 1–50, 1–100, and 1–300 (Fig. 2A). This approach is equivalent
to comparing images with exposure times of 0.3, 1, 5, 10 and 30 s respectively. Short effective exposure
times capture both short- and long-lived foci, whereas longer effective exposure times capture long-lived
foci exclusively, with short-lived foci blurring into the background. We observed similar numbers of
UmuC-mKate2 and mKate2-RumB foci present in cells over all effective exposure times (Fig. 2B). For
both probes approximately 2.5 foci were detected per cell in images with an effective exposure time of
0.3 s, whereas approximately 0.5 foci per cell (i.e. one focus per two cells) were detected in images with
an effective exposure time of 30 s. It is important to note that this approach does not allow for precise
determination of focus lifetimes; detection of a focus in an average projection does not necessarily imply
that the focus was present for the entire duration of the projection. Nevertheless, the analysis suggests that
many UmuC-mKate2 and mKate2-RumB foci persist for at least a few seconds. The ratio of mKate2RumB foci to UmuC-mKate2 foci increases with exposure time, indicating that a higher proportion of
mKate2-RumB foci are longer-lived relative to the UmuC-mKate2 foci. The greater longevity of RumB
foci suggests that pol VICE391 may have more prolonged access to DNA than E. coli pol V in recA730
cells. Interestingly, these apparent differences in focus lifetimes were much more pronounced in UVirradiated recA+ cells (Supplemental Figure 4), with UmuC-mKate2 foci being rarely visible in
projections longer than 10 s, whereas mKate2-RumB foci could be detected in projections of up to 80 s.
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7.3.4

UmuC/RumB: replisome colocalization analysis in undamaged recA730 ∆umuDC

cells
Having ascertained that recA730 cells produce similar numbers of UmuC-mKate2 and mKate2-rumB
foci, and that mKate2-rumB foci appear to be somewhat longer lived, we next set out to determine where
the two polymerases localize within cells. Specifically, we wished to investigate whether pol V and pol
VICE391 differ in their colocalization with replication fork markers. To facilitate two-color imaging of pol
V and pol VICE391 and replisomes, the strains described above also expressed a yellow fluorescent protein
fusion of the pol III HE τ-subunit (encoded by dnaX). We have previously used the dnaX-YPet fusion to
indicate the position of replisomes in cells (9). The dnaX-YPet allele used here is fully functional and has
no impact on the growth of cells (51). When collecting the movies described in Fig. 2, we also collected
an image of the DnaX-YPet signals (500 ms exposure time) to indicate the position of replisomes.

Fig.3. Colocalization measurements of DnaX-YPet with UmuC-mKate2 or mKate2-RumB in a
∆umuDC recA730 strain. A, Left panel: Merged images of DnaX-YPet (green) and UmuC-mKate2
(magenta, foci bound for 1s). Right panel: Merged images of DnaX-YPet (green) and mKate2-RumB
(magenta, foci bound for 1s). Scale bar: 5 μm. B, Left panel: percentage of DnaX foci that contain an
UmuC (grey) or RumB focus (red) at effective exposure times of 0.1, 0.3, 1, 5, 10 and 30 s. Right panel:
percentage of UmuC (grey) or RumB foci (red), that overlap with DnaX foci at effective exposure times
of 0.1, 0.3, 1, 5, 10 and 30 s
We measured rates of colocalization between replisome markers and UmuC-mKate2/mKate2-RumB
foci as a function of effective exposure time. We determined the percentage of UmuC-mKate2 foci that
formed in the vicinity of replisome foci (within 218 nm (41)) and the percentage of replisome foci that
contained a UmuC-mKate2 focus. Colocalization between mKate2-RumB and replisomes was determined
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similarly. At the shortest exposure time of 0.1s, approximately 20% of UmuC-mKate2 foci we detected
were colocalized with replisomes (Fig. 3A), in agreement with our previous measurements for
chromosomally expressed UmuC-mKate2 in recA730 cells (9). For longer effective exposure times (0.3–
30 s), the colocalization of UmuC-mKate2 foci with replisomes increased slightly to ~30%, suggesting
that longer-lived foci were more likely to form close to replisomes. Similarly, for RumB foci the
colocalization increased from 25% for the shortest exposure time (0.1 s) to ~35% for longer exposure
times (0.3–30 s). Thus, UmuC-mKate2 and mKate2-RumB foci colocalized with replisomes to a similar
extent and exhibited similar behaviors as a function of exposure time.
The proportion of replisomes that contain a UmuC or RumB focus was also determined.
Approximately 16% of replisomes had a colocalized UmuC-mKate2 focus detected at the shortest
effective exposure time (Fig. 3B). Similar results were observed for mKate2-RumB. In both cases
increasing the effective exposure time led to a decrease in colocalization as fewer UmuC-mKate2 or
mKate2-RumB foci were detected. The increased colocalization of replisomes containing a UmuCmKate2 focus over a group size of 30 s may be due to spurious detection of background signals as foci as
a consequence of the higher steady-state levels of pol V present in the UmuC-mKate2 cells.
Overall, the results of the colocalization analysis suggest few differences between pol V and pol
VICE391 in recA730 cells. Interestingly, similar analysis carried out for UV-irradiated recA+ cells revealed
stark differences between pol V and pol VICE391, with the later forming much more long-lived foci in the
vicinity of replication forks (Supplemental Figure 4). Thus, while differences in replisome colocalization
and focus lifetimes can occur for pol V and pol VICE391, the two polymerases behave similarly in untreated
recA730 cells. It is therefore unlikely that the higher mutagenesis observed for pol VICE391 in recA730
cells (Fig. 1) arises as a result of increased access of pol VICE391 to replication forks.

7.3.5

Repetitive binding of pol V and pol VICE391 at replisomes

Thus far, the single-molecule analysis had revealed differences in pol V and pol VICE391 focus
lifetimes in UV-irradiated recA+ cells but produced few clues to explain the higher rates of mutagenesis
observed for pol VICE391 in untreated recA730 cells. We reasoned that pol VICE391 could potentially support
higher rates of mutagenesis if it simply had more robust polymerase activity than pol V once suitable
substrates became available. This would allow pol VICE391 to synthesize more DNA in total and therefore
produce a larger number of mutations. Pursuing this idea further, we closely examined fluctuations in
mKate2 fluorescence signals in regions corresponding to UmuC-mKate2 or mKate2-RumB foci. Rather
than selecting regions-of-interest based on the positions of UmuC-mKate2 or mKate2-RumB foci, we
monitored mKate2 signals close to replisomes, so as not to bias our results towards longer-lived (and thus
more readily detected) states. Within microscope movies, intensities within 5x5 pixel selection boxes
(large enough to capture a single focus) placed at replisomes were monitored as a function of time for
both UmuC-mKate2 or mKate2-RumB in recA730 cells.
Interestingly, the intensity versus time trajectories for both proteins exhibited significant evidence of
dynamics occurring on the milliseconds–seconds timescale (Supplemental Figure 5). As expected, all
trajectories showed evidence of overall signal loss as a result of photobleaching, which in these
measurements occurred with a time constant bleach = 1.3 s. More strikingly, the trajectories showed
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frequent transitions between high and low fluorescence states, indicative of the rapid formation and loss
of mKate2 foci and consistent with repeated cycles of binding and dissociation of UmuC-mKate2 and
mKate2-RumB at replisome positions. Interestingly, the duration of the high fluorescence states appeared
to be longer for mKate2-RumB than for UmuC-mKate2. To examine these time-dependent fluctuations
more systematically, we calculated autocorrelation functions for each trajectory, comparing the mean of
these functions for UmuC-mKate2 signals against mKate2-RumB signals. Repeated cycles of focus
formation and loss would be expected to produce a characteristic signature in the autocorrelation
functions with a lifetime that represents the combined durations of the on (high intensity, bound) and off
(low intensity, unbound) states. The photobleaching-corrected autocorrelation function of UmuC-mKate2
signals produced a relatively weak signature (peaks at a value of 0.96) with a time constant acf_UmuC =
0.05 s (Fig. 4). The equivalent autocorrelation function for mKate2-RumB signal produced a much
stronger signature (peaks at a value of 0.85) with a time constant acf_RumB = 0.35 s. The stronger signature
observed for mKate2-RumB suggests that it undergoes repeated cycles of binding and dissociation at
replisomes more often than UmuC-mKate2, which produces a weaker autocorrelation signature. The time
constants indicate that each time mKate2-RumB binds near a replisome, it remains bound approximately
seven-fold longer than UmuC-mKate2. This longer binding time may increase the likelihood that the
association of the polymerase with DNA substrates would be productive (i.e. leading to the incorporation
of nucleotides). Alternatively, longer binding could allow the polymerase to incorporate more nucleotides
per binding event (i.e. it would have higher processivity). As these events occur repetitively, this could
have a major impact on the total amount of DNA synthesized by the two enzymes and thus the number of
mutations they introduce.

Fig.4. Autocorrelation analysis of mKate2 signal fluctuations at replisomes. Photobleachingnormalized autocorrelation functions for UmuC-mKate2 (gray) and mKate2-RumB (red). Intensities of
mKate2 signals within movies were monitored at replisome positions (Supplemental Fig 5).
Autocorrelation functions were calculated for each of the resulting intensity vs time trajectories. For each
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data set the mean of these functions was divided by the autocorrelation function of the photobleaching
curve to separate the effects of photobleaching from the effects of protein dynamics. To determine the
characteristic timescale for signal fluctuations within each data set, the initial part of each autocorrelation
curve (first 1 s) was fit with an exponential decay function.

7.3.6

Processivity of wild-type pol V and pol VICE391 in vitro

We have previously characterized the biochemical properties of E. coli pol V and found that it shows
optimal activity in vitro in the presence of a RecA* filament where it forms a pol V Mut complex
(UmuD′2C–RecA–ATP). In the presence of the β/γ-complex and single-strand DNA-binding protein
(SSB) pol V Mut readily catalyzes DNA replication on circular DNA templates (37, 38, 52, 53).
To compare the processivity of wild-type pol V and pol VICE391 in vitro and ensure that reaction
products were generated from a single polymerase-binding event, we (i) used at least 20-fold excess of
primer-templates over polymerase and (ii) carried out reactions in the absence of additional RecA* (to
prevent pol V Mut re-activation). However, even at the lowest enzyme-to-substrate ratios, i.e., conditions
that prevent re-initiation of primer extension on previously used primer-templates, the termination
probabilities at most template positions changed depending on incubation time, and therefore, accurate
quantification of these values is not feasible. Nevertheless, we can conclude that like pol V, pol VICE391 is
moderately processive (Fig. 5), generating replication products of several hundred nucleotides in length
per single polymerase-binding event by ~3 minutes after the reaction was initiated. As seen in Fig. 5, both
pol V and pol VICE391 synthesized replication products with lengths gradually increasing over the 16minute incubation period, while the overall primer utilization remained constant at all time points. The
presence of strong pause sites along the DNA template, especially opposite the first ~30 bases and the
fact that the length of replication products increases over at least 16 minutes, indicate that both
polymerases, despite being moderately processive, are very slow. Indeed, we previously reported that the
velocity of pol V-catalyzed DNA synthesis was ~0.3–1 nucleotides per second (37). Under the same
experimental conditions, pol VICE391 appears to synthesize DNA with a faster velocity than pol V,
inserting ~1.75-2 nucleotides per second (Fig. 5). As a result, pol VICE391 synthesizes substantially longer
DNA products compared to pol V at the same time point. This is best seen at shorter incubation times
(Fig. 5). For example, 20 seconds after initiation of the reactions catalyzed by pol V and pol VICE391, the
primers were extended by up to ~14 and ~30 nucleotides, respectively.
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Fig. 5. Processivity and velocity of pol V and pol VICE391-catalyzed DNA synthesis. RecA was
incubated for 3 min at 37°C with biotinylated 48-mer single-stranded oligonucleotide linked to
streptavidin-coated agarose resin in the presence of ATPγS to generate RecA* (RecA nucleoprotein
filament). Purified wild-type pol V or pol VICE391 were combined with RecA* and the resulting pol V Mut
complexes were purified by centrifugation. 100 pM pol V Mut or pol VICE391 Mut were added to the
reaction mixtures containing 1 mM ATP, 50 µM dNTPs, 2 nM primed ssDNA templates, 100 nM SSB,
50 nM β-clamp and 5 nM γ-complex. Primer extensions were carried out at 37°C for 20s, 40s, 1, 2, 4, 8,
or 16 min and analyzed by PAGE. Position of the bands corresponding to the unextended primers (pr), or
primers elongated by 5-30 nucleotides, as well as the position of the wells are indicated on the left side of
the gel.

7.3.7

Comparison of wild-type pol VICE391 and pol VICE391_Y13A in vitro

Next, we compared the enzymatic properties of wild-type pol VICE391 to the steric gate variant, pol
VICE391_Y13A in vitro (Fig. 6). We have demonstrated previously that pol V exhibits an exceptional
ability to misincorporate ribonucleotides into DNA in vitro (24). Thus, we initially assumed that pol
VICE391 would discriminate against ribonucleotide incorporation as poorly as pol V. To test this
hypothesis, we compared primer extension reactions in the presence of dNTPs and rNTPs (Fig. 6A, lanes
1-15). Unexpectedly, the amount and size distribution of reaction products accumulated after incubation
with ATP alone, or after addition of all four NTPs, were almost identical (Fig. 6A, lanes 1-5 and 11-15).
The efficiency of nucleotide incorporation and rate of the reactions with rNTPs were much lower
compared to the reactions with dNTPs. For example, pol VICE391 which was able to incorporate as many
as 2 dNTPs every second, synthesized RNA with a rate of ∼18 rNTPs per min.
We therefore conclude that pol VICE391 has much more stringent sugar discrimination compared to pol
V. This hypothesis can be supported by the comparison of the products of primer elongation reactions
carried out in the presence of ribo- or deoxyribonucleotides with and without subsequent alkali treatment
under conditions that completely hydrolyze DNA chains at the positions of rNTP insertion (Fig. 6A, lanes

244

4 & 5, 9 & 10, and 14 & 15). Indeed, although the reactions were carried out in the presence of ATP in
10-fold excess, pol VICE391 preferred to incorporate dNTP, as judged by the negligible alkali sensitivity of
reaction products (Fig. 6A, lane 10). Furthermore, products of reactions with ATP alone, or a mixture of
four NTPs were only partially sensitive to alkali cleavage as judged by the presence of bands
corresponding to primers elongated by 2-5 nucleotides (Fig. 6A, lanes 5, 10, and 15). These data suggest
that wild-type pol VICE391 discriminates against nucleotides with the wrong sugar so effectively that it
prefers to incorporate dNTPs present in only miniscule amounts within the reactions (as a contaminant of
NTPs).

Fig. 6. Effect of a Y13A RumB substitution on the biochemical properties of pol VICE391. Primer
extensions catalyzed by purified wild-type pol VICE391 (A) and its Y13A steric gate variant (B) were
carried out for 20s, 1, 3, or 10 min (lanes 1–4, 6-9, 11-14 respectively) under optimal conditions.
Reactions incubated for 10 min were split into two and treated with either 0.3 M KCl (lanes 4, 9, and 14)
or 0.3 M KOH (lanes 5, 10, and 15) for 2 h at 55°C. All reactions contained 1 mM ATP and were
performed either in the absence of additional nucleotide (lanes 1-5, indicated as “A”) or in the presence of
100 µM mixture of four dNTPs (lanes 6-10) or rNTPs (lanes 11-15). Lane with reaction mixture lacking
polymerase is indicated by dash (–). Position of the bands corresponding to the unextended primers (pr)
or primers elongated by 5-40 nucleotides, as well as position of the wells are indicated on the right side of
the gel. (C). Specificity of nucleotide incorporation by wild-type pol VICE391 and steric gate mutant pol
VICE391_Y13A. All reactions contained 1 mM ATP. Lane with reaction lacking polymerase is indicated by
dash (-) and reactions with no additional nucleotide are indicated as “A*”. These reactions were
terminated immediately after combining all components. Reactions in the presence of 100 µM of each
nucleotide individually were carried out for 5 min. Identity of the nucleotide added to the reaction is
shown below each lane. The extended sequence of templates with 5 consecutive Ts adjacent to the 3'
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primer end, is indicated to the right of the gel panel. The results presented are representative of several
independent experiments.
We then determined the effect of the substitution of the steric gate residue on the in vitro properties
of pol VICE391. The wild-type and mutant polymerases had similar overall catalytic parameters of DNA
synthesis, i.e., the percent of extended primers reached comparable levels for both polymerases when
reactions were performed at equal enzyme/template ratios (Figs. 6A & 6B). However, pol VICE391_Y13A
also had a distinct pattern of size distribution of replication products, i.e. at several positions, reaction
products consisted of two bands with slightly different electrophoretic mobility (see for example doublet
bands opposite the template T at the position +5, Fig. 6B, lanes 6-9). This pattern suggests that pol
VICE391_Y13A catalyzes a significant degree of misincorporation opposite these sites.
As anticipated, the Y13A substitution compromised the sugar selectivity of the enzyme leading to a
dramatically enhanced ability to insert rNTPs (Fig. 6B). An estimate for the time-dependent product
accumulation revealed that pol VICE391_Y13A synthesized RNA with ~7 times faster rates relative to the
wild-type enzyme. This is best illustrated by comparison of the products of the reactions terminated
immediately after combining all ingredients (Fig. 6C, lanes labeled as “A*”). pol VICE391_Y13A promptly
inserted as many as 7 AMPs, while the wild-type polymerase barely elongated primers by one
ribonucleotide. DNA replication by pol VICE391_Y13A using different nucleotide substrates (NTPs and
dNTPs) was not identical. For example, we detected several transient pauses specific for RNA synthesis
(such as seen at positions 8 and 10). However, the velocities of DNA and RNA synthesis by pol
VICE391_Y13A, length distribution of reaction products, and the maximum size of synthesized DNA and
RNA were similar. In reactions where dNTPs competed with ATP present at 10-fold excess, pol
VICE391_Y13A exclusively incorporated ATPs, at least opposite the first T (the first available template
base). As seen in Fig. 6B, all reaction products were digested by alkali hydrolysis independently of
nucleotide substrate used (lanes 5, 10, and 15).
The fidelity of the wild-type and steric gate mutant pol VICE391 were compared in reactions containing
each nucleotide individually (Fig. 6C). These assays suggest that both enzymes are highly error-prone and
are capable of incorporating multiple wrong dNTPs. The main difference is seen in reactions performed
in the presence of a single dNTP. In contrast to the wild type enzyme, pol VICE391_Y13A preferentially
selects the correctly-paired ribonucleotide (ATP) rather than incorporating the correct, or incorrect dNTP.
Thus, when a single dNTP was added to the reaction mixture containing pol VICE391_Y13A, ATP and
DNA template with five consecutive Ts adjacent to the 3' primer terminus, primers were extended by
incorporation of at least five sequential ATPs (Fig. 6C, note similar pattern of product distribution
opposite the first five template bases in all reactions with pol VICE391_Y13A).
We conclude that the major difference between wild-type pol VICE391, and the pol VICE391_Y13A
mutant is the ability of the steric gate mutant to readily incorporate polyribonucleotides into DNA.
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7.3.8

pol VICE391 _Y13A-dependent spontaneous mutagenesis

To investigate ribonucleotide incorporation by pol VICE391 _Y13A in E. coli, we measured
spontaneous His+ mutagenesis in a recA730 lexA(Def) ∆dinB ∆umuDC strain. Although recA730 is
thought to be in a constitutively activated state (RecA730*), this activity can be up- or down- regulated,
depending upon the genetic background of the strain (54) which leads to different levels of pol Vdependent spontaneous mutagenesis (26).

The highest level of pol V-dependent mutagenesis was

observed in a ΔrnhA strain, which we attribute to a stronger RecA730* activating signal in this
background, due to impaired replication in the absence of RNase HI, which is a pre-requisite for SOS
induction. Wild-type pol VICE391 exhibited high levels of spontaneous mutagenesis in all strain
backgrounds. There was also an indication of the ΔrnhA-associated mutagenesis increase, but due to the
high (>3000) number of mutants per plate, accurate quantification was unachievable (Table 3, line 3).
As observed previously with the E. coli pol V_Y11A mutant (26), the pol VICE391_Y13A mutant
exhibited a significant (~100-fold) reduction in spontaneous mutagenesis compared to wild-type pol
VICE391 (Table 3, line 1). This phenotype is attributed to efficient RER targeted to misincorporated
ribonucleotides, but also concomitant removal of misincorporated deoxyribonucleotides, so as to lower
the overall level of spontaneous mutagenesis. In E. coli cells lacking RNase HII (∆rnhB), pol
VICE391_Y13A His+ mutagenesis was restored from less than 1% to ~10% of wild-type pol VICE391 levels
(Table 3, line 2). Inactivation of RNase HI, or NER alone, had minimal effect on the level of mutagenesis
promoted by pol VICE391_Y13A, which is in agreement with a lead role for RNase HII in RER (Table 3,
line 2). A concomitant RNase HII-NER deficiency (∆rnhB ∆uvrA) restored spontaneous mutagenesis to
~17% of wild-type pol VICE391 (Table 3, line 4), suggesting that NER provides compensatory RER
functions when RNase HII is overwhelmed, or inactivated (26). These findings therefore support the idea
that errant ribonucleotides misincorporated by pol VICE391_Y13A stimulate RER mechanisms that also
result in the removal of misincorporated deoxyribonucleotides.
Intriguingly, spontaneous mutagenesis promoted by pol VICE391_Y13A was not restored to the same
extent as that observed for pol V_Y11A in the ∆rnhB or ∆rnhB ∆uvrA strains (~10% versus 31%, and
~17% versus 62%, respectively) (Table 3). We interpret these observations to indicate that RER pathways
remain active, despite the loss of RNase HII and NER functions. Our previous studies with pol V_Y11A
suggest that RNase HI plays a back-up role in RER in E. coli, but given that pol VICE391_Y13A has greater
access to DNA than pol V (Figs. 1-4) and is also more likely to misincorporate consecutive
ribonucleotides (Fig. 6), we suggest the back-up role of RNase HI is much more critical under these
circumstances.
We were unable to stably introduce the pol VICE391_Y13A plasmid, pJM1282, into ∆rnhB ∆rnhA, or
∆rnhB ∆rnhA ∆uvrA strains when grown at either 30°C or 37°C. In these instances, the transformation
efficiency of pJM1282 was ~1/200 of that of pRW320 (wild-type pol VICE391) and resulted in only a
handful of transformants. These transformants exhibited very slow growth and differing colony
morphology. Furthermore, restriction digests of pJM1282 purified from the ∆rnhB ∆rnhA, or ∆rnhB
∆rnhA ∆uvrA strains did not match that of the parental pRW320 (Supplemental Fig. 2), suggesting
increased plasmid instability under these conditions. No such instability was observed when the pol
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V_Y11A steric gate mutant was introduced into the ∆rnhB ∆rnhA ∆uvrA strain. The pJM1282 plasmid
instability observed in the ∆rnhB ∆rnhA, or ∆rnhB ∆rnhA ∆uvrA strains is therefore directly attributed to
the enhanced ability of pol VICE391_Y13A to incorporate (poly)ribonucleotides into the E.coli genome.

7.3.9

Leading vs lagging strand mutagenesis

To test the efficiency of RER pathways on both DNA strands in strains expressing pol VICE391_Y13A,
we employed a genetic system that allows us to determine the leading- and lagging- DNA strand
replication fidelity (33). The system is based on the measurement of mutagenesis in the lacZ reporter gene
which is integrated into the bacterial chromosome in one of two orientations with respect to the origin of
replication. The target sequence is replicated as a leading strand in one orientation and as a lagging strand
in the other orientation. The differences in mutant frequencies between the two orientations reflect the
replication fidelity of the leading and lagging DNA strand. We assayed a lacZ allele that reverts via an
A·T→T·A transversion (32), as such substitutions are the predominating pol V-dependent mutagenic
events observed in a recA730 lexA(Def) background (55, 56).
As shown in Table 4, expression of the wild-type pol VICE391 from a low-copy-number plasmid in the
recA730 lexA(Def) background resulted in a much stronger mutator effect on the lagging-strand (591.2 x
108) than on the leading- strand (28.9 x 108). While this observation is consistent with previously
published data for wild-type pol V in a recA730 background (11), we note that the level of mutagenesis
on the lagging strand in the presence of pol VICE391 is approximately 10-fold higher than that observed
with pol V (unpublished observations) which again emphasizes the enhanced capacity of pol VICE391 to
promote SOS-dependent mutagenesis compared to pol V. In contrast, mutagenesis in the presence of the
pol VICE391_Y13A mutant was notably reduced on both DNA strands, down to 3% of that observed for the
wild-type on the leading- and to 0.1% on the lagging-strand. As previously proposed for the pol V_Y11A
steric gate mutant (25, 26), the reduction in mutagenesis is consistent with ribonucleotide-induced RER
that removes misincorporated ribonucleotides, but also deoxyribonucleotides in their vicinity. The
analysis of pol VICE391_Y13A –dependent mutagenesis levels in strains deficient in RNase HII and/or
NER support this hypothesis. Importantly, a significant increase in mutagenesis was observed in strains
lacking RNase HII (ΔrnhB), which is in agreement with the primary role of RNase HII-mediated RER
(26). The lack of RNase HII in strains expressing pol VICE391_Y13A significantly increases the relative
mutagenesis compared to wild-type pol VICE391 on the leading strand (up to 50% of that observed for the
wild-type pol VICE391). The relative amount of pol VICE391_Y13A mutagenesis is also increased on the
lagging strand, but only to ~1% of that of the wild-type pol VICE391. These data suggest that RNase HII
plays a major role in RER on the leading strand, whereas pol VICE391_Y13A –dependent mutagenesis on
the lagging strand is kept to a minimum by other ribonucleotide-directed repair pathways (e.g. NER, and
RNase HI). Interestingly, upon inactivation of both RNase HII-dependent RER and NER, the amount of
relative mutagenesis is increased to 79% on the leading- but only to 4% on the lagging- strand, suggesting
that RER is still very efficient on the lagging strand, even in the absence of RNase HII and NER. We
hypothesize that this is most likely due to efficient RNase HI-dependent RER that mistakes the
polyribonucleotide tracts generated by pol VICE391_Y13A as primers for Okazaki fragment synthesis
generated during normal genome duplication.
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7.4

Discussion
pol VICE391 is a pol V ortholog, which when sub-cloned from its native ICE391 environment, becomes a

very potent, highly mutagenic DNA polymerase (29, 30). The molecular basis for the enhanced activity
leading to 3-5 fold higher levels of SOS-dependent mutagenesis compared to E. coli pol V has been of great
interest to us for over two decades (29). Since E. coli pol V activity is kept to a minimum though a plethora of
regulatory steps (7), it is easy to envisage that pol VICE391 activity could be enhanced by its differential
regulation compared to E. coli pol V at any of these stages. Indeed, we have recently shown that in addition to
LexA-controlled transcriptional regulation, pol VICE391 is subject to transcriptional control by the ICE391encoded SetR protein (57).
Here, we show that the enhanced mutagenesis is likely due to two factors; 1) in vitro, pol VICE391
replicates DNA ~2 to 6-fold faster than E. coli pol V (Fig. 6); 2) both pol V and pol VICE391 bind repetitively to
specific sites on the nucleoid, but with each cycle pol VICE391 resides on the DNA for significantly longer than
pol V (Fig. 4). Based upon these observations, low-fidelity pol VICE391 would be expected to duplicate
significantly more of the E. coli genome, which helps explain why pol VICE391 promotes higher levels of
mutagenesis than E. coli pol V, despite exhibiting a similar fidelity of DNA synthesis in vitro. However, we
cannot exclude the possibility of yet-to-be discovered differences in E. coli pol V and pol VICE391 activity that
may also contribute to the enhanced SOS-dependent mutator activity in vivo.
We have previously used a steric gate mutant of pol V to investigate the molecular mechanisms of RER
in E. coli (25, 26). We suggested that the primary line of defense against ribonucleotides that have been
incorporated by steric gate polymerase mutants is RNase HII-mediated RER, with back-up roles provided by
RNase HI and NER proteins. Based upon the fact that we restored the level of spontaneous mutagenesis
promoted by the pol V_Y11A mutant to that promoted by wild-type pol V, we assumed that we had identified
the major participants involved in RER in E. coli (26). We were therefore interested in determining if similar
phenotypes might be observed with a steric gate variant of pol VICE391, which as noted above, has greater
longevity in replication foci than pol V, and would therefore be expected to dramatically increase the number
of errantly misincorporated ribonucleotides into the E. coli genome.
Similar to our earlier studies with E. coli pol V and a steric gate pol V_Y11A mutant (26), our in vitro
assays indicate that both pol VICE391 and pol VICE391_Y13A exhibit low fidelity DNA synthesis (Fig. 6) and
both would be expected to promote high levels of spontaneous mutagenesis in a recA730 lexA(Def) strain if
RER-functions were inactivated. Lower levels of pol VICE391_Y13A-dependent mutagenesis are therefore
indicative of active RER which, during RER-patch re-synthesis, can replace incorrect deoxyribonucleotides
located in the vicinity of a target ribonucleotide. Our studies using strains with deletions in rnhB, rnhA and
uvrA alone, confirm that the principal pathway involved in the repair of misincorporated ribonucleotides is
RNase HII-mediated RER, since there was an increase in pol VICE391_Y13A dependent mutagenesis in the
rnhB strain, but not the rnhA or uvrA strains (Table 3). However, the level of restoration (10% of that
seen with wild-type pol VICE391) was significantly lower than observed with pol V and its steric gate mutant
(Table 3). Further differences were observed in the rnhB uvrA strain, where pol VICE391_Y13A mutagenesis
was just 17% of the wild-type pol VICE391 compared to 62% for pol V_Y11A vs. wild-type pol V (Table 3),
suggesting efficient RER, even in the absence of RNase HII, or NER proteins. The most likely candidate
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expected to compensate for the loss of RNase HII-dependent RER is rnhA encoded- RNase HI, since rnhB
strains expressing pol VICE391_Y13A and lacking rnhA-encoded RNase HI exhibit increased genomic/plasmid
instability (Supplemental Fig. 2). This is in contrast to pol V_Y11A strains that show no-such instability even
in the absence of RNase HII, RNase HI and NER proteins (26). We therefore conclude that under
circumstances where there is a significant increase in misincorporated ribonucleotides into the E.coli genome
and the compromise of primary RNase HII-mediated RER pathway, RNase HI may play an essential role in
protecting E. coli from the genomic instability caused by errant misincorporation of ribonucleotides. We have
tacitly assumed that it reflects a simple threshold for the level of misincorporated ribonucleotides in its
genome, but we cannot formally exclude the possibility that it is also the type of ribonucleotide (mono- vs.
poly-), or the location (such as better access to the lagging strand, or at alternate origins) that leads to a greater
dependency on RNase HI for genome stability in the absence of RNase HII.
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7.5

Tables and legends

Table 1. E. coli strains used in this study
Strain

Relevant Genotype

Source or Reference

MG1655

F- λ- rph-

E. coli Genetic Stock

JJC5945

F- λ- rph- dnaX-YPet::kan

Benedict Michel, (58)

BW72761

Hfr(PO2A) leu-63::Tn10 fhuA22 Δ(argF-lac)169

E. coli Genetic Stock

Center

Center
ompF627 relA1 spoT1

RW82

(umuDC)595::cat

(59)

RW880

F- λ- rph- (umuDC)595::cat

MG1655 x P1.RW82

SSH037

F- λ- rph- dnaX-YPet::kan (umuDC)595::cat

JJC5945 x P1.RW880

SSH073

as SSH037, but harboring pJM1337

This work

SSH074

as SSH037, but harboring pJM1350

This work

EAW287

F- λ- rph- recA730 sulA-

(9)

SSH116

F- λ- rph- recA730 sulA- dnaX-YPet

EAW287 x P1.AR164
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SSH117

F- λ- rph- recA730 sulA- dnaX-YPet (umuDC)595::cat

SSH116 x P1.RW880

SSH118

as SSH117, but harboring pJM1324

This work

SSH119

as SSH117, but harboring pJM1334

This work

RW584a

recA730 lexA51(Def) (umuDC)596::ermGT

(60)

RW1448b,c

recA730 lexA51(Def) (umuDC)596::ermGT

RW698 x BW7261

dinB61::ble

NR9566

dnaE915 yafC502::Tn10

Roel Schaaper, (61)

RW1560b

recA730 lexA51(Def) (umuDC)596::ermGT

RW1448 x P1.NR9566

dinB61::ble dnaE915 yafC502::Tn10

RW698a

recA730 lexA51(Def) (umuDC)596::ermGT

(25)

dinB61::ble

RW838a

recA730 lexA51(Def) (umuDC)596::ermGT

(25)

dinB61::ble ∆rnhB782::Kan

RW902a

recA730 lexA51(Def) (umuDC)596::ermGT
dinB61::ble ∆uvrA753::Kan
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(25)

RW1044a

recA730 lexA51(Def) (umuDC)596::ermGT

(25)

dinB61::ble rnhA319::cat

RW1092a

recA730 lexA51(Def) (umuDC)596:: ermGT

(25)

dinB61::ble ∆rnhB782 rnhA319::cat

RW990a

recA730 lexA51(Def) (umuDC)596::ermGT

(26)

dinB61::ble ∆rnhB782 ∆uvrA753::Kan

RW1190a

recA730 lexA51(Def) (umuDC)596::ermGT

(26)

dinB61::ble ∆rnhB782 rnhA319::cat ∆uvrA753::Kan

RW1450b,c

recA730 lexA51(Def) (umuDC)596::ermGT

RW838 x BW7261

dinB61::ble ∆rnhB782::Kan

EC9998b,c

recA730 lexA51(Def) (umuDC)596::ermGT

RW902 x BW7261

dinB61::ble ∆uvrA753::Kan

RW1510b,c

recA730 lexA51(Def) (umuDC)596::ermGT

RW990 x BW7261

dinB61::ble ∆rnhB782 ∆uvrA753::Kan

a

: Full genotype: thr-1 araD139 (gpt-proA)62 lacY1 tsx-33 glnV44 galK2 hisG4 rpsL31 xyl-5 mtl-1

argE3 thi-1 sulA211 lexA51(Def) recA730 ∆(umuDC)596::ermGT ∆dinB61::ble
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: As “a”, but gpt+ proA+ Δ(argF-lac)169

b

c

: For the lacZ reversion assay, the above strainsb were used to construct pairs of lacZ derivatives, as described in

(33). These strains carry a chromosomal copy of the lacZ missense allele from strain CC105 (32), in one of the two
orientations, with respect to the origin of replication (Left or Right).
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Table 2. E. coli plasmids used in this study

Plasmid
pGB2

Relevant Characteristics
Low-copy-number, SpcR vector

Source or Reference
(62)

pRW134

pGB2, umuD′C

(34)

pJM963

pGB2, umuD′C_Y11A [steric gate mutant]

(63)

pRW320

pGB2, rumA′B

(34)

pJM1282

pGB2, rumA′B_Y13A [steric gate mutant]

This work

pJM1324

pGB2, rumA′ mKate2-rumB

This work

pJM1334

pGB2, umuD′ umuC-mKate2

This work

pJM1347

pGB2, rumA′ mKate2-rumB_D103A-E104A

This work

[catalytically dead]

pJM1350

pGB2, rumA′ mKate2-rumB_ Q358A-L361A-F364A

This work

[-clamp mutant]

pARA1

High copy, AmpR, RumA′ expressed from the Ara promoter

(35)

pHRB1

pGB2, KanR, low expression of His-Tagged RumB

(35)

pJM1295

pHRB1, but expressing His-Tagged RumB_Y13A

This work
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Table 3. Spontaneous mutagenesis promoted by wild type and steric gate variants of pol V and pol
VICE391 in E. coli recA730 lexA(Def) ΔdinB ΔumuDC strains

pGB2

wt

3.2 ± 0.2

1

rnhB

2

rnhA

3

uvrA

4

5

Wild-type

Status of rNMP
repair genes

rnhB uvrA

a

SGa % of WT

polymerase

Steric Gate
polymerase

pol V

691 ± 9

73 ± 5

11

pol VICE391

>3000

27 ± 3

<1

pol V

671 ± 12

207 ± 4

31

pol VICE391

>3000

338 ± 6

~10

pol V

~3000

127 ± 3

~4

pol VICE391

≫3000

14 ± 1

<0.5

pol V

439 ± 2

65 ± 1

15

pol VICE391

>3000

44 ± 1

~1.5

pol V

382 ± 14

236 ± 15

62

pol VICE391

>3000

503 ± 67

~17

pol V homologs

2.8 ± 0.6

2.7 ± 0.3

2.9 ± 0.6

2.9 ± 0.4

: SG: Steric gate mutant polymerase
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Table 4. Leading- and lagging- strand mutagenesis promoted by wild type and steric gate
variant of pol VICE391 determined by assaying lacZ reversion via an A·T→T·A
transversion

Status of rNMP
repair genes

Strand

Frequency per108 cells

SG % of
WT

WT pol

SG pol

leading

28.9 ± 3.9

0.8 ± 0.3

3%

2

lagging

591.2 ± 58.4

0.3 ± 0.1

0.1%

3

leading

34.2 ± 5.8

17.2 ± 2.5

50%

lagging

575.1 ± 55.3

4.8 ± 0.9

0.8%

leading

22.4 ± 2.6

1.3 ± 0.3

6%

lagging

607.6 ± 86.7

2.0 ± 0.6

0.3%

1
wt

rnhB

4

5

uvrA

6

7

rnhB

leading

25.2 ± 3.4

19.9 ± 2.8

79%

8

uvrA

lagging

435.1 ± 56.4

17.4 ± 2.4

4%
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7.6

Supplementary Figures and Legends

Supplemental Figure 1A: Spontaneous mutagenesis promoted by wild-type pol V and N- or C- terminal
mKate2 fusion proteins. pGB2: Vector pRW134: Wild-type pol V (UmuD' - UmuC) pJM1337: UmuD' mKate2-UmuC pJM1334: UmuD' - UmuC-mKate2 Colonies growing on the plate are His+ revertants
and reflect the extent of spontaneous mutagenesis in the various strains.
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Supplemental Figure 1B: Spontaneous mutagenesis promoted by wild-type pol VICE391 and N- or Cterminal mKate2 fusion proteins. pGB2: Vector pRW320: Wild-type pol VICE391 (RumA' - RumB)
pJM1324: RumA' - mKate2-RumB pJM1325: RumA' - RumB-mKate2 Colonies growing on the plate are
His+ revertants and reflect the extent of spontaneous mutagenesis in the various strains.
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Supplemental Figure 2: Plasmid DNAs isolated from RW1190 (ΔrnhB ΔrnhA ΔuvrA). Lanes designated
λ and 100 indicate lambda DNA BstEII digested marker and 100 bp marker (New England Biolabs).
Plasmids pRW320 (wild-type RumA’-RumB) or pJM1282 (RumA’-RumB Y13A steric gate) were
freshly transformed into RW1190 (ΔrnhB ΔrnhA ΔuvrA) and one-day old transformant colonies were
inoculated into liquid LB and grown overnight. Miniprep DNA was prepared using the QIAprep Spin
Miniprep Kit (Qiagen). Miniprep DNA was digested with the HindIII restriction enzyme (New England
Biolabs) for an hour and subsequently electrophoresed on a 0.9% agarose gel. Lanes designated DH
indicate stock midi-prep plasmid DNAs (HiSpeed Plasmid Midi Kit, Qiagen) isolated from DH5a which
were also digested with HindIII. These stock plasmid DNAs were used for the transformations into
RW1190. HindIII digest of intact plasmid pRW320, or pJM1282, should result in two DNA bands of
~4.4 kb and ~1.5 kb. None of the HindIII digests of the RW1190/pRW320 miniprep DNAs show any
rearrangements. In contrast, all of the miniprep DNAs from RW1190/pJM1282 transformants showed
various drastic rearrangements or deletions leading to the inactivation of the Pol VICE391_Y13A steric
gate DNA polymerase.
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Supplemental Figure 3. Western blot of wild-type UmuC and UmuC-mKate2 expressed in RW584
(recA730 lexA(Def) ΔumuDC). pGB2: low copy vector. pRW134: wild-type UmuD'C expressed in
pGB2. pJM1334: UmuD'-UmuC-mKate2 expressed in pGB2.
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Supplemental Figure 4. Images of mKate2-RumB and catalytically inactive- or -binding site variants in
ΔumuDC recA+ at 60-90 min after 10 J/m2 UV light. A, Upper panels: Average projection over 5 s for
mKate2-RumB and its catalytically dead and - binding site mutant from left to right. Bottom panels:
Average projection over 50 s for mKate2- RumB and its catalytically dead and -binding site mutant
from left to right. Scale bar: 5 µm. B, Merged images of DnaX-YPet (green) and mKate2-RumB and
mutants (magenta, foci bound for 5 s). Scale bar: 5 µm.
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Supplemental Figure 5. Colocalization measurements of DnaX-YPet with UmuC-mKate2 or mKate2RumB in a DumuDC recA strain 60-90 min after 10 J/m UV light. A, Left panel: Merged images of
DnaX-YPet (green) and UmuC-mKate2 (magenta, foci bound for 30s). Right panel: Merged images of
DnaX-YPet (green) and mKate2-RumB (magenta, foci bound for 30s). Scale bar: 5 µm. B, Left panel:
Percentage of DnaX foci that contain a UmuC (grey), RumB focus (yellow) at different effective
exposure times of 10, 30, 50 and 80s. Right panel: Percentage of UmuC (grey) or RumB foci (yellow),
that overlap with DnaX foci at different effective exposure times of 10, 30, 50 and 80s.
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Supplemental Figure 6. Example intensity versus time trajectories for UmuC-mKate2 and mKate2-RumB
signals at replisomal positions. Regions-of interest placed at DnaX-YPet markers were used to monitor
fluctuations in UmuC- mKate2 and mKate2-RumB signals within fluorescence movies. Trajectories were
locally background corrected to minimize the contributions of signals arising from molecules that were
not bound in the vicinity of replisomes.
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8 Concluding remarks
8.1 The regulation of the DNA damage response
According to the conventional model, the SOS response is triggered by RecA* filaments that
form on single-stranded DNA gaps (ssDNA) and/or double-strand breaks (DSBs) (1–3). The RecA*
filaments facilitate the cleavage of the SOS repressor LexA (3). Consequently, proteins are expressed that
are involved in DNA repair and damage tolerance pathways, such as the error-prone DNA polymerases
IV and V (pols IV and V) (4,5). In the early stages of the SOS response, RecA and SulA (an inhibitor of
cell division) are strongly upregulated (6). 50 min after DNA damage induction, pol IV is expressed at
higher levels (Chapter 3). In the later stages of the SOS response (90 min), cells begin to produce more
pol V (7). These results indicate several control mechanisms for the SOS regulon and match with
previous findings. For instance, pol V expression underlies a strong LexA repressor box and is thus
expressed late in the SOS response (8,9). The study described in Chapter 4 however questions the
conventional model of the SOS response. Following thymine starvation, DSBs are the major trigger for
SOS induction, whereas single-stranded gaps only have a minor contribution.
8.1.1 Is double-strand break resection the key step for SOS induction?
During thymine starvation, ssDNA regions are converted to DSBs by reactive oxygen species or
ROS (Figure 8.1 A, (10)). Trimethoprim starves cells from thymine by inhibiting dihydrofolate reductase,
a pre-cursor in the synthesis of thymine (11–13). Under oxidising conditions, trimethoprim treatment
causes the formation of DSBs, triggering the SOS response (Figure 8.1 A, Chapter 4). SOS induction is
however blocked under radical-scavenging conditions (< 1% of SOS induction levels), even though
persistent ssDNA regions are generated (Figure 8.1 A). Consistent with the levels of SOS induction,
trimethoprim treatment under oxidising conditions triggered pol IV upregulation, whereas, the addition of
a ROS scavenger fully repressed pol IV expression (Chapter 4). Pol V activation however differed from
the results described for SOS induction and pol IV upregulation (Chapter 4). After trimethoprim treatment
under oxidising conditions, pol V is only slightly upregulated and localises to the cell membrane, thus
suggesting that pol V is not converted into its mutagenic active form, pol V Mut. In agreement, low levels
of UmuD and UmuDʹ are observed when treating with trimethoprim (Chapter 4). These observations
reveal that ROS-induced DSBs trigger pol IV upregulation but not pol V upregulation/activation
following trimethoprim treatment.
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Figure 8.1. Treatment with trimethoprim and ciprofloxacin induces DSBs under oxidised
conditions, triggering the SOS response. (A) Trimethoprim treatment depletes the nucleotide pool,
starving cells from thymine (12). Ultimately, single-stranded regions are accumulated due to inhibition of
replication (10). These ssDNA regions however only marginally trigger SOS induction (Chapter 4); pols
IV and V are not upregulated. Under oxidised conditions, ssDNA are converted into DSBs, starting the
SOS response. SOS induction can be blocked using ROS scavengers. (B) Following ciprofloxacin
treatment, stabilised ciprofloxacin-gyrase-DNA complexes are formed. These stabilised complexes
contain broken DNA and form at and away from replisomes (cartoon does not illustrate DSB formation
away from replisomes). Cleavage of ciprofloxacin-enzyme-DNA complexes generates DSBs which
induce the SOS response. In addition, ciprofloxacin treatment leads to the accumulation of ROS which
also induce DSBs, potentiating SOS induction.
Ciprofloxacin, an antibiotic of the quinolone class, inhibits DNA gyrase (Figure 8.1 B) as well as
Topoisomerase IV. These complexes contain broken DNA (14). When DNA is cleaved from these
ciprofloxacin-enzyme-DNA complexes, lethal DSBs are generated (Figure 8.1B, (14)). A recent study
revealed that gyrase foci form in the vicinity of replisomes with ~10 enzymes per focus (15). The vast
majority of gyrase foci are however bound elsewhere on the DNA, indicating that DSBs are formed at
and away from replisomes. It has been proposed that lethality may underlie gyrase inhibition and/or
endonuclease activity (14). In addition, killing by ciprofloxacin is potentiated by the accumulation of
reactive oxygen species (ROS), inducing DNA damage such as DSBs (Figure 8.1 B, (16)). During
ciprofloxacin treatment, the SOS response is induced following DSB processing (Chapter 4). Cells then
express pols IV and V at higher levels. In cells lacking recB, double-strand break resection is blocked as
well as SOS induction. recB mutants however still exhibited very low levels of SOS induction (< 1%)
which could be caused due to the formation ssDNA regions or RecJ activity at DSBs (2). During
ciprofloxacin treatment, the addition of a reactive oxygen species scavenger largely reduced SOS
induction by ~50%, suggestive of ROS generating DSBs. The addition of the ROS scavenger also
reduced the expression levels of each pols IV and V by ~50%. Independent of ROS levels, pol V is
released from the membrane and binds to DNA from 90 min after ciprofloxacin treatment (Chapter 4).
Consequently, ciprofloxacin-induced DSBs and ROS-induced DSBs during ciprofloxacin treatment cause
an increase in the expression level of pols IV and V.
Interestingly, during ciprofloxacin treatment, ROS induce non-replisomal binding sites for pol
IV, consistent with the production non-replisomal DSB. This observation raises many questions. How do
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ROS create non-replisomal binding sites for pol IV? Do ROS contribute to the cleavage of ciprofloxacinenzyme-DNA complexes, generating DSBs? Are DSBs processed differently when formed in the vicinity
of replisomes or away from replisomes, implying differences in toxicity?
Under the conditions described in this thesis, ciprofloxacin-induced DSBs cause pol V
activation, whereas following trimethoprim treatment, ROS-induced DSBs do not trigger pol V
activation. The difference in the cellular response to ciprofloxacin and trimethoprim treatment might be
due to the severity of DNA damage cells are experiencing. Ciprofloxacin immobilises gyrase on the DNA
at and away from replisomes (15), causing fragmentation of the entire bacterial chromosome. Starvation
from thymine however destroys the replication origin, leading to local fragmentation of the chromosome
(17). These results bring forward that further studies are necessary to fully understand the regulation of
the SOS response and its major triggers, such as RecA loading on ssDNA gaps or DSBs (18–20). Initial
data were recorded to understand the involvement of the recombination mediators RecF and RecO in
forming RecA* structures after UV irradiation (Chapter 6.7).
8.1.2 Molecular dynamics during homology search
Largely fragmented chromosomes (i.e. after ciprofloxacin treatment) and local fragmentation
(i.e. after trimethoprim treatment) show a difference in pol V activation, and thus, in the DNA damage
response. This suggests that the DNA damage caused by trimethoprim might be not as severe as the DNA
damage induced by ciprofloxacin. These variations might stem from the molecular dynamics of the
players involved (i.e. DNA substrates). Three main factors might influence the cellular response:
1. Local fragmentation might be repaired faster than largely fragmented chromosomes. To repair
largely fragmented and locally fragmented chromosomes, fragments must encounter its DNA partner for
homology pairing. Due to cells containing many recombinant DNA fragments, DNA strands will anneal
and peel off until finding the correct DNA sequence. The rate of homology search depends on the number
of DNA sequences; more DNA substrates imply a longer homology search. A heavily fragmented
chromosome produces many different DNA sequences as the chromosome is non-specifically broken into
DNA fragments. Local fragmentation at the origin is however specific, generating DNA fragments from a
smaller pool of DNA sequences. This implies that DNA repair of largely fragmented chromosomes will
take longer than DNA repair of locally fragmented chromosomes. In multichromosomal cells, resected
DSBs could undergo intra- and interchromosomal recombination, adding a different layer of complexity.
2. Scaffolding proteins might also change the molecular dynamics during homology search. It
has been shown that the chromosome gets compacted directly after UV exposure (21). DNA compaction
depends on the recombination mediator proteins RecA, RecO, RecR and RecN, suggesting that
recombination might compact the nucleoid. In the later stages of the UV-induced DNA damage response,
the chromosome relaxes and appears fragmented independently of recombination mediator proteins (21),
probably implying DSB formation. Similarly, following ciprofloxacin treatment, the chromosome appears
relaxed and fragmented (data not shown), presumably impeding recombinant search. Locally fragmented
chromosomes might still have a partially intact DNA scaffold, like a compacted nucleoid structure,
possibly allowing a faster homology search.

272

3. RecA* polymers are loaded on the 3ʹ overhang of DSBs, displacing the single-stranded
binding protein SSB (22). The lengths of these RecA* polymers could also play into molecular dynamics.
RecA* filaments grow directionally, extending the single-stranded DNA. In a cell with a largely
fragmented chromosome, one would imagine that many RecA* bundles are formed, probably imposing
steric hindrance and hampering homology search.
Beyond these three main factors, unknown interactions between other DNA damage response
proteins, which wait to be discovered, are also likely to play into the dynamics of the DNA damage
response.
8.2 Regulation of DNA polymerase IV
8.2.1 Pol IV has a role in double-strand break repair
In 1999, Escherichia coli was found to encode DNA polymerase IV (pol IV), promoting
mutagenesis when overexpressed (4). Biochemical experiments demonstrated that pol IV can bypass
various lesions (23-26). In vivo, pol IV was found to be involved in tolerating N2-guanine adducts (27,
28). Similar to the replicative DNA polymerase, processivity of pol IV is increased in the presence of the
β sliding clamp (29). Binding to the β sliding clamp allows pol IV to exchange for the replicative DNA
polymerase within the replisome in vitro (30, 31). In addition, the pol IV-β interaction supports
mutagenesis in vivo (32). Taking together these observations, pol IV has been described to carry out
translesion synthesis (TLS) at the replication fork.
Based on these biochemistry and genetics data, it was however not possible to visualize the main
binding sites of pol IV in living cells. Employing single-molecule live-cell imaging, the study described
in Chapter 2, 4 and 5 demonstrated that only 10% of pol IV binding events happen at replisomes for
different DNA damaging agents. This observation suggested that restart of stalled replisomes might thus
be a minor activity of pol IV. Nonetheless, it is unclear if each pol IV binding event represents DNA
synthesis.
Besides TLS, pol IV has also been demonstrated to participate in homologous recombination
reactions. Work from the Rosenberg and Foster lab showed that pol IV is involved in mutagenic doublestrand break repair (DSBR), under the control of the transcriptional activator RpoS (33-37). Additionally,
the O’Donnell and Goodman labs demonstrated that pol IV is significantly more error-prone at
recombination intermediates, called D-loops (38, 39). In agreement with pol IV working in DSBR, the
study described in Chapter 4 (Figure 8.2) demonstrated that double-strand break (DSB) resection is
crucial for the DNA binding activity of pol IV. To facilitate DSBR, DSBs are resected and RecA is
loaded onto the single-stranded DNA (ssDNA) region, forming a RecA* nucleoprotein filament.
Consistent with pol IV having a major role in DSBR, Chapter 5 describes that RecA* recruits pol IV to
DNA (Figure 8.2). Replisomal pol IV foci might also form at RecA* structures, consistent with RecA*
structures forming frequently at replisomes (40). In summary, this thesis supports the notion that pol IV
may be a recombination protein.
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Figure 8.2. Pol IV primarily works in homologous recombination. Single-stranded DNA can be
converted to DSBs by ROS. Following DSBs resection, RecA* structures are stabilised on the ssDNA
overhang. Pol IV is recruited to DNA by RecA* structures.
Interestingly, preliminary data indicate that pol IV and the recombination mediator protein RecO
do not share binding sites (percentage of colocalisation is below chance; data not shown). This initial
finding leads to a fundamental question: Under the conditions presented here, is RecO and/or RecBCD
involved in forming the RecA* filaments that recruit pol IV to the nucleoid? If RecO is involved in RecA
loading, pol IV would bind at RecA* structures after RecO has dissociated. Beyond this, the role of pol
IV with respect to antibiotics with different mechanisms has to be investigate in the future to paint a full
picture of pol IV in living cells. Additionally, the role of pol IV in transcription-coupled repair needs to
be further investigated (41).
8.2.2 UmuD and UmuDʹ regulate pol IV DNA binding activity
UmuD2 and UmuD′2 physically interact with pol IV, modulating its mutagenic activity (Figure
8.3 A, (42)). Pol IV by itself introduces -1 frameshifts (42). In the presence of UmuD, pol IV operates
error-free, whereas, UmuDʹ reduces -1 frameshift mutations introduced by pol IV (42). The study in
Chapter 5 describes uncleavable UmuDK97A increasing the binding lifetime of pol IV and the number of
binding events (pol IV foci per cell) compared to the umuD deletion background (Figure 8.3 B). In
contrast, UmuD′ reduces the binding lifetime of pol IV compared to the umuD deletion background
(Figure 8.3 B). Notably, UmuDK97A and UmuD′ were expressed from a plasmid at levels 4-5 times
higher than chromosomal expression levels.

Figure 8.3. UmuD is a biochemical switch for pol IV binding and regulates the mutagenic activity of
pol IV. (A) Pol IV works mostly error-free in the presence of UmuD (42). In the presence of UmuDʹ, -1
frameshift mutations introduced by pol IV are however increased. Curiously, UmuDʹ has an inhibitory
effect on the generation of -1 frameshifts. (B) UmuD promotes long-lived pol IV binding events at the
nucleoid (Chapter 5). UmuDʹ however strongly reduces pol IV binding time. In the absence of UmuD and
UmuDʹ, pol IV foci are longer lived than in the presence of UmuDʹ but shorter lived than in the presence
of UmuD.

274

The fact that UmuD variants differentially affect pol IV lifetimes could also be a result of the
interaction of the pol IV-UmuD complexes with RecA*. It has been reported that pol IV, UmuD2 and
RecA as well as pol IV, UmuDʹ2 and RecA form ternary complexes (42). Thus, differences in the binding
times of pol IV could also reflect the binding times of UmuD variants in complex with pol IV. Long-lived
pol IV foci in the presence of uncleavable UmuDK97A could originate from binding events of pol IVUmuDK97A complexes to RecA*. Thereby, uncleavable UmuDK97A (complexed with pol IV) could be
trapped at RecA* structures, captured in a state in which UmuD would usually catalyse its cleavage.
Short-lived pol IV foci in the presence of UmuDʹ could reflect the activity of a pol IV-UmuDʹ2 (pol IVUmuDʹ2-RecA respectively) which might unproductively bind to DNA or induce -1 frameshifts. This
complex might also have an error-free mode, consistent with UmuD′ reducing pol IV-dependent mutation
rates (42). The complex containing UmuDʹ2 is reminiscent of pol V Mut (UmuDʹ2C-RecA-ATP, (43)).
The function of such ternary complexes of pol IV are however unknown and only speculative.
Additionally, these observations might point towards a mechanism where UmuD or UmuDʹ enable or
block access of pol IV to the replisome must be further tested in the future.
Beyond this, alternative explanations for UmuD or UmuDʹ enabling or blocking pol IV access to
the replisome might be competition between, for instance, pol IV and UmuDʹ for binding partners or the
possibility that UmuD might allow pol IV to bind to certain binding sites which it cannot in the absence
of UmuD. The latter might be reflected in UmuD increasing the binding time of pol IV, allowing pol IV
to be recruited to certain binding sites, which might not necessarily reflect active DNA synthesis.
8.2.3 The recombination mediator protein RecF excludes pol IV from replisomes
In vitro, pol IV is capable of translesion synthesis at stalled replisomes, synthesising a DNA
patch over a lesion. In vivo however, (Chapter 2), pol IV rarely binds at replisomes. Initial findings
suggest that the recombination mediator RecF excludes pol IV from replisomes (Chapter 4.8, Figure 6).
Three points support this hypothesis: 1. At 30 min after DNA damage induction, colocalisation of RecF
with replisomes is increased (Chapter 6), while the colocalisation of pol IV with replisomes is decreased
(Chapter 4). 2. In cells lacking recF, the decrease in pol IV-replisome colocalisation is not observed
(Chapter 4.8). 3. Pol IV-RecF colocalisation is below chance colocalisation (data not shown), showing
that RecF and pol IV do not share binding sites.
RecF processes stalled replisomes after UV exposure, restarting replication (44). Following
repriming, this restart process might generate a gap left behind the replisome (post-replicative gap, Figure
8.4). Restart in this way might be valuable when replisomes encounter DNA lesions; RecF might be
involved in lesion skipping, creating post-replicative gaps that contain a lesion (Figure 8.4). Four
observations agree with RecF working in replisomes, especially after UV damage: 1. RecF is involved in
replication restart after UV irradiation (45). 2. Following DNA damage induction, RecF-replisome
colocalisation is increased (Chapter 6). 3. Impaired replication permits increased RecF binding at
replisomes. In cells expressing a mutant of the replicative helicase DnaB (dnaB8[Ts]), RecF-replisome
colocalisation is enhanced in the absence of DNA damage (Chapter 6). This DnaB mutant has impaired
ATPase activity at its permissive temperature, consistent with replication inhibition (46), where RecF foci
depend on active DNA replication.
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Figure 8.4. RecF processes stalled replisomes, creating post-replicative gaps. RecF frequently binds
at replisomes. Following DNA damage (t = 30 min), RecF block pol IV from binding at replisomes.
Thereby, RecF might allow repriming, generating a post-replicative gap.
These observations raise many questions. 1. What is the molecular basis of RecF inhibiting pol
IV binding to the replisome? 2. Which substrate does RecF block from pol IV binding? Is RecF involved
in producing a binding substrate for pol IV? Alternatively, does RecF generate binding sites for pol IV
elsewhere on the chromosome? 3. Does a recR deletion also result in increased pol IV-replisome
colocalisation compared to wild-type cells? RecR has been shown to increase the DNA binding activity of
RecF (47). 4. Does the deletion of recO change the percentage of pol IV-replisome colocalisation? RecO
might be involved in loading the RecA* filaments which recruit pol IV to DNA at and away from
replisomes (40). If the deletion of recO does not affect pol IV-replisome colocalisation, RecBCD might
be the primary factor for RecA* loading under the conditions described here. 4. Do recF, recR and recO
deletions affect the activity of DNA polymerase II (pol II) at or away from replisomes? 5. Do recF, recR
and recO deletions affect the activation of the highly mutagenic DNA polymerase V (pol V) and its
binding activity at or away from replisomes? To form active pol V Mut, pol V has to form a complex with
a RecA monomer from the 3ʹ end of a RecA* filament (48). In recombination deficient strains, RecA
loading is impaired which presumably impedes the activation of pol V. In recombination deficient strains
a change in pol V-replisome colocalisation might be observed. This would reveal that non-replisomal pol
V foci are due to pol V activation at RecA* filaments (7). Curiously, and similar to pol IV, initial findings
indicate that pol V does not share binding sites with RecO or RecF (data not shown).
8.3 Do reactive oxygen species contribute to resistance development?
Many antibiotics lead to the accumulation of reactive oxygen species (38). For instance, βlactams (cell wall synthesis inhibitor) and quinolones (DNA gyrase and Topoisomerase IV inhibitors)
potentiate ROS accumulation in bacteria (16,50). Even though β-lactams and quinolones have different
bacterial targets, both treatments alter the bacterial metabolism, accumulating ROS. Consequently, ROS
damage DNA, contributing to bacterial death. The phenomenon in which different antibiotic classes
trigger ROS-induced damage contributing to cell death has been described as the common killing
mechanism (49).
During quinolone treatment, ROS accumulation follows SOS induction using subinhibitory
concentration of ciprofloxacin (Chapter 4, (51,52)). Furthermore, ROS potentiates SOS induction levels
(Chapter 4, (51)). For instance, ROS-induced damage upregulates pol IV (Chapter 4). Beyond this, ROS
create binding sites for pol IV. Since pol IV binding to the nucleoid is dependent on DSB resection (RecB
activity, Chapter 4), pol IV may thus work at ROS-induced DSBs. Previous studies revealed that DSBs
are mutagenic hotspots for pol IV activity and other error-prone polymerases (33–39), indicating that
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ROS-induced DSBs might contribute to the mutagenicity of pol IV. This leads to the question if ROS
accumulation is in favour of bacterial killing or if ROS-induced DSBs contribute to the emergence of
resistant bacteria. The answer might however lie in between.
ROS also oxidise the nucleotide pool, creating chemically altered nucleotides (42). To counter
nucleotide pool oxidation, cells express proteins that cleanse the nucleotide pool from chemically altered
nucleotides (i.e. Escherichia coli MutT, (53,54)), thus preventing altered nucleotides being incorporated
by error-prone polymerases. Pol IV, for instance, has been shown to incorporate oxidised guanines (8oxo-dGs), generating a DNA lesion (53). It is however unknown in which context pol IV incorporates 8oxo-dG. Since DSB resection is essential for pol IV DNA binding activity, oxidised guanines might be
incorporated during DSBR or mutagenic DSBR respectively. Furthermore, incorporation of 8-oxo-dG
might be mutagenic because it can base-pair with adenine and cytosine (53). In contrast to E. coli pol IV,
its human homolog pol κ (55–57) preferentially pairs 8-oxo-dG with adenine (58). Additionally, pol κ
reduces inflammation-induced mutagenesis in mice (59). These observations indicate that the human
polymerase pol κ might differ from E. coli pol IV in its mutagenicity. Future studies are likely to shed
light on the activity differences of pol κ and pol IV.
8.5 Perspectives
The studies described throughout this thesis emphasise the complexity of the DNA damage
response. Within the DNA damage response, multiple proteins may compete for the same substrate (i.e.
RecF and pol IV, Chapter 4.8). Some proteins might stimulate the activity of another protein (i.e. UmuD
and pol IV, Chapter 5). Some proteins show differences in mutagenicity even though they are close
homologs (i.e. pol V Mut and pol VICE Mut, Chapter 7).
Using single-molecule microscopy, the complex interplay of proteins within the DNA damage
response can be monitored in live cells. With the introduction of single-molecule live-cell imaging in
recent years, it is possible to monitor the behaviour of proteins in live cells. In combination with mutants
that alter the protein’s behaviour, the protein’s role within cells can be functionally dissected. Besides
mutants, different DNA damaging sources can also give clues about the protein’s role with in the DNA
damage response. Furthermore, when studying proteins of the same pathway, it can be determined if these
proteins collectively or sequentially perform their function. For instance, in the case of the RecFOR
pathway, RecF, RecO and RecR were described to form an active RecFOR complex. Chapter 6 however
shows that RecF and RecO have distinct binding sites in cells and thus presumably different functions
within the recombination pathway.
In the future, new single-molecule in vivo assays are likely to give further insights into the
complexity of the DNA damage response. For instance, the introduction of protein-based in vivo DNA
‘road-blocks’ (dCas9, (60)) could be used to explore replisome dynamics when encountering a protein
DNA complex (i.e. transcription-coupled repair). Beyond this, DNA polymerases could be studied by
using fluorescent nucleotides, enabling a scientist to watch a polymerase as it synthesises DNA (Figure
8.5). This could be further used to develop a FRET-based assay that detect incorporation GA opposite of
TT by pol V, giving insights into its mutagenic behaviour in vivo. However, to understand mechanisms in
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detail, it is important to combine single-molecule assays with biochemical assays and structural studies,
employing for instance cryogenic electron microscopy.

Figure 8.5. Cells contain tetramethylrhodamine-dUTP foci. Prior to imaging cells were grown in the
presence of tetramethylrhodamine-dUTP and the detergent F68 Poloxamer (61). Using an exposure time
of 500 ms, some foci locate to the nucleoid region, whereas other foci from at the membrane. Image is
discoidal filtered. Scale bar: 5 μm.
Breaking down the complexity of the DNA damage response could uncover important
mechanisms underlying the emergence of antibiotic resistance mutations. Understanding these
mechanisms may allow the design of new drugs that are less likely to be overcome by bacteria.
Furthermore, the DNA repair and damage tolerance mechanisms found in simple bacterial organisms
might also translate to higher organism (i.e. S. cerevisiae and humans), having implications for the field
of cancer research.
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